data_5nce_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5nce _Structure_validation_residue.Date_analyzed 2017-06-02 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.43 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 60.9 mtt85 . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 120.877 0.37 . . . . 0.0 111.797 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 67.6 mtm -101.76 106.73 17.77 Favored 'General case' 0 CA--C 1.482 -1.649 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.6 m -85.02 114.31 22.08 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.049 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.525 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.4 ttpt -94.04 110.22 21.93 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.3 m -110.06 131.78 21.8 Favored Pre-proline 0 C--N 1.29 -2.003 0 C-N-CA 124.383 1.073 . . . . 0.0 110.156 -176.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -65.97 125.78 14.76 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.813 1.675 . . . . 0.0 112.16 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.6 p -59.42 138.37 57.68 Favored 'General case' 0 C--O 1.274 2.362 0 O-C-N 123.965 0.791 . . . . 0.0 111.584 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.6 -37.7 5.21 Favored Glycine 0 N--CA 1.421 -2.317 0 O-C-N 123.667 0.605 . . . . 0.0 113.545 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.481 ' HZ1' ' HG3' ' A' ' 27' ' ' GLU . 22.9 pttm . . . . . 0 N--CA 1.414 -2.26 0 C-N-CA 117.98 -1.488 . . . . 0.0 112.791 -174.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 N--CA 1.438 -1.037 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 8.7 t -86.49 71.84 10.37 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 176.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.1 m -76.9 -45.34 31.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.631 -0.668 . . . . 0.0 110.912 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -103.71 144.85 30.91 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 58.3 m-80 -73.23 -27.3 61.52 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 120.717 0.294 . . . . 0.0 111.13 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.1 m -60.2 -38.27 82.79 Favored 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 124.083 0.953 . . . . 0.0 112.494 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.478 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.1 p-10 -68.93 -42.46 76.74 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 121.391 -0.818 . . . . 0.0 110.197 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.564 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 16.9 t -59.2 -46.43 88.46 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 22.9 tttp -53.41 -54.85 30.86 Favored 'General case' 0 N--CA 1.394 -3.262 0 CA-C-N 112.453 -2.158 . . . . 0.0 108.878 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -62.36 -40.36 96.15 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 123.736 0.647 . . . . 0.0 111.96 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 19' ' ' ASN . 59.4 t -67.56 -41.07 85.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.267 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.5 m -67.17 -39.63 86.47 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 120.813 0.34 . . . . 0.0 110.714 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 61.4 mtp180 -64.03 -30.52 71.59 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-O 120.916 0.389 . . . . 0.0 110.888 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.4 p -82.45 -31.81 29.25 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.481 ' HG3' ' HZ1' ' A' ' 9' ' ' LYS . 51.5 mt-10 -66.51 -35.01 79.19 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.804 173.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.14 37.35 0.35 Allowed Glycine 0 C--N 1.316 -0.583 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.748 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.6 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 93.3 m-85 -126.19 147.11 58.39 Favored Pre-proline 0 N--CA 1.432 -1.372 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -62.52 -32.32 80.07 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 122.445 2.097 . . . . 0.0 112.427 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.464 HG22 ' HB2' ' A' ' 46' ' ' TYR . 7.2 t -159.97 170.83 20.51 Favored 'General case' 0 N--CA 1.42 -1.93 0 O-C-N 122.069 -0.395 . . . . 0.0 110.033 -176.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.73 154.27 25.73 Favored Glycine 0 N--CA 1.413 -2.89 0 N-CA-C 107.399 -2.281 . . . . 0.0 107.399 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.501 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 52.1 m -156.66 158.64 37.35 Favored 'General case' 0 C--N 1.281 -2.403 0 C-N-CA 123.868 0.867 . . . . 0.0 110.263 -176.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.5 m -91.91 150.18 21.17 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.216 0.532 . . . . 0.0 111.613 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.467 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 12.4 t70 -141.11 159.42 42.26 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.486 -178.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.35 105.98 9.88 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -140.04 7.07 2.22 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 m -148.31 160.96 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.56 0 CA-C-N 114.357 -1.292 . . . . 0.0 107.513 -175.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.58 84.37 0.43 Allowed 'General case' 0 C--N 1.32 -0.698 0 O-C-N 124.282 0.989 . . . . 0.0 109.699 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 148.19 -144.91 12.91 Favored Glycine 0 N--CA 1.404 -3.48 0 N-CA-C 108.708 -1.757 . . . . 0.0 108.708 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -129.08 124.92 36.05 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.8 tptt -111.3 128.29 55.9 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 121.346 0.593 . . . . 0.0 110.322 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 30.3 t -77.72 135.79 38.08 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.389 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 40.5 m-85 -130.72 146.72 52.26 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.498 0.666 . . . . 0.0 110.012 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.461 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 40.4 m -101.9 138.33 39.01 Favored 'General case' 0 C--N 1.253 -3.615 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.339 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.501 ' CE1' ' HB2' ' A' ' 33' ' ' SER . 33.9 m-85 -111.84 135.9 51.84 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.706 -178.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -146.94 142.37 17.01 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.951 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.29 118.32 5.47 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.472 2.115 . . . . 0.0 112.211 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 75.3 m -111.23 163.94 16.16 Favored Pre-proline 0 C--N 1.273 -2.718 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.43 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 26.5 Cg_exo . . . . . 0 C--O 1.261 1.641 0 C-N-CA 121.684 1.589 . . . . 0.0 110.163 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 50' ' ' PRO . 61.9 mtt85 . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 120.946 0.403 . . . . 0.0 111.812 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.1 mtt -105.85 109.36 21.29 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 46' ' ' TYR . 10.5 m -87.14 121.37 29.51 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.155 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.544 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 38.3 ttpt -98.96 110.56 23.15 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.2 m -113.16 132.3 22.47 Favored Pre-proline 0 C--N 1.3 -1.584 0 C-N-CA 124.293 1.037 . . . . 0.0 110.707 -176.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.71 132.24 30.11 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.459 2.106 . . . . 0.0 113.78 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.7 p -71.21 147.13 48.57 Favored 'General case' 0 C--O 1.267 1.983 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.591 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.74 -45.74 2.05 Favored Glycine 0 C--O 1.263 1.952 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.951 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.586 ' HD3' ' CD ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER . . . . . 0 CA--C 1.471 -2.081 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.62 -174.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 N--CA 1.445 -0.697 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 8.5 t -87.98 72.4 9.27 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.545 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 22.8 m -69.14 -45.45 79.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.388 173.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -115.81 151.74 34.65 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.969 0.414 . . . . 0.0 109.973 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.498 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 93.2 m-20 -73.11 -31.07 64.1 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -176.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.0 m -59.15 -37.85 78.3 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.452 ' O ' HG22 ' A' ' 23' ' ' VAL . 1.2 p-10 -68.85 -43.4 75.53 Favored 'General case' 0 CA--C 1.499 -0.989 0 O-C-N 121.55 -0.719 . . . . 0.0 109.868 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.541 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 17.8 t -61.52 -44.41 97.11 Favored 'General case' 0 CA--C 1.471 -2.087 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 22.3 tttp -54.74 -55.12 33.33 Favored 'General case' 0 N--CA 1.393 -3.277 0 CA-C-N 112.688 -2.051 . . . . 0.0 108.735 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -60.28 -45.11 94.48 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 123.916 0.76 . . . . 0.0 111.384 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 19' ' ' ASN . 85.4 t -62.48 -44.74 99.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.62 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.4 m -66.89 -34.6 78.15 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 122.806 0.442 . . . . 0.0 111.863 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 50.0 mtp180 -69.2 -27.21 65.29 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.162 0.506 . . . . 0.0 109.83 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.417 ' C ' ' HZ1' ' A' ' 9' ' ' LYS . 25.9 m -82.51 -27.68 31.58 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.735 175.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.586 ' CD ' ' HD3' ' A' ' 9' ' ' LYS . 8.7 mm-40 -67.06 -46.74 73.41 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 121.741 -0.599 . . . . 0.0 110.401 171.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 134.9 39.65 0.17 Allowed Glycine 0 C--N 1.311 -0.825 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.489 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 95.3 m-85 -127.11 148.01 64.12 Favored Pre-proline 0 N--CA 1.434 -1.239 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -61.39 -33.05 89.48 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.511 2.141 . . . . 0.0 112.363 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.457 HG21 ' HB2' ' A' ' 46' ' ' TYR . 7.6 t -159.35 170.52 21.63 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.038 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.6 153.66 25.48 Favored Glycine 0 N--CA 1.409 -3.146 0 N-CA-C 107.37 -2.292 . . . . 0.0 107.37 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.553 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 39.4 m -156.78 158.71 37.33 Favored 'General case' 0 C--N 1.279 -2.473 0 C-N-CA 124.014 0.926 . . . . 0.0 110.095 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 44.2 m -91.0 156.74 17.72 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.3 0.571 . . . . 0.0 112.331 -170.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.442 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 22.9 t70 -148.36 152.45 37.07 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.03 -177.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.66 107.77 14.1 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -141.19 7.48 2.0 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 m -149.59 160.6 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.506 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.217 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.68 84.2 0.45 Allowed 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 124.289 0.993 . . . . 0.0 109.094 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.71 -145.72 13.75 Favored Glycine 0 N--CA 1.403 -3.523 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.545 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 32.5 mtp85 -140.1 117.61 11.48 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 117.568 0.684 . . . . 0.0 109.938 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -102.74 136.45 42.56 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-O 121.33 0.586 . . . . 0.0 110.735 -172.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.4 t -87.51 135.78 33.21 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.184 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.544 ' CD1' ' HG2' ' A' ' 4' ' ' LYS . 40.1 m-85 -129.9 146.34 51.61 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-O 121.718 0.771 . . . . 0.0 110.482 175.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.489 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 35.4 m -97.61 136.92 37.3 Favored 'General case' 0 C--N 1.252 -3.645 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.056 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.553 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 25.8 m-85 -111.54 136.11 51.18 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.913 -177.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -146.73 144.02 19.66 Favored Pre-proline 0 C--N 1.295 -1.774 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.705 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.08 120.56 6.67 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.372 2.048 . . . . 0.0 112.566 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 84.1 m -113.02 163.93 16.77 Favored Pre-proline 0 C--N 1.277 -2.551 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 170.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.428 ' O ' ' HD2' ' A' ' 1' ' ' ARG . 26.2 Cg_exo . . . . . 0 C--O 1.235 0.34 0 C-N-CA 121.838 1.692 . . . . 0.0 110.47 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.439 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 62.9 mtt85 . . . . . 0 CA--C 1.507 -0.701 0 CA-C-O 121.063 0.459 . . . . 0.0 112.045 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 66.9 mtm -105.12 107.95 19.2 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 174.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.1 m -83.5 117.13 22.89 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.798 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.632 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 36.7 ttpt -97.09 110.16 22.77 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 100.0 m -113.33 128.17 25.98 Favored Pre-proline 0 C--N 1.294 -1.822 0 C-N-CA 123.998 0.919 . . . . 0.0 110.662 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -69.39 115.98 4.3 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.992 1.795 . . . . 0.0 112.998 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -54.8 141.38 33.08 Favored 'General case' 0 C--O 1.276 2.492 0 C-N-CA 124.98 1.312 . . . . 0.0 110.376 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.29 -19.33 10.72 Favored Glycine 0 N--CA 1.433 -1.511 0 O-C-N 124.205 0.941 . . . . 0.0 114.601 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.52 ' HZ2' ' HB ' ' A' ' 26' ' ' THR . 49.0 pttt . . . . . 0 C--O 1.245 0.82 0 CA-C-N 118.546 1.173 . . . . 0.0 111.759 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.438 -1.029 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 2.9 t -88.93 65.6 7.61 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.146 0.974 . . . . 0.0 109.605 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.0 m -89.3 -29.95 5.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.024 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -107.9 114.74 28.9 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.028 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.432 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 55.4 m-80 -61.79 -29.69 70.32 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.863 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.8 m -67.03 -25.72 66.41 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 122.574 0.349 . . . . 0.0 110.883 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.504 ' O ' HG21 ' A' ' 23' ' ' VAL . 45.1 t30 -70.78 -48.26 55.21 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.52 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 12.9 t -56.74 -47.59 79.69 Favored 'General case' 0 CA--C 1.476 -1.888 0 CA-C-N 114.2 -1.364 . . . . 0.0 108.131 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 21.0 tttp -54.37 -55.26 30.34 Favored 'General case' 0 N--CA 1.399 -3.018 0 CA-C-N 112.68 -2.054 . . . . 0.0 109.634 -175.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -63.25 -38.53 91.53 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 123.757 0.661 . . . . 0.0 111.568 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 19' ' ' ASN . 57.8 t -66.27 -45.73 89.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 95.4 m -63.63 -39.75 95.15 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 120.931 0.396 . . . . 0.0 111.071 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.584 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 59.3 mtp180 -64.76 -30.24 71.24 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 121.018 0.437 . . . . 0.0 110.502 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.52 ' HB ' ' HZ2' ' A' ' 9' ' ' LYS . 7.0 p -85.58 -27.63 25.39 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 176.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.407 ' HG3' ' HE2' ' A' ' 9' ' ' LYS . 50.6 mt-10 -66.97 -40.33 87.43 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.691 171.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 134.32 41.04 0.16 Allowed Glycine 0 C--N 1.318 -0.468 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.701 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.584 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 95.0 m-85 -130.3 148.64 70.66 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -177.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -61.99 -34.79 79.9 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.448 2.099 . . . . 0.0 112.354 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.479 HG21 ' HB2' ' A' ' 46' ' ' TYR . 7.3 t -157.95 170.98 21.1 Favored 'General case' 0 N--CA 1.422 -1.867 0 O-C-N 122.056 -0.402 . . . . 0.0 110.354 -176.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.52 153.84 25.48 Favored Glycine 0 N--CA 1.414 -2.777 0 N-CA-C 107.31 -2.316 . . . . 0.0 107.31 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.471 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 44.5 m -155.83 157.02 35.73 Favored 'General case' 0 C--N 1.281 -2.408 0 C-N-CA 123.5 0.72 . . . . 0.0 110.799 -176.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.0 m -94.85 125.72 39.69 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.788 -172.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.532 ' CG ' ' HZ1' ' A' ' 4' ' ' LYS . 30.7 t70 -122.66 166.92 14.1 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.839 -174.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -122.34 116.04 23.35 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.331 0.586 . . . . 0.0 110.949 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -148.39 6.28 0.75 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 m -147.84 167.66 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.22 82.18 0.53 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 122.173 0.987 . . . . 0.0 110.146 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.09 -140.31 9.94 Favored Glycine 0 N--CA 1.401 -3.647 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.704 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -126.2 130.6 51.28 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -111.65 130.56 55.72 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 40.4 t -75.49 134.5 40.8 Favored 'General case' 0 C--O 1.278 2.569 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.632 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 40.0 m-85 -131.86 141.75 49.5 Favored 'General case' 0 N--CA 1.42 -1.957 0 O-C-N 123.933 0.771 . . . . 0.0 109.729 175.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.473 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 54.2 m -96.81 139.01 33.5 Favored 'General case' 0 C--N 1.252 -3.671 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.965 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.479 ' HB2' HG21 ' A' ' 31' ' ' THR . 37.1 m-85 -112.35 134.72 53.73 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.767 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -147.1 143.91 18.97 Favored Pre-proline 0 C--N 1.295 -1.791 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.726 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.06 121.6 7.41 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.469 2.113 . . . . 0.0 112.655 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 77.0 m -116.14 161.83 29.14 Favored Pre-proline 0 C--N 1.278 -2.532 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 170.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.439 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 16.4 Cg_endo . . . . . 0 C--O 1.26 1.611 0 C-N-CA 122.018 1.812 . . . . 0.0 110.972 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.9 mtt -105.25 114.14 28.15 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 175.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 46' ' ' TYR . 15.8 m -93.01 122.59 35.53 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.221 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.461 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 27.3 ttpp -101.23 109.86 21.79 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.0 m -116.31 127.98 26.34 Favored Pre-proline 0 C--O 1.196 -1.729 0 C-N-CA 124.258 1.023 . . . . 0.0 111.117 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -66.98 125.08 13.08 Favored 'Trans proline' 0 N--CA 1.474 0.366 0 C-N-CA 122.365 2.043 . . . . 0.0 112.784 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -70.39 142.37 52.08 Favored 'General case' 0 C--O 1.273 2.339 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.67 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.17 -40.97 6.77 Favored Glycine 0 N--CA 1.427 -1.909 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.957 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.589 ' HD3' ' CD ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER . . . . . 0 CA--C 1.477 -1.862 0 C-N-CA 118.489 -1.285 . . . . 0.0 112.94 -175.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 . . . . . 0 N--CA 1.423 -1.781 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.9 t -85.66 67.7 10.16 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.503 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 18.7 m -74.25 -32.88 32.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.692 172.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -119.97 121.84 39.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.642 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -56.73 -27.01 58.43 Favored 'General case' 0 C--O 1.208 -1.099 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.881 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.3 m -66.91 -29.77 69.74 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -74.96 -40.58 60.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.595 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 16.2 t -59.17 -48.9 79.89 Favored 'General case' 0 CA--C 1.473 -2.013 0 CA-C-N 114.228 -1.351 . . . . 0.0 108.271 177.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HG3' ' H ' ' A' ' 32' ' ' GLY . 15.5 ttpt -55.01 -50.6 68.62 Favored 'General case' 0 N--CA 1.391 -3.404 0 CA-C-N 113.322 -1.763 . . . . 0.0 109.104 -176.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -60.09 -49.07 79.09 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.212 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 93.0 t -60.33 -43.49 93.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 123.207 0.317 . . . . 0.0 110.825 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 68.9 m -64.75 -38.51 91.23 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 122.991 0.517 . . . . 0.0 112.068 177.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.9 mtp180 -69.93 -25.08 63.5 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.191 0.52 . . . . 0.0 109.965 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -82.85 -27.67 30.65 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.895 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.589 ' CD ' ' HD3' ' A' ' 9' ' ' LYS . 7.8 mm-40 -68.6 -42.21 78.49 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.769 -0.582 . . . . 0.0 110.607 172.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.96 35.59 0.47 Allowed Glycine 0 C--N 1.312 -0.788 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 87.2 m-85 -121.19 149.53 51.85 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -60.12 -39.75 66.58 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.486 2.124 . . . . 0.0 112.441 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.483 HG21 ' HB2' ' A' ' 46' ' ' TYR . 9.4 t -154.66 174.2 15.32 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.141 -176.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.438 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -151.88 153.05 24.69 Favored Glycine 0 N--CA 1.418 -2.516 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.55 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 28.2 m -153.79 154.06 33.3 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 123.922 0.889 . . . . 0.0 110.391 -177.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.7 m -87.4 157.13 19.31 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.161 0.505 . . . . 0.0 112.109 -170.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.458 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 9.0 t70 -147.18 158.0 43.8 Favored 'General case' 0 C--O 1.257 1.46 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.061 -175.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.16 107.8 12.14 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -140.9 7.16 2.04 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 m -149.79 166.5 3.03 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.957 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -175.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.17 -30.13 66.15 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 123.974 0.796 . . . . 0.0 111.208 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.11 -170.23 42.66 Favored Glycine 0 N--CA 1.427 -1.927 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.503 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 19.9 mtp180 -114.29 118.17 33.17 Favored 'General case' 0 C--N 1.282 -2.351 0 O-C-N 121.698 -0.883 . . . . 0.0 109.731 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -102.14 149.68 24.03 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.309 -171.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 25.6 t -98.84 139.06 35.08 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.982 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.461 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 22.9 m-85 -132.49 135.74 46.21 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-O 122.052 0.93 . . . . 0.0 109.68 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.468 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 58.6 m -90.7 141.36 28.87 Favored 'General case' 0 C--N 1.246 -3.924 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.007 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.55 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 24.0 m-85 -111.75 134.92 52.99 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.829 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -147.28 145.61 22.48 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.854 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.04 116.66 4.72 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 122.395 2.063 . . . . 0.0 112.483 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.8 m -111.19 169.76 5.97 Favored Pre-proline 0 C--N 1.28 -2.44 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 171.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo . . . . . 0 C--O 1.255 1.327 0 C-N-CA 122.16 1.907 . . . . 0.0 111.832 175.583 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.427 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 59.5 mtt85 . . . . . 0 CA--C 1.513 -0.468 0 CA-C-O 121.157 0.503 . . . . 0.0 111.819 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 63.8 mtt -110.63 101.23 9.91 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 18.5 m -80.36 114.51 19.31 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.67 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.58 ' HZ3' ' CG ' ' A' ' 35' ' ' ASP . 38.6 ttpt -93.29 111.18 22.75 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.9 m -113.14 131.84 22.67 Favored Pre-proline 0 C--N 1.298 -1.651 0 C-N-CA 124.29 1.036 . . . . 0.0 110.18 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -72.17 114.46 3.99 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.015 1.81 . . . . 0.0 112.268 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.61 144.75 30.81 Favored 'General case' 0 C--O 1.269 2.127 0 C-N-CA 124.39 1.076 . . . . 0.0 110.475 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.66 -22.37 8.12 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 115.218 0.847 . . . . 0.0 115.218 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.472 ' CD ' HG12 ' A' ' 23' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.475 -1.916 0 C-N-CA 117.759 -1.576 . . . . 0.0 111.609 -174.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 N--CA 1.437 -1.121 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.566 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 4.3 t -83.22 71.84 10.18 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.946 0.879 . . . . 0.0 109.355 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.1 m -87.06 -32.17 6.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.603 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -108.38 120.51 42.6 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 54.8 m-80 -61.48 -28.35 69.23 Favored 'General case' 0 C--O 1.214 -0.766 0 O-C-N 123.731 0.644 . . . . 0.0 111.836 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.7 m -64.75 -28.32 69.5 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 123.593 0.757 . . . . 0.0 110.816 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -73.66 -46.37 46.95 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.566 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 15.9 t -56.87 -44.85 82.65 Favored 'General case' 0 CA--C 1.472 -2.02 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.079 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 22.6 tttp -55.08 -55.12 34.6 Favored 'General case' 0 N--CA 1.393 -3.276 0 CA-C-N 112.85 -1.977 . . . . 0.0 108.989 -175.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -61.72 -43.74 98.26 Favored 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 123.906 0.754 . . . . 0.0 110.957 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.472 HG12 ' CD ' ' A' ' 9' ' ' LYS . 89.8 t -60.29 -48.83 86.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.884 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.6 m -63.03 -39.53 95.03 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.826 0.85 . . . . 0.0 111.649 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 54.1 mtp180 -64.42 -30.95 71.98 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.238 0.542 . . . . 0.0 110.024 177.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.0 m -85.65 -11.06 54.76 Favored 'General case' 0 CA--C 1.58 2.114 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.656 176.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.412 ' OE2' ' HG3' ' A' ' 9' ' ' LYS . 61.8 mt-10 -88.06 -27.41 22.0 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.242 -0.911 . . . . 0.0 110.287 172.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.52 34.05 0.78 Allowed Glycine 0 C--N 1.318 -0.439 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.636 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.565 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.0 m-85 -124.14 148.85 58.77 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -63.59 -34.76 62.66 Favored 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 122.394 2.063 . . . . 0.0 112.277 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.439 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.0 t -156.96 170.67 21.99 Favored 'General case' 0 N--CA 1.416 -2.126 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.085 -176.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.33 154.93 26.17 Favored Glycine 0 N--CA 1.409 -3.163 0 N-CA-C 107.085 -2.406 . . . . 0.0 107.085 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.505 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 43.9 m -155.15 152.79 29.86 Favored 'General case' 0 C--N 1.277 -2.551 0 C-N-CA 123.628 0.771 . . . . 0.0 110.641 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 17' ' ' ASN . 51.0 m -92.4 127.78 38.01 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.448 -172.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.591 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 35.0 t70 -127.24 169.43 13.51 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.047 -175.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -121.23 118.44 29.61 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.246 0.546 . . . . 0.0 111.371 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -149.3 5.52 0.64 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 174.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 m -147.38 167.01 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.316 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.66 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.5 82.17 1.09 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.741 0.781 . . . . 0.0 108.916 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.45 -150.95 23.2 Favored Glycine 0 N--CA 1.406 -3.302 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -177.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -121.78 127.48 50.67 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 122.65 -0.323 . . . . 0.0 110.672 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -109.78 132.63 53.98 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.0 t -77.21 134.64 38.57 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 174.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.591 ' CD1' ' HB3' ' A' ' 35' ' ' ASP . 46.9 m-85 -130.54 141.65 50.48 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-O 121.553 0.692 . . . . 0.0 109.337 173.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.472 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 57.3 m -96.12 139.36 32.4 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.274 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CE1' ' HB2' ' A' ' 33' ' ' SER . 26.1 m-85 -112.9 134.23 54.51 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 121.002 0.429 . . . . 0.0 110.702 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -143.78 137.09 14.03 Favored Pre-proline 0 C--N 1.295 -1.798 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.337 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.84 118.8 5.89 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.796 2.331 . . . . 0.0 112.465 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.05 164.15 20.08 Favored Pre-proline 0 C--N 1.272 -2.786 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 171.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.427 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 32.9 Cg_exo . . . . . 0 C--O 1.264 1.796 0 C-N-CA 121.958 1.772 . . . . 0.0 110.952 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.645 ' HD3' ' OXT' ' A' ' 50' ' ' PRO . 31.7 mtp180 . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 121.184 0.516 . . . . 0.0 112.089 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.9 mtm -107.62 106.3 16.59 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.2 m -86.34 116.17 24.33 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.71 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.499 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.8 ttpt -92.97 111.42 23.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.8 m -114.9 130.47 24.15 Favored Pre-proline 0 C--N 1.295 -1.803 0 C-N-CA 124.337 1.055 . . . . 0.0 110.336 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.54 131.48 28.02 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.147 1.898 . . . . 0.0 113.253 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.0 p -59.95 143.46 51.57 Favored 'General case' 0 C--O 1.27 2.159 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.711 177.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.68 -32.31 6.01 Favored Glycine 0 N--CA 1.427 -1.918 0 O-C-N 123.58 0.55 . . . . 0.0 113.528 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.521 ' NZ ' ' HG3' ' A' ' 27' ' ' GLU . 16.1 pttm . . . . . 0 CA--C 1.501 -0.908 0 CA-C-N 118.276 1.038 . . . . 0.0 112.706 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 N--CA 1.436 -1.137 0 CA-C-O 120.773 0.32 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.1 t -93.43 64.15 3.62 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.868 0.842 . . . . 0.0 108.977 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.489 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 18.8 m -73.83 -34.78 41.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.027 172.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -119.69 125.52 48.88 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 91.4 m-20 -56.56 -28.18 59.57 Favored 'General case' 0 C--O 1.199 -1.596 0 O-C-N 124.312 1.007 . . . . 0.0 111.354 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 89.9 m -67.4 -29.65 69.21 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.528 ' O ' HG23 ' A' ' 23' ' ' VAL . 45.6 t30 -70.05 -46.27 65.35 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.59 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 24.3 t -57.62 -51.5 69.23 Favored 'General case' 0 CA--C 1.478 -1.823 0 CA-C-N 113.991 -1.459 . . . . 0.0 108.745 177.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 11.4 ttpt -51.64 -53.76 35.27 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-N 113.275 -1.784 . . . . 0.0 109.502 -174.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -62.7 -40.93 98.68 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.404 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 19' ' ' ASN . 60.2 t -65.97 -42.46 91.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.588 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.6 m -64.85 -41.99 95.26 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 120.973 0.416 . . . . 0.0 110.853 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 43.5 mtp180 -65.21 -29.32 70.11 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.004 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 p -81.65 -30.95 32.54 Favored 'General case' 0 C--O 1.215 -0.727 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 175.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.521 ' HG3' ' NZ ' ' A' ' 9' ' ' LYS . 48.1 mt-10 -68.67 -34.94 76.55 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.889 173.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.87 36.76 0.38 Allowed Glycine 0 C--N 1.314 -0.642 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.883 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.7 m-85 -123.57 148.9 57.2 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.37 -35.96 58.59 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.121 1.881 . . . . 0.0 112.294 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 46' ' ' TYR . 8.8 t -157.74 175.5 13.81 Favored 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.88 -175.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.88 153.72 25.0 Favored Glycine 0 N--CA 1.417 -2.616 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.554 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 32.8 m -155.24 160.98 41.25 Favored 'General case' 0 C--N 1.285 -2.2 0 C-N-CA 123.636 0.774 . . . . 0.0 110.763 -177.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.4 m -93.17 153.84 18.4 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -171.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.484 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 9.9 t70 -147.49 157.29 43.51 Favored 'General case' 0 C--O 1.255 1.376 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.173 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -121.71 110.77 16.36 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 121.549 0.69 . . . . 0.0 109.231 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -146.16 7.69 1.04 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.423 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 m -149.06 165.53 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.243 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.489 -174.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.34 83.11 1.41 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.56 -148.42 19.43 Favored Glycine 0 N--CA 1.405 -3.389 0 N-CA-C 107.833 -2.107 . . . . 0.0 107.833 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.489 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 19.1 mtp180 -137.6 118.08 13.82 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 117.663 0.732 . . . . 0.0 109.58 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -103.69 134.6 46.74 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-O 121.423 0.63 . . . . 0.0 111.146 -172.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 5.9 t -84.6 136.9 33.58 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.542 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.499 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 39.1 m-85 -129.84 138.97 51.28 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-O 121.8 0.81 . . . . 0.0 109.845 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.449 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 56.9 m -95.53 136.04 36.42 Favored 'General case' 0 C--N 1.246 -3.919 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.348 -177.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.554 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 27.9 m-85 -107.61 135.19 49.48 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.863 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -146.27 140.82 15.77 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.716 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 130.95 20.27 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.536 2.158 . . . . 0.0 112.506 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.3 p -129.81 158.26 74.24 Favored Pre-proline 0 C--N 1.27 -2.875 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 171.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.645 ' OXT' ' HD3' ' A' ' 1' ' ' ARG . 31.7 Cg_exo . . . . . 0 C--O 1.275 2.329 0 C-N-CA 121.894 1.729 . . . . 0.0 110.472 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 29.3 ttm105 . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 121.258 0.552 . . . . 0.0 111.756 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 90.4 mtp -98.04 105.88 18.09 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.631 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.9 m -85.38 118.02 24.66 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.705 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.531 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 37.5 ttpt -97.39 110.52 23.06 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 98.1 m -111.55 131.48 22.31 Favored Pre-proline 0 C--N 1.29 -2.001 0 C-N-CA 124.106 0.962 . . . . 0.0 110.31 -176.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -66.54 126.42 15.48 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.002 1.801 . . . . 0.0 112.36 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.1 p -63.2 142.28 58.44 Favored 'General case' 0 C--O 1.273 2.294 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.499 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.78 -32.75 5.53 Favored Glycine 0 N--CA 1.428 -1.889 0 CA-C-N 115.951 -0.568 . . . . 0.0 114.341 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.459 ' CD ' HG12 ' A' ' 23' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.476 -1.895 0 O-C-N 120.976 -1.308 . . . . 0.0 111.008 -173.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.435 -1.223 0 CA-C-O 121.275 0.559 . . . . 0.0 111.809 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.585 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 8.0 t -82.05 71.05 9.09 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.69 -60.17 3.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.787 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -100.93 140.71 34.84 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.931 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.484 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 91.8 m-20 -64.76 -28.01 69.29 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.496 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.6 m -63.85 -35.08 79.47 Favored 'General case' 0 CA--C 1.575 1.918 0 C-N-CA 123.236 0.614 . . . . 0.0 112.482 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.416 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.2 p-10 -72.26 -40.72 67.45 Favored 'General case' 0 CA--C 1.494 -1.193 0 O-C-N 121.179 -0.951 . . . . 0.0 109.761 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.585 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 23.1 t -59.82 -45.75 91.4 Favored 'General case' 0 CA--C 1.472 -2.043 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 24.0 tttp -53.69 -55.04 29.61 Favored 'General case' 0 N--CA 1.395 -3.215 0 CA-C-N 112.551 -2.113 . . . . 0.0 108.807 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -62.44 -43.71 98.16 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.24 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.459 HG12 ' CD ' ' A' ' 9' ' ' LYS . 92.3 t -60.94 -48.41 89.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.597 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.4 m -63.05 -38.54 91.6 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.789 0.835 . . . . 0.0 111.286 177.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 56.1 mtp180 -64.47 -31.36 72.53 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-O 121.282 0.563 . . . . 0.0 110.145 177.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.2 m -85.46 -10.66 55.81 Favored 'General case' 0 CA--C 1.578 2.032 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.548 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.429 ' OE2' ' HG3' ' A' ' 9' ' ' LYS . 68.7 mt-10 -88.13 -28.75 21.06 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.245 -0.909 . . . . 0.0 110.215 172.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.95 33.22 0.7 Allowed Glycine 0 C--N 1.318 -0.463 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.703 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.608 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.4 m-85 -123.89 147.51 54.03 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -63.69 -32.13 68.73 Favored 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.462 2.108 . . . . 0.0 112.269 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.448 HG21 ' HB2' ' A' ' 46' ' ' TYR . 7.1 t -159.37 171.5 19.66 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.02 -176.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -149.93 156.82 26.94 Favored Glycine 0 N--CA 1.408 -3.196 0 N-CA-C 107.405 -2.278 . . . . 0.0 107.405 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.538 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 39.8 m -157.42 156.89 32.99 Favored 'General case' 0 C--N 1.28 -2.445 0 C-N-CA 124.072 0.949 . . . . 0.0 110.235 -177.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.3 m -94.12 139.43 31.0 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.0 0.428 . . . . 0.0 111.257 -171.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.513 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 20.8 t70 -131.4 162.85 29.21 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.422 -176.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -120.6 112.55 19.05 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-O 121.627 0.727 . . . . 0.0 110.485 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -147.89 6.6 0.8 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.362 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 m -147.02 165.97 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.218 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.364 -175.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.25 83.46 0.75 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.826 0.822 . . . . 0.0 109.536 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.18 -143.35 12.04 Favored Glycine 0 N--CA 1.405 -3.37 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -127.01 125.9 42.22 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -111.42 125.02 53.44 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.39 0.614 . . . . 0.0 110.246 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 33.8 t -72.23 135.2 46.0 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.64 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.531 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 39.3 m-85 -130.55 143.21 50.61 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-O 121.499 0.666 . . . . 0.0 109.605 174.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.479 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 35.3 m -97.17 136.95 36.96 Favored 'General case' 0 C--N 1.25 -3.753 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.997 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.538 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 38.4 m-85 -112.18 136.15 51.95 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.585 -177.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -147.13 144.58 19.95 Favored Pre-proline 0 C--N 1.296 -1.743 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.907 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.93 120.56 6.42 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 122.457 2.105 . . . . 0.0 112.584 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.4 m -116.79 169.35 7.36 Favored Pre-proline 0 C--N 1.277 -2.553 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 171.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.263 1.734 0 C-N-CA 121.904 1.736 . . . . 0.0 110.208 174.777 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.426 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 58.2 mtt85 . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 121.063 0.459 . . . . 0.0 111.87 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.8 mtt -107.63 99.71 9.18 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 17.7 m -80.36 114.42 19.24 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.623 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.52 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.6 ttpt -92.63 110.33 21.76 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.4 m -108.8 131.9 21.5 Favored Pre-proline 0 C--N 1.301 -1.523 0 C-N-CA 124.27 1.028 . . . . 0.0 109.809 -174.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -72.3 116.28 4.65 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.66 1.573 . . . . 0.0 111.865 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -58.13 139.04 55.58 Favored 'General case' 0 C--O 1.278 2.558 0 C-N-CA 123.944 0.898 . . . . 0.0 111.097 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.57 -30.34 9.89 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.787 -175.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.478 ' HZ2' ' HG3' ' A' ' 27' ' ' GLU . 21.5 pttm . . . . . 0 N--CA 1.42 -1.954 0 C-N-CA 118.406 -1.318 . . . . 0.0 112.562 -175.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 . . . . . 0 N--CA 1.441 -0.881 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.1 t -91.8 60.15 3.85 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.549 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 17.4 m -69.98 -33.28 54.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.513 173.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -111.34 121.19 44.59 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.86 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -61.88 -26.08 67.94 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.059 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 97.8 m -67.43 -31.21 71.25 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.423 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -59.43 -54.25 48.87 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 5.9 t -56.64 -49.72 74.17 Favored 'General case' 0 CA--C 1.464 -2.341 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.243 -177.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HG3' ' H ' ' A' ' 32' ' ' GLY . 0.9 OUTLIER -55.48 -46.54 76.89 Favored 'General case' 0 N--CA 1.395 -3.2 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.607 -176.203 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -68.02 -44.09 77.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.229 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.13 -40.83 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.407 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.8 m -66.2 -41.86 89.58 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 120.866 0.365 . . . . 0.0 111.571 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 35.3 mtp180 -66.55 -28.63 68.68 Favored 'General case' 0 C--O 1.211 -0.958 0 CA-C-O 120.915 0.388 . . . . 0.0 111.017 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 p -81.92 -30.97 31.59 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.478 ' HG3' ' HZ2' ' A' ' 9' ' ' LYS . 53.1 mt-10 -68.3 -32.67 72.98 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.659 172.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.12 36.29 0.55 Allowed Glycine 0 C--N 1.315 -0.631 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.977 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 92.6 m-85 -122.13 149.23 53.87 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -60.82 -38.47 70.02 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.308 2.006 . . . . 0.0 112.277 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 46' ' ' TYR . 9.1 t -158.07 173.89 16.05 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.112 -175.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.432 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -153.99 154.13 25.3 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.43 ' HB3' ' CE2' ' A' ' 46' ' ' TYR . 23.2 t -150.3 154.58 38.12 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.6 m -87.47 156.16 19.68 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 120.831 0.348 . . . . 0.0 110.569 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.42 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 22.8 t70 -145.01 153.86 41.93 Favored 'General case' 0 C--O 1.255 1.368 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.564 -175.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -119.75 105.74 11.44 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -144.13 6.14 1.33 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.118 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.0 m -148.04 164.94 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.877 -175.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.1 80.94 0.96 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.048 0.928 . . . . 0.0 109.365 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.52 -147.38 16.75 Favored Glycine 0 N--CA 1.405 -3.43 0 N-CA-C 107.833 -2.107 . . . . 0.0 107.833 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.549 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 20.8 mtp180 -139.24 117.76 12.14 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 117.581 0.691 . . . . 0.0 109.668 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -101.05 146.93 26.81 Favored 'General case' 0 N--CA 1.422 -1.835 0 O-C-N 123.536 0.522 . . . . 0.0 109.975 -172.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.4 t -97.98 141.37 31.03 Favored 'General case' 0 C--O 1.266 1.964 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.52 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 47.4 m-85 -134.87 138.08 43.83 Favored 'General case' 0 N--CA 1.419 -1.983 0 O-C-N 124.165 0.916 . . . . 0.0 110.411 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.486 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 61.5 m -96.05 135.81 37.32 Favored 'General case' 0 C--N 1.258 -3.408 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.84 -177.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.48 ' HB2' HG23 ' A' ' 31' ' ' THR . 21.7 m-85 -106.92 134.64 49.77 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 120.863 0.363 . . . . 0.0 110.803 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -144.49 137.81 14.11 Favored Pre-proline 0 C--N 1.296 -1.755 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.846 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.4 120.68 7.32 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.659 2.24 . . . . 0.0 112.362 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 p -118.28 164.45 20.23 Favored Pre-proline 0 C--N 1.272 -2.778 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 171.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.426 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 34.6 Cg_exo . . . . . 0 C--O 1.263 1.732 0 C-N-CA 121.816 1.677 . . . . 0.0 110.875 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.421 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 63.0 mtt85 . . . . . 0 N--CA 1.469 0.492 0 CA-C-O 121.023 0.44 . . . . 0.0 112.157 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 89.2 mtp -99.25 101.16 12.38 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.9 m -81.97 116.09 21.44 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.532 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.49 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 38.8 ttpt -93.08 109.77 21.25 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.6 m -107.35 132.52 20.89 Favored Pre-proline 0 C--N 1.298 -1.655 0 C-N-CA 124.373 1.069 . . . . 0.0 109.821 -174.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -71.72 115.01 4.13 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.68 1.586 . . . . 0.0 111.998 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -58.26 140.87 52.41 Favored 'General case' 0 C--O 1.278 2.605 0 C-N-CA 124.078 0.951 . . . . 0.0 111.278 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.55 -33.11 6.93 Favored Glycine 0 N--CA 1.427 -1.951 0 CA-C-N 115.749 -0.659 . . . . 0.0 114.051 -175.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.465 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 50.1 pttt . . . . . 0 CA--C 1.474 -1.972 0 O-C-N 120.995 -1.297 . . . . 0.0 112.635 -174.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 . . . . . 0 N--CA 1.444 -0.73 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.555 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.0 t -89.45 60.35 5.16 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.505 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 17.4 m -68.25 -39.59 81.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.573 173.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -110.39 121.97 46.57 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.448 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 86.7 m-20 -57.44 -28.42 63.3 Favored 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 124.153 0.981 . . . . 0.0 111.239 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 51.9 m -68.65 -26.27 65.24 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.415 ' O ' HG23 ' A' ' 23' ' ' VAL . 60.7 t30 -73.64 -42.24 61.68 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.555 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 18.3 t -58.84 -49.7 76.75 Favored 'General case' 0 CA--C 1.475 -1.937 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.244 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -53.54 -51.84 61.62 Favored 'General case' 0 N--CA 1.399 -2.995 0 CA-C-N 113.018 -1.901 . . . . 0.0 109.028 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -59.88 -48.38 81.95 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 123.693 0.621 . . . . 0.0 111.38 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 19' ' ' ASN . 92.4 t -60.2 -47.36 92.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 O-C-N 123.417 0.448 . . . . 0.0 110.707 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.1 m -60.49 -42.85 97.16 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.441 0.696 . . . . 0.0 111.9 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.6 mtp180 -65.08 -30.47 71.43 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.083 0.468 . . . . 0.0 110.24 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 m -85.46 -16.72 38.72 Favored 'General case' 0 CA--C 1.574 1.871 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.888 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.465 ' HG3' ' HE2' ' A' ' 9' ' ' LYS . 55.1 mt-10 -78.92 -38.26 37.83 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.365 -0.834 . . . . 0.0 110.309 172.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 133.39 34.7 0.31 Allowed Glycine 0 C--N 1.31 -0.908 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.1 m-85 -121.78 147.92 49.59 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -59.58 -38.34 82.89 Favored 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 122.467 2.111 . . . . 0.0 112.325 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.494 HG22 ' HB2' ' A' ' 46' ' ' TYR . 8.8 t -158.85 176.38 12.41 Favored 'General case' 0 N--CA 1.426 -1.667 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.068 -175.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.28 158.97 28.81 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.3 t -156.63 162.37 39.86 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 17' ' ' ASN . 59.2 m -96.11 156.97 16.11 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.302 0.572 . . . . 0.0 111.63 -171.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.405 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 8.2 t70 -145.85 156.62 43.68 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 124.306 1.042 . . . . 0.0 108.61 -176.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.4 107.08 10.74 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -142.29 7.81 1.78 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.4 m -149.04 160.52 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.343 -175.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.26 82.99 0.24 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 122.204 1.002 . . . . 0.0 110.007 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.78 -143.41 10.41 Favored Glycine 0 N--CA 1.403 -3.527 0 N-CA-C 107.492 -2.243 . . . . 0.0 107.492 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.505 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 23.0 mtp180 -141.68 119.86 12.16 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 117.509 0.654 . . . . 0.0 109.481 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -102.17 142.77 32.9 Favored 'General case' 0 N--CA 1.428 -1.556 0 O-C-N 123.432 0.457 . . . . 0.0 110.346 -172.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.2 t -94.13 142.12 27.76 Favored 'General case' 0 C--O 1.268 2.049 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.338 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.49 ' CD1' ' HG2' ' A' ' 4' ' ' LYS . 51.6 m-85 -135.85 139.41 43.39 Favored 'General case' 0 N--CA 1.418 -2.044 0 O-C-N 124.159 0.912 . . . . 0.0 110.421 176.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.475 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 59.8 m -96.24 137.68 34.96 Favored 'General case' 0 C--N 1.261 -3.248 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.698 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.494 ' HB2' HG22 ' A' ' 31' ' ' THR . 22.0 m-85 -108.36 135.6 49.4 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 120.992 0.425 . . . . 0.0 110.939 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -147.43 145.75 22.71 Favored Pre-proline 0 C--N 1.298 -1.643 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.385 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.04 124.19 8.91 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.343 2.029 . . . . 0.0 112.605 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.0 m -117.01 166.38 13.09 Favored Pre-proline 0 C--N 1.276 -2.593 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 170.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.421 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 22.5 Cg_exo . . . . . 0 C--O 1.259 1.574 0 C-N-CA 121.661 1.574 . . . . 0.0 110.217 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.441 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 62.2 mtt85 . . . . . 0 N--CA 1.474 0.769 0 CA-C-O 120.96 0.41 . . . . 0.0 111.841 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 68.1 mtm -103.2 108.57 19.83 Favored 'General case' 0 CA--C 1.483 -1.616 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.7 m -85.92 116.68 24.3 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.073 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.489 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 36.9 ttpt -95.78 110.17 22.36 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.0 m -110.37 132.71 21.38 Favored Pre-proline 0 C--O 1.202 -1.407 0 C-N-CA 124.253 1.021 . . . . 0.0 110.385 -174.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -72.37 119.49 6.17 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 121.947 1.765 . . . . 0.0 112.489 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m -62.83 146.6 52.28 Favored 'General case' 0 C--O 1.274 2.365 0 C-N-CA 123.86 0.864 . . . . 0.0 110.8 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.85 -27.03 4.19 Favored Glycine 0 N--CA 1.432 -1.608 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.914 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.1 pttt . . . . . 0 CA--C 1.497 -1.089 0 CA-C-O 122.257 1.027 . . . . 0.0 111.784 -176.356 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.433 -1.285 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.5 t -83.77 67.35 9.48 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.962 0.887 . . . . 0.0 110.2 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.2 m -89.84 -25.59 5.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.978 174.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -113.76 115.75 28.3 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.189 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 92.2 m-20 -57.53 -31.17 65.82 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.939 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.2 m -66.92 -27.47 67.51 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 122.703 0.401 . . . . 0.0 111.133 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.484 ' O ' HG22 ' A' ' 23' ' ' VAL . 47.3 t30 -72.33 -46.24 56.44 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.1 t -57.82 -47.13 83.51 Favored 'General case' 0 CA--C 1.48 -1.746 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.0 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 23.2 tttp -54.6 -55.72 26.53 Favored 'General case' 0 N--CA 1.4 -2.932 0 CA-C-N 112.772 -2.013 . . . . 0.0 109.313 -175.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -61.29 -41.46 97.0 Favored 'General case' 0 CA--C 1.493 -1.237 0 O-C-N 124.001 0.813 . . . . 0.0 111.682 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 19' ' ' ASN . 89.6 t -61.95 -51.33 73.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 99.4 m -58.75 -40.8 84.94 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.221 0.95 . . . . 0.0 111.341 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 56.5 mtp180 -64.15 -33.18 75.18 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 121.063 0.458 . . . . 0.0 110.582 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.0 m -85.88 -13.34 48.21 Favored 'General case' 0 CA--C 1.579 2.095 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.031 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 23' ' ' VAL . 54.4 mt-10 -82.14 -39.66 22.95 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.352 -0.843 . . . . 0.0 109.627 172.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.46 38.82 0.13 Allowed Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.57 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 92.5 m-85 -128.01 148.89 69.24 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -62.55 -35.45 70.73 Favored 'Trans proline' 0 C--O 1.242 0.706 0 C-N-CA 122.463 2.109 . . . . 0.0 112.311 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.485 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.7 t -158.23 170.46 22.21 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.273 -176.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.76 155.91 26.69 Favored Glycine 0 N--CA 1.415 -2.703 0 N-CA-C 107.296 -2.321 . . . . 0.0 107.296 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.48 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 35.7 m -156.96 152.76 27.06 Favored 'General case' 0 C--N 1.283 -2.309 0 C-N-CA 123.79 0.836 . . . . 0.0 110.85 -176.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.7 m -94.96 132.1 40.18 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.237 0.541 . . . . 0.0 111.167 -172.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -120.32 156.31 31.56 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.124 -173.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.15 108.19 14.38 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -141.46 10.94 2.09 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.2 m -156.86 167.25 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.84 80.7 0.89 Allowed 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.682 0.753 . . . . 0.0 109.06 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.41 -157.99 27.46 Favored Glycine 0 N--CA 1.412 -2.907 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -124.43 132.25 53.5 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 117.206 0.503 . . . . 0.0 110.66 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -111.69 133.98 53.57 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 52.9 t -81.8 135.09 35.48 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.489 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 54.3 m-85 -132.31 140.2 48.49 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-O 121.79 0.805 . . . . 0.0 110.185 175.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.467 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 46.3 m -95.14 139.67 31.15 Favored 'General case' 0 C--N 1.252 -3.64 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.132 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.485 ' HB2' HG23 ' A' ' 31' ' ' THR . 35.4 m-85 -112.11 135.0 53.32 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.631 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -147.5 143.94 18.7 Favored Pre-proline 0 C--N 1.294 -1.841 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.603 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.17 122.07 7.74 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.352 2.035 . . . . 0.0 112.471 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 76.9 m -115.13 161.53 29.01 Favored Pre-proline 0 C--N 1.276 -2.607 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 170.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.441 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 17.7 Cg_endo . . . . . 0 C--O 1.262 1.719 0 C-N-CA 121.808 1.672 . . . . 0.0 110.836 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.425 ' HD2' ' O ' ' A' ' 50' ' ' PRO . 58.0 mtt85 . . . . . 0 CA--C 1.513 -0.466 0 CA-C-O 121.213 0.53 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 63.6 mtt -107.39 98.39 8.02 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 174.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.9 m -77.77 113.01 15.21 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.622 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.53 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.4 ttpt -92.94 110.56 22.02 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.4 m -109.36 131.4 21.88 Favored Pre-proline 0 C--N 1.296 -1.735 0 C-N-CA 124.137 0.975 . . . . 0.0 109.64 -174.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -71.76 114.63 4.01 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.755 1.637 . . . . 0.0 111.523 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -57.46 139.73 52.44 Favored 'General case' 0 C--O 1.274 2.359 0 C-N-CA 124.292 1.037 . . . . 0.0 111.36 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.64 -29.54 10.74 Favored Glycine 0 N--CA 1.425 -2.086 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.896 -176.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.555 ' HG3' ' CG ' ' A' ' 27' ' ' GLU . 34.1 mtmt . . . . . 0 CA--C 1.476 -1.889 0 CA-C-N 118.337 1.069 . . . . 0.0 109.078 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 CA--C 1.511 -0.543 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 6.9 t -88.33 64.0 7.39 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.887 0.851 . . . . 0.0 109.182 176.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 41' ' ' ARG . 19.3 m -72.85 -35.2 48.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.189 171.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -109.98 119.2 38.57 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.3 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 55.4 m-80 -64.77 -30.32 71.33 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.467 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.5 m -68.85 -24.47 64.36 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 122.568 0.347 . . . . 0.0 110.421 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.436 ' O ' HG23 ' A' ' 23' ' ' VAL . 54.2 t30 -74.01 -46.1 45.74 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.616 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 33.1 t -55.28 -47.32 75.69 Favored 'General case' 0 CA--C 1.474 -1.963 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.98 176.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 19.2 tttp -54.57 -53.26 56.94 Favored 'General case' 0 N--CA 1.391 -3.379 0 CA-C-N 112.278 -2.237 . . . . 0.0 109.33 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -61.86 -42.98 99.7 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 123.5 0.5 . . . . 0.0 111.521 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 19' ' ' ASN . 48.4 t -64.94 -43.94 96.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.019 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 74.6 m -64.0 -40.9 97.39 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 120.96 0.409 . . . . 0.0 111.388 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 52.7 mtp180 -67.06 -26.06 66.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.955 0.407 . . . . 0.0 110.727 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.43 ' CB ' ' HZ3' ' A' ' 9' ' ' LYS . 3.7 p -85.21 -36.43 20.98 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 175.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.555 ' CG ' ' HG3' ' A' ' 9' ' ' LYS . 56.9 mt-10 -57.04 -45.61 83.05 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 120.612 0.244 . . . . 0.0 111.333 168.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 135.39 43.72 0.11 Allowed Glycine 0 C--N 1.318 -0.46 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.849 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.473 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 89.5 m-85 -128.61 149.58 72.29 Favored Pre-proline 0 C--N 1.307 -1.266 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -62.25 -37.68 60.23 Favored 'Trans proline' 0 C--O 1.24 0.602 0 C-N-CA 122.394 2.063 . . . . 0.0 112.286 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.457 HG22 ' HB2' ' A' ' 46' ' ' TYR . 7.6 t -155.29 169.07 25.04 Favored 'General case' 0 N--CA 1.418 -2.065 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.438 -176.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.54 152.15 24.26 Favored Glycine 0 N--CA 1.408 -3.226 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.533 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 46.8 m -155.07 157.66 37.88 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 124.09 0.956 . . . . 0.0 110.002 -177.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 46.2 m -91.67 153.81 19.42 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.994 0.426 . . . . 0.0 112.076 -170.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.531 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 13.3 t70 -148.38 158.31 44.03 Favored 'General case' 0 C--O 1.255 1.349 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.542 -177.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -118.86 111.14 18.03 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-O 121.61 0.719 . . . . 0.0 109.902 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -145.38 6.42 1.11 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.479 177.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.82 164.41 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.265 -174.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.05 80.75 1.23 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.022 0.915 . . . . 0.0 109.002 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.26 -144.52 11.29 Favored Glycine 0 N--CA 1.403 -3.551 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.458 ' CZ ' ' HA ' ' A' ' 15' ' ' VAL . 19.7 mtp180 -139.55 118.59 12.6 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -104.75 144.51 31.64 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 121.268 0.556 . . . . 0.0 110.23 -173.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.3 t -92.83 141.27 28.62 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.997 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.531 ' CD1' ' HB3' ' A' ' 35' ' ' ASP . 42.5 m-85 -133.74 140.57 47.06 Favored 'General case' 0 N--CA 1.414 -2.242 0 O-C-N 124.053 0.846 . . . . 0.0 109.889 175.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.473 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 58.6 m -94.52 135.34 36.07 Favored 'General case' 0 C--N 1.255 -3.506 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.521 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.533 ' CE1' ' HB2' ' A' ' 33' ' ' SER . 28.0 m-85 -108.89 133.7 52.55 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.743 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -144.85 138.31 14.26 Favored Pre-proline 0 C--N 1.294 -1.812 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.975 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.4 121.7 8.24 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.744 2.296 . . . . 0.0 112.27 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.7 p -121.64 162.24 37.51 Favored Pre-proline 0 C--N 1.273 -2.755 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 172.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.425 ' O ' ' HD2' ' A' ' 1' ' ' ARG . 13.6 Cg_endo . . . . . 0 CA--C 1.533 0.464 0 C-N-CA 122.113 1.875 . . . . 0.0 111.503 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.64 ' HD3' ' O ' ' A' ' 50' ' ' PRO . 32.2 mtp180 . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 120.825 0.345 . . . . 0.0 111.677 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 69.5 mtm -105.01 113.81 27.63 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.1 m -90.96 117.93 29.94 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.112 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.477 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 39.4 ttpt -94.22 110.52 22.25 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.0 m -111.48 131.63 22.22 Favored Pre-proline 0 C--N 1.295 -1.765 0 C-N-CA 124.426 1.09 . . . . 0.0 110.357 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.04 129.31 21.54 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.051 1.834 . . . . 0.0 113.119 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.1 p -58.9 141.72 52.72 Favored 'General case' 0 C--O 1.269 2.102 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.45 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -97.71 -29.17 7.89 Favored Glycine 0 N--CA 1.431 -1.67 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.442 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.617 ' NZ ' ' HG3' ' A' ' 27' ' ' GLU . 9.6 pttm . . . . . 0 C--O 1.246 0.903 0 CA-C-N 117.889 0.844 . . . . 0.0 112.889 -175.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 . . . . . 0 N--CA 1.436 -1.168 0 CA-C-O 120.854 0.359 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.583 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.0 t -93.94 62.92 3.18 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.514 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 17.7 m -72.79 -34.78 47.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.865 172.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -120.8 127.71 52.2 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -176.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 93.2 m-20 -56.61 -27.94 59.34 Favored 'General case' 0 C--O 1.2 -1.548 0 C-N-CA 124.395 1.078 . . . . 0.0 111.57 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.6 m -64.38 -34.87 79.18 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 122.95 0.5 . . . . 0.0 112.29 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.535 ' O ' HG23 ' A' ' 23' ' ' VAL . 49.5 t30 -69.29 -45.35 69.83 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.583 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 20.7 t -58.22 -51.9 67.82 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-N 114.541 -1.208 . . . . 0.0 108.779 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 15.3 ttpt -52.17 -53.03 48.11 Favored 'General case' 0 N--CA 1.406 -2.645 0 CA-C-N 113.299 -1.773 . . . . 0.0 109.554 -174.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -61.61 -45.65 93.2 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.189 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 19' ' ' ASN . 58.3 t -60.22 -48.9 86.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 O-C-N 123.47 0.482 . . . . 0.0 110.262 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 95.2 m -59.33 -40.69 87.12 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 123.573 0.749 . . . . 0.0 111.418 177.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.2 mtp180 -66.02 -28.53 68.94 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.285 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.479 ' HB ' ' HZ1' ' A' ' 9' ' ' LYS . 4.4 m -77.73 -29.37 51.13 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.036 175.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.617 ' HG3' ' NZ ' ' A' ' 9' ' ' LYS . 42.2 mt-10 -75.57 -22.71 56.75 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.749 0.309 . . . . 0.0 111.448 177.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.94 21.89 3.39 Favored Glycine 0 CA--C 1.501 -0.84 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.234 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.7 m-85 -106.54 145.15 30.44 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -60.58 -33.99 92.98 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.521 2.147 . . . . 0.0 112.463 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.47 HG22 ' HB2' ' A' ' 46' ' ' TYR . 9.9 t -160.82 175.43 12.58 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -175.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.462 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -154.05 158.41 28.12 Favored Glycine 0 N--CA 1.428 -1.855 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.445 ' HB3' ' CE1' ' A' ' 46' ' ' TYR . 15.5 t -153.77 163.64 39.69 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 59.6 m -95.82 152.9 18.06 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.281 0.562 . . . . 0.0 112.041 -172.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.423 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 8.7 t70 -144.1 156.73 44.47 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 124.462 1.105 . . . . 0.0 108.26 -177.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.17 107.18 10.5 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -141.67 8.69 1.96 Allowed 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.3 m -150.28 161.16 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.544 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.34 82.35 0.37 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.207 1.004 . . . . 0.0 109.583 177.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.07 -146.9 15.52 Favored Glycine 0 N--CA 1.404 -3.497 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 -177.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.514 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 21.5 mtp180 -140.71 118.38 11.64 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 117.759 0.78 . . . . 0.0 109.319 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -103.1 132.6 49.24 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-O 121.394 0.616 . . . . 0.0 111.014 -171.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.6 t -84.17 138.87 32.77 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.646 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.477 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 43.5 m-85 -131.7 139.64 49.09 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.751 0.786 . . . . 0.0 110.023 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.494 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 44.6 m -95.33 138.65 32.73 Favored 'General case' 0 C--N 1.252 -3.632 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.518 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.47 ' HB2' HG22 ' A' ' 31' ' ' THR . 21.5 m-85 -110.79 136.75 49.37 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 120.853 0.359 . . . . 0.0 110.973 -178.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -146.72 143.18 18.19 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.68 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.37 119.86 6.4 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.343 2.029 . . . . 0.0 112.458 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 95.1 m -111.75 159.27 33.99 Favored Pre-proline 0 C--N 1.276 -2.61 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 171.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.64 ' O ' ' HD3' ' A' ' 1' ' ' ARG . 38.2 Cg_exo . . . . . 0 C--O 1.251 1.156 0 C-N-CA 121.685 1.59 . . . . 0.0 109.528 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.435 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 61.4 mtt85 . . . . . 0 CA--C 1.512 -0.519 0 CA-C-O 121.212 0.529 . . . . 0.0 111.777 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.6 mtm -110.41 101.03 9.78 Favored 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 175.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.5 m -80.1 112.23 17.22 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.289 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.562 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 37.3 ttpt -93.14 111.24 22.81 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.5 m -117.68 124.05 29.21 Favored Pre-proline 0 C--N 1.293 -1.889 0 C-N-CA 123.734 0.814 . . . . 0.0 110.385 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -64.16 123.31 11.66 Favored 'Trans proline' 0 CA--C 1.521 -0.137 0 C-N-CA 122.294 1.996 . . . . 0.0 112.72 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -61.38 141.72 57.43 Favored 'General case' 0 C--O 1.281 2.714 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.502 -177.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.31 -30.0 11.56 Favored Glycine 0 N--CA 1.419 -2.448 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.761 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 45.6 pttt . . . . . 0 N--CA 1.418 -2.068 0 C-N-CA 117.655 -1.618 . . . . 0.0 113.852 -174.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 N--CA 1.434 -1.243 0 CA-C-O 121.045 0.45 . . . . 0.0 112.171 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 7.6 t -83.36 70.48 10.18 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.645 0.736 . . . . 0.0 109.066 176.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.477 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 90.5 t -73.32 -51.12 27.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.242 171.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.514 ' OD1' ' HB ' ' A' ' 18' ' ' THR . 5.4 t-20 -98.97 124.32 43.86 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.21 -176.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.481 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 93.4 m-20 -62.14 -29.15 70.14 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 114.383 -1.28 . . . . 0.0 112.61 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.514 ' HB ' ' OD1' ' A' ' 16' ' ' ASN . 9.8 m -65.12 -34.09 77.57 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 123.204 0.602 . . . . 0.0 110.584 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -70.01 -45.15 67.86 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 15.1 t -56.95 -46.94 81.77 Favored 'General case' 0 CA--C 1.48 -1.739 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.084 177.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 21.3 tttp -55.53 -53.98 49.7 Favored 'General case' 0 N--CA 1.391 -3.39 0 CA-C-N 112.567 -2.106 . . . . 0.0 108.701 -176.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -58.42 -48.05 81.93 Favored 'General case' 0 CA--C 1.499 -0.995 0 O-C-N 123.99 0.806 . . . . 0.0 111.194 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.5 t -60.81 -47.32 93.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 O-C-N 123.313 0.383 . . . . 0.0 110.594 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 69.6 m -61.49 -40.42 94.51 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 123.2 0.6 . . . . 0.0 111.839 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.503 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 47.5 mtp180 -66.9 -28.86 68.65 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.268 0.556 . . . . 0.0 110.17 178.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.1 m -85.48 -18.58 33.13 Favored 'General case' 0 CA--C 1.572 1.826 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.493 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.476 ' HG3' ' HE2' ' A' ' 9' ' ' LYS . 57.4 mt-10 -78.23 -40.98 35.68 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.4 -0.812 . . . . 0.0 110.424 171.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 135.53 38.48 0.18 Allowed Glycine 0 C--N 1.312 -0.781 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.522 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 89.1 m-85 -126.89 149.99 70.42 Favored Pre-proline 0 C--N 1.308 -1.214 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -63.61 -35.69 57.53 Favored 'Trans proline' 0 C--O 1.242 0.684 0 C-N-CA 122.392 2.062 . . . . 0.0 112.514 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.467 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.5 t -157.15 169.89 23.74 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.23 -176.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.68 153.74 25.53 Favored Glycine 0 N--CA 1.41 -3.056 0 N-CA-C 107.933 -2.067 . . . . 0.0 107.933 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.584 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 34.6 m -157.5 149.53 22.4 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 124.447 1.099 . . . . 0.0 110.139 -177.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.1 m -85.33 141.89 29.72 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -171.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.815 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 16.9 t70 -149.55 -172.28 4.1 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -132.69 127.71 35.4 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 120.945 -1.097 . . . . 0.0 110.977 -173.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.653 ' CE1' ' HG2' ' A' ' 42' ' ' LYS . 5.8 p-80 -149.13 11.16 0.81 Allowed 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 167.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.5 HG11 ' CD2' ' A' ' 37' ' ' HIS . 2.5 m -147.76 155.86 9.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.791 -174.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.03 84.79 0.99 Allowed 'General case' 0 C--N 1.314 -0.944 0 O-C-N 124.385 1.053 . . . . 0.0 108.963 177.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.19 -137.4 5.48 Favored Glycine 0 N--CA 1.404 -3.435 0 N-CA-C 107.901 -2.08 . . . . 0.0 107.901 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.477 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 18.8 mtp180 -136.53 119.6 16.52 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 117.453 0.626 . . . . 0.0 110.821 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.653 ' HG2' ' CE1' ' A' ' 37' ' ' HIS . 50.3 tptt -105.36 145.94 30.1 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 121.705 0.764 . . . . 0.0 111.125 -172.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 40.8 t -92.26 141.03 29.01 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.577 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.815 ' CD2' ' HB3' ' A' ' 35' ' ' ASP . 31.9 m-85 -130.88 140.87 50.27 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.522 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 61.4 m -95.55 133.77 39.2 Favored 'General case' 1 C--N 1.24 -4.173 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.872 -179.633 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.584 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 22.8 m-85 -107.58 133.91 51.35 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.591 -177.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -140.87 134.45 14.84 Favored Pre-proline 0 C--N 1.295 -1.798 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.351 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.21 118.28 5.6 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.947 2.431 . . . . 0.0 112.682 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 p -116.76 161.29 32.97 Favored Pre-proline 0 C--N 1.271 -2.838 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 172.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.435 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 18.3 Cg_endo . . . . . 0 C--O 1.264 1.79 0 C-N-CA 121.947 1.764 . . . . 0.0 111.375 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.445 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 59.5 mtt85 . . . . . 0 N--CA 1.467 0.376 0 CA-C-O 121.086 0.47 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.0 mtt -111.82 101.44 9.78 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.2 m -81.48 111.89 18.22 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.738 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.482 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 38.1 ttpt -93.54 110.97 22.54 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.106 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.8 m -109.13 133.11 20.85 Favored Pre-proline 0 C--N 1.3 -1.567 0 C-N-CA 124.381 1.072 . . . . 0.0 109.837 -177.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -72.72 117.44 5.13 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 121.832 1.688 . . . . 0.0 112.15 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -61.8 146.81 48.41 Favored 'General case' 0 C--O 1.274 2.357 0 C-N-CA 123.728 0.811 . . . . 0.0 110.244 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -110.78 -24.77 5.42 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.497 -0.859 . . . . 0.0 114.014 -175.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.518 ' CD ' HG12 ' A' ' 23' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.484 -1.573 0 CA-C-O 122.153 0.978 . . . . 0.0 110.578 -174.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 . . . . . 0 CA--C 1.507 -0.69 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 6.3 t -90.5 64.35 5.8 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-O 121.868 0.842 . . . . 0.0 109.061 176.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.504 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 18.5 m -72.47 -36.47 54.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.559 171.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -111.74 121.46 45.16 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.3 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 54.7 m-80 -64.66 -31.21 72.32 Favored 'General case' 0 C--O 1.214 -0.787 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.451 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.0 m -67.43 -24.27 65.62 Favored 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 122.592 0.357 . . . . 0.0 110.537 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -73.69 -48.05 35.02 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.587 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 16.1 t -56.09 -44.36 78.94 Favored 'General case' 0 CA--C 1.477 -1.85 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.132 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 22.5 tttp -54.77 -54.95 35.4 Favored 'General case' 0 N--CA 1.392 -3.351 0 CA-C-N 112.79 -2.005 . . . . 0.0 109.264 -175.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -62.21 -43.06 99.69 Favored 'General case' 0 CA--C 1.497 -1.094 0 O-C-N 123.815 0.697 . . . . 0.0 110.745 -176.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.518 HG12 ' CD ' ' A' ' 9' ' ' LYS . 72.9 t -56.95 -52.52 54.52 Favored 'Isoleucine or valine' 0 C--O 1.253 1.257 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.702 178.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 92.9 m -63.31 -38.03 89.56 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 124.363 1.04 . . . . 0.0 111.829 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 53.7 mtp180 -65.21 -29.08 69.85 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.092 0.472 . . . . 0.0 110.171 177.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 m -85.65 -14.61 45.01 Favored 'General case' 0 CA--C 1.578 2.036 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.793 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.465 ' OE2' ' HG3' ' A' ' 9' ' ' LYS . 47.2 mt-10 -86.99 -25.4 24.3 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.293 -0.879 . . . . 0.0 110.543 174.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.33 39.84 0.57 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.607 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 91.8 m-85 -129.17 148.56 69.59 Favored Pre-proline 0 C--N 1.311 -1.067 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -64.0 -34.19 59.93 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.346 2.03 . . . . 0.0 112.267 177.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.435 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.1 t -156.93 168.74 26.57 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.005 -176.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.64 153.63 25.46 Favored Glycine 0 N--CA 1.408 -3.216 0 N-CA-C 106.853 -2.499 . . . . 0.0 106.853 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.576 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 46.1 m -155.91 158.97 38.87 Favored 'General case' 0 C--N 1.275 -2.644 0 C-N-CA 123.704 0.802 . . . . 0.0 110.297 -176.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.1 m -92.61 157.06 16.69 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.259 0.552 . . . . 0.0 111.841 -170.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.467 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 7.5 t70 -148.08 155.19 41.18 Favored 'General case' 0 C--O 1.256 1.438 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.989 -177.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -122.09 110.1 15.35 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -147.08 8.6 0.95 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.507 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.9 m -149.43 164.07 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.129 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.385 -174.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.4 80.47 1.4 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.108 0.956 . . . . 0.0 109.011 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.77 -148.22 18.07 Favored Glycine 0 N--CA 1.403 -3.521 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 -176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.504 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 20.8 mtp180 -139.1 117.85 12.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 117.517 0.659 . . . . 0.0 109.486 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -101.09 141.67 33.64 Favored 'General case' 0 N--CA 1.421 -1.886 0 O-C-N 123.519 0.512 . . . . 0.0 110.395 -172.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.3 t -94.75 139.1 31.71 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.974 177.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.482 ' CD1' ' HG2' ' A' ' 4' ' ' LYS . 46.6 m-85 -134.27 142.29 47.27 Favored 'General case' 0 N--CA 1.42 -1.939 0 O-C-N 123.956 0.785 . . . . 0.0 109.855 175.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.484 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 39.8 m -94.68 139.14 31.62 Favored 'General case' 0 C--N 1.256 -3.487 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.311 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 33' ' ' SER . 30.2 m-85 -113.99 134.49 54.81 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.783 -178.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -140.98 134.72 14.86 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.481 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.12 110.64 2.87 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.922 2.414 . . . . 0.0 112.237 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 p -109.29 163.17 17.64 Favored Pre-proline 0 C--N 1.274 -2.708 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 173.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.445 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 29.7 Cg_exo . . . . . 0 C--O 1.263 1.725 0 C-N-CA 121.938 1.759 . . . . 0.0 110.996 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ARG . . . . . 0.421 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 59.2 mtt85 . . . . . 0 CA--C 1.514 -0.437 0 CA-C-O 121.159 0.504 . . . . 0.0 111.835 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.3 mtt -108.71 100.62 9.83 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 174.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.5 m -80.67 114.56 19.64 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.605 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.512 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 38.7 ttpt -92.82 110.7 22.15 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.7 m -110.64 131.15 22.23 Favored Pre-proline 0 C--N 1.295 -1.798 0 C-N-CA 124.355 1.062 . . . . 0.0 110.126 -175.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -66.25 127.38 17.38 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 121.719 1.613 . . . . 0.0 111.968 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.3 p -60.07 143.41 52.13 Favored 'General case' 0 C--O 1.271 2.185 0 O-C-N 123.914 0.759 . . . . 0.0 111.415 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -97.1 -28.93 8.29 Favored Glycine 0 N--CA 1.425 -2.064 0 O-C-N 123.721 0.638 . . . . 0.0 114.518 -176.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.634 ' NZ ' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.26 1.62 0 CA-C-N 118.947 1.374 . . . . 0.0 112.47 -175.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 N--CA 1.446 -0.625 0 CA-C-O 120.9 0.381 . . . . 0.0 111.992 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.581 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 7.1 t -88.65 69.56 8.79 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.503 0.668 . . . . 0.0 109.263 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.516 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 62.1 t -68.23 -56.6 12.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.042 172.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -101.5 127.66 48.09 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.769 -176.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 91.0 m-20 -56.52 -31.17 63.85 Favored 'General case' 0 C--O 1.204 -1.292 0 C-N-CA 124.417 1.087 . . . . 0.0 111.518 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.4 m -64.25 -28.92 70.06 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 123.519 0.728 . . . . 0.0 111.192 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.418 ' O ' HG23 ' A' ' 23' ' ' VAL . 56.8 t30 -74.43 -45.1 48.63 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.581 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 24.9 t -56.77 -46.5 81.44 Favored 'General case' 0 CA--C 1.471 -2.084 0 CA-C-N 114.343 -1.298 . . . . 0.0 107.799 176.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 19.9 tttp -53.78 -54.89 31.84 Favored 'General case' 0 N--CA 1.394 -3.25 0 CA-C-N 112.664 -2.062 . . . . 0.0 109.219 -175.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -60.44 -45.66 92.86 Favored 'General case' 0 CA--C 1.502 -0.886 0 O-C-N 123.95 0.781 . . . . 0.0 110.794 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.506 HG12 ' CD ' ' A' ' 9' ' ' LYS . 95.6 t -60.74 -49.29 85.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.745 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 83.9 m -61.91 -37.97 86.61 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 123.025 0.53 . . . . 0.0 111.255 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 48.6 mtp180 -68.13 -25.18 65.16 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.809 0.338 . . . . 0.0 110.443 178.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.8 m -80.08 -37.39 33.91 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.763 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -69.88 -25.42 63.7 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.398 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.56 31.12 1.28 Allowed Glycine 0 CA--C 1.509 -0.318 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.523 176.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.501 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 89.4 m-85 -118.85 148.52 44.71 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.32 -35.32 73.99 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.419 2.08 . . . . 0.0 112.363 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.473 HG22 ' HB2' ' A' ' 46' ' ' TYR . 7.6 t -157.51 170.56 22.14 Favored 'General case' 0 N--CA 1.42 -1.96 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.156 -176.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.26 152.31 24.4 Favored Glycine 0 N--CA 1.403 -3.553 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.541 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 25.4 m -151.96 156.68 40.52 Favored 'General case' 0 C--N 1.278 -2.521 0 C-N-CA 124.557 1.143 . . . . 0.0 109.398 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.5 m -91.86 152.43 20.09 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 120.938 0.399 . . . . 0.0 111.823 -172.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.504 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 13.0 t70 -145.84 158.3 43.87 Favored 'General case' 0 C--O 1.256 1.44 0 C-N-CA 124.158 0.983 . . . . 0.0 108.885 -176.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.03 107.74 13.01 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -139.2 6.93 2.38 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 m -149.79 160.69 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.37 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.224 -174.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.55 83.9 0.6 Allowed 'General case' 0 C--N 1.323 -0.57 0 O-C-N 124.234 0.959 . . . . 0.0 109.04 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.85 -143.71 10.61 Favored Glycine 0 N--CA 1.402 -3.568 0 N-CA-C 107.854 -2.099 . . . . 0.0 107.854 -177.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.516 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 30.7 mtp180 -141.16 119.73 12.41 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 117.462 0.631 . . . . 0.0 109.798 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -108.16 138.77 43.86 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.338 0.589 . . . . 0.0 110.644 -173.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.0 t -85.21 136.09 33.67 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.296 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.512 ' CD1' ' HG2' ' A' ' 4' ' ' LYS . 32.5 m-85 -128.85 137.06 51.25 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-O 121.888 0.851 . . . . 0.0 109.991 175.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.501 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 44.5 m -95.08 134.36 37.87 Favored 'General case' 0 C--N 1.25 -3.726 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.417 -176.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.541 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 21.6 m-85 -107.38 135.8 48.25 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 120.893 0.378 . . . . 0.0 110.753 -178.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -144.8 138.67 14.6 Favored Pre-proline 0 C--N 1.298 -1.65 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.042 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.81 121.33 7.8 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.738 2.292 . . . . 0.0 112.513 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 p -119.18 164.16 22.77 Favored Pre-proline 0 C--N 1.272 -2.801 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 171.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.421 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 31.2 Cg_exo . . . . . 0 C--O 1.262 1.718 0 C-N-CA 121.847 1.698 . . . . 0.0 110.892 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.43 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 60.9 mtt85 . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 120.877 0.37 . . . . 0.0 111.797 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 67.6 mtm -101.76 106.73 17.77 Favored 'General case' 0 CA--C 1.482 -1.649 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.6 m -85.02 114.31 22.08 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.049 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.525 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.4 ttpt -94.04 110.22 21.93 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.3 m -110.06 131.78 21.8 Favored Pre-proline 0 C--N 1.29 -2.003 0 C-N-CA 124.383 1.073 . . . . 0.0 110.156 -176.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -65.97 125.78 14.76 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.813 1.675 . . . . 0.0 112.16 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.6 p -59.42 138.37 57.68 Favored 'General case' 0 C--O 1.274 2.362 0 O-C-N 123.965 0.791 . . . . 0.0 111.584 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.6 -37.7 5.21 Favored Glycine 0 N--CA 1.421 -2.317 0 O-C-N 123.667 0.605 . . . . 0.0 113.545 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.481 ' HZ1' ' HG3' ' A' ' 27' ' ' GLU . 22.9 pttm -103.22 -3.22 26.02 Favored 'General case' 0 N--CA 1.414 -2.26 0 C-N-CA 117.98 -1.488 . . . . 0.0 112.791 -174.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.521 ' O ' ' HD3' ' A' ' 11' ' ' LYS . 24.5 t80 -71.69 121.42 18.82 Favored 'General case' 0 CA--C 1.485 -1.55 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.472 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.521 ' HD3' ' O ' ' A' ' 10' ' ' PHE . 43.7 mmtm -133.17 103.58 6.08 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.284 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 146.76 -162.65 28.54 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 119.943 -1.123 . . . . 0.0 111.8 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -95.27 117.93 31.15 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 8.7 t -86.49 71.84 10.37 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 176.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.1 m -76.9 -45.34 31.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.631 -0.668 . . . . 0.0 110.912 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -103.71 144.85 30.91 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 58.3 m-80 -73.23 -27.3 61.52 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 120.717 0.294 . . . . 0.0 111.13 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.1 m -60.2 -38.27 82.79 Favored 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 124.083 0.953 . . . . 0.0 112.494 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.478 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.1 p-10 -68.93 -42.46 76.74 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 121.391 -0.818 . . . . 0.0 110.197 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.564 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 16.9 t -59.2 -46.43 88.46 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 22.9 tttp -53.41 -54.85 30.86 Favored 'General case' 0 N--CA 1.394 -3.262 0 CA-C-N 112.453 -2.158 . . . . 0.0 108.878 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -62.36 -40.36 96.15 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 123.736 0.647 . . . . 0.0 111.96 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 19' ' ' ASN . 59.4 t -67.56 -41.07 85.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.267 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.5 m -67.17 -39.63 86.47 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 120.813 0.34 . . . . 0.0 110.714 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 61.4 mtp180 -64.03 -30.52 71.59 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-O 120.916 0.389 . . . . 0.0 110.888 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.4 p -82.45 -31.81 29.25 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.481 ' HG3' ' HZ1' ' A' ' 9' ' ' LYS . 51.5 mt-10 -66.51 -35.01 79.19 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.804 173.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.14 37.35 0.35 Allowed Glycine 0 C--N 1.316 -0.583 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.748 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.6 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 93.3 m-85 -126.19 147.11 58.39 Favored Pre-proline 0 N--CA 1.432 -1.372 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -62.52 -32.32 80.07 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 122.445 2.097 . . . . 0.0 112.427 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.464 HG22 ' HB2' ' A' ' 46' ' ' TYR . 7.2 t -159.97 170.83 20.51 Favored 'General case' 0 N--CA 1.42 -1.93 0 O-C-N 122.069 -0.395 . . . . 0.0 110.033 -176.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.73 154.27 25.73 Favored Glycine 0 N--CA 1.413 -2.89 0 N-CA-C 107.399 -2.281 . . . . 0.0 107.399 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.501 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 52.1 m -156.66 158.64 37.35 Favored 'General case' 0 C--N 1.281 -2.403 0 C-N-CA 123.868 0.867 . . . . 0.0 110.263 -176.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.5 m -91.91 150.18 21.17 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.216 0.532 . . . . 0.0 111.613 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.467 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 12.4 t70 -141.11 159.42 42.26 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.486 -178.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.35 105.98 9.88 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -140.04 7.07 2.22 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 m -148.31 160.96 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.56 0 CA-C-N 114.357 -1.292 . . . . 0.0 107.513 -175.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.58 84.37 0.43 Allowed 'General case' 0 C--N 1.32 -0.698 0 O-C-N 124.282 0.989 . . . . 0.0 109.699 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 148.19 -144.91 12.91 Favored Glycine 0 N--CA 1.404 -3.48 0 N-CA-C 108.708 -1.757 . . . . 0.0 108.708 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -129.08 124.92 36.05 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.8 tptt -111.3 128.29 55.9 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 121.346 0.593 . . . . 0.0 110.322 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 30.3 t -77.72 135.79 38.08 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.389 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 40.5 m-85 -130.72 146.72 52.26 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.498 0.666 . . . . 0.0 110.012 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.461 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 40.4 m -101.9 138.33 39.01 Favored 'General case' 0 C--N 1.253 -3.615 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.339 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.501 ' CE1' ' HB2' ' A' ' 33' ' ' SER . 33.9 m-85 -111.84 135.9 51.84 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.706 -178.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -146.94 142.37 17.01 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.951 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.29 118.32 5.47 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.472 2.115 . . . . 0.0 112.211 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 75.3 m -111.23 163.94 16.16 Favored Pre-proline 0 C--N 1.273 -2.718 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.43 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 26.5 Cg_exo . . . . . 0 C--O 1.261 1.641 0 C-N-CA 121.684 1.589 . . . . 0.0 110.163 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 50' ' ' PRO . 61.9 mtt85 . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 120.946 0.403 . . . . 0.0 111.812 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.1 mtt -105.85 109.36 21.29 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 46' ' ' TYR . 10.5 m -87.14 121.37 29.51 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.155 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.544 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 38.3 ttpt -98.96 110.56 23.15 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.2 m -113.16 132.3 22.47 Favored Pre-proline 0 C--N 1.3 -1.584 0 C-N-CA 124.293 1.037 . . . . 0.0 110.707 -176.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.71 132.24 30.11 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.459 2.106 . . . . 0.0 113.78 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.7 p -71.21 147.13 48.57 Favored 'General case' 0 C--O 1.267 1.983 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.591 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.74 -45.74 2.05 Favored Glycine 0 C--O 1.263 1.952 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.951 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.586 ' HD3' ' CD ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -92.51 3.63 55.13 Favored 'General case' 0 CA--C 1.471 -2.081 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.62 -174.423 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.448 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 17.4 t80 -79.5 119.11 22.04 Favored 'General case' 0 N--CA 1.404 -2.736 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.942 177.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HD2' ' C ' ' A' ' 10' ' ' PHE . 7.6 mmmt -131.56 99.86 4.95 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 150.09 -166.99 30.04 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 119.658 -1.258 . . . . 0.0 112.261 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -87.54 118.44 27.02 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 123.252 0.621 . . . . 0.0 112.124 -178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 8.5 t -87.98 72.4 9.27 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.545 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 22.8 m -69.14 -45.45 79.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.388 173.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -115.81 151.74 34.65 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.969 0.414 . . . . 0.0 109.973 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.498 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 93.2 m-20 -73.11 -31.07 64.1 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -176.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.0 m -59.15 -37.85 78.3 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.452 ' O ' HG22 ' A' ' 23' ' ' VAL . 1.2 p-10 -68.85 -43.4 75.53 Favored 'General case' 0 CA--C 1.499 -0.989 0 O-C-N 121.55 -0.719 . . . . 0.0 109.868 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.541 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 17.8 t -61.52 -44.41 97.11 Favored 'General case' 0 CA--C 1.471 -2.087 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 22.3 tttp -54.74 -55.12 33.33 Favored 'General case' 0 N--CA 1.393 -3.277 0 CA-C-N 112.688 -2.051 . . . . 0.0 108.735 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -60.28 -45.11 94.48 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 123.916 0.76 . . . . 0.0 111.384 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 19' ' ' ASN . 85.4 t -62.48 -44.74 99.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.62 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.4 m -66.89 -34.6 78.15 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 122.806 0.442 . . . . 0.0 111.863 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 50.0 mtp180 -69.2 -27.21 65.29 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.162 0.506 . . . . 0.0 109.83 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.417 ' C ' ' HZ1' ' A' ' 9' ' ' LYS . 25.9 m -82.51 -27.68 31.58 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.735 175.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.586 ' CD ' ' HD3' ' A' ' 9' ' ' LYS . 8.7 mm-40 -67.06 -46.74 73.41 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 121.741 -0.599 . . . . 0.0 110.401 171.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 134.9 39.65 0.17 Allowed Glycine 0 C--N 1.311 -0.825 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.489 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 95.3 m-85 -127.11 148.01 64.12 Favored Pre-proline 0 N--CA 1.434 -1.239 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -61.39 -33.05 89.48 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.511 2.141 . . . . 0.0 112.363 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.457 HG21 ' HB2' ' A' ' 46' ' ' TYR . 7.6 t -159.35 170.52 21.63 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.038 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.6 153.66 25.48 Favored Glycine 0 N--CA 1.409 -3.146 0 N-CA-C 107.37 -2.292 . . . . 0.0 107.37 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.553 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 39.4 m -156.78 158.71 37.33 Favored 'General case' 0 C--N 1.279 -2.473 0 C-N-CA 124.014 0.926 . . . . 0.0 110.095 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 44.2 m -91.0 156.74 17.72 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.3 0.571 . . . . 0.0 112.331 -170.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.442 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 22.9 t70 -148.36 152.45 37.07 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.03 -177.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.66 107.77 14.1 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -141.19 7.48 2.0 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 m -149.59 160.6 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.506 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.217 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.68 84.2 0.45 Allowed 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 124.289 0.993 . . . . 0.0 109.094 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.71 -145.72 13.75 Favored Glycine 0 N--CA 1.403 -3.523 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.545 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 32.5 mtp85 -140.1 117.61 11.48 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 117.568 0.684 . . . . 0.0 109.938 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -102.74 136.45 42.56 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-O 121.33 0.586 . . . . 0.0 110.735 -172.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.4 t -87.51 135.78 33.21 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.184 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.544 ' CD1' ' HG2' ' A' ' 4' ' ' LYS . 40.1 m-85 -129.9 146.34 51.61 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-O 121.718 0.771 . . . . 0.0 110.482 175.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.489 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 35.4 m -97.61 136.92 37.3 Favored 'General case' 0 C--N 1.252 -3.645 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.056 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.553 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 25.8 m-85 -111.54 136.11 51.18 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.913 -177.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -146.73 144.02 19.66 Favored Pre-proline 0 C--N 1.295 -1.774 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.705 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.08 120.56 6.67 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.372 2.048 . . . . 0.0 112.566 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 84.1 m -113.02 163.93 16.77 Favored Pre-proline 0 C--N 1.277 -2.551 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 170.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.428 ' O ' ' HD2' ' A' ' 1' ' ' ARG . 26.2 Cg_exo . . . . . 0 C--O 1.235 0.34 0 C-N-CA 121.838 1.692 . . . . 0.0 110.47 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.439 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 62.9 mtt85 . . . . . 0 CA--C 1.507 -0.701 0 CA-C-O 121.063 0.459 . . . . 0.0 112.045 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 66.9 mtm -105.12 107.95 19.2 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 174.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.1 m -83.5 117.13 22.89 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.798 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.632 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 36.7 ttpt -97.09 110.16 22.77 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 100.0 m -113.33 128.17 25.98 Favored Pre-proline 0 C--N 1.294 -1.822 0 C-N-CA 123.998 0.919 . . . . 0.0 110.662 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -69.39 115.98 4.3 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.992 1.795 . . . . 0.0 112.998 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -54.8 141.38 33.08 Favored 'General case' 0 C--O 1.276 2.492 0 C-N-CA 124.98 1.312 . . . . 0.0 110.376 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.29 -19.33 10.72 Favored Glycine 0 N--CA 1.433 -1.511 0 O-C-N 124.205 0.941 . . . . 0.0 114.601 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.52 ' HZ2' ' HB ' ' A' ' 26' ' ' THR . 49.0 pttt -118.35 15.5 13.9 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 118.546 1.173 . . . . 0.0 111.759 -176.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.449 ' HA ' HG11 ' A' ' 23' ' ' VAL . 57.8 t80 -62.32 136.16 57.79 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 114.389 -1.278 . . . . 0.0 113.002 -178.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.01 122.47 35.97 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 113.816 -1.538 . . . . 0.0 112.469 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.4 -175.29 25.66 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.122 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.57 139.41 32.12 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 2.9 t -88.93 65.6 7.61 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.146 0.974 . . . . 0.0 109.605 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.0 m -89.3 -29.95 5.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.024 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -107.9 114.74 28.9 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.028 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.432 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 55.4 m-80 -61.79 -29.69 70.32 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.863 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.8 m -67.03 -25.72 66.41 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 122.574 0.349 . . . . 0.0 110.883 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.504 ' O ' HG21 ' A' ' 23' ' ' VAL . 45.1 t30 -70.78 -48.26 55.21 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.52 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 12.9 t -56.74 -47.59 79.69 Favored 'General case' 0 CA--C 1.476 -1.888 0 CA-C-N 114.2 -1.364 . . . . 0.0 108.131 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 21.0 tttp -54.37 -55.26 30.34 Favored 'General case' 0 N--CA 1.399 -3.018 0 CA-C-N 112.68 -2.054 . . . . 0.0 109.634 -175.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -63.25 -38.53 91.53 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 123.757 0.661 . . . . 0.0 111.568 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 19' ' ' ASN . 57.8 t -66.27 -45.73 89.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 95.4 m -63.63 -39.75 95.15 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 120.931 0.396 . . . . 0.0 111.071 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.584 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 59.3 mtp180 -64.76 -30.24 71.24 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 121.018 0.437 . . . . 0.0 110.502 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.52 ' HB ' ' HZ2' ' A' ' 9' ' ' LYS . 7.0 p -85.58 -27.63 25.39 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 176.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.407 ' HG3' ' HE2' ' A' ' 9' ' ' LYS . 50.6 mt-10 -66.97 -40.33 87.43 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.691 171.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 134.32 41.04 0.16 Allowed Glycine 0 C--N 1.318 -0.468 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.701 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.584 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 95.0 m-85 -130.3 148.64 70.66 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -177.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -61.99 -34.79 79.9 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.448 2.099 . . . . 0.0 112.354 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.479 HG21 ' HB2' ' A' ' 46' ' ' TYR . 7.3 t -157.95 170.98 21.1 Favored 'General case' 0 N--CA 1.422 -1.867 0 O-C-N 122.056 -0.402 . . . . 0.0 110.354 -176.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.52 153.84 25.48 Favored Glycine 0 N--CA 1.414 -2.777 0 N-CA-C 107.31 -2.316 . . . . 0.0 107.31 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.471 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 44.5 m -155.83 157.02 35.73 Favored 'General case' 0 C--N 1.281 -2.408 0 C-N-CA 123.5 0.72 . . . . 0.0 110.799 -176.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.0 m -94.85 125.72 39.69 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.788 -172.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.532 ' CG ' ' HZ1' ' A' ' 4' ' ' LYS . 30.7 t70 -122.66 166.92 14.1 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.839 -174.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -122.34 116.04 23.35 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.331 0.586 . . . . 0.0 110.949 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -148.39 6.28 0.75 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 m -147.84 167.66 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.22 82.18 0.53 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 122.173 0.987 . . . . 0.0 110.146 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.09 -140.31 9.94 Favored Glycine 0 N--CA 1.401 -3.647 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.704 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -126.2 130.6 51.28 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -111.65 130.56 55.72 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 40.4 t -75.49 134.5 40.8 Favored 'General case' 0 C--O 1.278 2.569 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.632 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 40.0 m-85 -131.86 141.75 49.5 Favored 'General case' 0 N--CA 1.42 -1.957 0 O-C-N 123.933 0.771 . . . . 0.0 109.729 175.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.473 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 54.2 m -96.81 139.01 33.5 Favored 'General case' 0 C--N 1.252 -3.671 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.965 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.479 ' HB2' HG21 ' A' ' 31' ' ' THR . 37.1 m-85 -112.35 134.72 53.73 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.767 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -147.1 143.91 18.97 Favored Pre-proline 0 C--N 1.295 -1.791 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.726 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.06 121.6 7.41 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.469 2.113 . . . . 0.0 112.655 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 77.0 m -116.14 161.83 29.14 Favored Pre-proline 0 C--N 1.278 -2.532 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 170.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.439 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 16.4 Cg_endo . . . . . 0 C--O 1.26 1.611 0 C-N-CA 122.018 1.812 . . . . 0.0 110.972 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.9 mtt -105.25 114.14 28.15 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 175.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 46' ' ' TYR . 15.8 m -93.01 122.59 35.53 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.221 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.461 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 27.3 ttpp -101.23 109.86 21.79 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.0 m -116.31 127.98 26.34 Favored Pre-proline 0 C--O 1.196 -1.729 0 C-N-CA 124.258 1.023 . . . . 0.0 111.117 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -66.98 125.08 13.08 Favored 'Trans proline' 0 N--CA 1.474 0.366 0 C-N-CA 122.365 2.043 . . . . 0.0 112.784 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -70.39 142.37 52.08 Favored 'General case' 0 C--O 1.273 2.339 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.67 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.17 -40.97 6.77 Favored Glycine 0 N--CA 1.427 -1.909 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.957 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.589 ' HD3' ' CD ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -90.95 4.24 52.51 Favored 'General case' 0 CA--C 1.477 -1.862 0 C-N-CA 118.489 -1.285 . . . . 0.0 112.94 -175.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -87.19 119.17 27.15 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.705 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -130.64 162.14 30.04 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 113.764 -1.562 . . . . 0.0 107.646 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.05 -137.71 13.43 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.252 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -122.65 113.94 19.92 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.9 t -85.66 67.7 10.16 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.503 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 18.7 m -74.25 -32.88 32.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.692 172.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -119.97 121.84 39.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.642 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -56.73 -27.01 58.43 Favored 'General case' 0 C--O 1.208 -1.099 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.881 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.3 m -66.91 -29.77 69.74 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -74.96 -40.58 60.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.595 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 16.2 t -59.17 -48.9 79.89 Favored 'General case' 0 CA--C 1.473 -2.013 0 CA-C-N 114.228 -1.351 . . . . 0.0 108.271 177.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HG3' ' H ' ' A' ' 32' ' ' GLY . 15.5 ttpt -55.01 -50.6 68.62 Favored 'General case' 0 N--CA 1.391 -3.404 0 CA-C-N 113.322 -1.763 . . . . 0.0 109.104 -176.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -60.09 -49.07 79.09 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.212 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 93.0 t -60.33 -43.49 93.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 123.207 0.317 . . . . 0.0 110.825 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 68.9 m -64.75 -38.51 91.23 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 122.991 0.517 . . . . 0.0 112.068 177.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.9 mtp180 -69.93 -25.08 63.5 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.191 0.52 . . . . 0.0 109.965 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -82.85 -27.67 30.65 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.895 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.589 ' CD ' ' HD3' ' A' ' 9' ' ' LYS . 7.8 mm-40 -68.6 -42.21 78.49 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.769 -0.582 . . . . 0.0 110.607 172.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.96 35.59 0.47 Allowed Glycine 0 C--N 1.312 -0.788 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 87.2 m-85 -121.19 149.53 51.85 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -60.12 -39.75 66.58 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.486 2.124 . . . . 0.0 112.441 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.483 HG21 ' HB2' ' A' ' 46' ' ' TYR . 9.4 t -154.66 174.2 15.32 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.141 -176.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.438 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -151.88 153.05 24.69 Favored Glycine 0 N--CA 1.418 -2.516 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.55 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 28.2 m -153.79 154.06 33.3 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 123.922 0.889 . . . . 0.0 110.391 -177.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.7 m -87.4 157.13 19.31 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.161 0.505 . . . . 0.0 112.109 -170.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.458 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 9.0 t70 -147.18 158.0 43.8 Favored 'General case' 0 C--O 1.257 1.46 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.061 -175.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.16 107.8 12.14 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -140.9 7.16 2.04 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 m -149.79 166.5 3.03 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.957 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -175.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.17 -30.13 66.15 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 123.974 0.796 . . . . 0.0 111.208 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.11 -170.23 42.66 Favored Glycine 0 N--CA 1.427 -1.927 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.503 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 19.9 mtp180 -114.29 118.17 33.17 Favored 'General case' 0 C--N 1.282 -2.351 0 O-C-N 121.698 -0.883 . . . . 0.0 109.731 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -102.14 149.68 24.03 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.309 -171.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 25.6 t -98.84 139.06 35.08 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.982 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.461 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 22.9 m-85 -132.49 135.74 46.21 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-O 122.052 0.93 . . . . 0.0 109.68 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.468 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 58.6 m -90.7 141.36 28.87 Favored 'General case' 0 C--N 1.246 -3.924 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.007 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.55 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 24.0 m-85 -111.75 134.92 52.99 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.829 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -147.28 145.61 22.48 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.854 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.04 116.66 4.72 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 122.395 2.063 . . . . 0.0 112.483 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.8 m -111.19 169.76 5.97 Favored Pre-proline 0 C--N 1.28 -2.44 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 171.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo . . . . . 0 C--O 1.255 1.327 0 C-N-CA 122.16 1.907 . . . . 0.0 111.832 175.583 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.427 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 59.5 mtt85 . . . . . 0 CA--C 1.513 -0.468 0 CA-C-O 121.157 0.503 . . . . 0.0 111.819 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 63.8 mtt -110.63 101.23 9.91 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 18.5 m -80.36 114.51 19.31 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.67 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.58 ' HZ3' ' CG ' ' A' ' 35' ' ' ASP . 38.6 ttpt -93.29 111.18 22.75 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.9 m -113.14 131.84 22.67 Favored Pre-proline 0 C--N 1.298 -1.651 0 C-N-CA 124.29 1.036 . . . . 0.0 110.18 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -72.17 114.46 3.99 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.015 1.81 . . . . 0.0 112.268 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.61 144.75 30.81 Favored 'General case' 0 C--O 1.269 2.127 0 C-N-CA 124.39 1.076 . . . . 0.0 110.475 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.66 -22.37 8.12 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 115.218 0.847 . . . . 0.0 115.218 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.472 ' CD ' HG12 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -108.19 -6.39 16.43 Favored 'General case' 0 CA--C 1.475 -1.916 0 C-N-CA 117.759 -1.576 . . . . 0.0 111.609 -174.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -65.62 144.4 56.97 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 113.395 -1.729 . . . . 0.0 109.936 172.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.48 132.4 9.71 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.555 176.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.66 -170.92 14.94 Favored Glycine 0 N--CA 1.433 -1.542 0 C-N-CA 120.466 -0.874 . . . . 0.0 111.49 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -87.78 114.43 24.38 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.566 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 4.3 t -83.22 71.84 10.18 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.946 0.879 . . . . 0.0 109.355 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.1 m -87.06 -32.17 6.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.603 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -108.38 120.51 42.6 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 54.8 m-80 -61.48 -28.35 69.23 Favored 'General case' 0 C--O 1.214 -0.766 0 O-C-N 123.731 0.644 . . . . 0.0 111.836 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.7 m -64.75 -28.32 69.5 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 123.593 0.757 . . . . 0.0 110.816 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -73.66 -46.37 46.95 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.566 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 15.9 t -56.87 -44.85 82.65 Favored 'General case' 0 CA--C 1.472 -2.02 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.079 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 22.6 tttp -55.08 -55.12 34.6 Favored 'General case' 0 N--CA 1.393 -3.276 0 CA-C-N 112.85 -1.977 . . . . 0.0 108.989 -175.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -61.72 -43.74 98.26 Favored 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 123.906 0.754 . . . . 0.0 110.957 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.472 HG12 ' CD ' ' A' ' 9' ' ' LYS . 89.8 t -60.29 -48.83 86.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.884 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.6 m -63.03 -39.53 95.03 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.826 0.85 . . . . 0.0 111.649 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 54.1 mtp180 -64.42 -30.95 71.98 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.238 0.542 . . . . 0.0 110.024 177.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.0 m -85.65 -11.06 54.76 Favored 'General case' 0 CA--C 1.58 2.114 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.656 176.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.412 ' OE2' ' HG3' ' A' ' 9' ' ' LYS . 61.8 mt-10 -88.06 -27.41 22.0 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.242 -0.911 . . . . 0.0 110.287 172.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.52 34.05 0.78 Allowed Glycine 0 C--N 1.318 -0.439 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.636 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.565 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.0 m-85 -124.14 148.85 58.77 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -63.59 -34.76 62.66 Favored 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 122.394 2.063 . . . . 0.0 112.277 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.439 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.0 t -156.96 170.67 21.99 Favored 'General case' 0 N--CA 1.416 -2.126 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.085 -176.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.33 154.93 26.17 Favored Glycine 0 N--CA 1.409 -3.163 0 N-CA-C 107.085 -2.406 . . . . 0.0 107.085 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.505 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 43.9 m -155.15 152.79 29.86 Favored 'General case' 0 C--N 1.277 -2.551 0 C-N-CA 123.628 0.771 . . . . 0.0 110.641 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 17' ' ' ASN . 51.0 m -92.4 127.78 38.01 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.448 -172.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.591 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 35.0 t70 -127.24 169.43 13.51 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.047 -175.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -121.23 118.44 29.61 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.246 0.546 . . . . 0.0 111.371 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -149.3 5.52 0.64 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 174.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 m -147.38 167.01 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.316 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.66 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.5 82.17 1.09 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.741 0.781 . . . . 0.0 108.916 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.45 -150.95 23.2 Favored Glycine 0 N--CA 1.406 -3.302 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -177.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -121.78 127.48 50.67 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 122.65 -0.323 . . . . 0.0 110.672 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -109.78 132.63 53.98 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.0 t -77.21 134.64 38.57 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 174.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.591 ' CD1' ' HB3' ' A' ' 35' ' ' ASP . 46.9 m-85 -130.54 141.65 50.48 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-O 121.553 0.692 . . . . 0.0 109.337 173.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.472 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 57.3 m -96.12 139.36 32.4 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.274 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.505 ' CE1' ' HB2' ' A' ' 33' ' ' SER . 26.1 m-85 -112.9 134.23 54.51 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 121.002 0.429 . . . . 0.0 110.702 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -143.78 137.09 14.03 Favored Pre-proline 0 C--N 1.295 -1.798 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.337 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.84 118.8 5.89 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.796 2.331 . . . . 0.0 112.465 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.05 164.15 20.08 Favored Pre-proline 0 C--N 1.272 -2.786 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 171.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.427 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 32.9 Cg_exo . . . . . 0 C--O 1.264 1.796 0 C-N-CA 121.958 1.772 . . . . 0.0 110.952 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.645 ' HD3' ' OXT' ' A' ' 50' ' ' PRO . 31.7 mtp180 . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 121.184 0.516 . . . . 0.0 112.089 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.9 mtm -107.62 106.3 16.59 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.2 m -86.34 116.17 24.33 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.71 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.499 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.8 ttpt -92.97 111.42 23.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.8 m -114.9 130.47 24.15 Favored Pre-proline 0 C--N 1.295 -1.803 0 C-N-CA 124.337 1.055 . . . . 0.0 110.336 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.54 131.48 28.02 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.147 1.898 . . . . 0.0 113.253 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.0 p -59.95 143.46 51.57 Favored 'General case' 0 C--O 1.27 2.159 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.711 177.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.68 -32.31 6.01 Favored Glycine 0 N--CA 1.427 -1.918 0 O-C-N 123.58 0.55 . . . . 0.0 113.528 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.521 ' NZ ' ' HG3' ' A' ' 27' ' ' GLU . 16.1 pttm -120.24 19.26 12.2 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 118.276 1.038 . . . . 0.0 112.706 -174.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.445 ' HA ' HG12 ' A' ' 23' ' ' VAL . 59.7 t80 -63.88 135.43 56.55 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.843 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.95 118.1 28.03 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 113.498 -1.683 . . . . 0.0 112.67 -176.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.6 -160.84 19.63 Favored Glycine 0 N--CA 1.434 -1.461 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.319 173.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -88.86 138.05 31.77 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 122.993 0.517 . . . . 0.0 110.768 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.1 t -93.43 64.15 3.62 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.868 0.842 . . . . 0.0 108.977 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.489 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 18.8 m -73.83 -34.78 41.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.027 172.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -119.69 125.52 48.88 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 91.4 m-20 -56.56 -28.18 59.57 Favored 'General case' 0 C--O 1.199 -1.596 0 O-C-N 124.312 1.007 . . . . 0.0 111.354 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 89.9 m -67.4 -29.65 69.21 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.528 ' O ' HG23 ' A' ' 23' ' ' VAL . 45.6 t30 -70.05 -46.27 65.35 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.59 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 24.3 t -57.62 -51.5 69.23 Favored 'General case' 0 CA--C 1.478 -1.823 0 CA-C-N 113.991 -1.459 . . . . 0.0 108.745 177.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 11.4 ttpt -51.64 -53.76 35.27 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-N 113.275 -1.784 . . . . 0.0 109.502 -174.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -62.7 -40.93 98.68 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.404 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 19' ' ' ASN . 60.2 t -65.97 -42.46 91.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.588 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.6 m -64.85 -41.99 95.26 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 120.973 0.416 . . . . 0.0 110.853 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 43.5 mtp180 -65.21 -29.32 70.11 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.004 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 p -81.65 -30.95 32.54 Favored 'General case' 0 C--O 1.215 -0.727 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 175.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.521 ' HG3' ' NZ ' ' A' ' 9' ' ' LYS . 48.1 mt-10 -68.67 -34.94 76.55 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.889 173.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.87 36.76 0.38 Allowed Glycine 0 C--N 1.314 -0.642 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.883 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.7 m-85 -123.57 148.9 57.2 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.37 -35.96 58.59 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.121 1.881 . . . . 0.0 112.294 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 46' ' ' TYR . 8.8 t -157.74 175.5 13.81 Favored 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.88 -175.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.88 153.72 25.0 Favored Glycine 0 N--CA 1.417 -2.616 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.554 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 32.8 m -155.24 160.98 41.25 Favored 'General case' 0 C--N 1.285 -2.2 0 C-N-CA 123.636 0.774 . . . . 0.0 110.763 -177.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.4 m -93.17 153.84 18.4 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -171.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.484 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 9.9 t70 -147.49 157.29 43.51 Favored 'General case' 0 C--O 1.255 1.376 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.173 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -121.71 110.77 16.36 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 121.549 0.69 . . . . 0.0 109.231 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -146.16 7.69 1.04 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.423 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 m -149.06 165.53 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.243 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.489 -174.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.34 83.11 1.41 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.56 -148.42 19.43 Favored Glycine 0 N--CA 1.405 -3.389 0 N-CA-C 107.833 -2.107 . . . . 0.0 107.833 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.489 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 19.1 mtp180 -137.6 118.08 13.82 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 117.663 0.732 . . . . 0.0 109.58 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -103.69 134.6 46.74 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-O 121.423 0.63 . . . . 0.0 111.146 -172.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 5.9 t -84.6 136.9 33.58 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.542 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.499 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 39.1 m-85 -129.84 138.97 51.28 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-O 121.8 0.81 . . . . 0.0 109.845 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.449 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 56.9 m -95.53 136.04 36.42 Favored 'General case' 0 C--N 1.246 -3.919 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.348 -177.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.554 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 27.9 m-85 -107.61 135.19 49.48 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.863 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -146.27 140.82 15.77 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.716 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 130.95 20.27 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.536 2.158 . . . . 0.0 112.506 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.3 p -129.81 158.26 74.24 Favored Pre-proline 0 C--N 1.27 -2.875 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 171.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.645 ' OXT' ' HD3' ' A' ' 1' ' ' ARG . 31.7 Cg_exo . . . . . 0 C--O 1.275 2.329 0 C-N-CA 121.894 1.729 . . . . 0.0 110.472 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 29.3 ttm105 . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 121.258 0.552 . . . . 0.0 111.756 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 90.4 mtp -98.04 105.88 18.09 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.631 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.9 m -85.38 118.02 24.66 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.705 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.531 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 37.5 ttpt -97.39 110.52 23.06 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 98.1 m -111.55 131.48 22.31 Favored Pre-proline 0 C--N 1.29 -2.001 0 C-N-CA 124.106 0.962 . . . . 0.0 110.31 -176.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -66.54 126.42 15.48 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.002 1.801 . . . . 0.0 112.36 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.1 p -63.2 142.28 58.44 Favored 'General case' 0 C--O 1.273 2.294 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.499 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.78 -32.75 5.53 Favored Glycine 0 N--CA 1.428 -1.889 0 CA-C-N 115.951 -0.568 . . . . 0.0 114.341 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.459 ' CD ' HG12 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -111.76 -1.56 15.58 Favored 'General case' 0 CA--C 1.476 -1.895 0 O-C-N 120.976 -1.308 . . . . 0.0 111.008 -173.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -75.14 129.49 37.62 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.067 169.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.75 102.72 2.39 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.238 174.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.51 -174.09 38.86 Favored Glycine 0 N--CA 1.426 -2.005 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -80.25 111.0 16.21 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.275 0.559 . . . . 0.0 111.809 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.585 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 8.0 t -82.05 71.05 9.09 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.69 -60.17 3.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.787 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -100.93 140.71 34.84 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.931 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.484 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 91.8 m-20 -64.76 -28.01 69.29 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.496 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.6 m -63.85 -35.08 79.47 Favored 'General case' 0 CA--C 1.575 1.918 0 C-N-CA 123.236 0.614 . . . . 0.0 112.482 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.416 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.2 p-10 -72.26 -40.72 67.45 Favored 'General case' 0 CA--C 1.494 -1.193 0 O-C-N 121.179 -0.951 . . . . 0.0 109.761 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.585 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 23.1 t -59.82 -45.75 91.4 Favored 'General case' 0 CA--C 1.472 -2.043 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 24.0 tttp -53.69 -55.04 29.61 Favored 'General case' 0 N--CA 1.395 -3.215 0 CA-C-N 112.551 -2.113 . . . . 0.0 108.807 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -62.44 -43.71 98.16 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.24 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.459 HG12 ' CD ' ' A' ' 9' ' ' LYS . 92.3 t -60.94 -48.41 89.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.597 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.4 m -63.05 -38.54 91.6 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.789 0.835 . . . . 0.0 111.286 177.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 56.1 mtp180 -64.47 -31.36 72.53 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-O 121.282 0.563 . . . . 0.0 110.145 177.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.2 m -85.46 -10.66 55.81 Favored 'General case' 0 CA--C 1.578 2.032 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.548 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.429 ' OE2' ' HG3' ' A' ' 9' ' ' LYS . 68.7 mt-10 -88.13 -28.75 21.06 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.245 -0.909 . . . . 0.0 110.215 172.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.95 33.22 0.7 Allowed Glycine 0 C--N 1.318 -0.463 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.703 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.608 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.4 m-85 -123.89 147.51 54.03 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -63.69 -32.13 68.73 Favored 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.462 2.108 . . . . 0.0 112.269 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.448 HG21 ' HB2' ' A' ' 46' ' ' TYR . 7.1 t -159.37 171.5 19.66 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.02 -176.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -149.93 156.82 26.94 Favored Glycine 0 N--CA 1.408 -3.196 0 N-CA-C 107.405 -2.278 . . . . 0.0 107.405 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.538 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 39.8 m -157.42 156.89 32.99 Favored 'General case' 0 C--N 1.28 -2.445 0 C-N-CA 124.072 0.949 . . . . 0.0 110.235 -177.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.3 m -94.12 139.43 31.0 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.0 0.428 . . . . 0.0 111.257 -171.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.513 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 20.8 t70 -131.4 162.85 29.21 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.422 -176.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -120.6 112.55 19.05 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-O 121.627 0.727 . . . . 0.0 110.485 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -147.89 6.6 0.8 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.362 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 m -147.02 165.97 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.218 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.364 -175.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.25 83.46 0.75 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.826 0.822 . . . . 0.0 109.536 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.18 -143.35 12.04 Favored Glycine 0 N--CA 1.405 -3.37 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -127.01 125.9 42.22 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -111.42 125.02 53.44 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.39 0.614 . . . . 0.0 110.246 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 33.8 t -72.23 135.2 46.0 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.64 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.531 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 39.3 m-85 -130.55 143.21 50.61 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-O 121.499 0.666 . . . . 0.0 109.605 174.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.479 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 35.3 m -97.17 136.95 36.96 Favored 'General case' 0 C--N 1.25 -3.753 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.997 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.538 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 38.4 m-85 -112.18 136.15 51.95 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.585 -177.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -147.13 144.58 19.95 Favored Pre-proline 0 C--N 1.296 -1.743 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.907 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.93 120.56 6.42 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 122.457 2.105 . . . . 0.0 112.584 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.4 m -116.79 169.35 7.36 Favored Pre-proline 0 C--N 1.277 -2.553 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 171.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.263 1.734 0 C-N-CA 121.904 1.736 . . . . 0.0 110.208 174.777 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.426 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 58.2 mtt85 . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 121.063 0.459 . . . . 0.0 111.87 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.8 mtt -107.63 99.71 9.18 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 17.7 m -80.36 114.42 19.24 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.623 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.52 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.6 ttpt -92.63 110.33 21.76 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.4 m -108.8 131.9 21.5 Favored Pre-proline 0 C--N 1.301 -1.523 0 C-N-CA 124.27 1.028 . . . . 0.0 109.809 -174.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -72.3 116.28 4.65 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.66 1.573 . . . . 0.0 111.865 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -58.13 139.04 55.58 Favored 'General case' 0 C--O 1.278 2.558 0 C-N-CA 123.944 0.898 . . . . 0.0 111.097 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.57 -30.34 9.89 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.787 -175.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.478 ' HZ2' ' HG3' ' A' ' 27' ' ' GLU . 21.5 pttm -105.05 7.01 33.79 Favored 'General case' 0 N--CA 1.42 -1.954 0 C-N-CA 118.406 -1.318 . . . . 0.0 112.562 -175.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -82.73 116.66 22.19 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.641 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -126.06 134.68 51.33 Favored 'General case' 0 C--N 1.269 -2.928 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.311 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.62 -161.41 14.17 Favored Glycine 0 N--CA 1.432 -1.608 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.877 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -97.81 123.57 41.83 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.1 t -91.8 60.15 3.85 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.549 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 17.4 m -69.98 -33.28 54.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.513 173.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -111.34 121.19 44.59 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.86 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -61.88 -26.08 67.94 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.059 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 97.8 m -67.43 -31.21 71.25 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.423 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -59.43 -54.25 48.87 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 5.9 t -56.64 -49.72 74.17 Favored 'General case' 0 CA--C 1.464 -2.341 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.243 -177.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HG3' ' H ' ' A' ' 32' ' ' GLY . 0.9 OUTLIER -55.48 -46.54 76.89 Favored 'General case' 0 N--CA 1.395 -3.2 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.607 -176.203 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -68.02 -44.09 77.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.229 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.13 -40.83 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.407 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.8 m -66.2 -41.86 89.58 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 120.866 0.365 . . . . 0.0 111.571 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 35.3 mtp180 -66.55 -28.63 68.68 Favored 'General case' 0 C--O 1.211 -0.958 0 CA-C-O 120.915 0.388 . . . . 0.0 111.017 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 p -81.92 -30.97 31.59 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.478 ' HG3' ' HZ2' ' A' ' 9' ' ' LYS . 53.1 mt-10 -68.3 -32.67 72.98 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.659 172.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.12 36.29 0.55 Allowed Glycine 0 C--N 1.315 -0.631 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.977 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 92.6 m-85 -122.13 149.23 53.87 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -60.82 -38.47 70.02 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.308 2.006 . . . . 0.0 112.277 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 46' ' ' TYR . 9.1 t -158.07 173.89 16.05 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.112 -175.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.432 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -153.99 154.13 25.3 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.43 ' HB3' ' CE2' ' A' ' 46' ' ' TYR . 23.2 t -150.3 154.58 38.12 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.6 m -87.47 156.16 19.68 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 120.831 0.348 . . . . 0.0 110.569 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.42 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 22.8 t70 -145.01 153.86 41.93 Favored 'General case' 0 C--O 1.255 1.368 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.564 -175.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -119.75 105.74 11.44 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -144.13 6.14 1.33 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.118 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.0 m -148.04 164.94 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.877 -175.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.1 80.94 0.96 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.048 0.928 . . . . 0.0 109.365 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.52 -147.38 16.75 Favored Glycine 0 N--CA 1.405 -3.43 0 N-CA-C 107.833 -2.107 . . . . 0.0 107.833 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.549 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 20.8 mtp180 -139.24 117.76 12.14 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 117.581 0.691 . . . . 0.0 109.668 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -101.05 146.93 26.81 Favored 'General case' 0 N--CA 1.422 -1.835 0 O-C-N 123.536 0.522 . . . . 0.0 109.975 -172.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.4 t -97.98 141.37 31.03 Favored 'General case' 0 C--O 1.266 1.964 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.52 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 47.4 m-85 -134.87 138.08 43.83 Favored 'General case' 0 N--CA 1.419 -1.983 0 O-C-N 124.165 0.916 . . . . 0.0 110.411 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.486 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 61.5 m -96.05 135.81 37.32 Favored 'General case' 0 C--N 1.258 -3.408 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.84 -177.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.48 ' HB2' HG23 ' A' ' 31' ' ' THR . 21.7 m-85 -106.92 134.64 49.77 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 120.863 0.363 . . . . 0.0 110.803 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -144.49 137.81 14.11 Favored Pre-proline 0 C--N 1.296 -1.755 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.846 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.4 120.68 7.32 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.659 2.24 . . . . 0.0 112.362 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 p -118.28 164.45 20.23 Favored Pre-proline 0 C--N 1.272 -2.778 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 171.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.426 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 34.6 Cg_exo . . . . . 0 C--O 1.263 1.732 0 C-N-CA 121.816 1.677 . . . . 0.0 110.875 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.421 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 63.0 mtt85 . . . . . 0 N--CA 1.469 0.492 0 CA-C-O 121.023 0.44 . . . . 0.0 112.157 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 89.2 mtp -99.25 101.16 12.38 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.9 m -81.97 116.09 21.44 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.532 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.49 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 38.8 ttpt -93.08 109.77 21.25 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.6 m -107.35 132.52 20.89 Favored Pre-proline 0 C--N 1.298 -1.655 0 C-N-CA 124.373 1.069 . . . . 0.0 109.821 -174.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -71.72 115.01 4.13 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.68 1.586 . . . . 0.0 111.998 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -58.26 140.87 52.41 Favored 'General case' 0 C--O 1.278 2.605 0 C-N-CA 124.078 0.951 . . . . 0.0 111.278 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.55 -33.11 6.93 Favored Glycine 0 N--CA 1.427 -1.951 0 CA-C-N 115.749 -0.659 . . . . 0.0 114.051 -175.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.465 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 50.1 pttt -103.51 6.99 37.8 Favored 'General case' 0 CA--C 1.474 -1.972 0 O-C-N 120.995 -1.297 . . . . 0.0 112.635 -174.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -87.42 127.4 35.22 Favored 'General case' 0 N--CA 1.4 -2.93 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.012 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.7 104.04 3.0 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.92 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 156.63 -167.51 33.61 Favored Glycine 0 N--CA 1.424 -2.163 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -84.82 119.18 25.02 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.555 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.0 t -89.45 60.35 5.16 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.505 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 17.4 m -68.25 -39.59 81.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.573 173.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -110.39 121.97 46.57 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.448 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 86.7 m-20 -57.44 -28.42 63.3 Favored 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 124.153 0.981 . . . . 0.0 111.239 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 51.9 m -68.65 -26.27 65.24 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.415 ' O ' HG23 ' A' ' 23' ' ' VAL . 60.7 t30 -73.64 -42.24 61.68 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.555 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 18.3 t -58.84 -49.7 76.75 Favored 'General case' 0 CA--C 1.475 -1.937 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.244 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -53.54 -51.84 61.62 Favored 'General case' 0 N--CA 1.399 -2.995 0 CA-C-N 113.018 -1.901 . . . . 0.0 109.028 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -59.88 -48.38 81.95 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 123.693 0.621 . . . . 0.0 111.38 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 19' ' ' ASN . 92.4 t -60.2 -47.36 92.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 O-C-N 123.417 0.448 . . . . 0.0 110.707 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.1 m -60.49 -42.85 97.16 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.441 0.696 . . . . 0.0 111.9 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.6 mtp180 -65.08 -30.47 71.43 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.083 0.468 . . . . 0.0 110.24 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 m -85.46 -16.72 38.72 Favored 'General case' 0 CA--C 1.574 1.871 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.888 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.465 ' HG3' ' HE2' ' A' ' 9' ' ' LYS . 55.1 mt-10 -78.92 -38.26 37.83 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.365 -0.834 . . . . 0.0 110.309 172.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 133.39 34.7 0.31 Allowed Glycine 0 C--N 1.31 -0.908 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.1 m-85 -121.78 147.92 49.59 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -59.58 -38.34 82.89 Favored 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 122.467 2.111 . . . . 0.0 112.325 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.494 HG22 ' HB2' ' A' ' 46' ' ' TYR . 8.8 t -158.85 176.38 12.41 Favored 'General case' 0 N--CA 1.426 -1.667 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.068 -175.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.28 158.97 28.81 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.3 t -156.63 162.37 39.86 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 17' ' ' ASN . 59.2 m -96.11 156.97 16.11 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.302 0.572 . . . . 0.0 111.63 -171.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.405 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 8.2 t70 -145.85 156.62 43.68 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 124.306 1.042 . . . . 0.0 108.61 -176.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.4 107.08 10.74 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -142.29 7.81 1.78 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.4 m -149.04 160.52 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.343 -175.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.26 82.99 0.24 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 122.204 1.002 . . . . 0.0 110.007 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.78 -143.41 10.41 Favored Glycine 0 N--CA 1.403 -3.527 0 N-CA-C 107.492 -2.243 . . . . 0.0 107.492 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.505 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 23.0 mtp180 -141.68 119.86 12.16 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 117.509 0.654 . . . . 0.0 109.481 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -102.17 142.77 32.9 Favored 'General case' 0 N--CA 1.428 -1.556 0 O-C-N 123.432 0.457 . . . . 0.0 110.346 -172.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.2 t -94.13 142.12 27.76 Favored 'General case' 0 C--O 1.268 2.049 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.338 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.49 ' CD1' ' HG2' ' A' ' 4' ' ' LYS . 51.6 m-85 -135.85 139.41 43.39 Favored 'General case' 0 N--CA 1.418 -2.044 0 O-C-N 124.159 0.912 . . . . 0.0 110.421 176.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.475 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 59.8 m -96.24 137.68 34.96 Favored 'General case' 0 C--N 1.261 -3.248 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.698 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.494 ' HB2' HG22 ' A' ' 31' ' ' THR . 22.0 m-85 -108.36 135.6 49.4 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 120.992 0.425 . . . . 0.0 110.939 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -147.43 145.75 22.71 Favored Pre-proline 0 C--N 1.298 -1.643 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.385 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.04 124.19 8.91 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.343 2.029 . . . . 0.0 112.605 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.0 m -117.01 166.38 13.09 Favored Pre-proline 0 C--N 1.276 -2.593 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 170.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.421 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 22.5 Cg_exo . . . . . 0 C--O 1.259 1.574 0 C-N-CA 121.661 1.574 . . . . 0.0 110.217 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.441 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 62.2 mtt85 . . . . . 0 N--CA 1.474 0.769 0 CA-C-O 120.96 0.41 . . . . 0.0 111.841 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 68.1 mtm -103.2 108.57 19.83 Favored 'General case' 0 CA--C 1.483 -1.616 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.7 m -85.92 116.68 24.3 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.073 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.489 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 36.9 ttpt -95.78 110.17 22.36 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.0 m -110.37 132.71 21.38 Favored Pre-proline 0 C--O 1.202 -1.407 0 C-N-CA 124.253 1.021 . . . . 0.0 110.385 -174.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -72.37 119.49 6.17 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 121.947 1.765 . . . . 0.0 112.489 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m -62.83 146.6 52.28 Favored 'General case' 0 C--O 1.274 2.365 0 C-N-CA 123.86 0.864 . . . . 0.0 110.8 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.85 -27.03 4.19 Favored Glycine 0 N--CA 1.432 -1.608 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.914 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -109.5 18.3 20.5 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-O 122.257 1.027 . . . . 0.0 111.784 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -69.23 140.27 54.51 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 113.997 -1.456 . . . . 0.0 112.244 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -131.16 134.71 46.77 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 114.284 -1.326 . . . . 0.0 111.709 -177.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.29 176.22 41.97 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.546 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.92 130.57 36.74 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.5 t -83.77 67.35 9.48 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.962 0.887 . . . . 0.0 110.2 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.2 m -89.84 -25.59 5.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.978 174.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -113.76 115.75 28.3 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.189 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 92.2 m-20 -57.53 -31.17 65.82 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.939 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.2 m -66.92 -27.47 67.51 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 122.703 0.401 . . . . 0.0 111.133 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.484 ' O ' HG22 ' A' ' 23' ' ' VAL . 47.3 t30 -72.33 -46.24 56.44 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.1 t -57.82 -47.13 83.51 Favored 'General case' 0 CA--C 1.48 -1.746 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.0 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 23.2 tttp -54.6 -55.72 26.53 Favored 'General case' 0 N--CA 1.4 -2.932 0 CA-C-N 112.772 -2.013 . . . . 0.0 109.313 -175.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -61.29 -41.46 97.0 Favored 'General case' 0 CA--C 1.493 -1.237 0 O-C-N 124.001 0.813 . . . . 0.0 111.682 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 19' ' ' ASN . 89.6 t -61.95 -51.33 73.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 99.4 m -58.75 -40.8 84.94 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.221 0.95 . . . . 0.0 111.341 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 56.5 mtp180 -64.15 -33.18 75.18 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 121.063 0.458 . . . . 0.0 110.582 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.0 m -85.88 -13.34 48.21 Favored 'General case' 0 CA--C 1.579 2.095 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.031 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 23' ' ' VAL . 54.4 mt-10 -82.14 -39.66 22.95 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.352 -0.843 . . . . 0.0 109.627 172.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.46 38.82 0.13 Allowed Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.57 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 92.5 m-85 -128.01 148.89 69.24 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -62.55 -35.45 70.73 Favored 'Trans proline' 0 C--O 1.242 0.706 0 C-N-CA 122.463 2.109 . . . . 0.0 112.311 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.485 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.7 t -158.23 170.46 22.21 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.273 -176.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.76 155.91 26.69 Favored Glycine 0 N--CA 1.415 -2.703 0 N-CA-C 107.296 -2.321 . . . . 0.0 107.296 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.48 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 35.7 m -156.96 152.76 27.06 Favored 'General case' 0 C--N 1.283 -2.309 0 C-N-CA 123.79 0.836 . . . . 0.0 110.85 -176.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.7 m -94.96 132.1 40.18 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.237 0.541 . . . . 0.0 111.167 -172.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -120.32 156.31 31.56 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.124 -173.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.15 108.19 14.38 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -141.46 10.94 2.09 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.2 m -156.86 167.25 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.84 80.7 0.89 Allowed 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.682 0.753 . . . . 0.0 109.06 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.41 -157.99 27.46 Favored Glycine 0 N--CA 1.412 -2.907 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -124.43 132.25 53.5 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 117.206 0.503 . . . . 0.0 110.66 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -111.69 133.98 53.57 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 52.9 t -81.8 135.09 35.48 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.489 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 54.3 m-85 -132.31 140.2 48.49 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-O 121.79 0.805 . . . . 0.0 110.185 175.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.467 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 46.3 m -95.14 139.67 31.15 Favored 'General case' 0 C--N 1.252 -3.64 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.132 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.485 ' HB2' HG23 ' A' ' 31' ' ' THR . 35.4 m-85 -112.11 135.0 53.32 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.631 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -147.5 143.94 18.7 Favored Pre-proline 0 C--N 1.294 -1.841 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.603 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.17 122.07 7.74 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.352 2.035 . . . . 0.0 112.471 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 76.9 m -115.13 161.53 29.01 Favored Pre-proline 0 C--N 1.276 -2.607 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 170.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.441 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 17.7 Cg_endo . . . . . 0 C--O 1.262 1.719 0 C-N-CA 121.808 1.672 . . . . 0.0 110.836 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.425 ' HD2' ' O ' ' A' ' 50' ' ' PRO . 58.0 mtt85 . . . . . 0 CA--C 1.513 -0.466 0 CA-C-O 121.213 0.53 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 63.6 mtt -107.39 98.39 8.02 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 174.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.9 m -77.77 113.01 15.21 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.622 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.53 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.4 ttpt -92.94 110.56 22.02 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.4 m -109.36 131.4 21.88 Favored Pre-proline 0 C--N 1.296 -1.735 0 C-N-CA 124.137 0.975 . . . . 0.0 109.64 -174.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -71.76 114.63 4.01 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.755 1.637 . . . . 0.0 111.523 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -57.46 139.73 52.44 Favored 'General case' 0 C--O 1.274 2.359 0 C-N-CA 124.292 1.037 . . . . 0.0 111.36 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.64 -29.54 10.74 Favored Glycine 0 N--CA 1.425 -2.086 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.896 -176.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.555 ' HG3' ' CG ' ' A' ' 27' ' ' GLU . 34.1 mtmt -92.51 -19.84 21.56 Favored 'General case' 0 CA--C 1.476 -1.889 0 CA-C-N 118.337 1.069 . . . . 0.0 109.078 -175.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -70.24 113.02 7.0 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.148 -1.387 . . . . 0.0 111.909 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -138.03 76.16 1.56 Allowed 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 113.592 -1.64 . . . . 0.0 112.593 -179.706 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.47 -167.19 38.1 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -82.78 120.2 25.32 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 6.9 t -88.33 64.0 7.39 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.887 0.851 . . . . 0.0 109.182 176.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 41' ' ' ARG . 19.3 m -72.85 -35.2 48.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.189 171.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -109.98 119.2 38.57 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.3 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 55.4 m-80 -64.77 -30.32 71.33 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.467 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.5 m -68.85 -24.47 64.36 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 122.568 0.347 . . . . 0.0 110.421 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.436 ' O ' HG23 ' A' ' 23' ' ' VAL . 54.2 t30 -74.01 -46.1 45.74 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.616 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 33.1 t -55.28 -47.32 75.69 Favored 'General case' 0 CA--C 1.474 -1.963 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.98 176.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 19.2 tttp -54.57 -53.26 56.94 Favored 'General case' 0 N--CA 1.391 -3.379 0 CA-C-N 112.278 -2.237 . . . . 0.0 109.33 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -61.86 -42.98 99.7 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 123.5 0.5 . . . . 0.0 111.521 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 19' ' ' ASN . 48.4 t -64.94 -43.94 96.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.019 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 74.6 m -64.0 -40.9 97.39 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 120.96 0.409 . . . . 0.0 111.388 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 52.7 mtp180 -67.06 -26.06 66.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.955 0.407 . . . . 0.0 110.727 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.43 ' CB ' ' HZ3' ' A' ' 9' ' ' LYS . 3.7 p -85.21 -36.43 20.98 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 175.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.555 ' CG ' ' HG3' ' A' ' 9' ' ' LYS . 56.9 mt-10 -57.04 -45.61 83.05 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 120.612 0.244 . . . . 0.0 111.333 168.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 135.39 43.72 0.11 Allowed Glycine 0 C--N 1.318 -0.46 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.849 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.473 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 89.5 m-85 -128.61 149.58 72.29 Favored Pre-proline 0 C--N 1.307 -1.266 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -62.25 -37.68 60.23 Favored 'Trans proline' 0 C--O 1.24 0.602 0 C-N-CA 122.394 2.063 . . . . 0.0 112.286 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.457 HG22 ' HB2' ' A' ' 46' ' ' TYR . 7.6 t -155.29 169.07 25.04 Favored 'General case' 0 N--CA 1.418 -2.065 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.438 -176.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.54 152.15 24.26 Favored Glycine 0 N--CA 1.408 -3.226 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.533 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 46.8 m -155.07 157.66 37.88 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 124.09 0.956 . . . . 0.0 110.002 -177.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 46.2 m -91.67 153.81 19.42 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.994 0.426 . . . . 0.0 112.076 -170.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.531 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 13.3 t70 -148.38 158.31 44.03 Favored 'General case' 0 C--O 1.255 1.349 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.542 -177.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -118.86 111.14 18.03 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-O 121.61 0.719 . . . . 0.0 109.902 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -145.38 6.42 1.11 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.479 177.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.82 164.41 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.265 -174.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.05 80.75 1.23 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.022 0.915 . . . . 0.0 109.002 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.26 -144.52 11.29 Favored Glycine 0 N--CA 1.403 -3.551 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.458 ' CZ ' ' HA ' ' A' ' 15' ' ' VAL . 19.7 mtp180 -139.55 118.59 12.6 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -104.75 144.51 31.64 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 121.268 0.556 . . . . 0.0 110.23 -173.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.3 t -92.83 141.27 28.62 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.997 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.531 ' CD1' ' HB3' ' A' ' 35' ' ' ASP . 42.5 m-85 -133.74 140.57 47.06 Favored 'General case' 0 N--CA 1.414 -2.242 0 O-C-N 124.053 0.846 . . . . 0.0 109.889 175.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.473 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 58.6 m -94.52 135.34 36.07 Favored 'General case' 0 C--N 1.255 -3.506 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.521 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.533 ' CE1' ' HB2' ' A' ' 33' ' ' SER . 28.0 m-85 -108.89 133.7 52.55 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.743 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -144.85 138.31 14.26 Favored Pre-proline 0 C--N 1.294 -1.812 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.975 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.4 121.7 8.24 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.744 2.296 . . . . 0.0 112.27 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.7 p -121.64 162.24 37.51 Favored Pre-proline 0 C--N 1.273 -2.755 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 172.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.425 ' O ' ' HD2' ' A' ' 1' ' ' ARG . 13.6 Cg_endo . . . . . 0 CA--C 1.533 0.464 0 C-N-CA 122.113 1.875 . . . . 0.0 111.503 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.64 ' HD3' ' O ' ' A' ' 50' ' ' PRO . 32.2 mtp180 . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 120.825 0.345 . . . . 0.0 111.677 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 69.5 mtm -105.01 113.81 27.63 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.1 m -90.96 117.93 29.94 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.112 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.477 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 39.4 ttpt -94.22 110.52 22.25 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.0 m -111.48 131.63 22.22 Favored Pre-proline 0 C--N 1.295 -1.765 0 C-N-CA 124.426 1.09 . . . . 0.0 110.357 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.04 129.31 21.54 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.051 1.834 . . . . 0.0 113.119 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.1 p -58.9 141.72 52.72 Favored 'General case' 0 C--O 1.269 2.102 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.45 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -97.71 -29.17 7.89 Favored Glycine 0 N--CA 1.431 -1.67 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.442 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.617 ' NZ ' ' HG3' ' A' ' 27' ' ' GLU . 9.6 pttm -126.01 23.56 7.14 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-N 117.889 0.844 . . . . 0.0 112.889 -175.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -67.96 140.16 56.41 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.85 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.63 131.55 51.44 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.893 -176.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.31 -157.47 28.01 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.103 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -93.22 138.48 31.57 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 122.724 0.41 . . . . 0.0 111.334 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.583 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.0 t -93.94 62.92 3.18 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.514 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 17.7 m -72.79 -34.78 47.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.865 172.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -120.8 127.71 52.2 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -176.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 93.2 m-20 -56.61 -27.94 59.34 Favored 'General case' 0 C--O 1.2 -1.548 0 C-N-CA 124.395 1.078 . . . . 0.0 111.57 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.6 m -64.38 -34.87 79.18 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 122.95 0.5 . . . . 0.0 112.29 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.535 ' O ' HG23 ' A' ' 23' ' ' VAL . 49.5 t30 -69.29 -45.35 69.83 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.583 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 20.7 t -58.22 -51.9 67.82 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-N 114.541 -1.208 . . . . 0.0 108.779 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 15.3 ttpt -52.17 -53.03 48.11 Favored 'General case' 0 N--CA 1.406 -2.645 0 CA-C-N 113.299 -1.773 . . . . 0.0 109.554 -174.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -61.61 -45.65 93.2 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.189 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 19' ' ' ASN . 58.3 t -60.22 -48.9 86.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 O-C-N 123.47 0.482 . . . . 0.0 110.262 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 95.2 m -59.33 -40.69 87.12 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 123.573 0.749 . . . . 0.0 111.418 177.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.2 mtp180 -66.02 -28.53 68.94 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.285 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.479 ' HB ' ' HZ1' ' A' ' 9' ' ' LYS . 4.4 m -77.73 -29.37 51.13 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.036 175.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.617 ' HG3' ' NZ ' ' A' ' 9' ' ' LYS . 42.2 mt-10 -75.57 -22.71 56.75 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.749 0.309 . . . . 0.0 111.448 177.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.94 21.89 3.39 Favored Glycine 0 CA--C 1.501 -0.84 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.234 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.7 m-85 -106.54 145.15 30.44 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -60.58 -33.99 92.98 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.521 2.147 . . . . 0.0 112.463 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.47 HG22 ' HB2' ' A' ' 46' ' ' TYR . 9.9 t -160.82 175.43 12.58 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -175.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.462 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -154.05 158.41 28.12 Favored Glycine 0 N--CA 1.428 -1.855 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.445 ' HB3' ' CE1' ' A' ' 46' ' ' TYR . 15.5 t -153.77 163.64 39.69 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 59.6 m -95.82 152.9 18.06 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.281 0.562 . . . . 0.0 112.041 -172.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.423 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 8.7 t70 -144.1 156.73 44.47 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 124.462 1.105 . . . . 0.0 108.26 -177.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.17 107.18 10.5 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -141.67 8.69 1.96 Allowed 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.3 m -150.28 161.16 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.544 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.34 82.35 0.37 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.207 1.004 . . . . 0.0 109.583 177.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.07 -146.9 15.52 Favored Glycine 0 N--CA 1.404 -3.497 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 -177.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.514 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 21.5 mtp180 -140.71 118.38 11.64 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 117.759 0.78 . . . . 0.0 109.319 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -103.1 132.6 49.24 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-O 121.394 0.616 . . . . 0.0 111.014 -171.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.6 t -84.17 138.87 32.77 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.646 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.477 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 43.5 m-85 -131.7 139.64 49.09 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.751 0.786 . . . . 0.0 110.023 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.494 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 44.6 m -95.33 138.65 32.73 Favored 'General case' 0 C--N 1.252 -3.632 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.518 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.47 ' HB2' HG22 ' A' ' 31' ' ' THR . 21.5 m-85 -110.79 136.75 49.37 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 120.853 0.359 . . . . 0.0 110.973 -178.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -146.72 143.18 18.19 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.68 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.37 119.86 6.4 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.343 2.029 . . . . 0.0 112.458 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 95.1 m -111.75 159.27 33.99 Favored Pre-proline 0 C--N 1.276 -2.61 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 171.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.64 ' O ' ' HD3' ' A' ' 1' ' ' ARG . 38.2 Cg_exo . . . . . 0 C--O 1.251 1.156 0 C-N-CA 121.685 1.59 . . . . 0.0 109.528 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.435 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 61.4 mtt85 . . . . . 0 CA--C 1.512 -0.519 0 CA-C-O 121.212 0.529 . . . . 0.0 111.777 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.6 mtm -110.41 101.03 9.78 Favored 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 175.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.5 m -80.1 112.23 17.22 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.289 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.562 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 37.3 ttpt -93.14 111.24 22.81 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.5 m -117.68 124.05 29.21 Favored Pre-proline 0 C--N 1.293 -1.889 0 C-N-CA 123.734 0.814 . . . . 0.0 110.385 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -64.16 123.31 11.66 Favored 'Trans proline' 0 CA--C 1.521 -0.137 0 C-N-CA 122.294 1.996 . . . . 0.0 112.72 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -61.38 141.72 57.43 Favored 'General case' 0 C--O 1.281 2.714 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.502 -177.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.31 -30.0 11.56 Favored Glycine 0 N--CA 1.419 -2.448 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.761 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 45.6 pttt -106.52 2.14 25.96 Favored 'General case' 0 N--CA 1.418 -2.068 0 C-N-CA 117.655 -1.618 . . . . 0.0 113.852 -174.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -83.08 129.95 35.08 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.457 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -131.38 162.69 29.56 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 173.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.7 -153.42 19.87 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.457 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -106.66 111.76 24.45 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.045 0.45 . . . . 0.0 112.171 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 7.6 t -83.36 70.48 10.18 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.645 0.736 . . . . 0.0 109.066 176.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.477 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 90.5 t -73.32 -51.12 27.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.242 171.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.514 ' OD1' ' HB ' ' A' ' 18' ' ' THR . 5.4 t-20 -98.97 124.32 43.86 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.21 -176.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.481 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 93.4 m-20 -62.14 -29.15 70.14 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 114.383 -1.28 . . . . 0.0 112.61 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.514 ' HB ' ' OD1' ' A' ' 16' ' ' ASN . 9.8 m -65.12 -34.09 77.57 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 123.204 0.602 . . . . 0.0 110.584 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -70.01 -45.15 67.86 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 15.1 t -56.95 -46.94 81.77 Favored 'General case' 0 CA--C 1.48 -1.739 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.084 177.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 21.3 tttp -55.53 -53.98 49.7 Favored 'General case' 0 N--CA 1.391 -3.39 0 CA-C-N 112.567 -2.106 . . . . 0.0 108.701 -176.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -58.42 -48.05 81.93 Favored 'General case' 0 CA--C 1.499 -0.995 0 O-C-N 123.99 0.806 . . . . 0.0 111.194 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.5 t -60.81 -47.32 93.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 O-C-N 123.313 0.383 . . . . 0.0 110.594 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 69.6 m -61.49 -40.42 94.51 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 123.2 0.6 . . . . 0.0 111.839 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.503 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 47.5 mtp180 -66.9 -28.86 68.65 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.268 0.556 . . . . 0.0 110.17 178.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.1 m -85.48 -18.58 33.13 Favored 'General case' 0 CA--C 1.572 1.826 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.493 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.476 ' HG3' ' HE2' ' A' ' 9' ' ' LYS . 57.4 mt-10 -78.23 -40.98 35.68 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.4 -0.812 . . . . 0.0 110.424 171.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 135.53 38.48 0.18 Allowed Glycine 0 C--N 1.312 -0.781 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.522 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 89.1 m-85 -126.89 149.99 70.42 Favored Pre-proline 0 C--N 1.308 -1.214 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -63.61 -35.69 57.53 Favored 'Trans proline' 0 C--O 1.242 0.684 0 C-N-CA 122.392 2.062 . . . . 0.0 112.514 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.467 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.5 t -157.15 169.89 23.74 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.23 -176.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.68 153.74 25.53 Favored Glycine 0 N--CA 1.41 -3.056 0 N-CA-C 107.933 -2.067 . . . . 0.0 107.933 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.584 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 34.6 m -157.5 149.53 22.4 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 124.447 1.099 . . . . 0.0 110.139 -177.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.1 m -85.33 141.89 29.72 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -171.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.815 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 16.9 t70 -149.55 -172.28 4.1 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -132.69 127.71 35.4 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 120.945 -1.097 . . . . 0.0 110.977 -173.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.653 ' CE1' ' HG2' ' A' ' 42' ' ' LYS . 5.8 p-80 -149.13 11.16 0.81 Allowed 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 167.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.5 HG11 ' CD2' ' A' ' 37' ' ' HIS . 2.5 m -147.76 155.86 9.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.791 -174.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.03 84.79 0.99 Allowed 'General case' 0 C--N 1.314 -0.944 0 O-C-N 124.385 1.053 . . . . 0.0 108.963 177.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.19 -137.4 5.48 Favored Glycine 0 N--CA 1.404 -3.435 0 N-CA-C 107.901 -2.08 . . . . 0.0 107.901 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.477 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 18.8 mtp180 -136.53 119.6 16.52 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 117.453 0.626 . . . . 0.0 110.821 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.653 ' HG2' ' CE1' ' A' ' 37' ' ' HIS . 50.3 tptt -105.36 145.94 30.1 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 121.705 0.764 . . . . 0.0 111.125 -172.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 40.8 t -92.26 141.03 29.01 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.577 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.815 ' CD2' ' HB3' ' A' ' 35' ' ' ASP . 31.9 m-85 -130.88 140.87 50.27 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.522 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 61.4 m -95.55 133.77 39.2 Favored 'General case' 1 C--N 1.24 -4.173 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.872 -179.633 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.584 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 22.8 m-85 -107.58 133.91 51.35 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.591 -177.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -140.87 134.45 14.84 Favored Pre-proline 0 C--N 1.295 -1.798 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.351 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.21 118.28 5.6 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.947 2.431 . . . . 0.0 112.682 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 p -116.76 161.29 32.97 Favored Pre-proline 0 C--N 1.271 -2.838 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 172.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.435 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 18.3 Cg_endo . . . . . 0 C--O 1.264 1.79 0 C-N-CA 121.947 1.764 . . . . 0.0 111.375 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.445 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 59.5 mtt85 . . . . . 0 N--CA 1.467 0.376 0 CA-C-O 121.086 0.47 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.0 mtt -111.82 101.44 9.78 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.2 m -81.48 111.89 18.22 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.738 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.482 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 38.1 ttpt -93.54 110.97 22.54 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.106 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.8 m -109.13 133.11 20.85 Favored Pre-proline 0 C--N 1.3 -1.567 0 C-N-CA 124.381 1.072 . . . . 0.0 109.837 -177.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -72.72 117.44 5.13 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 121.832 1.688 . . . . 0.0 112.15 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -61.8 146.81 48.41 Favored 'General case' 0 C--O 1.274 2.357 0 C-N-CA 123.728 0.811 . . . . 0.0 110.244 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -110.78 -24.77 5.42 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.497 -0.859 . . . . 0.0 114.014 -175.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.518 ' CD ' HG12 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -105.53 -3.2 22.7 Favored 'General case' 0 CA--C 1.484 -1.573 0 CA-C-O 122.153 0.978 . . . . 0.0 110.578 -174.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.436 ' CD2' HG21 ' A' ' 23' ' ' VAL . 30.4 t80 -67.19 116.75 8.33 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 113.471 -1.695 . . . . 0.0 108.499 171.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -128.29 94.05 3.8 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 150.65 -161.12 28.89 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.693 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -90.19 127.79 36.21 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 6.3 t -90.5 64.35 5.8 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-O 121.868 0.842 . . . . 0.0 109.061 176.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.504 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 18.5 m -72.47 -36.47 54.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.559 171.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -111.74 121.46 45.16 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.3 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 54.7 m-80 -64.66 -31.21 72.32 Favored 'General case' 0 C--O 1.214 -0.787 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.451 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.0 m -67.43 -24.27 65.62 Favored 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 122.592 0.357 . . . . 0.0 110.537 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -73.69 -48.05 35.02 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.587 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 16.1 t -56.09 -44.36 78.94 Favored 'General case' 0 CA--C 1.477 -1.85 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.132 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 22.5 tttp -54.77 -54.95 35.4 Favored 'General case' 0 N--CA 1.392 -3.351 0 CA-C-N 112.79 -2.005 . . . . 0.0 109.264 -175.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -62.21 -43.06 99.69 Favored 'General case' 0 CA--C 1.497 -1.094 0 O-C-N 123.815 0.697 . . . . 0.0 110.745 -176.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.518 HG12 ' CD ' ' A' ' 9' ' ' LYS . 72.9 t -56.95 -52.52 54.52 Favored 'Isoleucine or valine' 0 C--O 1.253 1.257 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.702 178.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 92.9 m -63.31 -38.03 89.56 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 124.363 1.04 . . . . 0.0 111.829 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 53.7 mtp180 -65.21 -29.08 69.85 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.092 0.472 . . . . 0.0 110.171 177.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 m -85.65 -14.61 45.01 Favored 'General case' 0 CA--C 1.578 2.036 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.793 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.465 ' OE2' ' HG3' ' A' ' 9' ' ' LYS . 47.2 mt-10 -86.99 -25.4 24.3 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.293 -0.879 . . . . 0.0 110.543 174.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.33 39.84 0.57 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.607 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 91.8 m-85 -129.17 148.56 69.59 Favored Pre-proline 0 C--N 1.311 -1.067 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -64.0 -34.19 59.93 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.346 2.03 . . . . 0.0 112.267 177.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.435 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.1 t -156.93 168.74 26.57 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.005 -176.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.64 153.63 25.46 Favored Glycine 0 N--CA 1.408 -3.216 0 N-CA-C 106.853 -2.499 . . . . 0.0 106.853 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.576 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 46.1 m -155.91 158.97 38.87 Favored 'General case' 0 C--N 1.275 -2.644 0 C-N-CA 123.704 0.802 . . . . 0.0 110.297 -176.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.1 m -92.61 157.06 16.69 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.259 0.552 . . . . 0.0 111.841 -170.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.467 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 7.5 t70 -148.08 155.19 41.18 Favored 'General case' 0 C--O 1.256 1.438 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.989 -177.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -122.09 110.1 15.35 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -147.08 8.6 0.95 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.507 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.9 m -149.43 164.07 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.129 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.385 -174.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.4 80.47 1.4 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.108 0.956 . . . . 0.0 109.011 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.77 -148.22 18.07 Favored Glycine 0 N--CA 1.403 -3.521 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 -176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.504 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 20.8 mtp180 -139.1 117.85 12.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 117.517 0.659 . . . . 0.0 109.486 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -101.09 141.67 33.64 Favored 'General case' 0 N--CA 1.421 -1.886 0 O-C-N 123.519 0.512 . . . . 0.0 110.395 -172.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.3 t -94.75 139.1 31.71 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.974 177.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.482 ' CD1' ' HG2' ' A' ' 4' ' ' LYS . 46.6 m-85 -134.27 142.29 47.27 Favored 'General case' 0 N--CA 1.42 -1.939 0 O-C-N 123.956 0.785 . . . . 0.0 109.855 175.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.484 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 39.8 m -94.68 139.14 31.62 Favored 'General case' 0 C--N 1.256 -3.487 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.311 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 33' ' ' SER . 30.2 m-85 -113.99 134.49 54.81 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.783 -178.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -140.98 134.72 14.86 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.481 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.12 110.64 2.87 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.922 2.414 . . . . 0.0 112.237 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 p -109.29 163.17 17.64 Favored Pre-proline 0 C--N 1.274 -2.708 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 173.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.445 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 29.7 Cg_exo . . . . . 0 C--O 1.263 1.725 0 C-N-CA 121.938 1.759 . . . . 0.0 110.996 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.421 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 59.2 mtt85 . . . . . 0 CA--C 1.514 -0.437 0 CA-C-O 121.159 0.504 . . . . 0.0 111.835 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.3 mtt -108.71 100.62 9.83 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 174.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.5 m -80.67 114.56 19.64 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.605 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.512 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 38.7 ttpt -92.82 110.7 22.15 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.7 m -110.64 131.15 22.23 Favored Pre-proline 0 C--N 1.295 -1.798 0 C-N-CA 124.355 1.062 . . . . 0.0 110.126 -175.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -66.25 127.38 17.38 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 121.719 1.613 . . . . 0.0 111.968 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.3 p -60.07 143.41 52.13 Favored 'General case' 0 C--O 1.271 2.185 0 O-C-N 123.914 0.759 . . . . 0.0 111.415 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -97.1 -28.93 8.29 Favored Glycine 0 N--CA 1.425 -2.064 0 O-C-N 123.721 0.638 . . . . 0.0 114.518 -176.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.634 ' NZ ' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -121.13 -2.64 9.61 Favored 'General case' 0 C--O 1.26 1.62 0 CA-C-N 118.947 1.374 . . . . 0.0 112.47 -175.505 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -65.66 120.62 13.28 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 113.76 -1.564 . . . . 0.0 109.202 169.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -137.09 84.54 2.07 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.516 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 166.07 -166.16 38.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -83.7 119.12 24.39 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 122.88 0.472 . . . . 0.0 111.992 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.581 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 7.1 t -88.65 69.56 8.79 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.503 0.668 . . . . 0.0 109.263 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.516 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 62.1 t -68.23 -56.6 12.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.042 172.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -101.5 127.66 48.09 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.769 -176.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 91.0 m-20 -56.52 -31.17 63.85 Favored 'General case' 0 C--O 1.204 -1.292 0 C-N-CA 124.417 1.087 . . . . 0.0 111.518 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.4 m -64.25 -28.92 70.06 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 123.519 0.728 . . . . 0.0 111.192 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.418 ' O ' HG23 ' A' ' 23' ' ' VAL . 56.8 t30 -74.43 -45.1 48.63 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.581 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 24.9 t -56.77 -46.5 81.44 Favored 'General case' 0 CA--C 1.471 -2.084 0 CA-C-N 114.343 -1.298 . . . . 0.0 107.799 176.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 19.9 tttp -53.78 -54.89 31.84 Favored 'General case' 0 N--CA 1.394 -3.25 0 CA-C-N 112.664 -2.062 . . . . 0.0 109.219 -175.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -60.44 -45.66 92.86 Favored 'General case' 0 CA--C 1.502 -0.886 0 O-C-N 123.95 0.781 . . . . 0.0 110.794 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.506 HG12 ' CD ' ' A' ' 9' ' ' LYS . 95.6 t -60.74 -49.29 85.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.745 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 83.9 m -61.91 -37.97 86.61 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 123.025 0.53 . . . . 0.0 111.255 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 48.6 mtp180 -68.13 -25.18 65.16 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.809 0.338 . . . . 0.0 110.443 178.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.8 m -80.08 -37.39 33.91 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.763 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -69.88 -25.42 63.7 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.398 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.56 31.12 1.28 Allowed Glycine 0 CA--C 1.509 -0.318 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.523 176.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.501 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 89.4 m-85 -118.85 148.52 44.71 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.32 -35.32 73.99 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.419 2.08 . . . . 0.0 112.363 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.473 HG22 ' HB2' ' A' ' 46' ' ' TYR . 7.6 t -157.51 170.56 22.14 Favored 'General case' 0 N--CA 1.42 -1.96 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.156 -176.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.26 152.31 24.4 Favored Glycine 0 N--CA 1.403 -3.553 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.541 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 25.4 m -151.96 156.68 40.52 Favored 'General case' 0 C--N 1.278 -2.521 0 C-N-CA 124.557 1.143 . . . . 0.0 109.398 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.5 m -91.86 152.43 20.09 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 120.938 0.399 . . . . 0.0 111.823 -172.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.504 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 13.0 t70 -145.84 158.3 43.87 Favored 'General case' 0 C--O 1.256 1.44 0 C-N-CA 124.158 0.983 . . . . 0.0 108.885 -176.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.03 107.74 13.01 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -139.2 6.93 2.38 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 m -149.79 160.69 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.37 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.224 -174.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.55 83.9 0.6 Allowed 'General case' 0 C--N 1.323 -0.57 0 O-C-N 124.234 0.959 . . . . 0.0 109.04 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.85 -143.71 10.61 Favored Glycine 0 N--CA 1.402 -3.568 0 N-CA-C 107.854 -2.099 . . . . 0.0 107.854 -177.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.516 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 30.7 mtp180 -141.16 119.73 12.41 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 117.462 0.631 . . . . 0.0 109.798 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -108.16 138.77 43.86 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.338 0.589 . . . . 0.0 110.644 -173.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.0 t -85.21 136.09 33.67 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.296 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.512 ' CD1' ' HG2' ' A' ' 4' ' ' LYS . 32.5 m-85 -128.85 137.06 51.25 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-O 121.888 0.851 . . . . 0.0 109.991 175.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.501 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 44.5 m -95.08 134.36 37.87 Favored 'General case' 0 C--N 1.25 -3.726 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.417 -176.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.541 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 21.6 m-85 -107.38 135.8 48.25 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 120.893 0.378 . . . . 0.0 110.753 -178.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -144.8 138.67 14.6 Favored Pre-proline 0 C--N 1.298 -1.65 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.042 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.81 121.33 7.8 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.738 2.292 . . . . 0.0 112.513 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 p -119.18 164.16 22.77 Favored Pre-proline 0 C--N 1.272 -2.801 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 171.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.421 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 31.2 Cg_exo . . . . . 0 C--O 1.262 1.718 0 C-N-CA 121.847 1.698 . . . . 0.0 110.892 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.424 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 60.9 mtt85 . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 120.877 0.37 . . . . 0.0 111.797 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 67.6 mtm -101.76 106.73 17.77 Favored 'General case' 0 CA--C 1.482 -1.649 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.6 m -85.02 114.31 22.08 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.049 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.525 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.4 ttpt -94.04 110.22 21.93 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.3 m -110.06 131.78 21.8 Favored Pre-proline 0 C--N 1.29 -2.003 0 C-N-CA 124.383 1.073 . . . . 0.0 110.156 -176.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -65.97 125.78 14.76 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.813 1.675 . . . . 0.0 112.16 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.6 p -59.42 138.37 57.68 Favored 'General case' 0 C--O 1.274 2.362 0 O-C-N 123.965 0.791 . . . . 0.0 111.584 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.6 -37.7 5.21 Favored Glycine 0 N--CA 1.421 -2.317 0 O-C-N 123.667 0.605 . . . . 0.0 113.545 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.509 ' NZ ' ' HG3' ' A' ' 27' ' ' GLU . 22.9 pttm . . . . . 0 N--CA 1.414 -2.26 0 C-N-CA 117.98 -1.488 . . . . 0.0 112.791 -174.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 N--CA 1.438 -1.037 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 8.7 t -86.49 71.84 10.37 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 176.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.1 m -76.9 -45.34 31.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.631 -0.668 . . . . 0.0 110.912 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -103.71 144.85 30.91 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 58.3 m-80 -73.23 -27.3 61.52 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 120.717 0.294 . . . . 0.0 111.13 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.1 m -60.2 -38.27 82.79 Favored 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 124.083 0.953 . . . . 0.0 112.494 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.472 HD21 ' HA ' ' A' ' 14' ' ' CYS . 1.1 p-10 -68.93 -42.46 76.74 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 121.391 -0.818 . . . . 0.0 110.197 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.645 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 16.9 t -59.2 -46.43 88.46 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 22.9 tttp -53.41 -54.85 30.86 Favored 'General case' 0 N--CA 1.394 -3.262 0 CA-C-N 112.453 -2.158 . . . . 0.0 108.878 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -62.36 -40.36 96.15 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 123.736 0.647 . . . . 0.0 111.96 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 19' ' ' ASN . 59.4 t -67.56 -41.07 85.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.267 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.5 m -67.17 -39.63 86.47 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 120.813 0.34 . . . . 0.0 110.714 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.584 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 61.4 mtp180 -64.03 -30.52 71.59 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-O 120.916 0.389 . . . . 0.0 110.888 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.4 p -82.45 -31.81 29.25 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.509 ' HG3' ' NZ ' ' A' ' 9' ' ' LYS . 51.5 mt-10 -66.51 -35.01 79.19 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.804 173.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.14 37.35 0.35 Allowed Glycine 0 C--N 1.316 -0.583 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.748 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.584 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 93.3 m-85 -126.19 147.11 58.39 Favored Pre-proline 0 N--CA 1.432 -1.372 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -62.52 -32.32 80.07 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 122.445 2.097 . . . . 0.0 112.427 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.557 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.2 t -159.97 170.83 20.51 Favored 'General case' 0 N--CA 1.42 -1.93 0 O-C-N 122.069 -0.395 . . . . 0.0 110.033 -176.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 45' ' ' CYS . . . -148.73 154.27 25.73 Favored Glycine 0 N--CA 1.413 -2.89 0 N-CA-C 107.399 -2.281 . . . . 0.0 107.399 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.553 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 52.1 m -156.66 158.64 37.35 Favored 'General case' 0 C--N 1.281 -2.403 0 C-N-CA 123.868 0.867 . . . . 0.0 110.263 -176.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.5 m -91.91 150.18 21.17 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.216 0.532 . . . . 0.0 111.613 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.5 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 12.4 t70 -141.11 159.42 42.26 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.486 -178.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.35 105.98 9.88 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -140.04 7.07 2.22 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 m -148.31 160.96 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.56 0 CA-C-N 114.357 -1.292 . . . . 0.0 107.513 -175.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.58 84.37 0.43 Allowed 'General case' 0 C--N 1.32 -0.698 0 O-C-N 124.282 0.989 . . . . 0.0 109.699 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 148.19 -144.91 12.91 Favored Glycine 0 N--CA 1.404 -3.48 0 N-CA-C 108.708 -1.757 . . . . 0.0 108.708 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -129.08 124.92 36.05 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.8 tptt -111.3 128.29 55.9 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 121.346 0.593 . . . . 0.0 110.322 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 30.3 t -77.72 135.79 38.08 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.389 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 40.5 m-85 -130.72 146.72 52.26 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.498 0.666 . . . . 0.0 110.012 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.463 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 40.4 m -101.9 138.33 39.01 Favored 'General case' 0 C--N 1.253 -3.615 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.339 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.557 ' HB2' HG23 ' A' ' 31' ' ' THR . 33.9 m-85 -111.84 135.9 51.84 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.706 -178.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -146.94 142.37 17.01 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.951 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.29 118.32 5.47 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.472 2.115 . . . . 0.0 112.211 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 75.3 m -111.23 163.94 16.16 Favored Pre-proline 0 C--N 1.273 -2.718 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.424 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 26.5 Cg_exo . . . . . 0 C--O 1.261 1.641 0 C-N-CA 121.684 1.589 . . . . 0.0 110.163 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.425 ' HD2' ' O ' ' A' ' 50' ' ' PRO . 61.9 mtt85 . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 120.946 0.403 . . . . 0.0 111.812 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.1 mtt -105.85 109.36 21.29 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 46' ' ' TYR . 10.5 m -87.14 121.37 29.51 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.155 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.547 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 38.3 ttpt -98.96 110.56 23.15 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.2 m -113.16 132.3 22.47 Favored Pre-proline 0 C--N 1.3 -1.584 0 C-N-CA 124.293 1.037 . . . . 0.0 110.707 -176.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.71 132.24 30.11 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.459 2.106 . . . . 0.0 113.78 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.7 p -71.21 147.13 48.57 Favored 'General case' 0 C--O 1.267 1.983 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.591 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.74 -45.74 2.05 Favored Glycine 0 C--O 1.263 1.952 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.951 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.539 ' HD3' ' CD ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER . . . . . 0 CA--C 1.471 -2.081 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.62 -174.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 N--CA 1.445 -0.697 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 8.5 t -87.98 72.4 9.27 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.552 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 22.8 m -69.14 -45.45 79.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.388 173.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -115.81 151.74 34.65 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.969 0.414 . . . . 0.0 109.973 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 93.2 m-20 -73.11 -31.07 64.1 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -176.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.0 m -59.15 -37.85 78.3 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.403 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.2 p-10 -68.85 -43.4 75.53 Favored 'General case' 0 CA--C 1.499 -0.989 0 O-C-N 121.55 -0.719 . . . . 0.0 109.868 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.615 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 17.8 t -61.52 -44.41 97.11 Favored 'General case' 0 CA--C 1.471 -2.087 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 22.3 tttp -54.74 -55.12 33.33 Favored 'General case' 0 N--CA 1.393 -3.277 0 CA-C-N 112.688 -2.051 . . . . 0.0 108.735 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -60.28 -45.11 94.48 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 123.916 0.76 . . . . 0.0 111.384 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 19' ' ' ASN . 85.4 t -62.48 -44.74 99.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.62 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.4 m -66.89 -34.6 78.15 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 122.806 0.442 . . . . 0.0 111.863 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 50.0 mtp180 -69.2 -27.21 65.29 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.162 0.506 . . . . 0.0 109.83 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.9 m -82.51 -27.68 31.58 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.735 175.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.539 ' CD ' ' HD3' ' A' ' 9' ' ' LYS . 8.7 mm-40 -67.06 -46.74 73.41 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 121.741 -0.599 . . . . 0.0 110.401 171.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 134.9 39.65 0.17 Allowed Glycine 0 C--N 1.311 -0.825 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.496 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 95.3 m-85 -127.11 148.01 64.12 Favored Pre-proline 0 N--CA 1.434 -1.239 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -61.39 -33.05 89.48 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.511 2.141 . . . . 0.0 112.363 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.506 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.6 t -159.35 170.52 21.63 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.038 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.6 153.66 25.48 Favored Glycine 0 N--CA 1.409 -3.146 0 N-CA-C 107.37 -2.292 . . . . 0.0 107.37 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.597 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 39.4 m -156.78 158.71 37.33 Favored 'General case' 0 C--N 1.279 -2.473 0 C-N-CA 124.014 0.926 . . . . 0.0 110.095 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 44.2 m -91.0 156.74 17.72 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.3 0.571 . . . . 0.0 112.331 -170.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.485 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 22.9 t70 -148.36 152.45 37.07 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.03 -177.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.66 107.77 14.1 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -141.19 7.48 2.0 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 m -149.59 160.6 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.506 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.217 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.68 84.2 0.45 Allowed 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 124.289 0.993 . . . . 0.0 109.094 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.71 -145.72 13.75 Favored Glycine 0 N--CA 1.403 -3.523 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.552 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 32.5 mtp85 -140.1 117.61 11.48 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 117.568 0.684 . . . . 0.0 109.938 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -102.74 136.45 42.56 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-O 121.33 0.586 . . . . 0.0 110.735 -172.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.4 t -87.51 135.78 33.21 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.184 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.547 ' CD1' ' HG2' ' A' ' 4' ' ' LYS . 40.1 m-85 -129.9 146.34 51.61 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-O 121.718 0.771 . . . . 0.0 110.482 175.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.496 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 35.4 m -97.61 136.92 37.3 Favored 'General case' 0 C--N 1.252 -3.645 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.056 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.597 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 25.8 m-85 -111.54 136.11 51.18 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.913 -177.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -146.73 144.02 19.66 Favored Pre-proline 0 C--N 1.295 -1.774 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.705 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.08 120.56 6.67 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.372 2.048 . . . . 0.0 112.566 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 84.1 m -113.02 163.93 16.77 Favored Pre-proline 0 C--N 1.277 -2.551 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 170.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.425 ' O ' ' HD2' ' A' ' 1' ' ' ARG . 26.2 Cg_exo . . . . . 0 C--O 1.235 0.34 0 C-N-CA 121.838 1.692 . . . . 0.0 110.47 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.436 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 62.9 mtt85 . . . . . 0 CA--C 1.507 -0.701 0 CA-C-O 121.063 0.459 . . . . 0.0 112.045 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 66.9 mtm -105.12 107.95 19.2 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 174.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.1 m -83.5 117.13 22.89 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.798 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.639 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 36.7 ttpt -97.09 110.16 22.77 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 100.0 m -113.33 128.17 25.98 Favored Pre-proline 0 C--N 1.294 -1.822 0 C-N-CA 123.998 0.919 . . . . 0.0 110.662 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -69.39 115.98 4.3 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.992 1.795 . . . . 0.0 112.998 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -54.8 141.38 33.08 Favored 'General case' 0 C--O 1.276 2.492 0 C-N-CA 124.98 1.312 . . . . 0.0 110.376 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.29 -19.33 10.72 Favored Glycine 0 N--CA 1.433 -1.511 0 O-C-N 124.205 0.941 . . . . 0.0 114.601 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.473 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 49.0 pttt . . . . . 0 C--O 1.245 0.82 0 CA-C-N 118.546 1.173 . . . . 0.0 111.759 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.438 -1.029 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 2.9 t -88.93 65.6 7.61 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.146 0.974 . . . . 0.0 109.605 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.0 m -89.3 -29.95 5.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.024 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -107.9 114.74 28.9 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.028 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 55.4 m-80 -61.79 -29.69 70.32 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.863 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.8 m -67.03 -25.72 66.41 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 122.574 0.349 . . . . 0.0 110.883 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.497 ' O ' HG23 ' A' ' 23' ' ' VAL . 45.1 t30 -70.78 -48.26 55.21 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.595 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 12.9 t -56.74 -47.59 79.69 Favored 'General case' 0 CA--C 1.476 -1.888 0 CA-C-N 114.2 -1.364 . . . . 0.0 108.131 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 21.0 tttp -54.37 -55.26 30.34 Favored 'General case' 0 N--CA 1.399 -3.018 0 CA-C-N 112.68 -2.054 . . . . 0.0 109.634 -175.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -63.25 -38.53 91.53 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 123.757 0.661 . . . . 0.0 111.568 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 19' ' ' ASN . 57.8 t -66.27 -45.73 89.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 95.4 m -63.63 -39.75 95.15 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 120.931 0.396 . . . . 0.0 111.071 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.573 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 59.3 mtp180 -64.76 -30.24 71.24 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 121.018 0.437 . . . . 0.0 110.502 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.0 p -85.58 -27.63 25.39 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.473 ' HG3' ' HE2' ' A' ' 9' ' ' LYS . 50.6 mt-10 -66.97 -40.33 87.43 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.691 171.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 134.32 41.04 0.16 Allowed Glycine 0 C--N 1.318 -0.468 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.701 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.573 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 95.0 m-85 -130.3 148.64 70.66 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -177.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -61.99 -34.79 79.9 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.448 2.099 . . . . 0.0 112.354 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.551 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.3 t -157.95 170.98 21.1 Favored 'General case' 0 N--CA 1.422 -1.867 0 O-C-N 122.056 -0.402 . . . . 0.0 110.354 -176.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 45' ' ' CYS . . . -148.52 153.84 25.48 Favored Glycine 0 N--CA 1.414 -2.777 0 N-CA-C 107.31 -2.316 . . . . 0.0 107.31 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.521 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 44.5 m -155.83 157.02 35.73 Favored 'General case' 0 C--N 1.281 -2.408 0 C-N-CA 123.5 0.72 . . . . 0.0 110.799 -176.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.416 ' SG ' ' HA ' ' A' ' 17' ' ' ASN . 58.0 m -94.85 125.72 39.69 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.788 -172.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.55 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 30.7 t70 -122.66 166.92 14.1 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.839 -174.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -122.34 116.04 23.35 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.331 0.586 . . . . 0.0 110.949 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -148.39 6.28 0.75 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 m -147.84 167.66 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.22 82.18 0.53 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 122.173 0.987 . . . . 0.0 110.146 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.09 -140.31 9.94 Favored Glycine 0 N--CA 1.401 -3.647 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.704 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -126.2 130.6 51.28 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -111.65 130.56 55.72 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 40.4 t -75.49 134.5 40.8 Favored 'General case' 0 C--O 1.278 2.569 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.639 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 40.0 m-85 -131.86 141.75 49.5 Favored 'General case' 0 N--CA 1.42 -1.957 0 O-C-N 123.933 0.771 . . . . 0.0 109.729 175.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.469 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 54.2 m -96.81 139.01 33.5 Favored 'General case' 0 C--N 1.252 -3.671 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.965 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.551 ' HB2' HG23 ' A' ' 31' ' ' THR . 37.1 m-85 -112.35 134.72 53.73 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.767 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -147.1 143.91 18.97 Favored Pre-proline 0 C--N 1.295 -1.791 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.726 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.06 121.6 7.41 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.469 2.113 . . . . 0.0 112.655 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 77.0 m -116.14 161.83 29.14 Favored Pre-proline 0 C--N 1.278 -2.532 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 170.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.436 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 16.4 Cg_endo . . . . . 0 C--O 1.26 1.611 0 C-N-CA 122.018 1.812 . . . . 0.0 110.972 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.9 mtt -105.25 114.14 28.15 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 175.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 46' ' ' TYR . 15.8 m -93.01 122.59 35.53 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.221 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.469 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 27.3 ttpp -101.23 109.86 21.79 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.0 m -116.31 127.98 26.34 Favored Pre-proline 0 C--O 1.196 -1.729 0 C-N-CA 124.258 1.023 . . . . 0.0 111.117 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -66.98 125.08 13.08 Favored 'Trans proline' 0 N--CA 1.474 0.366 0 C-N-CA 122.365 2.043 . . . . 0.0 112.784 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -70.39 142.37 52.08 Favored 'General case' 0 C--O 1.273 2.339 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.67 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.17 -40.97 6.77 Favored Glycine 0 N--CA 1.427 -1.909 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.957 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.536 ' HD3' ' CD ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER . . . . . 0 CA--C 1.477 -1.862 0 C-N-CA 118.489 -1.285 . . . . 0.0 112.94 -175.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.4 ' HB3' HG13 ' A' ' 15' ' ' VAL . 12.7 m-85 . . . . . 0 N--CA 1.423 -1.781 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.668 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.9 t -85.66 67.7 10.16 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.508 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 18.7 m -74.25 -32.88 32.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.692 172.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -119.97 121.84 39.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.642 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 92.9 m-20 -56.73 -27.01 58.43 Favored 'General case' 0 C--O 1.208 -1.099 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.881 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.3 m -66.91 -29.77 69.74 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -74.96 -40.58 60.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.668 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 16.2 t -59.17 -48.9 79.89 Favored 'General case' 0 CA--C 1.473 -2.013 0 CA-C-N 114.228 -1.351 . . . . 0.0 108.271 177.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.522 ' HG3' ' H ' ' A' ' 32' ' ' GLY . 15.5 ttpt -55.01 -50.6 68.62 Favored 'General case' 0 N--CA 1.391 -3.404 0 CA-C-N 113.322 -1.763 . . . . 0.0 109.104 -176.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -60.09 -49.07 79.09 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.212 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 93.0 t -60.33 -43.49 93.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 123.207 0.317 . . . . 0.0 110.825 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 68.9 m -64.75 -38.51 91.23 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 122.991 0.517 . . . . 0.0 112.068 177.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.403 ' HD2' ' HG2' ' A' ' 21' ' ' LYS . 35.9 mtp180 -69.93 -25.08 63.5 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.191 0.52 . . . . 0.0 109.965 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -82.85 -27.67 30.65 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.895 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.536 ' CD ' ' HD3' ' A' ' 9' ' ' LYS . 7.8 mm-40 -68.6 -42.21 78.49 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.769 -0.582 . . . . 0.0 110.607 172.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.96 35.59 0.47 Allowed Glycine 0 C--N 1.312 -0.788 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.454 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 87.2 m-85 -121.19 149.53 51.85 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -60.12 -39.75 66.58 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.486 2.124 . . . . 0.0 112.441 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.552 HG23 ' HB2' ' A' ' 46' ' ' TYR . 9.4 t -154.66 174.2 15.32 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.141 -176.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.522 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -151.88 153.05 24.69 Favored Glycine 0 N--CA 1.418 -2.516 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.621 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 28.2 m -153.79 154.06 33.3 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 123.922 0.889 . . . . 0.0 110.391 -177.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.7 m -87.4 157.13 19.31 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.161 0.505 . . . . 0.0 112.109 -170.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.502 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 9.0 t70 -147.18 158.0 43.8 Favored 'General case' 0 C--O 1.257 1.46 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.061 -175.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.16 107.8 12.14 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -140.9 7.16 2.04 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 m -149.79 166.5 3.03 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.957 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -175.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.17 -30.13 66.15 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 123.974 0.796 . . . . 0.0 111.208 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.11 -170.23 42.66 Favored Glycine 0 N--CA 1.427 -1.927 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.508 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 19.9 mtp180 -114.29 118.17 33.17 Favored 'General case' 0 C--N 1.282 -2.351 0 O-C-N 121.698 -0.883 . . . . 0.0 109.731 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -102.14 149.68 24.03 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.309 -171.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 25.6 t -98.84 139.06 35.08 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.982 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.502 ' CD1' ' HB3' ' A' ' 35' ' ' ASP . 22.9 m-85 -132.49 135.74 46.21 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-O 122.052 0.93 . . . . 0.0 109.68 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.454 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 58.6 m -90.7 141.36 28.87 Favored 'General case' 0 C--N 1.246 -3.924 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.007 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.621 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 24.0 m-85 -111.75 134.92 52.99 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.829 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -147.28 145.61 22.48 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.854 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.04 116.66 4.72 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 122.395 2.063 . . . . 0.0 112.483 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.401 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 72.8 m -111.19 169.76 5.97 Favored Pre-proline 0 C--N 1.28 -2.44 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 171.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 49' ' ' CYS . 13.5 Cg_endo . . . . . 0 C--O 1.255 1.327 0 C-N-CA 122.16 1.907 . . . . 0.0 111.832 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.425 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 59.5 mtt85 . . . . . 0 CA--C 1.513 -0.468 0 CA-C-O 121.157 0.503 . . . . 0.0 111.819 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 63.8 mtt -110.63 101.23 9.91 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 18.5 m -80.36 114.51 19.31 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.67 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.516 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.6 ttpt -93.29 111.18 22.75 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 96.9 m -113.14 131.84 22.67 Favored Pre-proline 0 C--N 1.298 -1.651 0 C-N-CA 124.29 1.036 . . . . 0.0 110.18 -176.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 4.6 Cg_exo -72.17 114.46 3.99 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.015 1.81 . . . . 0.0 112.268 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.61 144.75 30.81 Favored 'General case' 0 C--O 1.269 2.127 0 C-N-CA 124.39 1.076 . . . . 0.0 110.475 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.66 -22.37 8.12 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 115.218 0.847 . . . . 0.0 115.218 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.574 ' HD2' HG13 ' A' ' 23' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.475 -1.916 0 C-N-CA 117.759 -1.576 . . . . 0.0 111.609 -174.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 N--CA 1.437 -1.121 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 4.3 t -83.22 71.84 10.18 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.946 0.879 . . . . 0.0 109.355 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.1 m -87.06 -32.17 6.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.603 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -108.38 120.51 42.6 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 54.8 m-80 -61.48 -28.35 69.23 Favored 'General case' 0 C--O 1.214 -0.766 0 O-C-N 123.731 0.644 . . . . 0.0 111.836 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.7 m -64.75 -28.32 69.5 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 123.593 0.757 . . . . 0.0 110.816 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -73.66 -46.37 46.95 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.653 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 15.9 t -56.87 -44.85 82.65 Favored 'General case' 0 CA--C 1.472 -2.02 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.079 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 22.6 tttp -55.08 -55.12 34.6 Favored 'General case' 0 N--CA 1.393 -3.276 0 CA-C-N 112.85 -1.977 . . . . 0.0 108.989 -175.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -61.72 -43.74 98.26 Favored 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 123.906 0.754 . . . . 0.0 110.957 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.574 HG13 ' HD2' ' A' ' 9' ' ' LYS . 89.8 t -60.29 -48.83 86.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.884 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.6 m -63.03 -39.53 95.03 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.826 0.85 . . . . 0.0 111.649 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 54.1 mtp180 -64.42 -30.95 71.98 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.238 0.542 . . . . 0.0 110.024 177.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.0 m -85.65 -11.06 54.76 Favored 'General case' 0 CA--C 1.58 2.114 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.656 176.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -88.06 -27.41 22.0 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.242 -0.911 . . . . 0.0 110.287 172.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.52 34.05 0.78 Allowed Glycine 0 C--N 1.318 -0.439 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.636 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.0 m-85 -124.14 148.85 58.77 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -63.59 -34.76 62.66 Favored 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 122.394 2.063 . . . . 0.0 112.277 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.508 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.0 t -156.96 170.67 21.99 Favored 'General case' 0 N--CA 1.416 -2.126 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.085 -176.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 45' ' ' CYS . . . -148.33 154.93 26.17 Favored Glycine 0 N--CA 1.409 -3.163 0 N-CA-C 107.085 -2.406 . . . . 0.0 107.085 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.546 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 43.9 m -155.15 152.79 29.86 Favored 'General case' 0 C--N 1.277 -2.551 0 C-N-CA 123.628 0.771 . . . . 0.0 110.641 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.418 ' SG ' ' HA ' ' A' ' 17' ' ' ASN . 51.0 m -92.4 127.78 38.01 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.448 -172.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.631 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 35.0 t70 -127.24 169.43 13.51 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.047 -175.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -121.23 118.44 29.61 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.246 0.546 . . . . 0.0 111.371 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -149.3 5.52 0.64 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 174.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 m -147.38 167.01 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.316 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.66 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.5 82.17 1.09 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.741 0.781 . . . . 0.0 108.916 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.45 -150.95 23.2 Favored Glycine 0 N--CA 1.406 -3.302 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -177.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -121.78 127.48 50.67 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 122.65 -0.323 . . . . 0.0 110.672 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -109.78 132.63 53.98 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.0 t -77.21 134.64 38.57 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 174.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.631 ' CD1' ' HB3' ' A' ' 35' ' ' ASP . 46.9 m-85 -130.54 141.65 50.48 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-O 121.553 0.692 . . . . 0.0 109.337 173.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.461 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 57.3 m -96.12 139.36 32.4 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.274 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.546 ' CE1' ' HB2' ' A' ' 33' ' ' SER . 26.1 m-85 -112.9 134.23 54.51 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 121.002 0.429 . . . . 0.0 110.702 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -143.78 137.09 14.03 Favored Pre-proline 0 C--N 1.295 -1.798 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.337 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.84 118.8 5.89 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.796 2.331 . . . . 0.0 112.465 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.05 164.15 20.08 Favored Pre-proline 0 C--N 1.272 -2.786 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 171.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.425 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 32.9 Cg_exo . . . . . 0 C--O 1.264 1.796 0 C-N-CA 121.958 1.772 . . . . 0.0 110.952 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.692 ' HD3' ' OXT' ' A' ' 50' ' ' PRO . 31.7 mtp180 . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 121.184 0.516 . . . . 0.0 112.089 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.9 mtm -107.62 106.3 16.59 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.2 m -86.34 116.17 24.33 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.71 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.506 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.8 ttpt -92.97 111.42 23.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.8 m -114.9 130.47 24.15 Favored Pre-proline 0 C--N 1.295 -1.803 0 C-N-CA 124.337 1.055 . . . . 0.0 110.336 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.54 131.48 28.02 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.147 1.898 . . . . 0.0 113.253 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.0 p -59.95 143.46 51.57 Favored 'General case' 0 C--O 1.27 2.159 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.711 177.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.68 -32.31 6.01 Favored Glycine 0 N--CA 1.427 -1.918 0 O-C-N 123.58 0.55 . . . . 0.0 113.528 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.556 ' NZ ' ' HG3' ' A' ' 27' ' ' GLU . 16.1 pttm . . . . . 0 CA--C 1.501 -0.908 0 CA-C-N 118.276 1.038 . . . . 0.0 112.706 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 N--CA 1.436 -1.137 0 CA-C-O 120.773 0.32 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.1 t -93.43 64.15 3.62 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.868 0.842 . . . . 0.0 108.977 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.501 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 18.8 m -73.83 -34.78 41.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.027 172.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -119.69 125.52 48.88 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.51 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 91.4 m-20 -56.56 -28.18 59.57 Favored 'General case' 0 C--O 1.199 -1.596 0 O-C-N 124.312 1.007 . . . . 0.0 111.354 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 89.9 m -67.4 -29.65 69.21 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.513 ' O ' HG23 ' A' ' 23' ' ' VAL . 45.6 t30 -70.05 -46.27 65.35 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.651 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 24.3 t -57.62 -51.5 69.23 Favored 'General case' 0 CA--C 1.478 -1.823 0 CA-C-N 113.991 -1.459 . . . . 0.0 108.745 177.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 11.4 ttpt -51.64 -53.76 35.27 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-N 113.275 -1.784 . . . . 0.0 109.502 -174.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -62.7 -40.93 98.68 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.404 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 19' ' ' ASN . 60.2 t -65.97 -42.46 91.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.588 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.6 m -64.85 -41.99 95.26 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 120.973 0.416 . . . . 0.0 110.853 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 43.5 mtp180 -65.21 -29.32 70.11 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.004 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 p -81.65 -30.95 32.54 Favored 'General case' 0 C--O 1.215 -0.727 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 175.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.556 ' HG3' ' NZ ' ' A' ' 9' ' ' LYS . 48.1 mt-10 -68.67 -34.94 76.55 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.889 173.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.87 36.76 0.38 Allowed Glycine 0 C--N 1.314 -0.642 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.883 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.7 m-85 -123.57 148.9 57.2 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.37 -35.96 58.59 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.121 1.881 . . . . 0.0 112.294 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.527 HG23 ' HB2' ' A' ' 46' ' ' TYR . 8.8 t -157.74 175.5 13.81 Favored 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.88 -175.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -154.88 153.72 25.0 Favored Glycine 0 N--CA 1.417 -2.616 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.593 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 32.8 m -155.24 160.98 41.25 Favored 'General case' 0 C--N 1.285 -2.2 0 C-N-CA 123.636 0.774 . . . . 0.0 110.763 -177.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.4 m -93.17 153.84 18.4 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -171.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.516 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 9.9 t70 -147.49 157.29 43.51 Favored 'General case' 0 C--O 1.255 1.376 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.173 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -121.71 110.77 16.36 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 121.549 0.69 . . . . 0.0 109.231 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -146.16 7.69 1.04 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.423 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 m -149.06 165.53 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.243 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.489 -174.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.34 83.11 1.41 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.56 -148.42 19.43 Favored Glycine 0 N--CA 1.405 -3.389 0 N-CA-C 107.833 -2.107 . . . . 0.0 107.833 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.501 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 19.1 mtp180 -137.6 118.08 13.82 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 117.663 0.732 . . . . 0.0 109.58 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -103.69 134.6 46.74 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-O 121.423 0.63 . . . . 0.0 111.146 -172.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 5.9 t -84.6 136.9 33.58 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.542 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.516 ' CD1' ' HB3' ' A' ' 35' ' ' ASP . 39.1 m-85 -129.84 138.97 51.28 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-O 121.8 0.81 . . . . 0.0 109.845 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.438 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 56.9 m -95.53 136.04 36.42 Favored 'General case' 0 C--N 1.246 -3.919 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.348 -177.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.593 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 27.9 m-85 -107.61 135.19 49.48 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.863 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -146.27 140.82 15.77 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.716 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 130.95 20.27 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.536 2.158 . . . . 0.0 112.506 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.3 p -129.81 158.26 74.24 Favored Pre-proline 0 C--N 1.27 -2.875 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 171.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.692 ' OXT' ' HD3' ' A' ' 1' ' ' ARG . 31.7 Cg_exo . . . . . 0 C--O 1.275 2.329 0 C-N-CA 121.894 1.729 . . . . 0.0 110.472 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 29.3 ttm105 . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 121.258 0.552 . . . . 0.0 111.756 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 90.4 mtp -98.04 105.88 18.09 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.631 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.9 m -85.38 118.02 24.66 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.705 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.533 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 37.5 ttpt -97.39 110.52 23.06 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 98.1 m -111.55 131.48 22.31 Favored Pre-proline 0 C--N 1.29 -2.001 0 C-N-CA 124.106 0.962 . . . . 0.0 110.31 -176.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -66.54 126.42 15.48 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.002 1.801 . . . . 0.0 112.36 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.1 p -63.2 142.28 58.44 Favored 'General case' 0 C--O 1.273 2.294 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.499 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.78 -32.75 5.53 Favored Glycine 0 N--CA 1.428 -1.889 0 CA-C-N 115.951 -0.568 . . . . 0.0 114.341 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.525 ' HD2' HG13 ' A' ' 23' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.476 -1.895 0 O-C-N 120.976 -1.308 . . . . 0.0 111.008 -173.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.435 -1.223 0 CA-C-O 121.275 0.559 . . . . 0.0 111.809 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.666 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 8.0 t -82.05 71.05 9.09 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.69 -60.17 3.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.787 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -100.93 140.71 34.84 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.931 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 91.8 m-20 -64.76 -28.01 69.29 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.496 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.6 m -63.85 -35.08 79.47 Favored 'General case' 0 CA--C 1.575 1.918 0 C-N-CA 123.236 0.614 . . . . 0.0 112.482 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.466 HD21 ' HA ' ' A' ' 14' ' ' CYS . 1.2 p-10 -72.26 -40.72 67.45 Favored 'General case' 0 CA--C 1.494 -1.193 0 O-C-N 121.179 -0.951 . . . . 0.0 109.761 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.666 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 23.1 t -59.82 -45.75 91.4 Favored 'General case' 0 CA--C 1.472 -2.043 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 24.0 tttp -53.69 -55.04 29.61 Favored 'General case' 0 N--CA 1.395 -3.215 0 CA-C-N 112.551 -2.113 . . . . 0.0 108.807 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -62.44 -43.71 98.16 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.24 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.525 HG13 ' HD2' ' A' ' 9' ' ' LYS . 92.3 t -60.94 -48.41 89.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.597 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.4 m -63.05 -38.54 91.6 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.789 0.835 . . . . 0.0 111.286 177.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 56.1 mtp180 -64.47 -31.36 72.53 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-O 121.282 0.563 . . . . 0.0 110.145 177.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.2 m -85.46 -10.66 55.81 Favored 'General case' 0 CA--C 1.578 2.032 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.548 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 23' ' ' VAL . 68.7 mt-10 -88.13 -28.75 21.06 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.245 -0.909 . . . . 0.0 110.215 172.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.95 33.22 0.7 Allowed Glycine 0 C--N 1.318 -0.463 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.703 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.603 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.4 m-85 -123.89 147.51 54.03 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -63.69 -32.13 68.73 Favored 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.462 2.108 . . . . 0.0 112.269 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.494 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.1 t -159.37 171.5 19.66 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.02 -176.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -149.93 156.82 26.94 Favored Glycine 0 N--CA 1.408 -3.196 0 N-CA-C 107.405 -2.278 . . . . 0.0 107.405 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.571 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 39.8 m -157.42 156.89 32.99 Favored 'General case' 0 C--N 1.28 -2.445 0 C-N-CA 124.072 0.949 . . . . 0.0 110.235 -177.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.3 m -94.12 139.43 31.0 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.0 0.428 . . . . 0.0 111.257 -171.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.551 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 20.8 t70 -131.4 162.85 29.21 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.422 -176.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -120.6 112.55 19.05 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-O 121.627 0.727 . . . . 0.0 110.485 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -147.89 6.6 0.8 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.362 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 m -147.02 165.97 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.218 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.364 -175.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.25 83.46 0.75 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.826 0.822 . . . . 0.0 109.536 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.18 -143.35 12.04 Favored Glycine 0 N--CA 1.405 -3.37 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -127.01 125.9 42.22 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -111.42 125.02 53.44 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.39 0.614 . . . . 0.0 110.246 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 33.8 t -72.23 135.2 46.0 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.64 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.551 ' CD1' ' HB3' ' A' ' 35' ' ' ASP . 39.3 m-85 -130.55 143.21 50.61 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-O 121.499 0.666 . . . . 0.0 109.605 174.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.482 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 35.3 m -97.17 136.95 36.96 Favored 'General case' 0 C--N 1.25 -3.753 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.997 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.571 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 38.4 m-85 -112.18 136.15 51.95 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.585 -177.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -147.13 144.58 19.95 Favored Pre-proline 0 C--N 1.296 -1.743 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.907 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.93 120.56 6.42 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 122.457 2.105 . . . . 0.0 112.584 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.4 m -116.79 169.35 7.36 Favored Pre-proline 0 C--N 1.277 -2.553 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 171.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.263 1.734 0 C-N-CA 121.904 1.736 . . . . 0.0 110.208 174.777 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.418 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 58.2 mtt85 . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 121.063 0.459 . . . . 0.0 111.87 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.8 mtt -107.63 99.71 9.18 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 17.7 m -80.36 114.42 19.24 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.623 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.526 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.6 ttpt -92.63 110.33 21.76 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 33.4 m -108.8 131.9 21.5 Favored Pre-proline 0 C--N 1.301 -1.523 0 C-N-CA 124.27 1.028 . . . . 0.0 109.809 -174.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 5.8 Cg_exo -72.3 116.28 4.65 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.66 1.573 . . . . 0.0 111.865 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -58.13 139.04 55.58 Favored 'General case' 0 C--O 1.278 2.558 0 C-N-CA 123.944 0.898 . . . . 0.0 111.097 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.57 -30.34 9.89 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.787 -175.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.488 ' NZ ' ' HG3' ' A' ' 27' ' ' GLU . 21.5 pttm . . . . . 0 N--CA 1.42 -1.954 0 C-N-CA 118.406 -1.318 . . . . 0.0 112.562 -175.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 . . . . . 0 N--CA 1.441 -0.881 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.1 t -91.8 60.15 3.85 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.558 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 17.4 m -69.98 -33.28 54.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.513 173.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.488 HD21 ' HB ' ' A' ' 18' ' ' THR . 19.5 t30 -111.34 121.19 44.59 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.86 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -61.88 -26.08 67.94 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.059 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.488 ' HB ' HD21 ' A' ' 16' ' ' ASN . 97.8 m -67.43 -31.21 71.25 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.423 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -59.43 -54.25 48.87 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.591 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 5.9 t -56.64 -49.72 74.17 Favored 'General case' 0 CA--C 1.464 -2.341 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.243 -177.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.505 ' HG3' ' H ' ' A' ' 32' ' ' GLY . 0.9 OUTLIER -55.48 -46.54 76.89 Favored 'General case' 0 N--CA 1.395 -3.2 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.607 -176.203 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -68.02 -44.09 77.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.229 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.13 -40.83 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.407 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.8 m -66.2 -41.86 89.58 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 120.866 0.365 . . . . 0.0 111.571 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 35.3 mtp180 -66.55 -28.63 68.68 Favored 'General case' 0 C--O 1.211 -0.958 0 CA-C-O 120.915 0.388 . . . . 0.0 111.017 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 p -81.92 -30.97 31.59 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.488 ' HG3' ' NZ ' ' A' ' 9' ' ' LYS . 53.1 mt-10 -68.3 -32.67 72.98 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.659 172.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.12 36.29 0.55 Allowed Glycine 0 C--N 1.315 -0.631 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.977 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 92.6 m-85 -122.13 149.23 53.87 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -60.82 -38.47 70.02 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.308 2.006 . . . . 0.0 112.277 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.529 HG23 ' HB2' ' A' ' 46' ' ' TYR . 9.1 t -158.07 173.89 16.05 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.112 -175.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.505 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -153.99 154.13 25.3 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.458 ' HB3' ' CE2' ' A' ' 46' ' ' TYR . 23.2 t -150.3 154.58 38.12 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.6 m -87.47 156.16 19.68 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 120.831 0.348 . . . . 0.0 110.569 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.469 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 22.8 t70 -145.01 153.86 41.93 Favored 'General case' 0 C--O 1.255 1.368 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.564 -175.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -119.75 105.74 11.44 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -144.13 6.14 1.33 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.118 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.0 m -148.04 164.94 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.877 -175.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.1 80.94 0.96 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.048 0.928 . . . . 0.0 109.365 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.52 -147.38 16.75 Favored Glycine 0 N--CA 1.405 -3.43 0 N-CA-C 107.833 -2.107 . . . . 0.0 107.833 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.558 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 20.8 mtp180 -139.24 117.76 12.14 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 117.581 0.691 . . . . 0.0 109.668 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -101.05 146.93 26.81 Favored 'General case' 0 N--CA 1.422 -1.835 0 O-C-N 123.536 0.522 . . . . 0.0 109.975 -172.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.4 t -97.98 141.37 31.03 Favored 'General case' 0 C--O 1.266 1.964 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.526 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 47.4 m-85 -134.87 138.08 43.83 Favored 'General case' 0 N--CA 1.419 -1.983 0 O-C-N 124.165 0.916 . . . . 0.0 110.411 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.475 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 61.5 m -96.05 135.81 37.32 Favored 'General case' 0 C--N 1.258 -3.408 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.84 -177.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.529 ' HB2' HG23 ' A' ' 31' ' ' THR . 21.7 m-85 -106.92 134.64 49.77 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 120.863 0.363 . . . . 0.0 110.803 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -144.49 137.81 14.11 Favored Pre-proline 0 C--N 1.296 -1.755 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.846 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.4 120.68 7.32 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.659 2.24 . . . . 0.0 112.362 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 p -118.28 164.45 20.23 Favored Pre-proline 0 C--N 1.272 -2.778 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 171.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.418 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 34.6 Cg_exo . . . . . 0 C--O 1.263 1.732 0 C-N-CA 121.816 1.677 . . . . 0.0 110.875 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.42 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 63.0 mtt85 . . . . . 0 N--CA 1.469 0.492 0 CA-C-O 121.023 0.44 . . . . 0.0 112.157 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 89.2 mtp -99.25 101.16 12.38 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.9 m -81.97 116.09 21.44 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.532 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.496 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 38.8 ttpt -93.08 109.77 21.25 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.6 m -107.35 132.52 20.89 Favored Pre-proline 0 C--N 1.298 -1.655 0 C-N-CA 124.373 1.069 . . . . 0.0 109.821 -174.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -71.72 115.01 4.13 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.68 1.586 . . . . 0.0 111.998 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -58.26 140.87 52.41 Favored 'General case' 0 C--O 1.278 2.605 0 C-N-CA 124.078 0.951 . . . . 0.0 111.278 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.55 -33.11 6.93 Favored Glycine 0 N--CA 1.427 -1.951 0 CA-C-N 115.749 -0.659 . . . . 0.0 114.051 -175.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.48 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 50.1 pttt . . . . . 0 CA--C 1.474 -1.972 0 O-C-N 120.995 -1.297 . . . . 0.0 112.635 -174.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 . . . . . 0 N--CA 1.444 -0.73 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.0 t -89.45 60.35 5.16 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.513 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 17.4 m -68.25 -39.59 81.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.573 173.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -110.39 121.97 46.57 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.457 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 86.7 m-20 -57.44 -28.42 63.3 Favored 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 124.153 0.981 . . . . 0.0 111.239 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 51.9 m -68.65 -26.27 65.24 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -73.64 -42.24 61.68 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.641 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 18.3 t -58.84 -49.7 76.75 Favored 'General case' 0 CA--C 1.475 -1.937 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.244 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HG3' ' H ' ' A' ' 32' ' ' GLY . 12.7 ttpt -53.54 -51.84 61.62 Favored 'General case' 0 N--CA 1.399 -2.995 0 CA-C-N 113.018 -1.901 . . . . 0.0 109.028 -175.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -59.88 -48.38 81.95 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 123.693 0.621 . . . . 0.0 111.38 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.4 t -60.2 -47.36 92.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 O-C-N 123.417 0.448 . . . . 0.0 110.707 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.1 m -60.49 -42.85 97.16 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.441 0.696 . . . . 0.0 111.9 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.6 mtp180 -65.08 -30.47 71.43 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.083 0.468 . . . . 0.0 110.24 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 m -85.46 -16.72 38.72 Favored 'General case' 0 CA--C 1.574 1.871 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.888 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.48 ' HG3' ' HE2' ' A' ' 9' ' ' LYS . 55.1 mt-10 -78.92 -38.26 37.83 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.365 -0.834 . . . . 0.0 110.309 172.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 133.39 34.7 0.31 Allowed Glycine 0 C--N 1.31 -0.908 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.1 m-85 -121.78 147.92 49.59 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -59.58 -38.34 82.89 Favored 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 122.467 2.111 . . . . 0.0 112.325 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.539 HG23 ' HB2' ' A' ' 46' ' ' TYR . 8.8 t -158.85 176.38 12.41 Favored 'General case' 0 N--CA 1.426 -1.667 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.068 -175.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.451 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -155.28 158.97 28.81 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.3 t -156.63 162.37 39.86 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 17' ' ' ASN . 59.2 m -96.11 156.97 16.11 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.302 0.572 . . . . 0.0 111.63 -171.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.439 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 8.2 t70 -145.85 156.62 43.68 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 124.306 1.042 . . . . 0.0 108.61 -176.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.4 107.08 10.74 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -142.29 7.81 1.78 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.4 m -149.04 160.52 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.343 -175.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.26 82.99 0.24 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 122.204 1.002 . . . . 0.0 110.007 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.78 -143.41 10.41 Favored Glycine 0 N--CA 1.403 -3.527 0 N-CA-C 107.492 -2.243 . . . . 0.0 107.492 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.513 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 23.0 mtp180 -141.68 119.86 12.16 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 117.509 0.654 . . . . 0.0 109.481 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -102.17 142.77 32.9 Favored 'General case' 0 N--CA 1.428 -1.556 0 O-C-N 123.432 0.457 . . . . 0.0 110.346 -172.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.2 t -94.13 142.12 27.76 Favored 'General case' 0 C--O 1.268 2.049 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.338 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.496 ' CD1' ' HG2' ' A' ' 4' ' ' LYS . 51.6 m-85 -135.85 139.41 43.39 Favored 'General case' 0 N--CA 1.418 -2.044 0 O-C-N 124.159 0.912 . . . . 0.0 110.421 176.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.465 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 59.8 m -96.24 137.68 34.96 Favored 'General case' 0 C--N 1.261 -3.248 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.698 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.539 ' HB2' HG23 ' A' ' 31' ' ' THR . 22.0 m-85 -108.36 135.6 49.4 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 120.992 0.425 . . . . 0.0 110.939 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -147.43 145.75 22.71 Favored Pre-proline 0 C--N 1.298 -1.643 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.385 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.04 124.19 8.91 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.343 2.029 . . . . 0.0 112.605 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.0 m -117.01 166.38 13.09 Favored Pre-proline 0 C--N 1.276 -2.593 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 170.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.42 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 22.5 Cg_exo . . . . . 0 C--O 1.259 1.574 0 C-N-CA 121.661 1.574 . . . . 0.0 110.217 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.439 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 62.2 mtt85 . . . . . 0 N--CA 1.474 0.769 0 CA-C-O 120.96 0.41 . . . . 0.0 111.841 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 68.1 mtm -103.2 108.57 19.83 Favored 'General case' 0 CA--C 1.483 -1.616 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.7 m -85.92 116.68 24.3 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.073 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.496 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 36.9 ttpt -95.78 110.17 22.36 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 67.0 m -110.37 132.71 21.38 Favored Pre-proline 0 C--O 1.202 -1.407 0 C-N-CA 124.253 1.021 . . . . 0.0 110.385 -174.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 5.1 Cg_exo -72.37 119.49 6.17 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 121.947 1.765 . . . . 0.0 112.489 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m -62.83 146.6 52.28 Favored 'General case' 0 C--O 1.274 2.365 0 C-N-CA 123.86 0.864 . . . . 0.0 110.8 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.85 -27.03 4.19 Favored Glycine 0 N--CA 1.432 -1.608 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.914 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.1 pttt . . . . . 0 CA--C 1.497 -1.089 0 CA-C-O 122.257 1.027 . . . . 0.0 111.784 -176.356 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.433 -1.285 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.459 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 2.5 t -83.77 67.35 9.48 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.962 0.887 . . . . 0.0 110.2 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.2 m -89.84 -25.59 5.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.978 174.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -113.76 115.75 28.3 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.189 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 92.2 m-20 -57.53 -31.17 65.82 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.939 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.2 m -66.92 -27.47 67.51 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 122.703 0.401 . . . . 0.0 111.133 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.481 ' O ' HG23 ' A' ' 23' ' ' VAL . 47.3 t30 -72.33 -46.24 56.44 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.459 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 9.1 t -57.82 -47.13 83.51 Favored 'General case' 0 CA--C 1.48 -1.746 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.0 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 23.2 tttp -54.6 -55.72 26.53 Favored 'General case' 0 N--CA 1.4 -2.932 0 CA-C-N 112.772 -2.013 . . . . 0.0 109.313 -175.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -61.29 -41.46 97.0 Favored 'General case' 0 CA--C 1.493 -1.237 0 O-C-N 124.001 0.813 . . . . 0.0 111.682 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 19' ' ' ASN . 89.6 t -61.95 -51.33 73.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 99.4 m -58.75 -40.8 84.94 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.221 0.95 . . . . 0.0 111.341 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 56.5 mtp180 -64.15 -33.18 75.18 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 121.063 0.458 . . . . 0.0 110.582 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.0 m -85.88 -13.34 48.21 Favored 'General case' 0 CA--C 1.579 2.095 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.031 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 23' ' ' VAL . 54.4 mt-10 -82.14 -39.66 22.95 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.352 -0.843 . . . . 0.0 109.627 172.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.46 38.82 0.13 Allowed Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.57 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 92.5 m-85 -128.01 148.89 69.24 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -62.55 -35.45 70.73 Favored 'Trans proline' 0 C--O 1.242 0.706 0 C-N-CA 122.463 2.109 . . . . 0.0 112.311 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.563 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.7 t -158.23 170.46 22.21 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.273 -176.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 45' ' ' CYS . . . -147.76 155.91 26.69 Favored Glycine 0 N--CA 1.415 -2.703 0 N-CA-C 107.296 -2.321 . . . . 0.0 107.296 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.535 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 35.7 m -156.96 152.76 27.06 Favored 'General case' 0 C--N 1.283 -2.309 0 C-N-CA 123.79 0.836 . . . . 0.0 110.85 -176.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.7 m -94.96 132.1 40.18 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.237 0.541 . . . . 0.0 111.167 -172.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.4 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 26.8 t70 -120.32 156.31 31.56 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.124 -173.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.15 108.19 14.38 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -141.46 10.94 2.09 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.2 m -156.86 167.25 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.84 80.7 0.89 Allowed 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.682 0.753 . . . . 0.0 109.06 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.41 -157.99 27.46 Favored Glycine 0 N--CA 1.412 -2.907 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -124.43 132.25 53.5 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 117.206 0.503 . . . . 0.0 110.66 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -111.69 133.98 53.57 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 52.9 t -81.8 135.09 35.48 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.496 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 54.3 m-85 -132.31 140.2 48.49 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-O 121.79 0.805 . . . . 0.0 110.185 175.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.457 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 46.3 m -95.14 139.67 31.15 Favored 'General case' 0 C--N 1.252 -3.64 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.132 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.563 ' HB2' HG23 ' A' ' 31' ' ' THR . 35.4 m-85 -112.11 135.0 53.32 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.631 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -147.5 143.94 18.7 Favored Pre-proline 0 C--N 1.294 -1.841 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.603 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.17 122.07 7.74 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.352 2.035 . . . . 0.0 112.471 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 76.9 m -115.13 161.53 29.01 Favored Pre-proline 0 C--N 1.276 -2.607 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 170.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.439 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 17.7 Cg_endo . . . . . 0 C--O 1.262 1.719 0 C-N-CA 121.808 1.672 . . . . 0.0 110.836 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.425 ' HD2' ' O ' ' A' ' 50' ' ' PRO . 58.0 mtt85 . . . . . 0 CA--C 1.513 -0.466 0 CA-C-O 121.213 0.53 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 63.6 mtt -107.39 98.39 8.02 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 174.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.9 m -77.77 113.01 15.21 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.622 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.535 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.4 ttpt -92.94 110.56 22.02 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.4 m -109.36 131.4 21.88 Favored Pre-proline 0 C--N 1.296 -1.735 0 C-N-CA 124.137 0.975 . . . . 0.0 109.64 -174.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -71.76 114.63 4.01 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.755 1.637 . . . . 0.0 111.523 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -57.46 139.73 52.44 Favored 'General case' 0 C--O 1.274 2.359 0 C-N-CA 124.292 1.037 . . . . 0.0 111.36 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.64 -29.54 10.74 Favored Glycine 0 N--CA 1.425 -2.086 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.896 -176.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.588 ' HG3' ' CG ' ' A' ' 27' ' ' GLU . 34.1 mtmt . . . . . 0 CA--C 1.476 -1.889 0 CA-C-N 118.337 1.069 . . . . 0.0 109.078 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 CA--C 1.511 -0.543 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.679 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 6.9 t -88.33 64.0 7.39 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.887 0.851 . . . . 0.0 109.182 176.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.464 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 19.3 m -72.85 -35.2 48.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.189 171.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -109.98 119.2 38.57 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.3 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 55.4 m-80 -64.77 -30.32 71.33 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.467 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.5 m -68.85 -24.47 64.36 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 122.568 0.347 . . . . 0.0 110.421 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.422 ' O ' HG23 ' A' ' 23' ' ' VAL . 54.2 t30 -74.01 -46.1 45.74 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.679 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 33.1 t -55.28 -47.32 75.69 Favored 'General case' 0 CA--C 1.474 -1.963 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.98 176.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 19.2 tttp -54.57 -53.26 56.94 Favored 'General case' 0 N--CA 1.391 -3.379 0 CA-C-N 112.278 -2.237 . . . . 0.0 109.33 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -61.86 -42.98 99.7 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 123.5 0.5 . . . . 0.0 111.521 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 19' ' ' ASN . 48.4 t -64.94 -43.94 96.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.019 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 74.6 m -64.0 -40.9 97.39 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 120.96 0.409 . . . . 0.0 111.388 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 52.7 mtp180 -67.06 -26.06 66.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.955 0.407 . . . . 0.0 110.727 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.7 p -85.21 -36.43 20.98 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 175.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.588 ' CG ' ' HG3' ' A' ' 9' ' ' LYS . 56.9 mt-10 -57.04 -45.61 83.05 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 120.612 0.244 . . . . 0.0 111.333 168.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 135.39 43.72 0.11 Allowed Glycine 0 C--N 1.318 -0.46 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.849 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.466 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 89.5 m-85 -128.61 149.58 72.29 Favored Pre-proline 0 C--N 1.307 -1.266 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -62.25 -37.68 60.23 Favored 'Trans proline' 0 C--O 1.24 0.602 0 C-N-CA 122.394 2.063 . . . . 0.0 112.286 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.536 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.6 t -155.29 169.07 25.04 Favored 'General case' 0 N--CA 1.418 -2.065 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.438 -176.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.54 152.15 24.26 Favored Glycine 0 N--CA 1.408 -3.226 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.577 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 46.8 m -155.07 157.66 37.88 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 124.09 0.956 . . . . 0.0 110.002 -177.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 46.2 m -91.67 153.81 19.42 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.994 0.426 . . . . 0.0 112.076 -170.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.567 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 13.3 t70 -148.38 158.31 44.03 Favored 'General case' 0 C--O 1.255 1.349 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.542 -177.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -118.86 111.14 18.03 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-O 121.61 0.719 . . . . 0.0 109.902 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -145.38 6.42 1.11 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.479 177.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.82 164.41 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.265 -174.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.05 80.75 1.23 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.022 0.915 . . . . 0.0 109.002 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.26 -144.52 11.29 Favored Glycine 0 N--CA 1.403 -3.551 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.464 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 19.7 mtp180 -139.55 118.59 12.6 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -104.75 144.51 31.64 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 121.268 0.556 . . . . 0.0 110.23 -173.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.3 t -92.83 141.27 28.62 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.997 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.567 ' CD1' ' HB3' ' A' ' 35' ' ' ASP . 42.5 m-85 -133.74 140.57 47.06 Favored 'General case' 0 N--CA 1.414 -2.242 0 O-C-N 124.053 0.846 . . . . 0.0 109.889 175.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.466 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 58.6 m -94.52 135.34 36.07 Favored 'General case' 0 C--N 1.255 -3.506 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.521 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 33' ' ' SER . 28.0 m-85 -108.89 133.7 52.55 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.743 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -144.85 138.31 14.26 Favored Pre-proline 0 C--N 1.294 -1.812 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.975 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.4 121.7 8.24 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.744 2.296 . . . . 0.0 112.27 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.7 p -121.64 162.24 37.51 Favored Pre-proline 0 C--N 1.273 -2.755 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 172.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.425 ' O ' ' HD2' ' A' ' 1' ' ' ARG . 13.6 Cg_endo . . . . . 0 CA--C 1.533 0.464 0 C-N-CA 122.113 1.875 . . . . 0.0 111.503 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.697 ' HD3' ' O ' ' A' ' 50' ' ' PRO . 32.2 mtp180 . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 120.825 0.345 . . . . 0.0 111.677 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 69.5 mtm -105.01 113.81 27.63 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.1 m -90.96 117.93 29.94 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.112 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.481 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 39.4 ttpt -94.22 110.52 22.25 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.0 m -111.48 131.63 22.22 Favored Pre-proline 0 C--N 1.295 -1.765 0 C-N-CA 124.426 1.09 . . . . 0.0 110.357 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.04 129.31 21.54 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.051 1.834 . . . . 0.0 113.119 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.1 p -58.9 141.72 52.72 Favored 'General case' 0 C--O 1.269 2.102 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.45 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -97.71 -29.17 7.89 Favored Glycine 0 N--CA 1.431 -1.67 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.442 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.663 ' NZ ' ' HG3' ' A' ' 27' ' ' GLU . 9.6 pttm . . . . . 0 C--O 1.246 0.903 0 CA-C-N 117.889 0.844 . . . . 0.0 112.889 -175.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.415 ' HB3' HG13 ' A' ' 15' ' ' VAL . 5.6 m-85 . . . . . 0 N--CA 1.436 -1.168 0 CA-C-O 120.854 0.359 . . . . 0.0 111.334 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.0 t -93.94 62.92 3.18 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.522 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 17.7 m -72.79 -34.78 47.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.865 172.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -120.8 127.71 52.2 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -176.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 93.2 m-20 -56.61 -27.94 59.34 Favored 'General case' 0 C--O 1.2 -1.548 0 C-N-CA 124.395 1.078 . . . . 0.0 111.57 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.6 m -64.38 -34.87 79.18 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 122.95 0.5 . . . . 0.0 112.29 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.524 ' O ' HG23 ' A' ' 23' ' ' VAL . 49.5 t30 -69.29 -45.35 69.83 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.644 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 20.7 t -58.22 -51.9 67.82 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-N 114.541 -1.208 . . . . 0.0 108.779 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.528 ' HG3' ' H ' ' A' ' 32' ' ' GLY . 15.3 ttpt -52.17 -53.03 48.11 Favored 'General case' 0 N--CA 1.406 -2.645 0 CA-C-N 113.299 -1.773 . . . . 0.0 109.554 -174.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -61.61 -45.65 93.2 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.189 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 19' ' ' ASN . 58.3 t -60.22 -48.9 86.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 O-C-N 123.47 0.482 . . . . 0.0 110.262 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 95.2 m -59.33 -40.69 87.12 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 123.573 0.749 . . . . 0.0 111.418 177.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.2 mtp180 -66.02 -28.53 68.94 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.285 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.424 ' HB ' ' NZ ' ' A' ' 9' ' ' LYS . 4.4 m -77.73 -29.37 51.13 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.036 175.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.663 ' HG3' ' NZ ' ' A' ' 9' ' ' LYS . 42.2 mt-10 -75.57 -22.71 56.75 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.749 0.309 . . . . 0.0 111.448 177.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.94 21.89 3.39 Favored Glycine 0 CA--C 1.501 -0.84 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.234 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.7 m-85 -106.54 145.15 30.44 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -60.58 -33.99 92.98 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.521 2.147 . . . . 0.0 112.463 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.542 HG23 ' HB2' ' A' ' 46' ' ' TYR . 9.9 t -160.82 175.43 12.58 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -175.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.528 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -154.05 158.41 28.12 Favored Glycine 0 N--CA 1.428 -1.855 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.465 ' HB3' ' CE1' ' A' ' 46' ' ' TYR . 15.5 t -153.77 163.64 39.69 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 59.6 m -95.82 152.9 18.06 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.281 0.562 . . . . 0.0 112.041 -172.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.453 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 8.7 t70 -144.1 156.73 44.47 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 124.462 1.105 . . . . 0.0 108.26 -177.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.17 107.18 10.5 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -141.67 8.69 1.96 Allowed 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.3 m -150.28 161.16 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.544 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.34 82.35 0.37 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.207 1.004 . . . . 0.0 109.583 177.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.07 -146.9 15.52 Favored Glycine 0 N--CA 1.404 -3.497 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 -177.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.522 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 21.5 mtp180 -140.71 118.38 11.64 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 117.759 0.78 . . . . 0.0 109.319 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -103.1 132.6 49.24 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-O 121.394 0.616 . . . . 0.0 111.014 -171.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.6 t -84.17 138.87 32.77 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.646 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.481 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 43.5 m-85 -131.7 139.64 49.09 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.751 0.786 . . . . 0.0 110.023 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.496 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 44.6 m -95.33 138.65 32.73 Favored 'General case' 0 C--N 1.252 -3.632 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.518 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.542 ' HB2' HG23 ' A' ' 31' ' ' THR . 21.5 m-85 -110.79 136.75 49.37 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 120.853 0.359 . . . . 0.0 110.973 -178.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -146.72 143.18 18.19 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.68 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.37 119.86 6.4 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.343 2.029 . . . . 0.0 112.458 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 95.1 m -111.75 159.27 33.99 Favored Pre-proline 0 C--N 1.276 -2.61 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 171.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.697 ' O ' ' HD3' ' A' ' 1' ' ' ARG . 38.2 Cg_exo . . . . . 0 C--O 1.251 1.156 0 C-N-CA 121.685 1.59 . . . . 0.0 109.528 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.435 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 61.4 mtt85 . . . . . 0 CA--C 1.512 -0.519 0 CA-C-O 121.212 0.529 . . . . 0.0 111.777 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.6 mtm -110.41 101.03 9.78 Favored 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 175.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.5 m -80.1 112.23 17.22 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.289 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.564 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 37.3 ttpt -93.14 111.24 22.81 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.5 m -117.68 124.05 29.21 Favored Pre-proline 0 C--N 1.293 -1.889 0 C-N-CA 123.734 0.814 . . . . 0.0 110.385 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -64.16 123.31 11.66 Favored 'Trans proline' 0 CA--C 1.521 -0.137 0 C-N-CA 122.294 1.996 . . . . 0.0 112.72 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -61.38 141.72 57.43 Favored 'General case' 0 C--O 1.281 2.714 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.502 -177.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.31 -30.0 11.56 Favored Glycine 0 N--CA 1.419 -2.448 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.761 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.523 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 45.6 pttt . . . . . 0 N--CA 1.418 -2.068 0 C-N-CA 117.655 -1.618 . . . . 0.0 113.852 -174.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 N--CA 1.434 -1.243 0 CA-C-O 121.045 0.45 . . . . 0.0 112.171 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.604 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 7.6 t -83.36 70.48 10.18 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.645 0.736 . . . . 0.0 109.066 176.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.487 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 90.5 t -73.32 -51.12 27.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.242 171.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.505 ' OD1' ' HB ' ' A' ' 18' ' ' THR . 5.4 t-20 -98.97 124.32 43.86 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.21 -176.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 93.4 m-20 -62.14 -29.15 70.14 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 114.383 -1.28 . . . . 0.0 112.61 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.505 ' HB ' ' OD1' ' A' ' 16' ' ' ASN . 9.8 m -65.12 -34.09 77.57 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 123.204 0.602 . . . . 0.0 110.584 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -70.01 -45.15 67.86 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.604 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 15.1 t -56.95 -46.94 81.77 Favored 'General case' 0 CA--C 1.48 -1.739 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.084 177.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 21.3 tttp -55.53 -53.98 49.7 Favored 'General case' 0 N--CA 1.391 -3.39 0 CA-C-N 112.567 -2.106 . . . . 0.0 108.701 -176.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -58.42 -48.05 81.93 Favored 'General case' 0 CA--C 1.499 -0.995 0 O-C-N 123.99 0.806 . . . . 0.0 111.194 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.5 t -60.81 -47.32 93.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 O-C-N 123.313 0.383 . . . . 0.0 110.594 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 69.6 m -61.49 -40.42 94.51 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 123.2 0.6 . . . . 0.0 111.839 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 47.5 mtp180 -66.9 -28.86 68.65 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.268 0.556 . . . . 0.0 110.17 178.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.1 m -85.48 -18.58 33.13 Favored 'General case' 0 CA--C 1.572 1.826 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.493 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.523 ' HG3' ' HE2' ' A' ' 9' ' ' LYS . 57.4 mt-10 -78.23 -40.98 35.68 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.4 -0.812 . . . . 0.0 110.424 171.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 135.53 38.48 0.18 Allowed Glycine 0 C--N 1.312 -0.781 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.51 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 89.1 m-85 -126.89 149.99 70.42 Favored Pre-proline 0 C--N 1.308 -1.214 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -63.61 -35.69 57.53 Favored 'Trans proline' 0 C--O 1.242 0.684 0 C-N-CA 122.392 2.062 . . . . 0.0 112.514 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.527 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.5 t -157.15 169.89 23.74 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.23 -176.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.68 153.74 25.53 Favored Glycine 0 N--CA 1.41 -3.056 0 N-CA-C 107.933 -2.067 . . . . 0.0 107.933 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.634 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 34.6 m -157.5 149.53 22.4 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 124.447 1.099 . . . . 0.0 110.139 -177.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.1 m -85.33 141.89 29.72 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -171.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.848 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 16.9 t70 -149.55 -172.28 4.1 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -132.69 127.71 35.4 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 120.945 -1.097 . . . . 0.0 110.977 -173.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.669 ' CE1' ' HG2' ' A' ' 42' ' ' LYS . 5.8 p-80 -149.13 11.16 0.81 Allowed 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 167.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.509 HG13 ' CD2' ' A' ' 37' ' ' HIS . 2.5 m -147.76 155.86 9.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.791 -174.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.03 84.79 0.99 Allowed 'General case' 0 C--N 1.314 -0.944 0 O-C-N 124.385 1.053 . . . . 0.0 108.963 177.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.19 -137.4 5.48 Favored Glycine 0 N--CA 1.404 -3.435 0 N-CA-C 107.901 -2.08 . . . . 0.0 107.901 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.487 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 18.8 mtp180 -136.53 119.6 16.52 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 117.453 0.626 . . . . 0.0 110.821 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.669 ' HG2' ' CE1' ' A' ' 37' ' ' HIS . 50.3 tptt -105.36 145.94 30.1 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 121.705 0.764 . . . . 0.0 111.125 -172.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 40.8 t -92.26 141.03 29.01 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.577 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.848 ' CD2' ' HB3' ' A' ' 35' ' ' ASP . 31.9 m-85 -130.88 140.87 50.27 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.51 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 61.4 m -95.55 133.77 39.2 Favored 'General case' 1 C--N 1.24 -4.173 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.872 -179.633 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.634 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 22.8 m-85 -107.58 133.91 51.35 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.591 -177.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -140.87 134.45 14.84 Favored Pre-proline 0 C--N 1.295 -1.798 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.351 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.21 118.28 5.6 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.947 2.431 . . . . 0.0 112.682 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 p -116.76 161.29 32.97 Favored Pre-proline 0 C--N 1.271 -2.838 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 172.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.435 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 18.3 Cg_endo . . . . . 0 C--O 1.264 1.79 0 C-N-CA 121.947 1.764 . . . . 0.0 111.375 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.445 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 59.5 mtt85 . . . . . 0 N--CA 1.467 0.376 0 CA-C-O 121.086 0.47 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.0 mtt -111.82 101.44 9.78 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.2 m -81.48 111.89 18.22 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.738 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.484 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 38.1 ttpt -93.54 110.97 22.54 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.106 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 86.8 m -109.13 133.11 20.85 Favored Pre-proline 0 C--N 1.3 -1.567 0 C-N-CA 124.381 1.072 . . . . 0.0 109.837 -177.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 3.8 Cg_exo -72.72 117.44 5.13 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 121.832 1.688 . . . . 0.0 112.15 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -61.8 146.81 48.41 Favored 'General case' 0 C--O 1.274 2.357 0 C-N-CA 123.728 0.811 . . . . 0.0 110.244 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -110.78 -24.77 5.42 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.497 -0.859 . . . . 0.0 114.014 -175.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.698 ' HD2' HG13 ' A' ' 23' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.484 -1.573 0 CA-C-O 122.153 0.978 . . . . 0.0 110.578 -174.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 . . . . . 0 CA--C 1.507 -0.69 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 6.3 t -90.5 64.35 5.8 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-O 121.868 0.842 . . . . 0.0 109.061 176.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.514 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 18.5 m -72.47 -36.47 54.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.559 171.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -111.74 121.46 45.16 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.3 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 54.7 m-80 -64.66 -31.21 72.32 Favored 'General case' 0 C--O 1.214 -0.787 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.451 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.0 m -67.43 -24.27 65.62 Favored 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 122.592 0.357 . . . . 0.0 110.537 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -73.69 -48.05 35.02 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.651 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 16.1 t -56.09 -44.36 78.94 Favored 'General case' 0 CA--C 1.477 -1.85 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.132 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 22.5 tttp -54.77 -54.95 35.4 Favored 'General case' 0 N--CA 1.392 -3.351 0 CA-C-N 112.79 -2.005 . . . . 0.0 109.264 -175.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -62.21 -43.06 99.69 Favored 'General case' 0 CA--C 1.497 -1.094 0 O-C-N 123.815 0.697 . . . . 0.0 110.745 -176.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.698 HG13 ' HD2' ' A' ' 9' ' ' LYS . 72.9 t -56.95 -52.52 54.52 Favored 'Isoleucine or valine' 0 C--O 1.253 1.257 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.702 178.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 92.9 m -63.31 -38.03 89.56 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 124.363 1.04 . . . . 0.0 111.829 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 53.7 mtp180 -65.21 -29.08 69.85 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.092 0.472 . . . . 0.0 110.171 177.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 m -85.65 -14.61 45.01 Favored 'General case' 0 CA--C 1.578 2.036 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.793 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.475 ' OE2' ' HG3' ' A' ' 9' ' ' LYS . 47.2 mt-10 -86.99 -25.4 24.3 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.293 -0.879 . . . . 0.0 110.543 174.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.33 39.84 0.57 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.607 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 91.8 m-85 -129.17 148.56 69.59 Favored Pre-proline 0 C--N 1.311 -1.067 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -64.0 -34.19 59.93 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.346 2.03 . . . . 0.0 112.267 177.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.51 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.1 t -156.93 168.74 26.57 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.005 -176.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.64 153.63 25.46 Favored Glycine 0 N--CA 1.408 -3.216 0 N-CA-C 106.853 -2.499 . . . . 0.0 106.853 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.621 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 46.1 m -155.91 158.97 38.87 Favored 'General case' 0 C--N 1.275 -2.644 0 C-N-CA 123.704 0.802 . . . . 0.0 110.297 -176.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.1 m -92.61 157.06 16.69 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.259 0.552 . . . . 0.0 111.841 -170.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.505 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 7.5 t70 -148.08 155.19 41.18 Favored 'General case' 0 C--O 1.256 1.438 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.989 -177.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -122.09 110.1 15.35 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -147.08 8.6 0.95 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.507 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.9 m -149.43 164.07 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.129 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.385 -174.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.4 80.47 1.4 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.108 0.956 . . . . 0.0 109.011 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.77 -148.22 18.07 Favored Glycine 0 N--CA 1.403 -3.521 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 -176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.514 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 20.8 mtp180 -139.1 117.85 12.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 117.517 0.659 . . . . 0.0 109.486 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -101.09 141.67 33.64 Favored 'General case' 0 N--CA 1.421 -1.886 0 O-C-N 123.519 0.512 . . . . 0.0 110.395 -172.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.3 t -94.75 139.1 31.71 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.974 177.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.505 ' CD2' ' HB3' ' A' ' 35' ' ' ASP . 46.6 m-85 -134.27 142.29 47.27 Favored 'General case' 0 N--CA 1.42 -1.939 0 O-C-N 123.956 0.785 . . . . 0.0 109.855 175.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.487 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 39.8 m -94.68 139.14 31.62 Favored 'General case' 0 C--N 1.256 -3.487 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.311 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.621 ' CE1' ' HB2' ' A' ' 33' ' ' SER . 30.2 m-85 -113.99 134.49 54.81 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.783 -178.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HE2' ' OG1' ' A' ' 5' ' ' THR . 51.9 pttt -140.98 134.72 14.86 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.481 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.12 110.64 2.87 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.922 2.414 . . . . 0.0 112.237 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 p -109.29 163.17 17.64 Favored Pre-proline 0 C--N 1.274 -2.708 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 173.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.445 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 29.7 Cg_exo . . . . . 0 C--O 1.263 1.725 0 C-N-CA 121.938 1.759 . . . . 0.0 110.996 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ARG . . . . . 0.418 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 59.2 mtt85 . . . . . 0 CA--C 1.514 -0.437 0 CA-C-O 121.159 0.504 . . . . 0.0 111.835 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.3 mtt -108.71 100.62 9.83 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 174.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.5 m -80.67 114.56 19.64 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.605 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.518 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 38.7 ttpt -92.82 110.7 22.15 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.7 m -110.64 131.15 22.23 Favored Pre-proline 0 C--N 1.295 -1.798 0 C-N-CA 124.355 1.062 . . . . 0.0 110.126 -175.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -66.25 127.38 17.38 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 121.719 1.613 . . . . 0.0 111.968 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.3 p -60.07 143.41 52.13 Favored 'General case' 0 C--O 1.271 2.185 0 O-C-N 123.914 0.759 . . . . 0.0 111.415 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -97.1 -28.93 8.29 Favored Glycine 0 N--CA 1.425 -2.064 0 O-C-N 123.721 0.638 . . . . 0.0 114.518 -176.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.556 ' NZ ' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.26 1.62 0 CA-C-N 118.947 1.374 . . . . 0.0 112.47 -175.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 N--CA 1.446 -0.625 0 CA-C-O 120.9 0.381 . . . . 0.0 111.992 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.663 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 7.1 t -88.65 69.56 8.79 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.503 0.668 . . . . 0.0 109.263 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.524 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 62.1 t -68.23 -56.6 12.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.042 172.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -101.5 127.66 48.09 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.769 -176.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 91.0 m-20 -56.52 -31.17 63.85 Favored 'General case' 0 C--O 1.204 -1.292 0 C-N-CA 124.417 1.087 . . . . 0.0 111.518 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.4 m -64.25 -28.92 70.06 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 123.519 0.728 . . . . 0.0 111.192 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -74.43 -45.1 48.63 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.663 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 24.9 t -56.77 -46.5 81.44 Favored 'General case' 0 CA--C 1.471 -2.084 0 CA-C-N 114.343 -1.298 . . . . 0.0 107.799 176.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 19.9 tttp -53.78 -54.89 31.84 Favored 'General case' 0 N--CA 1.394 -3.25 0 CA-C-N 112.664 -2.062 . . . . 0.0 109.219 -175.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -60.44 -45.66 92.86 Favored 'General case' 0 CA--C 1.502 -0.886 0 O-C-N 123.95 0.781 . . . . 0.0 110.794 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.514 HG13 ' CD ' ' A' ' 9' ' ' LYS . 95.6 t -60.74 -49.29 85.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.745 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.407 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 83.9 m -61.91 -37.97 86.61 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 123.025 0.53 . . . . 0.0 111.255 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 48.6 mtp180 -68.13 -25.18 65.16 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.809 0.338 . . . . 0.0 110.443 178.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.8 m -80.08 -37.39 33.91 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.763 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -69.88 -25.42 63.7 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.398 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.56 31.12 1.28 Allowed Glycine 0 CA--C 1.509 -0.318 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.523 176.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.487 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 89.4 m-85 -118.85 148.52 44.71 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.32 -35.32 73.99 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.419 2.08 . . . . 0.0 112.363 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.553 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.6 t -157.51 170.56 22.14 Favored 'General case' 0 N--CA 1.42 -1.96 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.156 -176.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.26 152.31 24.4 Favored Glycine 0 N--CA 1.403 -3.553 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.61 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 25.4 m -151.96 156.68 40.52 Favored 'General case' 0 C--N 1.278 -2.521 0 C-N-CA 124.557 1.143 . . . . 0.0 109.398 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.5 m -91.86 152.43 20.09 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 120.938 0.399 . . . . 0.0 111.823 -172.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.545 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 13.0 t70 -145.84 158.3 43.87 Favored 'General case' 0 C--O 1.256 1.44 0 C-N-CA 124.158 0.983 . . . . 0.0 108.885 -176.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.03 107.74 13.01 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -139.2 6.93 2.38 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 m -149.79 160.69 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.37 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.224 -174.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.55 83.9 0.6 Allowed 'General case' 0 C--N 1.323 -0.57 0 O-C-N 124.234 0.959 . . . . 0.0 109.04 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.85 -143.71 10.61 Favored Glycine 0 N--CA 1.402 -3.568 0 N-CA-C 107.854 -2.099 . . . . 0.0 107.854 -177.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.524 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 30.7 mtp180 -141.16 119.73 12.41 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 117.462 0.631 . . . . 0.0 109.798 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -108.16 138.77 43.86 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.338 0.589 . . . . 0.0 110.644 -173.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.0 t -85.21 136.09 33.67 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.296 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.545 ' CD2' ' HB3' ' A' ' 35' ' ' ASP . 32.5 m-85 -128.85 137.06 51.25 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-O 121.888 0.851 . . . . 0.0 109.991 175.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.487 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 44.5 m -95.08 134.36 37.87 Favored 'General case' 0 C--N 1.25 -3.726 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.417 -176.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.61 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 21.6 m-85 -107.38 135.8 48.25 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 120.893 0.378 . . . . 0.0 110.753 -178.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -144.8 138.67 14.6 Favored Pre-proline 0 C--N 1.298 -1.65 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.042 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.81 121.33 7.8 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.738 2.292 . . . . 0.0 112.513 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 p -119.18 164.16 22.77 Favored Pre-proline 0 C--N 1.272 -2.801 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 171.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.418 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 31.2 Cg_exo . . . . . 0 C--O 1.262 1.718 0 C-N-CA 121.847 1.698 . . . . 0.0 110.892 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.424 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 60.9 mtt85 . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 120.877 0.37 . . . . 0.0 111.797 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 67.6 mtm -101.76 106.73 17.77 Favored 'General case' 0 CA--C 1.482 -1.649 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.6 m -85.02 114.31 22.08 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.049 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.525 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.4 ttpt -94.04 110.22 21.93 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.3 m -110.06 131.78 21.8 Favored Pre-proline 0 C--N 1.29 -2.003 0 C-N-CA 124.383 1.073 . . . . 0.0 110.156 -176.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -65.97 125.78 14.76 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.813 1.675 . . . . 0.0 112.16 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.6 p -59.42 138.37 57.68 Favored 'General case' 0 C--O 1.274 2.362 0 O-C-N 123.965 0.791 . . . . 0.0 111.584 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.6 -37.7 5.21 Favored Glycine 0 N--CA 1.421 -2.317 0 O-C-N 123.667 0.605 . . . . 0.0 113.545 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.509 ' NZ ' ' HG3' ' A' ' 27' ' ' GLU . 22.9 pttm -103.22 -3.22 26.02 Favored 'General case' 0 N--CA 1.414 -2.26 0 C-N-CA 117.98 -1.488 . . . . 0.0 112.791 -174.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.522 ' O ' ' HD3' ' A' ' 11' ' ' LYS . 24.5 t80 -71.69 121.42 18.82 Favored 'General case' 0 CA--C 1.485 -1.55 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.472 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HD3' ' O ' ' A' ' 10' ' ' PHE . 43.7 mmtm -133.17 103.58 6.08 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.284 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 146.76 -162.65 28.54 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 119.943 -1.123 . . . . 0.0 111.8 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -95.27 117.93 31.15 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 8.7 t -86.49 71.84 10.37 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 176.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.1 m -76.9 -45.34 31.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.631 -0.668 . . . . 0.0 110.912 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -103.71 144.85 30.91 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 58.3 m-80 -73.23 -27.3 61.52 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 120.717 0.294 . . . . 0.0 111.13 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.1 m -60.2 -38.27 82.79 Favored 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 124.083 0.953 . . . . 0.0 112.494 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.472 HD21 ' HA ' ' A' ' 14' ' ' CYS . 1.1 p-10 -68.93 -42.46 76.74 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 121.391 -0.818 . . . . 0.0 110.197 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.645 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 16.9 t -59.2 -46.43 88.46 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 22.9 tttp -53.41 -54.85 30.86 Favored 'General case' 0 N--CA 1.394 -3.262 0 CA-C-N 112.453 -2.158 . . . . 0.0 108.878 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -62.36 -40.36 96.15 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 123.736 0.647 . . . . 0.0 111.96 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 19' ' ' ASN . 59.4 t -67.56 -41.07 85.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.267 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.5 m -67.17 -39.63 86.47 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 120.813 0.34 . . . . 0.0 110.714 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.584 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 61.4 mtp180 -64.03 -30.52 71.59 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-O 120.916 0.389 . . . . 0.0 110.888 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.4 p -82.45 -31.81 29.25 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.509 ' HG3' ' NZ ' ' A' ' 9' ' ' LYS . 51.5 mt-10 -66.51 -35.01 79.19 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.804 173.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.14 37.35 0.35 Allowed Glycine 0 C--N 1.316 -0.583 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.748 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.584 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 93.3 m-85 -126.19 147.11 58.39 Favored Pre-proline 0 N--CA 1.432 -1.372 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -62.52 -32.32 80.07 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 122.445 2.097 . . . . 0.0 112.427 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.557 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.2 t -159.97 170.83 20.51 Favored 'General case' 0 N--CA 1.42 -1.93 0 O-C-N 122.069 -0.395 . . . . 0.0 110.033 -176.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 45' ' ' CYS . . . -148.73 154.27 25.73 Favored Glycine 0 N--CA 1.413 -2.89 0 N-CA-C 107.399 -2.281 . . . . 0.0 107.399 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.553 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 52.1 m -156.66 158.64 37.35 Favored 'General case' 0 C--N 1.281 -2.403 0 C-N-CA 123.868 0.867 . . . . 0.0 110.263 -176.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.5 m -91.91 150.18 21.17 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.216 0.532 . . . . 0.0 111.613 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.5 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 12.4 t70 -141.11 159.42 42.26 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.486 -178.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.35 105.98 9.88 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -140.04 7.07 2.22 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 m -148.31 160.96 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.56 0 CA-C-N 114.357 -1.292 . . . . 0.0 107.513 -175.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.58 84.37 0.43 Allowed 'General case' 0 C--N 1.32 -0.698 0 O-C-N 124.282 0.989 . . . . 0.0 109.699 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 148.19 -144.91 12.91 Favored Glycine 0 N--CA 1.404 -3.48 0 N-CA-C 108.708 -1.757 . . . . 0.0 108.708 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -129.08 124.92 36.05 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.8 tptt -111.3 128.29 55.9 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 121.346 0.593 . . . . 0.0 110.322 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 30.3 t -77.72 135.79 38.08 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.389 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 40.5 m-85 -130.72 146.72 52.26 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.498 0.666 . . . . 0.0 110.012 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.463 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 40.4 m -101.9 138.33 39.01 Favored 'General case' 0 C--N 1.253 -3.615 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.339 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.557 ' HB2' HG23 ' A' ' 31' ' ' THR . 33.9 m-85 -111.84 135.9 51.84 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.706 -178.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -146.94 142.37 17.01 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.951 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.29 118.32 5.47 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.472 2.115 . . . . 0.0 112.211 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 75.3 m -111.23 163.94 16.16 Favored Pre-proline 0 C--N 1.273 -2.718 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.424 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 26.5 Cg_exo . . . . . 0 C--O 1.261 1.641 0 C-N-CA 121.684 1.589 . . . . 0.0 110.163 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.425 ' HD2' ' O ' ' A' ' 50' ' ' PRO . 61.9 mtt85 . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 120.946 0.403 . . . . 0.0 111.812 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.1 mtt -105.85 109.36 21.29 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 46' ' ' TYR . 10.5 m -87.14 121.37 29.51 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.155 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.547 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 38.3 ttpt -98.96 110.56 23.15 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.2 m -113.16 132.3 22.47 Favored Pre-proline 0 C--N 1.3 -1.584 0 C-N-CA 124.293 1.037 . . . . 0.0 110.707 -176.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.71 132.24 30.11 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.459 2.106 . . . . 0.0 113.78 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.7 p -71.21 147.13 48.57 Favored 'General case' 0 C--O 1.267 1.983 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.591 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.74 -45.74 2.05 Favored Glycine 0 C--O 1.263 1.952 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.951 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.539 ' HD3' ' CD ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -92.51 3.63 55.13 Favored 'General case' 0 CA--C 1.471 -2.081 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.62 -174.423 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.464 ' CD2' HG21 ' A' ' 23' ' ' VAL . 17.4 t80 -79.5 119.11 22.04 Favored 'General case' 0 N--CA 1.404 -2.736 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.942 177.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' HD2' ' C ' ' A' ' 10' ' ' PHE . 7.6 mmmt -131.56 99.86 4.95 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 150.09 -166.99 30.04 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 119.658 -1.258 . . . . 0.0 112.261 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -87.54 118.44 27.02 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 123.252 0.621 . . . . 0.0 112.124 -178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 8.5 t -87.98 72.4 9.27 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.552 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 22.8 m -69.14 -45.45 79.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.388 173.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -115.81 151.74 34.65 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.969 0.414 . . . . 0.0 109.973 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 93.2 m-20 -73.11 -31.07 64.1 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -176.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.0 m -59.15 -37.85 78.3 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.403 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.2 p-10 -68.85 -43.4 75.53 Favored 'General case' 0 CA--C 1.499 -0.989 0 O-C-N 121.55 -0.719 . . . . 0.0 109.868 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.615 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 17.8 t -61.52 -44.41 97.11 Favored 'General case' 0 CA--C 1.471 -2.087 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 22.3 tttp -54.74 -55.12 33.33 Favored 'General case' 0 N--CA 1.393 -3.277 0 CA-C-N 112.688 -2.051 . . . . 0.0 108.735 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -60.28 -45.11 94.48 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 123.916 0.76 . . . . 0.0 111.384 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.464 HG21 ' CD2' ' A' ' 10' ' ' PHE . 85.4 t -62.48 -44.74 99.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.62 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.4 m -66.89 -34.6 78.15 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 122.806 0.442 . . . . 0.0 111.863 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 50.0 mtp180 -69.2 -27.21 65.29 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.162 0.506 . . . . 0.0 109.83 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.9 m -82.51 -27.68 31.58 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.735 175.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.539 ' CD ' ' HD3' ' A' ' 9' ' ' LYS . 8.7 mm-40 -67.06 -46.74 73.41 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 121.741 -0.599 . . . . 0.0 110.401 171.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 134.9 39.65 0.17 Allowed Glycine 0 C--N 1.311 -0.825 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.496 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 95.3 m-85 -127.11 148.01 64.12 Favored Pre-proline 0 N--CA 1.434 -1.239 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -61.39 -33.05 89.48 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.511 2.141 . . . . 0.0 112.363 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.506 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.6 t -159.35 170.52 21.63 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.038 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.6 153.66 25.48 Favored Glycine 0 N--CA 1.409 -3.146 0 N-CA-C 107.37 -2.292 . . . . 0.0 107.37 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.597 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 39.4 m -156.78 158.71 37.33 Favored 'General case' 0 C--N 1.279 -2.473 0 C-N-CA 124.014 0.926 . . . . 0.0 110.095 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 44.2 m -91.0 156.74 17.72 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.3 0.571 . . . . 0.0 112.331 -170.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.485 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 22.9 t70 -148.36 152.45 37.07 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.03 -177.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.66 107.77 14.1 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -141.19 7.48 2.0 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 m -149.59 160.6 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.506 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.217 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.68 84.2 0.45 Allowed 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 124.289 0.993 . . . . 0.0 109.094 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.71 -145.72 13.75 Favored Glycine 0 N--CA 1.403 -3.523 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.552 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 32.5 mtp85 -140.1 117.61 11.48 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 117.568 0.684 . . . . 0.0 109.938 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -102.74 136.45 42.56 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-O 121.33 0.586 . . . . 0.0 110.735 -172.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.4 t -87.51 135.78 33.21 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.184 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.547 ' CD1' ' HG2' ' A' ' 4' ' ' LYS . 40.1 m-85 -129.9 146.34 51.61 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-O 121.718 0.771 . . . . 0.0 110.482 175.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.496 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 35.4 m -97.61 136.92 37.3 Favored 'General case' 0 C--N 1.252 -3.645 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.056 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.597 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 25.8 m-85 -111.54 136.11 51.18 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.913 -177.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -146.73 144.02 19.66 Favored Pre-proline 0 C--N 1.295 -1.774 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.705 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.08 120.56 6.67 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.372 2.048 . . . . 0.0 112.566 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 84.1 m -113.02 163.93 16.77 Favored Pre-proline 0 C--N 1.277 -2.551 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 170.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.425 ' O ' ' HD2' ' A' ' 1' ' ' ARG . 26.2 Cg_exo . . . . . 0 C--O 1.235 0.34 0 C-N-CA 121.838 1.692 . . . . 0.0 110.47 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.436 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 62.9 mtt85 . . . . . 0 CA--C 1.507 -0.701 0 CA-C-O 121.063 0.459 . . . . 0.0 112.045 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 66.9 mtm -105.12 107.95 19.2 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 174.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.1 m -83.5 117.13 22.89 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.798 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.639 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 36.7 ttpt -97.09 110.16 22.77 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 100.0 m -113.33 128.17 25.98 Favored Pre-proline 0 C--N 1.294 -1.822 0 C-N-CA 123.998 0.919 . . . . 0.0 110.662 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -69.39 115.98 4.3 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.992 1.795 . . . . 0.0 112.998 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -54.8 141.38 33.08 Favored 'General case' 0 C--O 1.276 2.492 0 C-N-CA 124.98 1.312 . . . . 0.0 110.376 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.29 -19.33 10.72 Favored Glycine 0 N--CA 1.433 -1.511 0 O-C-N 124.205 0.941 . . . . 0.0 114.601 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.473 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 49.0 pttt -118.35 15.5 13.9 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 118.546 1.173 . . . . 0.0 111.759 -176.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.51 ' HA ' HG11 ' A' ' 23' ' ' VAL . 57.8 t80 -62.32 136.16 57.79 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 114.389 -1.278 . . . . 0.0 113.002 -178.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.01 122.47 35.97 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 113.816 -1.538 . . . . 0.0 112.469 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.4 -175.29 25.66 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.122 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.57 139.41 32.12 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 2.9 t -88.93 65.6 7.61 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.146 0.974 . . . . 0.0 109.605 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.0 m -89.3 -29.95 5.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.024 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -107.9 114.74 28.9 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.028 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 55.4 m-80 -61.79 -29.69 70.32 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.863 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.8 m -67.03 -25.72 66.41 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 122.574 0.349 . . . . 0.0 110.883 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.497 ' O ' HG23 ' A' ' 23' ' ' VAL . 45.1 t30 -70.78 -48.26 55.21 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.595 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 12.9 t -56.74 -47.59 79.69 Favored 'General case' 0 CA--C 1.476 -1.888 0 CA-C-N 114.2 -1.364 . . . . 0.0 108.131 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 21.0 tttp -54.37 -55.26 30.34 Favored 'General case' 0 N--CA 1.399 -3.018 0 CA-C-N 112.68 -2.054 . . . . 0.0 109.634 -175.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -63.25 -38.53 91.53 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 123.757 0.661 . . . . 0.0 111.568 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.51 HG11 ' HA ' ' A' ' 10' ' ' PHE . 57.8 t -66.27 -45.73 89.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 95.4 m -63.63 -39.75 95.15 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 120.931 0.396 . . . . 0.0 111.071 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.573 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 59.3 mtp180 -64.76 -30.24 71.24 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 121.018 0.437 . . . . 0.0 110.502 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.0 p -85.58 -27.63 25.39 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.473 ' HG3' ' HE2' ' A' ' 9' ' ' LYS . 50.6 mt-10 -66.97 -40.33 87.43 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.691 171.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 134.32 41.04 0.16 Allowed Glycine 0 C--N 1.318 -0.468 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.701 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.573 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 95.0 m-85 -130.3 148.64 70.66 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -177.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -61.99 -34.79 79.9 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.448 2.099 . . . . 0.0 112.354 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.551 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.3 t -157.95 170.98 21.1 Favored 'General case' 0 N--CA 1.422 -1.867 0 O-C-N 122.056 -0.402 . . . . 0.0 110.354 -176.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 45' ' ' CYS . . . -148.52 153.84 25.48 Favored Glycine 0 N--CA 1.414 -2.777 0 N-CA-C 107.31 -2.316 . . . . 0.0 107.31 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.521 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 44.5 m -155.83 157.02 35.73 Favored 'General case' 0 C--N 1.281 -2.408 0 C-N-CA 123.5 0.72 . . . . 0.0 110.799 -176.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.416 ' SG ' ' HA ' ' A' ' 17' ' ' ASN . 58.0 m -94.85 125.72 39.69 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.788 -172.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.55 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 30.7 t70 -122.66 166.92 14.1 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.839 -174.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -122.34 116.04 23.35 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.331 0.586 . . . . 0.0 110.949 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -148.39 6.28 0.75 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 m -147.84 167.66 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.22 82.18 0.53 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 122.173 0.987 . . . . 0.0 110.146 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.09 -140.31 9.94 Favored Glycine 0 N--CA 1.401 -3.647 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.704 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -126.2 130.6 51.28 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -111.65 130.56 55.72 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 40.4 t -75.49 134.5 40.8 Favored 'General case' 0 C--O 1.278 2.569 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.639 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 40.0 m-85 -131.86 141.75 49.5 Favored 'General case' 0 N--CA 1.42 -1.957 0 O-C-N 123.933 0.771 . . . . 0.0 109.729 175.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.469 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 54.2 m -96.81 139.01 33.5 Favored 'General case' 0 C--N 1.252 -3.671 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.965 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.551 ' HB2' HG23 ' A' ' 31' ' ' THR . 37.1 m-85 -112.35 134.72 53.73 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.767 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -147.1 143.91 18.97 Favored Pre-proline 0 C--N 1.295 -1.791 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.726 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.06 121.6 7.41 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.469 2.113 . . . . 0.0 112.655 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 77.0 m -116.14 161.83 29.14 Favored Pre-proline 0 C--N 1.278 -2.532 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 170.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.436 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 16.4 Cg_endo . . . . . 0 C--O 1.26 1.611 0 C-N-CA 122.018 1.812 . . . . 0.0 110.972 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.9 mtt -105.25 114.14 28.15 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 175.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 46' ' ' TYR . 15.8 m -93.01 122.59 35.53 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.221 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.469 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 27.3 ttpp -101.23 109.86 21.79 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.0 m -116.31 127.98 26.34 Favored Pre-proline 0 C--O 1.196 -1.729 0 C-N-CA 124.258 1.023 . . . . 0.0 111.117 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -66.98 125.08 13.08 Favored 'Trans proline' 0 N--CA 1.474 0.366 0 C-N-CA 122.365 2.043 . . . . 0.0 112.784 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -70.39 142.37 52.08 Favored 'General case' 0 C--O 1.273 2.339 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.67 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.17 -40.97 6.77 Favored Glycine 0 N--CA 1.427 -1.909 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.957 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.536 ' HD3' ' CD ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -90.95 4.24 52.51 Favored 'General case' 0 CA--C 1.477 -1.862 0 C-N-CA 118.489 -1.285 . . . . 0.0 112.94 -175.221 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.488 ' CD2' HG21 ' A' ' 23' ' ' VAL . 13.8 t80 -87.19 119.17 27.15 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.705 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -130.64 162.14 30.04 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 113.764 -1.562 . . . . 0.0 107.646 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.05 -137.71 13.43 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.252 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.4 ' HB3' HG13 ' A' ' 15' ' ' VAL . 12.7 m-85 -122.65 113.94 19.92 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.668 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.9 t -85.66 67.7 10.16 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.508 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 18.7 m -74.25 -32.88 32.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.692 172.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -119.97 121.84 39.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.642 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 92.9 m-20 -56.73 -27.01 58.43 Favored 'General case' 0 C--O 1.208 -1.099 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.881 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.3 m -66.91 -29.77 69.74 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -74.96 -40.58 60.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.668 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 16.2 t -59.17 -48.9 79.89 Favored 'General case' 0 CA--C 1.473 -2.013 0 CA-C-N 114.228 -1.351 . . . . 0.0 108.271 177.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.522 ' HG3' ' H ' ' A' ' 32' ' ' GLY . 15.5 ttpt -55.01 -50.6 68.62 Favored 'General case' 0 N--CA 1.391 -3.404 0 CA-C-N 113.322 -1.763 . . . . 0.0 109.104 -176.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -60.09 -49.07 79.09 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.212 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.488 HG21 ' CD2' ' A' ' 10' ' ' PHE . 93.0 t -60.33 -43.49 93.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 123.207 0.317 . . . . 0.0 110.825 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 68.9 m -64.75 -38.51 91.23 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 122.991 0.517 . . . . 0.0 112.068 177.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.403 ' HD2' ' HG2' ' A' ' 21' ' ' LYS . 35.9 mtp180 -69.93 -25.08 63.5 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.191 0.52 . . . . 0.0 109.965 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -82.85 -27.67 30.65 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.895 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.536 ' CD ' ' HD3' ' A' ' 9' ' ' LYS . 7.8 mm-40 -68.6 -42.21 78.49 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.769 -0.582 . . . . 0.0 110.607 172.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.96 35.59 0.47 Allowed Glycine 0 C--N 1.312 -0.788 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.454 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 87.2 m-85 -121.19 149.53 51.85 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -60.12 -39.75 66.58 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.486 2.124 . . . . 0.0 112.441 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.552 HG23 ' HB2' ' A' ' 46' ' ' TYR . 9.4 t -154.66 174.2 15.32 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.141 -176.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.522 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -151.88 153.05 24.69 Favored Glycine 0 N--CA 1.418 -2.516 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.621 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 28.2 m -153.79 154.06 33.3 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 123.922 0.889 . . . . 0.0 110.391 -177.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.7 m -87.4 157.13 19.31 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.161 0.505 . . . . 0.0 112.109 -170.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.502 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 9.0 t70 -147.18 158.0 43.8 Favored 'General case' 0 C--O 1.257 1.46 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.061 -175.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.16 107.8 12.14 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -140.9 7.16 2.04 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 m -149.79 166.5 3.03 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.957 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -175.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.17 -30.13 66.15 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 123.974 0.796 . . . . 0.0 111.208 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.11 -170.23 42.66 Favored Glycine 0 N--CA 1.427 -1.927 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.508 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 19.9 mtp180 -114.29 118.17 33.17 Favored 'General case' 0 C--N 1.282 -2.351 0 O-C-N 121.698 -0.883 . . . . 0.0 109.731 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -102.14 149.68 24.03 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.309 -171.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 25.6 t -98.84 139.06 35.08 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.982 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.502 ' CD1' ' HB3' ' A' ' 35' ' ' ASP . 22.9 m-85 -132.49 135.74 46.21 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-O 122.052 0.93 . . . . 0.0 109.68 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.454 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 58.6 m -90.7 141.36 28.87 Favored 'General case' 0 C--N 1.246 -3.924 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.007 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.621 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 24.0 m-85 -111.75 134.92 52.99 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.829 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -147.28 145.61 22.48 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.854 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.04 116.66 4.72 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 122.395 2.063 . . . . 0.0 112.483 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.401 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 72.8 m -111.19 169.76 5.97 Favored Pre-proline 0 C--N 1.28 -2.44 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 171.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 49' ' ' CYS . 13.5 Cg_endo . . . . . 0 C--O 1.255 1.327 0 C-N-CA 122.16 1.907 . . . . 0.0 111.832 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.425 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 59.5 mtt85 . . . . . 0 CA--C 1.513 -0.468 0 CA-C-O 121.157 0.503 . . . . 0.0 111.819 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 63.8 mtt -110.63 101.23 9.91 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 18.5 m -80.36 114.51 19.31 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.67 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.516 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.6 ttpt -93.29 111.18 22.75 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 96.9 m -113.14 131.84 22.67 Favored Pre-proline 0 C--N 1.298 -1.651 0 C-N-CA 124.29 1.036 . . . . 0.0 110.18 -176.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 4.6 Cg_exo -72.17 114.46 3.99 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.015 1.81 . . . . 0.0 112.268 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.61 144.75 30.81 Favored 'General case' 0 C--O 1.269 2.127 0 C-N-CA 124.39 1.076 . . . . 0.0 110.475 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.66 -22.37 8.12 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 115.218 0.847 . . . . 0.0 115.218 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.574 ' HD2' HG13 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -108.19 -6.39 16.43 Favored 'General case' 0 CA--C 1.475 -1.916 0 C-N-CA 117.759 -1.576 . . . . 0.0 111.609 -174.314 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.444 ' CD2' HG21 ' A' ' 23' ' ' VAL . 29.7 t80 -65.62 144.4 56.97 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 113.395 -1.729 . . . . 0.0 109.936 172.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.48 132.4 9.71 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.555 176.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.66 -170.92 14.94 Favored Glycine 0 N--CA 1.433 -1.542 0 C-N-CA 120.466 -0.874 . . . . 0.0 111.49 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -87.78 114.43 24.38 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 4.3 t -83.22 71.84 10.18 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.946 0.879 . . . . 0.0 109.355 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.1 m -87.06 -32.17 6.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.603 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -108.38 120.51 42.6 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 54.8 m-80 -61.48 -28.35 69.23 Favored 'General case' 0 C--O 1.214 -0.766 0 O-C-N 123.731 0.644 . . . . 0.0 111.836 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.7 m -64.75 -28.32 69.5 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 123.593 0.757 . . . . 0.0 110.816 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -73.66 -46.37 46.95 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.653 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 15.9 t -56.87 -44.85 82.65 Favored 'General case' 0 CA--C 1.472 -2.02 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.079 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 22.6 tttp -55.08 -55.12 34.6 Favored 'General case' 0 N--CA 1.393 -3.276 0 CA-C-N 112.85 -1.977 . . . . 0.0 108.989 -175.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -61.72 -43.74 98.26 Favored 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 123.906 0.754 . . . . 0.0 110.957 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.574 HG13 ' HD2' ' A' ' 9' ' ' LYS . 89.8 t -60.29 -48.83 86.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.884 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.6 m -63.03 -39.53 95.03 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.826 0.85 . . . . 0.0 111.649 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 54.1 mtp180 -64.42 -30.95 71.98 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.238 0.542 . . . . 0.0 110.024 177.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.0 m -85.65 -11.06 54.76 Favored 'General case' 0 CA--C 1.58 2.114 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.656 176.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -88.06 -27.41 22.0 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.242 -0.911 . . . . 0.0 110.287 172.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.52 34.05 0.78 Allowed Glycine 0 C--N 1.318 -0.439 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.636 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.0 m-85 -124.14 148.85 58.77 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -63.59 -34.76 62.66 Favored 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 122.394 2.063 . . . . 0.0 112.277 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.508 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.0 t -156.96 170.67 21.99 Favored 'General case' 0 N--CA 1.416 -2.126 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.085 -176.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 45' ' ' CYS . . . -148.33 154.93 26.17 Favored Glycine 0 N--CA 1.409 -3.163 0 N-CA-C 107.085 -2.406 . . . . 0.0 107.085 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.546 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 43.9 m -155.15 152.79 29.86 Favored 'General case' 0 C--N 1.277 -2.551 0 C-N-CA 123.628 0.771 . . . . 0.0 110.641 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.418 ' SG ' ' HA ' ' A' ' 17' ' ' ASN . 51.0 m -92.4 127.78 38.01 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.448 -172.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.631 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 35.0 t70 -127.24 169.43 13.51 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.047 -175.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -121.23 118.44 29.61 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.246 0.546 . . . . 0.0 111.371 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -149.3 5.52 0.64 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 174.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 m -147.38 167.01 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.316 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.66 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.5 82.17 1.09 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.741 0.781 . . . . 0.0 108.916 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.45 -150.95 23.2 Favored Glycine 0 N--CA 1.406 -3.302 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -177.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -121.78 127.48 50.67 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 122.65 -0.323 . . . . 0.0 110.672 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -109.78 132.63 53.98 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.0 t -77.21 134.64 38.57 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 174.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.631 ' CD1' ' HB3' ' A' ' 35' ' ' ASP . 46.9 m-85 -130.54 141.65 50.48 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-O 121.553 0.692 . . . . 0.0 109.337 173.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.461 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 57.3 m -96.12 139.36 32.4 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.274 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.546 ' CE1' ' HB2' ' A' ' 33' ' ' SER . 26.1 m-85 -112.9 134.23 54.51 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 121.002 0.429 . . . . 0.0 110.702 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -143.78 137.09 14.03 Favored Pre-proline 0 C--N 1.295 -1.798 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.337 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.84 118.8 5.89 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.796 2.331 . . . . 0.0 112.465 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.05 164.15 20.08 Favored Pre-proline 0 C--N 1.272 -2.786 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 171.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.425 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 32.9 Cg_exo . . . . . 0 C--O 1.264 1.796 0 C-N-CA 121.958 1.772 . . . . 0.0 110.952 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.692 ' HD3' ' OXT' ' A' ' 50' ' ' PRO . 31.7 mtp180 . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 121.184 0.516 . . . . 0.0 112.089 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.9 mtm -107.62 106.3 16.59 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.2 m -86.34 116.17 24.33 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.71 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.506 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.8 ttpt -92.97 111.42 23.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.8 m -114.9 130.47 24.15 Favored Pre-proline 0 C--N 1.295 -1.803 0 C-N-CA 124.337 1.055 . . . . 0.0 110.336 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.54 131.48 28.02 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.147 1.898 . . . . 0.0 113.253 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 10' ' ' PHE . 10.0 p -59.95 143.46 51.57 Favored 'General case' 0 C--O 1.27 2.159 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.711 177.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.68 -32.31 6.01 Favored Glycine 0 N--CA 1.427 -1.918 0 O-C-N 123.58 0.55 . . . . 0.0 113.528 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.556 ' NZ ' ' HG3' ' A' ' 27' ' ' GLU . 16.1 pttm -120.24 19.26 12.2 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 118.276 1.038 . . . . 0.0 112.706 -174.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.543 ' HA ' HG11 ' A' ' 23' ' ' VAL . 59.7 t80 -63.88 135.43 56.55 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.843 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.95 118.1 28.03 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 113.498 -1.683 . . . . 0.0 112.67 -176.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.6 -160.84 19.63 Favored Glycine 0 N--CA 1.434 -1.461 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.319 173.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -88.86 138.05 31.77 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 122.993 0.517 . . . . 0.0 110.768 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.1 t -93.43 64.15 3.62 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.868 0.842 . . . . 0.0 108.977 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.501 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 18.8 m -73.83 -34.78 41.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.027 172.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -119.69 125.52 48.88 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.51 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 91.4 m-20 -56.56 -28.18 59.57 Favored 'General case' 0 C--O 1.199 -1.596 0 O-C-N 124.312 1.007 . . . . 0.0 111.354 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 89.9 m -67.4 -29.65 69.21 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.513 ' O ' HG23 ' A' ' 23' ' ' VAL . 45.6 t30 -70.05 -46.27 65.35 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.651 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 24.3 t -57.62 -51.5 69.23 Favored 'General case' 0 CA--C 1.478 -1.823 0 CA-C-N 113.991 -1.459 . . . . 0.0 108.745 177.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 11.4 ttpt -51.64 -53.76 35.27 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-N 113.275 -1.784 . . . . 0.0 109.502 -174.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -62.7 -40.93 98.68 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.404 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.543 HG11 ' HA ' ' A' ' 10' ' ' PHE . 60.2 t -65.97 -42.46 91.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.588 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.6 m -64.85 -41.99 95.26 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 120.973 0.416 . . . . 0.0 110.853 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 43.5 mtp180 -65.21 -29.32 70.11 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.004 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 p -81.65 -30.95 32.54 Favored 'General case' 0 C--O 1.215 -0.727 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 175.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.556 ' HG3' ' NZ ' ' A' ' 9' ' ' LYS . 48.1 mt-10 -68.67 -34.94 76.55 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.889 173.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.87 36.76 0.38 Allowed Glycine 0 C--N 1.314 -0.642 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.883 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.7 m-85 -123.57 148.9 57.2 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.37 -35.96 58.59 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.121 1.881 . . . . 0.0 112.294 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.527 HG23 ' HB2' ' A' ' 46' ' ' TYR . 8.8 t -157.74 175.5 13.81 Favored 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.88 -175.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -154.88 153.72 25.0 Favored Glycine 0 N--CA 1.417 -2.616 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.593 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 32.8 m -155.24 160.98 41.25 Favored 'General case' 0 C--N 1.285 -2.2 0 C-N-CA 123.636 0.774 . . . . 0.0 110.763 -177.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.4 m -93.17 153.84 18.4 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -171.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.516 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 9.9 t70 -147.49 157.29 43.51 Favored 'General case' 0 C--O 1.255 1.376 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.173 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -121.71 110.77 16.36 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 121.549 0.69 . . . . 0.0 109.231 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -146.16 7.69 1.04 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.423 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 m -149.06 165.53 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.243 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.489 -174.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.34 83.11 1.41 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.56 -148.42 19.43 Favored Glycine 0 N--CA 1.405 -3.389 0 N-CA-C 107.833 -2.107 . . . . 0.0 107.833 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.501 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 19.1 mtp180 -137.6 118.08 13.82 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 117.663 0.732 . . . . 0.0 109.58 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -103.69 134.6 46.74 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-O 121.423 0.63 . . . . 0.0 111.146 -172.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 5.9 t -84.6 136.9 33.58 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.542 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.516 ' CD1' ' HB3' ' A' ' 35' ' ' ASP . 39.1 m-85 -129.84 138.97 51.28 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-O 121.8 0.81 . . . . 0.0 109.845 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.438 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 56.9 m -95.53 136.04 36.42 Favored 'General case' 0 C--N 1.246 -3.919 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.348 -177.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.593 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 27.9 m-85 -107.61 135.19 49.48 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.863 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -146.27 140.82 15.77 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.716 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 130.95 20.27 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.536 2.158 . . . . 0.0 112.506 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.3 p -129.81 158.26 74.24 Favored Pre-proline 0 C--N 1.27 -2.875 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 171.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.692 ' OXT' ' HD3' ' A' ' 1' ' ' ARG . 31.7 Cg_exo . . . . . 0 C--O 1.275 2.329 0 C-N-CA 121.894 1.729 . . . . 0.0 110.472 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 29.3 ttm105 . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 121.258 0.552 . . . . 0.0 111.756 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 90.4 mtp -98.04 105.88 18.09 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.631 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.9 m -85.38 118.02 24.66 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.705 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.533 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 37.5 ttpt -97.39 110.52 23.06 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 98.1 m -111.55 131.48 22.31 Favored Pre-proline 0 C--N 1.29 -2.001 0 C-N-CA 124.106 0.962 . . . . 0.0 110.31 -176.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -66.54 126.42 15.48 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.002 1.801 . . . . 0.0 112.36 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.1 p -63.2 142.28 58.44 Favored 'General case' 0 C--O 1.273 2.294 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.499 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.78 -32.75 5.53 Favored Glycine 0 N--CA 1.428 -1.889 0 CA-C-N 115.951 -0.568 . . . . 0.0 114.341 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.525 ' HD2' HG13 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -111.76 -1.56 15.58 Favored 'General case' 0 CA--C 1.476 -1.895 0 O-C-N 120.976 -1.308 . . . . 0.0 111.008 -173.739 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.459 ' CD2' HG21 ' A' ' 23' ' ' VAL . 28.0 t80 -75.14 129.49 37.62 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.067 169.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.75 102.72 2.39 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.238 174.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.51 -174.09 38.86 Favored Glycine 0 N--CA 1.426 -2.005 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -80.25 111.0 16.21 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.275 0.559 . . . . 0.0 111.809 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.666 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 8.0 t -82.05 71.05 9.09 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.69 -60.17 3.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.787 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -100.93 140.71 34.84 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.931 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 91.8 m-20 -64.76 -28.01 69.29 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.496 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.6 m -63.85 -35.08 79.47 Favored 'General case' 0 CA--C 1.575 1.918 0 C-N-CA 123.236 0.614 . . . . 0.0 112.482 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.466 HD21 ' HA ' ' A' ' 14' ' ' CYS . 1.2 p-10 -72.26 -40.72 67.45 Favored 'General case' 0 CA--C 1.494 -1.193 0 O-C-N 121.179 -0.951 . . . . 0.0 109.761 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.666 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 23.1 t -59.82 -45.75 91.4 Favored 'General case' 0 CA--C 1.472 -2.043 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 24.0 tttp -53.69 -55.04 29.61 Favored 'General case' 0 N--CA 1.395 -3.215 0 CA-C-N 112.551 -2.113 . . . . 0.0 108.807 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -62.44 -43.71 98.16 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.24 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.525 HG13 ' HD2' ' A' ' 9' ' ' LYS . 92.3 t -60.94 -48.41 89.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.597 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.4 m -63.05 -38.54 91.6 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.789 0.835 . . . . 0.0 111.286 177.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 56.1 mtp180 -64.47 -31.36 72.53 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-O 121.282 0.563 . . . . 0.0 110.145 177.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.2 m -85.46 -10.66 55.81 Favored 'General case' 0 CA--C 1.578 2.032 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.548 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 23' ' ' VAL . 68.7 mt-10 -88.13 -28.75 21.06 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.245 -0.909 . . . . 0.0 110.215 172.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.95 33.22 0.7 Allowed Glycine 0 C--N 1.318 -0.463 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.703 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.603 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.4 m-85 -123.89 147.51 54.03 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -63.69 -32.13 68.73 Favored 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.462 2.108 . . . . 0.0 112.269 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.494 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.1 t -159.37 171.5 19.66 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.02 -176.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -149.93 156.82 26.94 Favored Glycine 0 N--CA 1.408 -3.196 0 N-CA-C 107.405 -2.278 . . . . 0.0 107.405 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.571 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 39.8 m -157.42 156.89 32.99 Favored 'General case' 0 C--N 1.28 -2.445 0 C-N-CA 124.072 0.949 . . . . 0.0 110.235 -177.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.3 m -94.12 139.43 31.0 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.0 0.428 . . . . 0.0 111.257 -171.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.551 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 20.8 t70 -131.4 162.85 29.21 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.422 -176.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -120.6 112.55 19.05 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-O 121.627 0.727 . . . . 0.0 110.485 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -147.89 6.6 0.8 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.362 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 m -147.02 165.97 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.218 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.364 -175.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.25 83.46 0.75 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.826 0.822 . . . . 0.0 109.536 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.18 -143.35 12.04 Favored Glycine 0 N--CA 1.405 -3.37 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -127.01 125.9 42.22 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -111.42 125.02 53.44 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.39 0.614 . . . . 0.0 110.246 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 33.8 t -72.23 135.2 46.0 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.64 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.551 ' CD1' ' HB3' ' A' ' 35' ' ' ASP . 39.3 m-85 -130.55 143.21 50.61 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-O 121.499 0.666 . . . . 0.0 109.605 174.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.482 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 35.3 m -97.17 136.95 36.96 Favored 'General case' 0 C--N 1.25 -3.753 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.997 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.571 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 38.4 m-85 -112.18 136.15 51.95 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.585 -177.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -147.13 144.58 19.95 Favored Pre-proline 0 C--N 1.296 -1.743 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.907 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.93 120.56 6.42 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 122.457 2.105 . . . . 0.0 112.584 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.4 m -116.79 169.35 7.36 Favored Pre-proline 0 C--N 1.277 -2.553 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 171.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.263 1.734 0 C-N-CA 121.904 1.736 . . . . 0.0 110.208 174.777 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.418 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 58.2 mtt85 . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 121.063 0.459 . . . . 0.0 111.87 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.8 mtt -107.63 99.71 9.18 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 17.7 m -80.36 114.42 19.24 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.623 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.526 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.6 ttpt -92.63 110.33 21.76 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 33.4 m -108.8 131.9 21.5 Favored Pre-proline 0 C--N 1.301 -1.523 0 C-N-CA 124.27 1.028 . . . . 0.0 109.809 -174.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 5.8 Cg_exo -72.3 116.28 4.65 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.66 1.573 . . . . 0.0 111.865 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -58.13 139.04 55.58 Favored 'General case' 0 C--O 1.278 2.558 0 C-N-CA 123.944 0.898 . . . . 0.0 111.097 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.57 -30.34 9.89 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.787 -175.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.488 ' NZ ' ' HG3' ' A' ' 27' ' ' GLU . 21.5 pttm -105.05 7.01 33.79 Favored 'General case' 0 N--CA 1.42 -1.954 0 C-N-CA 118.406 -1.318 . . . . 0.0 112.562 -175.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.41 ' CD2' HG21 ' A' ' 23' ' ' VAL . 24.6 t80 -82.73 116.66 22.19 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.641 177.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -126.06 134.68 51.33 Favored 'General case' 0 C--N 1.269 -2.928 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.311 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.62 -161.41 14.17 Favored Glycine 0 N--CA 1.432 -1.608 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.877 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -97.81 123.57 41.83 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.1 t -91.8 60.15 3.85 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.558 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 17.4 m -69.98 -33.28 54.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.513 173.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.488 HD21 ' HB ' ' A' ' 18' ' ' THR . 19.5 t30 -111.34 121.19 44.59 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.86 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -61.88 -26.08 67.94 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.059 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.488 ' HB ' HD21 ' A' ' 16' ' ' ASN . 97.8 m -67.43 -31.21 71.25 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.423 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -59.43 -54.25 48.87 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.591 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 5.9 t -56.64 -49.72 74.17 Favored 'General case' 0 CA--C 1.464 -2.341 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.243 -177.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.505 ' HG3' ' H ' ' A' ' 32' ' ' GLY . 0.9 OUTLIER -55.48 -46.54 76.89 Favored 'General case' 0 N--CA 1.395 -3.2 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.607 -176.203 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -68.02 -44.09 77.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.229 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.41 HG21 ' CD2' ' A' ' 10' ' ' PHE . 76.2 t -64.13 -40.83 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.407 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.8 m -66.2 -41.86 89.58 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 120.866 0.365 . . . . 0.0 111.571 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 35.3 mtp180 -66.55 -28.63 68.68 Favored 'General case' 0 C--O 1.211 -0.958 0 CA-C-O 120.915 0.388 . . . . 0.0 111.017 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 p -81.92 -30.97 31.59 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.488 ' HG3' ' NZ ' ' A' ' 9' ' ' LYS . 53.1 mt-10 -68.3 -32.67 72.98 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.659 172.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.12 36.29 0.55 Allowed Glycine 0 C--N 1.315 -0.631 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.977 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 92.6 m-85 -122.13 149.23 53.87 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -60.82 -38.47 70.02 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.308 2.006 . . . . 0.0 112.277 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.529 HG23 ' HB2' ' A' ' 46' ' ' TYR . 9.1 t -158.07 173.89 16.05 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.112 -175.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.505 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -153.99 154.13 25.3 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.458 ' HB3' ' CE2' ' A' ' 46' ' ' TYR . 23.2 t -150.3 154.58 38.12 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.6 m -87.47 156.16 19.68 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 120.831 0.348 . . . . 0.0 110.569 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.469 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 22.8 t70 -145.01 153.86 41.93 Favored 'General case' 0 C--O 1.255 1.368 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.564 -175.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -119.75 105.74 11.44 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -144.13 6.14 1.33 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.118 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.0 m -148.04 164.94 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.877 -175.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.1 80.94 0.96 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.048 0.928 . . . . 0.0 109.365 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.52 -147.38 16.75 Favored Glycine 0 N--CA 1.405 -3.43 0 N-CA-C 107.833 -2.107 . . . . 0.0 107.833 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.558 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 20.8 mtp180 -139.24 117.76 12.14 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 117.581 0.691 . . . . 0.0 109.668 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -101.05 146.93 26.81 Favored 'General case' 0 N--CA 1.422 -1.835 0 O-C-N 123.536 0.522 . . . . 0.0 109.975 -172.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.4 t -97.98 141.37 31.03 Favored 'General case' 0 C--O 1.266 1.964 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.526 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 47.4 m-85 -134.87 138.08 43.83 Favored 'General case' 0 N--CA 1.419 -1.983 0 O-C-N 124.165 0.916 . . . . 0.0 110.411 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.475 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 61.5 m -96.05 135.81 37.32 Favored 'General case' 0 C--N 1.258 -3.408 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.84 -177.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.529 ' HB2' HG23 ' A' ' 31' ' ' THR . 21.7 m-85 -106.92 134.64 49.77 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 120.863 0.363 . . . . 0.0 110.803 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -144.49 137.81 14.11 Favored Pre-proline 0 C--N 1.296 -1.755 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.846 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.4 120.68 7.32 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.659 2.24 . . . . 0.0 112.362 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 p -118.28 164.45 20.23 Favored Pre-proline 0 C--N 1.272 -2.778 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 171.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.418 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 34.6 Cg_exo . . . . . 0 C--O 1.263 1.732 0 C-N-CA 121.816 1.677 . . . . 0.0 110.875 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.42 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 63.0 mtt85 . . . . . 0 N--CA 1.469 0.492 0 CA-C-O 121.023 0.44 . . . . 0.0 112.157 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 89.2 mtp -99.25 101.16 12.38 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.9 m -81.97 116.09 21.44 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.532 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.496 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 38.8 ttpt -93.08 109.77 21.25 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.6 m -107.35 132.52 20.89 Favored Pre-proline 0 C--N 1.298 -1.655 0 C-N-CA 124.373 1.069 . . . . 0.0 109.821 -174.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -71.72 115.01 4.13 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.68 1.586 . . . . 0.0 111.998 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -58.26 140.87 52.41 Favored 'General case' 0 C--O 1.278 2.605 0 C-N-CA 124.078 0.951 . . . . 0.0 111.278 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.55 -33.11 6.93 Favored Glycine 0 N--CA 1.427 -1.951 0 CA-C-N 115.749 -0.659 . . . . 0.0 114.051 -175.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.48 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 50.1 pttt -103.51 6.99 37.8 Favored 'General case' 0 CA--C 1.474 -1.972 0 O-C-N 120.995 -1.297 . . . . 0.0 112.635 -174.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.455 ' CD2' HG21 ' A' ' 23' ' ' VAL . 22.8 t80 -87.42 127.4 35.22 Favored 'General case' 0 N--CA 1.4 -2.93 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.012 176.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.41 ' HE3' ' HB3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -151.7 104.04 3.0 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.92 176.08 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 156.63 -167.51 33.61 Favored Glycine 0 N--CA 1.424 -2.163 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -84.82 119.18 25.02 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.0 t -89.45 60.35 5.16 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.513 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 17.4 m -68.25 -39.59 81.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.573 173.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -110.39 121.97 46.57 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.457 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 86.7 m-20 -57.44 -28.42 63.3 Favored 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 124.153 0.981 . . . . 0.0 111.239 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 51.9 m -68.65 -26.27 65.24 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -73.64 -42.24 61.68 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.641 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 18.3 t -58.84 -49.7 76.75 Favored 'General case' 0 CA--C 1.475 -1.937 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.244 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HG3' ' H ' ' A' ' 32' ' ' GLY . 12.7 ttpt -53.54 -51.84 61.62 Favored 'General case' 0 N--CA 1.399 -2.995 0 CA-C-N 113.018 -1.901 . . . . 0.0 109.028 -175.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -59.88 -48.38 81.95 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 123.693 0.621 . . . . 0.0 111.38 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.455 HG21 ' CD2' ' A' ' 10' ' ' PHE . 92.4 t -60.2 -47.36 92.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 O-C-N 123.417 0.448 . . . . 0.0 110.707 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.1 m -60.49 -42.85 97.16 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.441 0.696 . . . . 0.0 111.9 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.6 mtp180 -65.08 -30.47 71.43 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.083 0.468 . . . . 0.0 110.24 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 m -85.46 -16.72 38.72 Favored 'General case' 0 CA--C 1.574 1.871 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.888 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.48 ' HG3' ' HE2' ' A' ' 9' ' ' LYS . 55.1 mt-10 -78.92 -38.26 37.83 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.365 -0.834 . . . . 0.0 110.309 172.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 133.39 34.7 0.31 Allowed Glycine 0 C--N 1.31 -0.908 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.1 m-85 -121.78 147.92 49.59 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -59.58 -38.34 82.89 Favored 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 122.467 2.111 . . . . 0.0 112.325 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.539 HG23 ' HB2' ' A' ' 46' ' ' TYR . 8.8 t -158.85 176.38 12.41 Favored 'General case' 0 N--CA 1.426 -1.667 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.068 -175.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.451 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -155.28 158.97 28.81 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.3 t -156.63 162.37 39.86 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 17' ' ' ASN . 59.2 m -96.11 156.97 16.11 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.302 0.572 . . . . 0.0 111.63 -171.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.439 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 8.2 t70 -145.85 156.62 43.68 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 124.306 1.042 . . . . 0.0 108.61 -176.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.4 107.08 10.74 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -142.29 7.81 1.78 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.4 m -149.04 160.52 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.343 -175.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.26 82.99 0.24 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 122.204 1.002 . . . . 0.0 110.007 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.78 -143.41 10.41 Favored Glycine 0 N--CA 1.403 -3.527 0 N-CA-C 107.492 -2.243 . . . . 0.0 107.492 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.513 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 23.0 mtp180 -141.68 119.86 12.16 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 117.509 0.654 . . . . 0.0 109.481 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -102.17 142.77 32.9 Favored 'General case' 0 N--CA 1.428 -1.556 0 O-C-N 123.432 0.457 . . . . 0.0 110.346 -172.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.2 t -94.13 142.12 27.76 Favored 'General case' 0 C--O 1.268 2.049 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.338 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.496 ' CD1' ' HG2' ' A' ' 4' ' ' LYS . 51.6 m-85 -135.85 139.41 43.39 Favored 'General case' 0 N--CA 1.418 -2.044 0 O-C-N 124.159 0.912 . . . . 0.0 110.421 176.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.465 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 59.8 m -96.24 137.68 34.96 Favored 'General case' 0 C--N 1.261 -3.248 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.698 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.539 ' HB2' HG23 ' A' ' 31' ' ' THR . 22.0 m-85 -108.36 135.6 49.4 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 120.992 0.425 . . . . 0.0 110.939 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -147.43 145.75 22.71 Favored Pre-proline 0 C--N 1.298 -1.643 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.385 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.04 124.19 8.91 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.343 2.029 . . . . 0.0 112.605 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.0 m -117.01 166.38 13.09 Favored Pre-proline 0 C--N 1.276 -2.593 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 170.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.42 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 22.5 Cg_exo . . . . . 0 C--O 1.259 1.574 0 C-N-CA 121.661 1.574 . . . . 0.0 110.217 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.439 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 62.2 mtt85 . . . . . 0 N--CA 1.474 0.769 0 CA-C-O 120.96 0.41 . . . . 0.0 111.841 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 68.1 mtm -103.2 108.57 19.83 Favored 'General case' 0 CA--C 1.483 -1.616 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.7 m -85.92 116.68 24.3 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.073 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.496 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 36.9 ttpt -95.78 110.17 22.36 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 67.0 m -110.37 132.71 21.38 Favored Pre-proline 0 C--O 1.202 -1.407 0 C-N-CA 124.253 1.021 . . . . 0.0 110.385 -174.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 5.1 Cg_exo -72.37 119.49 6.17 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 121.947 1.765 . . . . 0.0 112.489 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m -62.83 146.6 52.28 Favored 'General case' 0 C--O 1.274 2.365 0 C-N-CA 123.86 0.864 . . . . 0.0 110.8 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.85 -27.03 4.19 Favored Glycine 0 N--CA 1.432 -1.608 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.914 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -109.5 18.3 20.5 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-O 122.257 1.027 . . . . 0.0 111.784 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.452 ' HA ' HG11 ' A' ' 23' ' ' VAL . 51.4 t80 -69.23 140.27 54.51 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 113.997 -1.456 . . . . 0.0 112.244 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.433 ' O ' ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -131.16 134.71 46.77 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 114.284 -1.326 . . . . 0.0 111.709 -177.774 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.29 176.22 41.97 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.546 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.92 130.57 36.74 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.459 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 2.5 t -83.77 67.35 9.48 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.962 0.887 . . . . 0.0 110.2 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.2 m -89.84 -25.59 5.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.978 174.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -113.76 115.75 28.3 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.189 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 92.2 m-20 -57.53 -31.17 65.82 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.939 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.2 m -66.92 -27.47 67.51 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 122.703 0.401 . . . . 0.0 111.133 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.481 ' O ' HG23 ' A' ' 23' ' ' VAL . 47.3 t30 -72.33 -46.24 56.44 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.459 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 9.1 t -57.82 -47.13 83.51 Favored 'General case' 0 CA--C 1.48 -1.746 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.0 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 23.2 tttp -54.6 -55.72 26.53 Favored 'General case' 0 N--CA 1.4 -2.932 0 CA-C-N 112.772 -2.013 . . . . 0.0 109.313 -175.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -61.29 -41.46 97.0 Favored 'General case' 0 CA--C 1.493 -1.237 0 O-C-N 124.001 0.813 . . . . 0.0 111.682 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 19' ' ' ASN . 89.6 t -61.95 -51.33 73.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 99.4 m -58.75 -40.8 84.94 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.221 0.95 . . . . 0.0 111.341 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 56.5 mtp180 -64.15 -33.18 75.18 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 121.063 0.458 . . . . 0.0 110.582 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.0 m -85.88 -13.34 48.21 Favored 'General case' 0 CA--C 1.579 2.095 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.031 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 23' ' ' VAL . 54.4 mt-10 -82.14 -39.66 22.95 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.352 -0.843 . . . . 0.0 109.627 172.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.46 38.82 0.13 Allowed Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.57 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 92.5 m-85 -128.01 148.89 69.24 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -62.55 -35.45 70.73 Favored 'Trans proline' 0 C--O 1.242 0.706 0 C-N-CA 122.463 2.109 . . . . 0.0 112.311 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.563 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.7 t -158.23 170.46 22.21 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.273 -176.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 45' ' ' CYS . . . -147.76 155.91 26.69 Favored Glycine 0 N--CA 1.415 -2.703 0 N-CA-C 107.296 -2.321 . . . . 0.0 107.296 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.535 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 35.7 m -156.96 152.76 27.06 Favored 'General case' 0 C--N 1.283 -2.309 0 C-N-CA 123.79 0.836 . . . . 0.0 110.85 -176.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.7 m -94.96 132.1 40.18 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.237 0.541 . . . . 0.0 111.167 -172.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.4 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 26.8 t70 -120.32 156.31 31.56 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.124 -173.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.15 108.19 14.38 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -141.46 10.94 2.09 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.2 m -156.86 167.25 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.84 80.7 0.89 Allowed 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.682 0.753 . . . . 0.0 109.06 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.41 -157.99 27.46 Favored Glycine 0 N--CA 1.412 -2.907 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -124.43 132.25 53.5 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 117.206 0.503 . . . . 0.0 110.66 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -111.69 133.98 53.57 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 52.9 t -81.8 135.09 35.48 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.496 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 54.3 m-85 -132.31 140.2 48.49 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-O 121.79 0.805 . . . . 0.0 110.185 175.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.457 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 46.3 m -95.14 139.67 31.15 Favored 'General case' 0 C--N 1.252 -3.64 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.132 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.563 ' HB2' HG23 ' A' ' 31' ' ' THR . 35.4 m-85 -112.11 135.0 53.32 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.631 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -147.5 143.94 18.7 Favored Pre-proline 0 C--N 1.294 -1.841 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.603 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.17 122.07 7.74 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.352 2.035 . . . . 0.0 112.471 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 76.9 m -115.13 161.53 29.01 Favored Pre-proline 0 C--N 1.276 -2.607 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 170.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.439 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 17.7 Cg_endo . . . . . 0 C--O 1.262 1.719 0 C-N-CA 121.808 1.672 . . . . 0.0 110.836 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.425 ' HD2' ' O ' ' A' ' 50' ' ' PRO . 58.0 mtt85 . . . . . 0 CA--C 1.513 -0.466 0 CA-C-O 121.213 0.53 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 63.6 mtt -107.39 98.39 8.02 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 174.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.9 m -77.77 113.01 15.21 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.622 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.535 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.4 ttpt -92.94 110.56 22.02 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.4 m -109.36 131.4 21.88 Favored Pre-proline 0 C--N 1.296 -1.735 0 C-N-CA 124.137 0.975 . . . . 0.0 109.64 -174.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -71.76 114.63 4.01 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.755 1.637 . . . . 0.0 111.523 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -57.46 139.73 52.44 Favored 'General case' 0 C--O 1.274 2.359 0 C-N-CA 124.292 1.037 . . . . 0.0 111.36 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.64 -29.54 10.74 Favored Glycine 0 N--CA 1.425 -2.086 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.896 -176.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.588 ' HG3' ' CG ' ' A' ' 27' ' ' GLU . 34.1 mtmt -92.51 -19.84 21.56 Favored 'General case' 0 CA--C 1.476 -1.889 0 CA-C-N 118.337 1.069 . . . . 0.0 109.078 -175.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -70.24 113.02 7.0 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.148 -1.387 . . . . 0.0 111.909 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -138.03 76.16 1.56 Allowed 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 113.592 -1.64 . . . . 0.0 112.593 -179.706 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.47 -167.19 38.1 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -82.78 120.2 25.32 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.679 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 6.9 t -88.33 64.0 7.39 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.887 0.851 . . . . 0.0 109.182 176.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.464 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 19.3 m -72.85 -35.2 48.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.189 171.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -109.98 119.2 38.57 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.3 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 55.4 m-80 -64.77 -30.32 71.33 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.467 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.5 m -68.85 -24.47 64.36 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 122.568 0.347 . . . . 0.0 110.421 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.422 ' O ' HG23 ' A' ' 23' ' ' VAL . 54.2 t30 -74.01 -46.1 45.74 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.679 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 33.1 t -55.28 -47.32 75.69 Favored 'General case' 0 CA--C 1.474 -1.963 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.98 176.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 19.2 tttp -54.57 -53.26 56.94 Favored 'General case' 0 N--CA 1.391 -3.379 0 CA-C-N 112.278 -2.237 . . . . 0.0 109.33 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -61.86 -42.98 99.7 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 123.5 0.5 . . . . 0.0 111.521 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 19' ' ' ASN . 48.4 t -64.94 -43.94 96.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.019 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 74.6 m -64.0 -40.9 97.39 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 120.96 0.409 . . . . 0.0 111.388 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 52.7 mtp180 -67.06 -26.06 66.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.955 0.407 . . . . 0.0 110.727 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.7 p -85.21 -36.43 20.98 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 175.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.588 ' CG ' ' HG3' ' A' ' 9' ' ' LYS . 56.9 mt-10 -57.04 -45.61 83.05 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 120.612 0.244 . . . . 0.0 111.333 168.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 135.39 43.72 0.11 Allowed Glycine 0 C--N 1.318 -0.46 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.849 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.466 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 89.5 m-85 -128.61 149.58 72.29 Favored Pre-proline 0 C--N 1.307 -1.266 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -62.25 -37.68 60.23 Favored 'Trans proline' 0 C--O 1.24 0.602 0 C-N-CA 122.394 2.063 . . . . 0.0 112.286 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.536 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.6 t -155.29 169.07 25.04 Favored 'General case' 0 N--CA 1.418 -2.065 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.438 -176.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.54 152.15 24.26 Favored Glycine 0 N--CA 1.408 -3.226 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.577 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 46.8 m -155.07 157.66 37.88 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 124.09 0.956 . . . . 0.0 110.002 -177.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 46.2 m -91.67 153.81 19.42 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.994 0.426 . . . . 0.0 112.076 -170.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.567 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 13.3 t70 -148.38 158.31 44.03 Favored 'General case' 0 C--O 1.255 1.349 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.542 -177.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -118.86 111.14 18.03 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-O 121.61 0.719 . . . . 0.0 109.902 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -145.38 6.42 1.11 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.479 177.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.82 164.41 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.265 -174.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.05 80.75 1.23 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.022 0.915 . . . . 0.0 109.002 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.26 -144.52 11.29 Favored Glycine 0 N--CA 1.403 -3.551 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.464 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 19.7 mtp180 -139.55 118.59 12.6 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -104.75 144.51 31.64 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 121.268 0.556 . . . . 0.0 110.23 -173.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.3 t -92.83 141.27 28.62 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.997 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.567 ' CD1' ' HB3' ' A' ' 35' ' ' ASP . 42.5 m-85 -133.74 140.57 47.06 Favored 'General case' 0 N--CA 1.414 -2.242 0 O-C-N 124.053 0.846 . . . . 0.0 109.889 175.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.466 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 58.6 m -94.52 135.34 36.07 Favored 'General case' 0 C--N 1.255 -3.506 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.521 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 33' ' ' SER . 28.0 m-85 -108.89 133.7 52.55 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.743 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -144.85 138.31 14.26 Favored Pre-proline 0 C--N 1.294 -1.812 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.975 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.4 121.7 8.24 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.744 2.296 . . . . 0.0 112.27 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.7 p -121.64 162.24 37.51 Favored Pre-proline 0 C--N 1.273 -2.755 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 172.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.425 ' O ' ' HD2' ' A' ' 1' ' ' ARG . 13.6 Cg_endo . . . . . 0 CA--C 1.533 0.464 0 C-N-CA 122.113 1.875 . . . . 0.0 111.503 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.697 ' HD3' ' O ' ' A' ' 50' ' ' PRO . 32.2 mtp180 . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 120.825 0.345 . . . . 0.0 111.677 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 69.5 mtm -105.01 113.81 27.63 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.1 m -90.96 117.93 29.94 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.112 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.481 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 39.4 ttpt -94.22 110.52 22.25 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.0 m -111.48 131.63 22.22 Favored Pre-proline 0 C--N 1.295 -1.765 0 C-N-CA 124.426 1.09 . . . . 0.0 110.357 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.04 129.31 21.54 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.051 1.834 . . . . 0.0 113.119 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 10' ' ' PHE . 11.1 p -58.9 141.72 52.72 Favored 'General case' 0 C--O 1.269 2.102 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.45 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -97.71 -29.17 7.89 Favored Glycine 0 N--CA 1.431 -1.67 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.442 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.663 ' NZ ' ' HG3' ' A' ' 27' ' ' GLU . 9.6 pttm -126.01 23.56 7.14 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-N 117.889 0.844 . . . . 0.0 112.889 -175.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.481 ' HA ' HG11 ' A' ' 23' ' ' VAL . 63.6 t80 -67.96 140.16 56.41 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.85 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.421 ' HD2' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -126.63 131.55 51.44 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.893 -176.504 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.31 -157.47 28.01 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.103 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.415 ' HB3' HG13 ' A' ' 15' ' ' VAL . 5.6 m-85 -93.22 138.48 31.57 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 122.724 0.41 . . . . 0.0 111.334 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.0 t -93.94 62.92 3.18 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.522 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 17.7 m -72.79 -34.78 47.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.865 172.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -120.8 127.71 52.2 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -176.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 93.2 m-20 -56.61 -27.94 59.34 Favored 'General case' 0 C--O 1.2 -1.548 0 C-N-CA 124.395 1.078 . . . . 0.0 111.57 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.6 m -64.38 -34.87 79.18 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 122.95 0.5 . . . . 0.0 112.29 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.524 ' O ' HG23 ' A' ' 23' ' ' VAL . 49.5 t30 -69.29 -45.35 69.83 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.644 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 20.7 t -58.22 -51.9 67.82 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-N 114.541 -1.208 . . . . 0.0 108.779 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.528 ' HG3' ' H ' ' A' ' 32' ' ' GLY . 15.3 ttpt -52.17 -53.03 48.11 Favored 'General case' 0 N--CA 1.406 -2.645 0 CA-C-N 113.299 -1.773 . . . . 0.0 109.554 -174.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -61.61 -45.65 93.2 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.189 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 19' ' ' ASN . 58.3 t -60.22 -48.9 86.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 O-C-N 123.47 0.482 . . . . 0.0 110.262 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 95.2 m -59.33 -40.69 87.12 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 123.573 0.749 . . . . 0.0 111.418 177.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.2 mtp180 -66.02 -28.53 68.94 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.285 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.424 ' HB ' ' NZ ' ' A' ' 9' ' ' LYS . 4.4 m -77.73 -29.37 51.13 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.036 175.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.663 ' HG3' ' NZ ' ' A' ' 9' ' ' LYS . 42.2 mt-10 -75.57 -22.71 56.75 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.749 0.309 . . . . 0.0 111.448 177.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.94 21.89 3.39 Favored Glycine 0 CA--C 1.501 -0.84 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.234 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.7 m-85 -106.54 145.15 30.44 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -60.58 -33.99 92.98 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.521 2.147 . . . . 0.0 112.463 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.542 HG23 ' HB2' ' A' ' 46' ' ' TYR . 9.9 t -160.82 175.43 12.58 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -175.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.528 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -154.05 158.41 28.12 Favored Glycine 0 N--CA 1.428 -1.855 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.465 ' HB3' ' CE1' ' A' ' 46' ' ' TYR . 15.5 t -153.77 163.64 39.69 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 59.6 m -95.82 152.9 18.06 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.281 0.562 . . . . 0.0 112.041 -172.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.453 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 8.7 t70 -144.1 156.73 44.47 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 124.462 1.105 . . . . 0.0 108.26 -177.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.17 107.18 10.5 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -141.67 8.69 1.96 Allowed 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.3 m -150.28 161.16 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.544 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.34 82.35 0.37 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.207 1.004 . . . . 0.0 109.583 177.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.07 -146.9 15.52 Favored Glycine 0 N--CA 1.404 -3.497 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 -177.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.522 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 21.5 mtp180 -140.71 118.38 11.64 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 117.759 0.78 . . . . 0.0 109.319 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -103.1 132.6 49.24 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-O 121.394 0.616 . . . . 0.0 111.014 -171.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.6 t -84.17 138.87 32.77 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.646 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.481 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 43.5 m-85 -131.7 139.64 49.09 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.751 0.786 . . . . 0.0 110.023 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.496 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 44.6 m -95.33 138.65 32.73 Favored 'General case' 0 C--N 1.252 -3.632 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.518 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.542 ' HB2' HG23 ' A' ' 31' ' ' THR . 21.5 m-85 -110.79 136.75 49.37 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 120.853 0.359 . . . . 0.0 110.973 -178.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -146.72 143.18 18.19 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.68 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.37 119.86 6.4 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.343 2.029 . . . . 0.0 112.458 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 95.1 m -111.75 159.27 33.99 Favored Pre-proline 0 C--N 1.276 -2.61 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 171.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.697 ' O ' ' HD3' ' A' ' 1' ' ' ARG . 38.2 Cg_exo . . . . . 0 C--O 1.251 1.156 0 C-N-CA 121.685 1.59 . . . . 0.0 109.528 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.435 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 61.4 mtt85 . . . . . 0 CA--C 1.512 -0.519 0 CA-C-O 121.212 0.529 . . . . 0.0 111.777 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.6 mtm -110.41 101.03 9.78 Favored 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 175.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.5 m -80.1 112.23 17.22 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.289 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.564 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 37.3 ttpt -93.14 111.24 22.81 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.5 m -117.68 124.05 29.21 Favored Pre-proline 0 C--N 1.293 -1.889 0 C-N-CA 123.734 0.814 . . . . 0.0 110.385 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -64.16 123.31 11.66 Favored 'Trans proline' 0 CA--C 1.521 -0.137 0 C-N-CA 122.294 1.996 . . . . 0.0 112.72 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -61.38 141.72 57.43 Favored 'General case' 0 C--O 1.281 2.714 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.502 -177.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.31 -30.0 11.56 Favored Glycine 0 N--CA 1.419 -2.448 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.761 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.523 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 45.6 pttt -106.52 2.14 25.96 Favored 'General case' 0 N--CA 1.418 -2.068 0 C-N-CA 117.655 -1.618 . . . . 0.0 113.852 -174.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.485 ' CD2' HG21 ' A' ' 23' ' ' VAL . 25.5 t80 -83.08 129.95 35.08 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.457 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -131.38 162.69 29.56 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 173.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.7 -153.42 19.87 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.457 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -106.66 111.76 24.45 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.045 0.45 . . . . 0.0 112.171 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.604 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 7.6 t -83.36 70.48 10.18 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.645 0.736 . . . . 0.0 109.066 176.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.487 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 90.5 t -73.32 -51.12 27.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.242 171.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.505 ' OD1' ' HB ' ' A' ' 18' ' ' THR . 5.4 t-20 -98.97 124.32 43.86 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.21 -176.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 93.4 m-20 -62.14 -29.15 70.14 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 114.383 -1.28 . . . . 0.0 112.61 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.505 ' HB ' ' OD1' ' A' ' 16' ' ' ASN . 9.8 m -65.12 -34.09 77.57 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 123.204 0.602 . . . . 0.0 110.584 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -70.01 -45.15 67.86 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.604 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 15.1 t -56.95 -46.94 81.77 Favored 'General case' 0 CA--C 1.48 -1.739 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.084 177.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 21.3 tttp -55.53 -53.98 49.7 Favored 'General case' 0 N--CA 1.391 -3.39 0 CA-C-N 112.567 -2.106 . . . . 0.0 108.701 -176.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -58.42 -48.05 81.93 Favored 'General case' 0 CA--C 1.499 -0.995 0 O-C-N 123.99 0.806 . . . . 0.0 111.194 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.485 HG21 ' CD2' ' A' ' 10' ' ' PHE . 67.5 t -60.81 -47.32 93.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 O-C-N 123.313 0.383 . . . . 0.0 110.594 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 69.6 m -61.49 -40.42 94.51 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 123.2 0.6 . . . . 0.0 111.839 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 47.5 mtp180 -66.9 -28.86 68.65 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.268 0.556 . . . . 0.0 110.17 178.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.1 m -85.48 -18.58 33.13 Favored 'General case' 0 CA--C 1.572 1.826 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.493 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.523 ' HG3' ' HE2' ' A' ' 9' ' ' LYS . 57.4 mt-10 -78.23 -40.98 35.68 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.4 -0.812 . . . . 0.0 110.424 171.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 135.53 38.48 0.18 Allowed Glycine 0 C--N 1.312 -0.781 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.51 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 89.1 m-85 -126.89 149.99 70.42 Favored Pre-proline 0 C--N 1.308 -1.214 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -63.61 -35.69 57.53 Favored 'Trans proline' 0 C--O 1.242 0.684 0 C-N-CA 122.392 2.062 . . . . 0.0 112.514 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.527 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.5 t -157.15 169.89 23.74 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.23 -176.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.68 153.74 25.53 Favored Glycine 0 N--CA 1.41 -3.056 0 N-CA-C 107.933 -2.067 . . . . 0.0 107.933 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.634 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 34.6 m -157.5 149.53 22.4 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 124.447 1.099 . . . . 0.0 110.139 -177.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.1 m -85.33 141.89 29.72 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -171.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.848 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 16.9 t70 -149.55 -172.28 4.1 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -132.69 127.71 35.4 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 120.945 -1.097 . . . . 0.0 110.977 -173.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.669 ' CE1' ' HG2' ' A' ' 42' ' ' LYS . 5.8 p-80 -149.13 11.16 0.81 Allowed 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 167.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.509 HG13 ' CD2' ' A' ' 37' ' ' HIS . 2.5 m -147.76 155.86 9.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.791 -174.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.03 84.79 0.99 Allowed 'General case' 0 C--N 1.314 -0.944 0 O-C-N 124.385 1.053 . . . . 0.0 108.963 177.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.19 -137.4 5.48 Favored Glycine 0 N--CA 1.404 -3.435 0 N-CA-C 107.901 -2.08 . . . . 0.0 107.901 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.487 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 18.8 mtp180 -136.53 119.6 16.52 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 117.453 0.626 . . . . 0.0 110.821 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.669 ' HG2' ' CE1' ' A' ' 37' ' ' HIS . 50.3 tptt -105.36 145.94 30.1 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 121.705 0.764 . . . . 0.0 111.125 -172.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 40.8 t -92.26 141.03 29.01 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.577 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.848 ' CD2' ' HB3' ' A' ' 35' ' ' ASP . 31.9 m-85 -130.88 140.87 50.27 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.51 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 61.4 m -95.55 133.77 39.2 Favored 'General case' 1 C--N 1.24 -4.173 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.872 -179.633 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.634 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 22.8 m-85 -107.58 133.91 51.35 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.591 -177.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -140.87 134.45 14.84 Favored Pre-proline 0 C--N 1.295 -1.798 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.351 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.21 118.28 5.6 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.947 2.431 . . . . 0.0 112.682 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 p -116.76 161.29 32.97 Favored Pre-proline 0 C--N 1.271 -2.838 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 172.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.435 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 18.3 Cg_endo . . . . . 0 C--O 1.264 1.79 0 C-N-CA 121.947 1.764 . . . . 0.0 111.375 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.445 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 59.5 mtt85 . . . . . 0 N--CA 1.467 0.376 0 CA-C-O 121.086 0.47 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.0 mtt -111.82 101.44 9.78 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.2 m -81.48 111.89 18.22 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.738 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.484 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 38.1 ttpt -93.54 110.97 22.54 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.106 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 86.8 m -109.13 133.11 20.85 Favored Pre-proline 0 C--N 1.3 -1.567 0 C-N-CA 124.381 1.072 . . . . 0.0 109.837 -177.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 3.8 Cg_exo -72.72 117.44 5.13 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 121.832 1.688 . . . . 0.0 112.15 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -61.8 146.81 48.41 Favored 'General case' 0 C--O 1.274 2.357 0 C-N-CA 123.728 0.811 . . . . 0.0 110.244 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -110.78 -24.77 5.42 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.497 -0.859 . . . . 0.0 114.014 -175.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.698 ' HD2' HG13 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -105.53 -3.2 22.7 Favored 'General case' 0 CA--C 1.484 -1.573 0 CA-C-O 122.153 0.978 . . . . 0.0 110.578 -174.76 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.476 ' CD2' HG21 ' A' ' 23' ' ' VAL . 30.4 t80 -67.19 116.75 8.33 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 113.471 -1.695 . . . . 0.0 108.499 171.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -128.29 94.05 3.8 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 150.65 -161.12 28.89 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.693 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -90.19 127.79 36.21 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 6.3 t -90.5 64.35 5.8 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-O 121.868 0.842 . . . . 0.0 109.061 176.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.514 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 18.5 m -72.47 -36.47 54.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.559 171.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -111.74 121.46 45.16 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.3 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 54.7 m-80 -64.66 -31.21 72.32 Favored 'General case' 0 C--O 1.214 -0.787 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.451 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.0 m -67.43 -24.27 65.62 Favored 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 122.592 0.357 . . . . 0.0 110.537 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -73.69 -48.05 35.02 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.651 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 16.1 t -56.09 -44.36 78.94 Favored 'General case' 0 CA--C 1.477 -1.85 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.132 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 22.5 tttp -54.77 -54.95 35.4 Favored 'General case' 0 N--CA 1.392 -3.351 0 CA-C-N 112.79 -2.005 . . . . 0.0 109.264 -175.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -62.21 -43.06 99.69 Favored 'General case' 0 CA--C 1.497 -1.094 0 O-C-N 123.815 0.697 . . . . 0.0 110.745 -176.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.698 HG13 ' HD2' ' A' ' 9' ' ' LYS . 72.9 t -56.95 -52.52 54.52 Favored 'Isoleucine or valine' 0 C--O 1.253 1.257 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.702 178.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 92.9 m -63.31 -38.03 89.56 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 124.363 1.04 . . . . 0.0 111.829 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 53.7 mtp180 -65.21 -29.08 69.85 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.092 0.472 . . . . 0.0 110.171 177.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 m -85.65 -14.61 45.01 Favored 'General case' 0 CA--C 1.578 2.036 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.793 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.475 ' OE2' ' HG3' ' A' ' 9' ' ' LYS . 47.2 mt-10 -86.99 -25.4 24.3 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.293 -0.879 . . . . 0.0 110.543 174.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.33 39.84 0.57 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.607 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 91.8 m-85 -129.17 148.56 69.59 Favored Pre-proline 0 C--N 1.311 -1.067 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -64.0 -34.19 59.93 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.346 2.03 . . . . 0.0 112.267 177.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.51 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.1 t -156.93 168.74 26.57 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.005 -176.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.64 153.63 25.46 Favored Glycine 0 N--CA 1.408 -3.216 0 N-CA-C 106.853 -2.499 . . . . 0.0 106.853 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.621 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 46.1 m -155.91 158.97 38.87 Favored 'General case' 0 C--N 1.275 -2.644 0 C-N-CA 123.704 0.802 . . . . 0.0 110.297 -176.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.1 m -92.61 157.06 16.69 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.259 0.552 . . . . 0.0 111.841 -170.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.505 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 7.5 t70 -148.08 155.19 41.18 Favored 'General case' 0 C--O 1.256 1.438 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.989 -177.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -122.09 110.1 15.35 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -147.08 8.6 0.95 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.507 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.9 m -149.43 164.07 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.129 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.385 -174.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.4 80.47 1.4 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.108 0.956 . . . . 0.0 109.011 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.77 -148.22 18.07 Favored Glycine 0 N--CA 1.403 -3.521 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 -176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.514 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 20.8 mtp180 -139.1 117.85 12.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 117.517 0.659 . . . . 0.0 109.486 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -101.09 141.67 33.64 Favored 'General case' 0 N--CA 1.421 -1.886 0 O-C-N 123.519 0.512 . . . . 0.0 110.395 -172.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.3 t -94.75 139.1 31.71 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.974 177.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.505 ' CD2' ' HB3' ' A' ' 35' ' ' ASP . 46.6 m-85 -134.27 142.29 47.27 Favored 'General case' 0 N--CA 1.42 -1.939 0 O-C-N 123.956 0.785 . . . . 0.0 109.855 175.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.487 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 39.8 m -94.68 139.14 31.62 Favored 'General case' 0 C--N 1.256 -3.487 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.311 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.621 ' CE1' ' HB2' ' A' ' 33' ' ' SER . 30.2 m-85 -113.99 134.49 54.81 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.783 -178.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HE2' ' OG1' ' A' ' 5' ' ' THR . 51.9 pttt -140.98 134.72 14.86 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.481 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.12 110.64 2.87 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.922 2.414 . . . . 0.0 112.237 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 p -109.29 163.17 17.64 Favored Pre-proline 0 C--N 1.274 -2.708 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 173.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.445 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 29.7 Cg_exo . . . . . 0 C--O 1.263 1.725 0 C-N-CA 121.938 1.759 . . . . 0.0 110.996 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.418 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 59.2 mtt85 . . . . . 0 CA--C 1.514 -0.437 0 CA-C-O 121.159 0.504 . . . . 0.0 111.835 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.3 mtt -108.71 100.62 9.83 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 174.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.5 m -80.67 114.56 19.64 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.605 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.518 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 38.7 ttpt -92.82 110.7 22.15 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.7 m -110.64 131.15 22.23 Favored Pre-proline 0 C--N 1.295 -1.798 0 C-N-CA 124.355 1.062 . . . . 0.0 110.126 -175.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -66.25 127.38 17.38 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 121.719 1.613 . . . . 0.0 111.968 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.3 p -60.07 143.41 52.13 Favored 'General case' 0 C--O 1.271 2.185 0 O-C-N 123.914 0.759 . . . . 0.0 111.415 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -97.1 -28.93 8.29 Favored Glycine 0 N--CA 1.425 -2.064 0 O-C-N 123.721 0.638 . . . . 0.0 114.518 -176.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.556 ' NZ ' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -121.13 -2.64 9.61 Favored 'General case' 0 C--O 1.26 1.62 0 CA-C-N 118.947 1.374 . . . . 0.0 112.47 -175.505 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.457 ' CD2' HG21 ' A' ' 23' ' ' VAL . 32.0 t80 -65.66 120.62 13.28 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 113.76 -1.564 . . . . 0.0 109.202 169.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -137.09 84.54 2.07 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.516 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 166.07 -166.16 38.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -83.7 119.12 24.39 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 122.88 0.472 . . . . 0.0 111.992 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.663 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 7.1 t -88.65 69.56 8.79 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.503 0.668 . . . . 0.0 109.263 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.524 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 62.1 t -68.23 -56.6 12.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.042 172.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -101.5 127.66 48.09 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.769 -176.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 91.0 m-20 -56.52 -31.17 63.85 Favored 'General case' 0 C--O 1.204 -1.292 0 C-N-CA 124.417 1.087 . . . . 0.0 111.518 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.4 m -64.25 -28.92 70.06 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 123.519 0.728 . . . . 0.0 111.192 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -74.43 -45.1 48.63 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.663 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 24.9 t -56.77 -46.5 81.44 Favored 'General case' 0 CA--C 1.471 -2.084 0 CA-C-N 114.343 -1.298 . . . . 0.0 107.799 176.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 19.9 tttp -53.78 -54.89 31.84 Favored 'General case' 0 N--CA 1.394 -3.25 0 CA-C-N 112.664 -2.062 . . . . 0.0 109.219 -175.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -60.44 -45.66 92.86 Favored 'General case' 0 CA--C 1.502 -0.886 0 O-C-N 123.95 0.781 . . . . 0.0 110.794 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.514 HG13 ' CD ' ' A' ' 9' ' ' LYS . 95.6 t -60.74 -49.29 85.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.745 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.407 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 83.9 m -61.91 -37.97 86.61 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 123.025 0.53 . . . . 0.0 111.255 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 48.6 mtp180 -68.13 -25.18 65.16 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.809 0.338 . . . . 0.0 110.443 178.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.8 m -80.08 -37.39 33.91 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.763 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -69.88 -25.42 63.7 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.398 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.56 31.12 1.28 Allowed Glycine 0 CA--C 1.509 -0.318 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.523 176.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.487 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 89.4 m-85 -118.85 148.52 44.71 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.32 -35.32 73.99 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.419 2.08 . . . . 0.0 112.363 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.553 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.6 t -157.51 170.56 22.14 Favored 'General case' 0 N--CA 1.42 -1.96 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.156 -176.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.26 152.31 24.4 Favored Glycine 0 N--CA 1.403 -3.553 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.61 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 25.4 m -151.96 156.68 40.52 Favored 'General case' 0 C--N 1.278 -2.521 0 C-N-CA 124.557 1.143 . . . . 0.0 109.398 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.5 m -91.86 152.43 20.09 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 120.938 0.399 . . . . 0.0 111.823 -172.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.545 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 13.0 t70 -145.84 158.3 43.87 Favored 'General case' 0 C--O 1.256 1.44 0 C-N-CA 124.158 0.983 . . . . 0.0 108.885 -176.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.03 107.74 13.01 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -139.2 6.93 2.38 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 m -149.79 160.69 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.37 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.224 -174.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.55 83.9 0.6 Allowed 'General case' 0 C--N 1.323 -0.57 0 O-C-N 124.234 0.959 . . . . 0.0 109.04 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.85 -143.71 10.61 Favored Glycine 0 N--CA 1.402 -3.568 0 N-CA-C 107.854 -2.099 . . . . 0.0 107.854 -177.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.524 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 30.7 mtp180 -141.16 119.73 12.41 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 117.462 0.631 . . . . 0.0 109.798 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -108.16 138.77 43.86 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.338 0.589 . . . . 0.0 110.644 -173.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.0 t -85.21 136.09 33.67 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.296 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.545 ' CD2' ' HB3' ' A' ' 35' ' ' ASP . 32.5 m-85 -128.85 137.06 51.25 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-O 121.888 0.851 . . . . 0.0 109.991 175.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.487 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 44.5 m -95.08 134.36 37.87 Favored 'General case' 0 C--N 1.25 -3.726 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.417 -176.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.61 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 21.6 m-85 -107.38 135.8 48.25 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 120.893 0.378 . . . . 0.0 110.753 -178.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -144.8 138.67 14.6 Favored Pre-proline 0 C--N 1.298 -1.65 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.042 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.81 121.33 7.8 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.738 2.292 . . . . 0.0 112.513 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 p -119.18 164.16 22.77 Favored Pre-proline 0 C--N 1.272 -2.801 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 171.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.418 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 31.2 Cg_exo . . . . . 0 C--O 1.262 1.718 0 C-N-CA 121.847 1.698 . . . . 0.0 110.892 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.424 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 60.9 mtt85 . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 120.877 0.37 . . . . 0.0 111.797 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 67.6 mtm -101.76 106.73 17.77 Favored 'General case' 0 CA--C 1.482 -1.649 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.6 m -85.02 114.31 22.08 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.049 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.525 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.4 ttpt -94.04 110.22 21.93 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.3 m -110.06 131.78 21.8 Favored Pre-proline 0 C--N 1.29 -2.003 0 C-N-CA 124.383 1.073 . . . . 0.0 110.156 -176.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -65.97 125.78 14.76 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.813 1.675 . . . . 0.0 112.16 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.6 p -59.42 138.37 57.68 Favored 'General case' 0 C--O 1.274 2.362 0 O-C-N 123.965 0.791 . . . . 0.0 111.584 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.6 -37.7 5.21 Favored Glycine 0 N--CA 1.421 -2.317 0 O-C-N 123.667 0.605 . . . . 0.0 113.545 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.509 ' NZ ' ' HG3' ' A' ' 27' ' ' GLU . 22.9 pttm . . . . . 0 N--CA 1.414 -2.26 0 C-N-CA 117.98 -1.488 . . . . 0.0 112.791 -174.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 N--CA 1.438 -1.037 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 8.7 t -86.49 71.84 10.37 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 176.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.1 m -76.9 -45.34 31.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.631 -0.668 . . . . 0.0 110.912 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -103.71 144.85 30.91 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 58.3 m-80 -73.23 -27.3 61.52 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 120.717 0.294 . . . . 0.0 111.13 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.1 m -60.2 -38.27 82.79 Favored 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 124.083 0.953 . . . . 0.0 112.494 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.472 HD21 ' HA ' ' A' ' 14' ' ' CYS . 1.1 p-10 -68.93 -42.46 76.74 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 121.391 -0.818 . . . . 0.0 110.197 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.645 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 16.9 t -59.2 -46.43 88.46 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 22.9 tttp -53.41 -54.85 30.86 Favored 'General case' 0 N--CA 1.394 -3.262 0 CA-C-N 112.453 -2.158 . . . . 0.0 108.878 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -62.36 -40.36 96.15 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 123.736 0.647 . . . . 0.0 111.96 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 19' ' ' ASN . 59.4 t -67.56 -41.07 85.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.267 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.5 m -67.17 -39.63 86.47 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 120.813 0.34 . . . . 0.0 110.714 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.584 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 61.4 mtp180 -64.03 -30.52 71.59 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-O 120.916 0.389 . . . . 0.0 110.888 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.4 p -82.45 -31.81 29.25 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.509 ' HG3' ' NZ ' ' A' ' 9' ' ' LYS . 51.5 mt-10 -66.51 -35.01 79.19 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.804 173.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.14 37.35 0.35 Allowed Glycine 0 C--N 1.316 -0.583 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.748 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.584 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 93.3 m-85 -126.19 147.11 58.39 Favored Pre-proline 0 N--CA 1.432 -1.372 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -62.52 -32.32 80.07 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 122.445 2.097 . . . . 0.0 112.427 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.557 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.2 t -159.97 170.83 20.51 Favored 'General case' 0 N--CA 1.42 -1.93 0 O-C-N 122.069 -0.395 . . . . 0.0 110.033 -176.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 45' ' ' CYS . . . -148.73 154.27 25.73 Favored Glycine 0 N--CA 1.413 -2.89 0 N-CA-C 107.399 -2.281 . . . . 0.0 107.399 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.553 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 52.1 m -156.66 158.64 37.35 Favored 'General case' 0 C--N 1.281 -2.403 0 C-N-CA 123.868 0.867 . . . . 0.0 110.263 -176.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.5 m -91.91 150.18 21.17 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.216 0.532 . . . . 0.0 111.613 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.5 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 12.4 t70 -141.11 159.42 42.26 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.486 -178.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.35 105.98 9.88 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -140.04 7.07 2.22 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 m -148.31 160.96 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.56 0 CA-C-N 114.357 -1.292 . . . . 0.0 107.513 -175.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.58 84.37 0.43 Allowed 'General case' 0 C--N 1.32 -0.698 0 O-C-N 124.282 0.989 . . . . 0.0 109.699 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 148.19 -144.91 12.91 Favored Glycine 0 N--CA 1.404 -3.48 0 N-CA-C 108.708 -1.757 . . . . 0.0 108.708 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -129.08 124.92 36.05 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.8 tptt -111.3 128.29 55.9 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 121.346 0.593 . . . . 0.0 110.322 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 30.3 t -77.72 135.79 38.08 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.389 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 40.5 m-85 -130.72 146.72 52.26 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.498 0.666 . . . . 0.0 110.012 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.463 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 40.4 m -101.9 138.33 39.01 Favored 'General case' 0 C--N 1.253 -3.615 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.339 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.557 ' HB2' HG23 ' A' ' 31' ' ' THR . 33.9 m-85 -111.84 135.9 51.84 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.706 -178.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -146.94 142.37 17.01 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.951 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.29 118.32 5.47 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.472 2.115 . . . . 0.0 112.211 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 75.3 m -111.23 163.94 16.16 Favored Pre-proline 0 C--N 1.273 -2.718 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.424 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 26.5 Cg_exo . . . . . 0 C--O 1.261 1.641 0 C-N-CA 121.684 1.589 . . . . 0.0 110.163 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.425 ' HD2' ' O ' ' A' ' 50' ' ' PRO . 61.9 mtt85 . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 120.946 0.403 . . . . 0.0 111.812 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.1 mtt -105.85 109.36 21.29 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 46' ' ' TYR . 10.5 m -87.14 121.37 29.51 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.155 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.547 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 38.3 ttpt -98.96 110.56 23.15 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.2 m -113.16 132.3 22.47 Favored Pre-proline 0 C--N 1.3 -1.584 0 C-N-CA 124.293 1.037 . . . . 0.0 110.707 -176.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.71 132.24 30.11 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.459 2.106 . . . . 0.0 113.78 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.7 p -71.21 147.13 48.57 Favored 'General case' 0 C--O 1.267 1.983 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.591 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.74 -45.74 2.05 Favored Glycine 0 C--O 1.263 1.952 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.951 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.539 ' HD3' ' CD ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER . . . . . 0 CA--C 1.471 -2.081 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.62 -174.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 N--CA 1.445 -0.697 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 8.5 t -87.98 72.4 9.27 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.552 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 22.8 m -69.14 -45.45 79.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.388 173.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -115.81 151.74 34.65 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.969 0.414 . . . . 0.0 109.973 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 93.2 m-20 -73.11 -31.07 64.1 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -176.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.0 m -59.15 -37.85 78.3 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.403 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.2 p-10 -68.85 -43.4 75.53 Favored 'General case' 0 CA--C 1.499 -0.989 0 O-C-N 121.55 -0.719 . . . . 0.0 109.868 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.615 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 17.8 t -61.52 -44.41 97.11 Favored 'General case' 0 CA--C 1.471 -2.087 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 22.3 tttp -54.74 -55.12 33.33 Favored 'General case' 0 N--CA 1.393 -3.277 0 CA-C-N 112.688 -2.051 . . . . 0.0 108.735 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -60.28 -45.11 94.48 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 123.916 0.76 . . . . 0.0 111.384 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 19' ' ' ASN . 85.4 t -62.48 -44.74 99.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.62 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.4 m -66.89 -34.6 78.15 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 122.806 0.442 . . . . 0.0 111.863 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 50.0 mtp180 -69.2 -27.21 65.29 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.162 0.506 . . . . 0.0 109.83 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.9 m -82.51 -27.68 31.58 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.735 175.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.539 ' CD ' ' HD3' ' A' ' 9' ' ' LYS . 8.7 mm-40 -67.06 -46.74 73.41 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 121.741 -0.599 . . . . 0.0 110.401 171.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 134.9 39.65 0.17 Allowed Glycine 0 C--N 1.311 -0.825 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.496 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 95.3 m-85 -127.11 148.01 64.12 Favored Pre-proline 0 N--CA 1.434 -1.239 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -61.39 -33.05 89.48 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.511 2.141 . . . . 0.0 112.363 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.506 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.6 t -159.35 170.52 21.63 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.038 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.6 153.66 25.48 Favored Glycine 0 N--CA 1.409 -3.146 0 N-CA-C 107.37 -2.292 . . . . 0.0 107.37 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.597 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 39.4 m -156.78 158.71 37.33 Favored 'General case' 0 C--N 1.279 -2.473 0 C-N-CA 124.014 0.926 . . . . 0.0 110.095 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 44.2 m -91.0 156.74 17.72 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.3 0.571 . . . . 0.0 112.331 -170.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.485 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 22.9 t70 -148.36 152.45 37.07 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.03 -177.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.66 107.77 14.1 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -141.19 7.48 2.0 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 m -149.59 160.6 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.506 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.217 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.68 84.2 0.45 Allowed 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 124.289 0.993 . . . . 0.0 109.094 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.71 -145.72 13.75 Favored Glycine 0 N--CA 1.403 -3.523 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.552 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 32.5 mtp85 -140.1 117.61 11.48 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 117.568 0.684 . . . . 0.0 109.938 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -102.74 136.45 42.56 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-O 121.33 0.586 . . . . 0.0 110.735 -172.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.4 t -87.51 135.78 33.21 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.184 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.547 ' CD1' ' HG2' ' A' ' 4' ' ' LYS . 40.1 m-85 -129.9 146.34 51.61 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-O 121.718 0.771 . . . . 0.0 110.482 175.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.496 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 35.4 m -97.61 136.92 37.3 Favored 'General case' 0 C--N 1.252 -3.645 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.056 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.597 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 25.8 m-85 -111.54 136.11 51.18 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.913 -177.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -146.73 144.02 19.66 Favored Pre-proline 0 C--N 1.295 -1.774 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.705 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.08 120.56 6.67 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.372 2.048 . . . . 0.0 112.566 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 84.1 m -113.02 163.93 16.77 Favored Pre-proline 0 C--N 1.277 -2.551 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 170.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.425 ' O ' ' HD2' ' A' ' 1' ' ' ARG . 26.2 Cg_exo . . . . . 0 C--O 1.235 0.34 0 C-N-CA 121.838 1.692 . . . . 0.0 110.47 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.436 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 62.9 mtt85 . . . . . 0 CA--C 1.507 -0.701 0 CA-C-O 121.063 0.459 . . . . 0.0 112.045 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 66.9 mtm -105.12 107.95 19.2 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 174.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.1 m -83.5 117.13 22.89 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.798 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.639 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 36.7 ttpt -97.09 110.16 22.77 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 100.0 m -113.33 128.17 25.98 Favored Pre-proline 0 C--N 1.294 -1.822 0 C-N-CA 123.998 0.919 . . . . 0.0 110.662 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -69.39 115.98 4.3 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.992 1.795 . . . . 0.0 112.998 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -54.8 141.38 33.08 Favored 'General case' 0 C--O 1.276 2.492 0 C-N-CA 124.98 1.312 . . . . 0.0 110.376 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.29 -19.33 10.72 Favored Glycine 0 N--CA 1.433 -1.511 0 O-C-N 124.205 0.941 . . . . 0.0 114.601 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.473 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 49.0 pttt . . . . . 0 C--O 1.245 0.82 0 CA-C-N 118.546 1.173 . . . . 0.0 111.759 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.438 -1.029 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 2.9 t -88.93 65.6 7.61 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.146 0.974 . . . . 0.0 109.605 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.0 m -89.3 -29.95 5.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.024 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -107.9 114.74 28.9 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.028 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 55.4 m-80 -61.79 -29.69 70.32 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.863 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.8 m -67.03 -25.72 66.41 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 122.574 0.349 . . . . 0.0 110.883 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.497 ' O ' HG23 ' A' ' 23' ' ' VAL . 45.1 t30 -70.78 -48.26 55.21 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.595 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 12.9 t -56.74 -47.59 79.69 Favored 'General case' 0 CA--C 1.476 -1.888 0 CA-C-N 114.2 -1.364 . . . . 0.0 108.131 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 21.0 tttp -54.37 -55.26 30.34 Favored 'General case' 0 N--CA 1.399 -3.018 0 CA-C-N 112.68 -2.054 . . . . 0.0 109.634 -175.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -63.25 -38.53 91.53 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 123.757 0.661 . . . . 0.0 111.568 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 19' ' ' ASN . 57.8 t -66.27 -45.73 89.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 95.4 m -63.63 -39.75 95.15 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 120.931 0.396 . . . . 0.0 111.071 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.573 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 59.3 mtp180 -64.76 -30.24 71.24 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 121.018 0.437 . . . . 0.0 110.502 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.0 p -85.58 -27.63 25.39 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.473 ' HG3' ' HE2' ' A' ' 9' ' ' LYS . 50.6 mt-10 -66.97 -40.33 87.43 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.691 171.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 134.32 41.04 0.16 Allowed Glycine 0 C--N 1.318 -0.468 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.701 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.573 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 95.0 m-85 -130.3 148.64 70.66 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -177.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -61.99 -34.79 79.9 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.448 2.099 . . . . 0.0 112.354 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.551 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.3 t -157.95 170.98 21.1 Favored 'General case' 0 N--CA 1.422 -1.867 0 O-C-N 122.056 -0.402 . . . . 0.0 110.354 -176.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 45' ' ' CYS . . . -148.52 153.84 25.48 Favored Glycine 0 N--CA 1.414 -2.777 0 N-CA-C 107.31 -2.316 . . . . 0.0 107.31 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.521 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 44.5 m -155.83 157.02 35.73 Favored 'General case' 0 C--N 1.281 -2.408 0 C-N-CA 123.5 0.72 . . . . 0.0 110.799 -176.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.416 ' SG ' ' HA ' ' A' ' 17' ' ' ASN . 58.0 m -94.85 125.72 39.69 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.788 -172.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.55 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 30.7 t70 -122.66 166.92 14.1 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.839 -174.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -122.34 116.04 23.35 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.331 0.586 . . . . 0.0 110.949 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -148.39 6.28 0.75 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 m -147.84 167.66 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.22 82.18 0.53 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 122.173 0.987 . . . . 0.0 110.146 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.09 -140.31 9.94 Favored Glycine 0 N--CA 1.401 -3.647 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.704 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -126.2 130.6 51.28 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -111.65 130.56 55.72 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 40.4 t -75.49 134.5 40.8 Favored 'General case' 0 C--O 1.278 2.569 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.639 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 40.0 m-85 -131.86 141.75 49.5 Favored 'General case' 0 N--CA 1.42 -1.957 0 O-C-N 123.933 0.771 . . . . 0.0 109.729 175.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.469 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 54.2 m -96.81 139.01 33.5 Favored 'General case' 0 C--N 1.252 -3.671 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.965 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.551 ' HB2' HG23 ' A' ' 31' ' ' THR . 37.1 m-85 -112.35 134.72 53.73 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.767 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -147.1 143.91 18.97 Favored Pre-proline 0 C--N 1.295 -1.791 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.726 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.06 121.6 7.41 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.469 2.113 . . . . 0.0 112.655 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 77.0 m -116.14 161.83 29.14 Favored Pre-proline 0 C--N 1.278 -2.532 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 170.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.436 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 16.4 Cg_endo . . . . . 0 C--O 1.26 1.611 0 C-N-CA 122.018 1.812 . . . . 0.0 110.972 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.9 mtt -105.25 114.14 28.15 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 175.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 46' ' ' TYR . 15.8 m -93.01 122.59 35.53 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.221 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.469 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 27.3 ttpp -101.23 109.86 21.79 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.0 m -116.31 127.98 26.34 Favored Pre-proline 0 C--O 1.196 -1.729 0 C-N-CA 124.258 1.023 . . . . 0.0 111.117 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -66.98 125.08 13.08 Favored 'Trans proline' 0 N--CA 1.474 0.366 0 C-N-CA 122.365 2.043 . . . . 0.0 112.784 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -70.39 142.37 52.08 Favored 'General case' 0 C--O 1.273 2.339 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.67 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.17 -40.97 6.77 Favored Glycine 0 N--CA 1.427 -1.909 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.957 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.536 ' HD3' ' CD ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER . . . . . 0 CA--C 1.477 -1.862 0 C-N-CA 118.489 -1.285 . . . . 0.0 112.94 -175.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.4 ' HB3' HG13 ' A' ' 15' ' ' VAL . 12.7 m-85 . . . . . 0 N--CA 1.423 -1.781 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.668 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.9 t -85.66 67.7 10.16 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.508 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 18.7 m -74.25 -32.88 32.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.692 172.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -119.97 121.84 39.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.642 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 92.9 m-20 -56.73 -27.01 58.43 Favored 'General case' 0 C--O 1.208 -1.099 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.881 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.3 m -66.91 -29.77 69.74 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -74.96 -40.58 60.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.668 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 16.2 t -59.17 -48.9 79.89 Favored 'General case' 0 CA--C 1.473 -2.013 0 CA-C-N 114.228 -1.351 . . . . 0.0 108.271 177.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.522 ' HG3' ' H ' ' A' ' 32' ' ' GLY . 15.5 ttpt -55.01 -50.6 68.62 Favored 'General case' 0 N--CA 1.391 -3.404 0 CA-C-N 113.322 -1.763 . . . . 0.0 109.104 -176.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -60.09 -49.07 79.09 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.212 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 93.0 t -60.33 -43.49 93.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 123.207 0.317 . . . . 0.0 110.825 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 68.9 m -64.75 -38.51 91.23 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 122.991 0.517 . . . . 0.0 112.068 177.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.403 ' HD2' ' HG2' ' A' ' 21' ' ' LYS . 35.9 mtp180 -69.93 -25.08 63.5 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.191 0.52 . . . . 0.0 109.965 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -82.85 -27.67 30.65 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.895 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.536 ' CD ' ' HD3' ' A' ' 9' ' ' LYS . 7.8 mm-40 -68.6 -42.21 78.49 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.769 -0.582 . . . . 0.0 110.607 172.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.96 35.59 0.47 Allowed Glycine 0 C--N 1.312 -0.788 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.454 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 87.2 m-85 -121.19 149.53 51.85 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -60.12 -39.75 66.58 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.486 2.124 . . . . 0.0 112.441 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.552 HG23 ' HB2' ' A' ' 46' ' ' TYR . 9.4 t -154.66 174.2 15.32 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.141 -176.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.522 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -151.88 153.05 24.69 Favored Glycine 0 N--CA 1.418 -2.516 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.621 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 28.2 m -153.79 154.06 33.3 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 123.922 0.889 . . . . 0.0 110.391 -177.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.7 m -87.4 157.13 19.31 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.161 0.505 . . . . 0.0 112.109 -170.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.502 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 9.0 t70 -147.18 158.0 43.8 Favored 'General case' 0 C--O 1.257 1.46 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.061 -175.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.16 107.8 12.14 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -140.9 7.16 2.04 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 m -149.79 166.5 3.03 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.957 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -175.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.17 -30.13 66.15 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 123.974 0.796 . . . . 0.0 111.208 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.11 -170.23 42.66 Favored Glycine 0 N--CA 1.427 -1.927 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.508 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 19.9 mtp180 -114.29 118.17 33.17 Favored 'General case' 0 C--N 1.282 -2.351 0 O-C-N 121.698 -0.883 . . . . 0.0 109.731 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -102.14 149.68 24.03 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.309 -171.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 25.6 t -98.84 139.06 35.08 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.982 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.502 ' CD1' ' HB3' ' A' ' 35' ' ' ASP . 22.9 m-85 -132.49 135.74 46.21 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-O 122.052 0.93 . . . . 0.0 109.68 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.454 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 58.6 m -90.7 141.36 28.87 Favored 'General case' 0 C--N 1.246 -3.924 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.007 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.621 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 24.0 m-85 -111.75 134.92 52.99 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.829 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -147.28 145.61 22.48 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.854 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.04 116.66 4.72 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 122.395 2.063 . . . . 0.0 112.483 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.401 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 72.8 m -111.19 169.76 5.97 Favored Pre-proline 0 C--N 1.28 -2.44 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 171.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 49' ' ' CYS . 13.5 Cg_endo . . . . . 0 C--O 1.255 1.327 0 C-N-CA 122.16 1.907 . . . . 0.0 111.832 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.425 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 59.5 mtt85 . . . . . 0 CA--C 1.513 -0.468 0 CA-C-O 121.157 0.503 . . . . 0.0 111.819 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 63.8 mtt -110.63 101.23 9.91 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 18.5 m -80.36 114.51 19.31 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.67 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.516 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.6 ttpt -93.29 111.18 22.75 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 96.9 m -113.14 131.84 22.67 Favored Pre-proline 0 C--N 1.298 -1.651 0 C-N-CA 124.29 1.036 . . . . 0.0 110.18 -176.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 4.6 Cg_exo -72.17 114.46 3.99 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.015 1.81 . . . . 0.0 112.268 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.61 144.75 30.81 Favored 'General case' 0 C--O 1.269 2.127 0 C-N-CA 124.39 1.076 . . . . 0.0 110.475 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.66 -22.37 8.12 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 115.218 0.847 . . . . 0.0 115.218 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.574 ' HD2' HG13 ' A' ' 23' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.475 -1.916 0 C-N-CA 117.759 -1.576 . . . . 0.0 111.609 -174.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 N--CA 1.437 -1.121 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 4.3 t -83.22 71.84 10.18 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.946 0.879 . . . . 0.0 109.355 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.1 m -87.06 -32.17 6.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.603 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -108.38 120.51 42.6 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 54.8 m-80 -61.48 -28.35 69.23 Favored 'General case' 0 C--O 1.214 -0.766 0 O-C-N 123.731 0.644 . . . . 0.0 111.836 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.7 m -64.75 -28.32 69.5 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 123.593 0.757 . . . . 0.0 110.816 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -73.66 -46.37 46.95 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.653 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 15.9 t -56.87 -44.85 82.65 Favored 'General case' 0 CA--C 1.472 -2.02 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.079 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 22.6 tttp -55.08 -55.12 34.6 Favored 'General case' 0 N--CA 1.393 -3.276 0 CA-C-N 112.85 -1.977 . . . . 0.0 108.989 -175.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -61.72 -43.74 98.26 Favored 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 123.906 0.754 . . . . 0.0 110.957 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.574 HG13 ' HD2' ' A' ' 9' ' ' LYS . 89.8 t -60.29 -48.83 86.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.884 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.6 m -63.03 -39.53 95.03 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.826 0.85 . . . . 0.0 111.649 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 54.1 mtp180 -64.42 -30.95 71.98 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.238 0.542 . . . . 0.0 110.024 177.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.0 m -85.65 -11.06 54.76 Favored 'General case' 0 CA--C 1.58 2.114 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.656 176.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -88.06 -27.41 22.0 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.242 -0.911 . . . . 0.0 110.287 172.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.52 34.05 0.78 Allowed Glycine 0 C--N 1.318 -0.439 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.636 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.0 m-85 -124.14 148.85 58.77 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -63.59 -34.76 62.66 Favored 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 122.394 2.063 . . . . 0.0 112.277 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.508 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.0 t -156.96 170.67 21.99 Favored 'General case' 0 N--CA 1.416 -2.126 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.085 -176.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 45' ' ' CYS . . . -148.33 154.93 26.17 Favored Glycine 0 N--CA 1.409 -3.163 0 N-CA-C 107.085 -2.406 . . . . 0.0 107.085 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.546 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 43.9 m -155.15 152.79 29.86 Favored 'General case' 0 C--N 1.277 -2.551 0 C-N-CA 123.628 0.771 . . . . 0.0 110.641 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.418 ' SG ' ' HA ' ' A' ' 17' ' ' ASN . 51.0 m -92.4 127.78 38.01 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.448 -172.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.631 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 35.0 t70 -127.24 169.43 13.51 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.047 -175.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -121.23 118.44 29.61 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.246 0.546 . . . . 0.0 111.371 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -149.3 5.52 0.64 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 174.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 m -147.38 167.01 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.316 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.66 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.5 82.17 1.09 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.741 0.781 . . . . 0.0 108.916 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.45 -150.95 23.2 Favored Glycine 0 N--CA 1.406 -3.302 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -177.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -121.78 127.48 50.67 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 122.65 -0.323 . . . . 0.0 110.672 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -109.78 132.63 53.98 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.0 t -77.21 134.64 38.57 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 174.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.631 ' CD1' ' HB3' ' A' ' 35' ' ' ASP . 46.9 m-85 -130.54 141.65 50.48 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-O 121.553 0.692 . . . . 0.0 109.337 173.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.461 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 57.3 m -96.12 139.36 32.4 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.274 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.546 ' CE1' ' HB2' ' A' ' 33' ' ' SER . 26.1 m-85 -112.9 134.23 54.51 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 121.002 0.429 . . . . 0.0 110.702 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -143.78 137.09 14.03 Favored Pre-proline 0 C--N 1.295 -1.798 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.337 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.84 118.8 5.89 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.796 2.331 . . . . 0.0 112.465 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.05 164.15 20.08 Favored Pre-proline 0 C--N 1.272 -2.786 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 171.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.425 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 32.9 Cg_exo . . . . . 0 C--O 1.264 1.796 0 C-N-CA 121.958 1.772 . . . . 0.0 110.952 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.692 ' HD3' ' OXT' ' A' ' 50' ' ' PRO . 31.7 mtp180 . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 121.184 0.516 . . . . 0.0 112.089 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.9 mtm -107.62 106.3 16.59 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.2 m -86.34 116.17 24.33 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.71 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.506 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.8 ttpt -92.97 111.42 23.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.8 m -114.9 130.47 24.15 Favored Pre-proline 0 C--N 1.295 -1.803 0 C-N-CA 124.337 1.055 . . . . 0.0 110.336 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.54 131.48 28.02 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.147 1.898 . . . . 0.0 113.253 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.0 p -59.95 143.46 51.57 Favored 'General case' 0 C--O 1.27 2.159 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.711 177.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.68 -32.31 6.01 Favored Glycine 0 N--CA 1.427 -1.918 0 O-C-N 123.58 0.55 . . . . 0.0 113.528 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.556 ' NZ ' ' HG3' ' A' ' 27' ' ' GLU . 16.1 pttm . . . . . 0 CA--C 1.501 -0.908 0 CA-C-N 118.276 1.038 . . . . 0.0 112.706 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 N--CA 1.436 -1.137 0 CA-C-O 120.773 0.32 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.1 t -93.43 64.15 3.62 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.868 0.842 . . . . 0.0 108.977 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.501 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 18.8 m -73.83 -34.78 41.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.027 172.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -119.69 125.52 48.88 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.51 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 91.4 m-20 -56.56 -28.18 59.57 Favored 'General case' 0 C--O 1.199 -1.596 0 O-C-N 124.312 1.007 . . . . 0.0 111.354 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 89.9 m -67.4 -29.65 69.21 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.513 ' O ' HG23 ' A' ' 23' ' ' VAL . 45.6 t30 -70.05 -46.27 65.35 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.651 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 24.3 t -57.62 -51.5 69.23 Favored 'General case' 0 CA--C 1.478 -1.823 0 CA-C-N 113.991 -1.459 . . . . 0.0 108.745 177.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 11.4 ttpt -51.64 -53.76 35.27 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-N 113.275 -1.784 . . . . 0.0 109.502 -174.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -62.7 -40.93 98.68 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.404 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 19' ' ' ASN . 60.2 t -65.97 -42.46 91.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.588 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.6 m -64.85 -41.99 95.26 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 120.973 0.416 . . . . 0.0 110.853 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 43.5 mtp180 -65.21 -29.32 70.11 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.004 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 p -81.65 -30.95 32.54 Favored 'General case' 0 C--O 1.215 -0.727 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 175.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.556 ' HG3' ' NZ ' ' A' ' 9' ' ' LYS . 48.1 mt-10 -68.67 -34.94 76.55 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.889 173.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.87 36.76 0.38 Allowed Glycine 0 C--N 1.314 -0.642 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.883 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.7 m-85 -123.57 148.9 57.2 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.37 -35.96 58.59 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.121 1.881 . . . . 0.0 112.294 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.527 HG23 ' HB2' ' A' ' 46' ' ' TYR . 8.8 t -157.74 175.5 13.81 Favored 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.88 -175.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -154.88 153.72 25.0 Favored Glycine 0 N--CA 1.417 -2.616 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.593 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 32.8 m -155.24 160.98 41.25 Favored 'General case' 0 C--N 1.285 -2.2 0 C-N-CA 123.636 0.774 . . . . 0.0 110.763 -177.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.4 m -93.17 153.84 18.4 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -171.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.516 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 9.9 t70 -147.49 157.29 43.51 Favored 'General case' 0 C--O 1.255 1.376 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.173 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -121.71 110.77 16.36 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 121.549 0.69 . . . . 0.0 109.231 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -146.16 7.69 1.04 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.423 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 m -149.06 165.53 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.243 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.489 -174.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.34 83.11 1.41 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.56 -148.42 19.43 Favored Glycine 0 N--CA 1.405 -3.389 0 N-CA-C 107.833 -2.107 . . . . 0.0 107.833 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.501 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 19.1 mtp180 -137.6 118.08 13.82 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 117.663 0.732 . . . . 0.0 109.58 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -103.69 134.6 46.74 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-O 121.423 0.63 . . . . 0.0 111.146 -172.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 5.9 t -84.6 136.9 33.58 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.542 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.516 ' CD1' ' HB3' ' A' ' 35' ' ' ASP . 39.1 m-85 -129.84 138.97 51.28 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-O 121.8 0.81 . . . . 0.0 109.845 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.438 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 56.9 m -95.53 136.04 36.42 Favored 'General case' 0 C--N 1.246 -3.919 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.348 -177.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.593 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 27.9 m-85 -107.61 135.19 49.48 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.863 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -146.27 140.82 15.77 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.716 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 130.95 20.27 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.536 2.158 . . . . 0.0 112.506 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.3 p -129.81 158.26 74.24 Favored Pre-proline 0 C--N 1.27 -2.875 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 171.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.692 ' OXT' ' HD3' ' A' ' 1' ' ' ARG . 31.7 Cg_exo . . . . . 0 C--O 1.275 2.329 0 C-N-CA 121.894 1.729 . . . . 0.0 110.472 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 29.3 ttm105 . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 121.258 0.552 . . . . 0.0 111.756 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 90.4 mtp -98.04 105.88 18.09 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.631 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.9 m -85.38 118.02 24.66 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.705 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.533 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 37.5 ttpt -97.39 110.52 23.06 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 98.1 m -111.55 131.48 22.31 Favored Pre-proline 0 C--N 1.29 -2.001 0 C-N-CA 124.106 0.962 . . . . 0.0 110.31 -176.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -66.54 126.42 15.48 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.002 1.801 . . . . 0.0 112.36 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.1 p -63.2 142.28 58.44 Favored 'General case' 0 C--O 1.273 2.294 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.499 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.78 -32.75 5.53 Favored Glycine 0 N--CA 1.428 -1.889 0 CA-C-N 115.951 -0.568 . . . . 0.0 114.341 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.525 ' HD2' HG13 ' A' ' 23' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.476 -1.895 0 O-C-N 120.976 -1.308 . . . . 0.0 111.008 -173.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.435 -1.223 0 CA-C-O 121.275 0.559 . . . . 0.0 111.809 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.666 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 8.0 t -82.05 71.05 9.09 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.69 -60.17 3.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.787 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -100.93 140.71 34.84 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.931 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 91.8 m-20 -64.76 -28.01 69.29 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.496 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.6 m -63.85 -35.08 79.47 Favored 'General case' 0 CA--C 1.575 1.918 0 C-N-CA 123.236 0.614 . . . . 0.0 112.482 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.466 HD21 ' HA ' ' A' ' 14' ' ' CYS . 1.2 p-10 -72.26 -40.72 67.45 Favored 'General case' 0 CA--C 1.494 -1.193 0 O-C-N 121.179 -0.951 . . . . 0.0 109.761 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.666 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 23.1 t -59.82 -45.75 91.4 Favored 'General case' 0 CA--C 1.472 -2.043 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 24.0 tttp -53.69 -55.04 29.61 Favored 'General case' 0 N--CA 1.395 -3.215 0 CA-C-N 112.551 -2.113 . . . . 0.0 108.807 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -62.44 -43.71 98.16 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.24 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.525 HG13 ' HD2' ' A' ' 9' ' ' LYS . 92.3 t -60.94 -48.41 89.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.597 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.4 m -63.05 -38.54 91.6 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.789 0.835 . . . . 0.0 111.286 177.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 56.1 mtp180 -64.47 -31.36 72.53 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-O 121.282 0.563 . . . . 0.0 110.145 177.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.2 m -85.46 -10.66 55.81 Favored 'General case' 0 CA--C 1.578 2.032 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.548 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 23' ' ' VAL . 68.7 mt-10 -88.13 -28.75 21.06 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.245 -0.909 . . . . 0.0 110.215 172.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.95 33.22 0.7 Allowed Glycine 0 C--N 1.318 -0.463 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.703 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.603 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.4 m-85 -123.89 147.51 54.03 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -63.69 -32.13 68.73 Favored 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.462 2.108 . . . . 0.0 112.269 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.494 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.1 t -159.37 171.5 19.66 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.02 -176.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -149.93 156.82 26.94 Favored Glycine 0 N--CA 1.408 -3.196 0 N-CA-C 107.405 -2.278 . . . . 0.0 107.405 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.571 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 39.8 m -157.42 156.89 32.99 Favored 'General case' 0 C--N 1.28 -2.445 0 C-N-CA 124.072 0.949 . . . . 0.0 110.235 -177.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.3 m -94.12 139.43 31.0 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.0 0.428 . . . . 0.0 111.257 -171.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.551 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 20.8 t70 -131.4 162.85 29.21 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.422 -176.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -120.6 112.55 19.05 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-O 121.627 0.727 . . . . 0.0 110.485 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -147.89 6.6 0.8 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.362 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 m -147.02 165.97 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.218 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.364 -175.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.25 83.46 0.75 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.826 0.822 . . . . 0.0 109.536 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.18 -143.35 12.04 Favored Glycine 0 N--CA 1.405 -3.37 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -127.01 125.9 42.22 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -111.42 125.02 53.44 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.39 0.614 . . . . 0.0 110.246 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 33.8 t -72.23 135.2 46.0 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.64 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.551 ' CD1' ' HB3' ' A' ' 35' ' ' ASP . 39.3 m-85 -130.55 143.21 50.61 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-O 121.499 0.666 . . . . 0.0 109.605 174.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.482 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 35.3 m -97.17 136.95 36.96 Favored 'General case' 0 C--N 1.25 -3.753 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.997 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.571 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 38.4 m-85 -112.18 136.15 51.95 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.585 -177.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -147.13 144.58 19.95 Favored Pre-proline 0 C--N 1.296 -1.743 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.907 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.93 120.56 6.42 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 122.457 2.105 . . . . 0.0 112.584 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.4 m -116.79 169.35 7.36 Favored Pre-proline 0 C--N 1.277 -2.553 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 171.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.263 1.734 0 C-N-CA 121.904 1.736 . . . . 0.0 110.208 174.777 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.418 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 58.2 mtt85 . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 121.063 0.459 . . . . 0.0 111.87 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.8 mtt -107.63 99.71 9.18 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 17.7 m -80.36 114.42 19.24 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.623 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.526 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.6 ttpt -92.63 110.33 21.76 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 33.4 m -108.8 131.9 21.5 Favored Pre-proline 0 C--N 1.301 -1.523 0 C-N-CA 124.27 1.028 . . . . 0.0 109.809 -174.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 5.8 Cg_exo -72.3 116.28 4.65 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.66 1.573 . . . . 0.0 111.865 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -58.13 139.04 55.58 Favored 'General case' 0 C--O 1.278 2.558 0 C-N-CA 123.944 0.898 . . . . 0.0 111.097 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.57 -30.34 9.89 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.787 -175.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.488 ' NZ ' ' HG3' ' A' ' 27' ' ' GLU . 21.5 pttm . . . . . 0 N--CA 1.42 -1.954 0 C-N-CA 118.406 -1.318 . . . . 0.0 112.562 -175.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 . . . . . 0 N--CA 1.441 -0.881 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.1 t -91.8 60.15 3.85 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.558 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 17.4 m -69.98 -33.28 54.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.513 173.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.488 HD21 ' HB ' ' A' ' 18' ' ' THR . 19.5 t30 -111.34 121.19 44.59 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.86 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -61.88 -26.08 67.94 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.059 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.488 ' HB ' HD21 ' A' ' 16' ' ' ASN . 97.8 m -67.43 -31.21 71.25 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.423 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -59.43 -54.25 48.87 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.591 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 5.9 t -56.64 -49.72 74.17 Favored 'General case' 0 CA--C 1.464 -2.341 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.243 -177.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.505 ' HG3' ' H ' ' A' ' 32' ' ' GLY . 0.9 OUTLIER -55.48 -46.54 76.89 Favored 'General case' 0 N--CA 1.395 -3.2 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.607 -176.203 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -68.02 -44.09 77.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.229 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.13 -40.83 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.407 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.8 m -66.2 -41.86 89.58 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 120.866 0.365 . . . . 0.0 111.571 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 35.3 mtp180 -66.55 -28.63 68.68 Favored 'General case' 0 C--O 1.211 -0.958 0 CA-C-O 120.915 0.388 . . . . 0.0 111.017 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 p -81.92 -30.97 31.59 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.488 ' HG3' ' NZ ' ' A' ' 9' ' ' LYS . 53.1 mt-10 -68.3 -32.67 72.98 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.659 172.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.12 36.29 0.55 Allowed Glycine 0 C--N 1.315 -0.631 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.977 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 92.6 m-85 -122.13 149.23 53.87 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -60.82 -38.47 70.02 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.308 2.006 . . . . 0.0 112.277 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.529 HG23 ' HB2' ' A' ' 46' ' ' TYR . 9.1 t -158.07 173.89 16.05 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.112 -175.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.505 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -153.99 154.13 25.3 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.458 ' HB3' ' CE2' ' A' ' 46' ' ' TYR . 23.2 t -150.3 154.58 38.12 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.6 m -87.47 156.16 19.68 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 120.831 0.348 . . . . 0.0 110.569 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.469 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 22.8 t70 -145.01 153.86 41.93 Favored 'General case' 0 C--O 1.255 1.368 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.564 -175.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -119.75 105.74 11.44 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -144.13 6.14 1.33 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.118 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.0 m -148.04 164.94 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.877 -175.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.1 80.94 0.96 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.048 0.928 . . . . 0.0 109.365 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.52 -147.38 16.75 Favored Glycine 0 N--CA 1.405 -3.43 0 N-CA-C 107.833 -2.107 . . . . 0.0 107.833 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.558 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 20.8 mtp180 -139.24 117.76 12.14 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 117.581 0.691 . . . . 0.0 109.668 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -101.05 146.93 26.81 Favored 'General case' 0 N--CA 1.422 -1.835 0 O-C-N 123.536 0.522 . . . . 0.0 109.975 -172.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.4 t -97.98 141.37 31.03 Favored 'General case' 0 C--O 1.266 1.964 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.526 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 47.4 m-85 -134.87 138.08 43.83 Favored 'General case' 0 N--CA 1.419 -1.983 0 O-C-N 124.165 0.916 . . . . 0.0 110.411 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.475 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 61.5 m -96.05 135.81 37.32 Favored 'General case' 0 C--N 1.258 -3.408 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.84 -177.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.529 ' HB2' HG23 ' A' ' 31' ' ' THR . 21.7 m-85 -106.92 134.64 49.77 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 120.863 0.363 . . . . 0.0 110.803 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -144.49 137.81 14.11 Favored Pre-proline 0 C--N 1.296 -1.755 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.846 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.4 120.68 7.32 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.659 2.24 . . . . 0.0 112.362 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 p -118.28 164.45 20.23 Favored Pre-proline 0 C--N 1.272 -2.778 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 171.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.418 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 34.6 Cg_exo . . . . . 0 C--O 1.263 1.732 0 C-N-CA 121.816 1.677 . . . . 0.0 110.875 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.42 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 63.0 mtt85 . . . . . 0 N--CA 1.469 0.492 0 CA-C-O 121.023 0.44 . . . . 0.0 112.157 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 89.2 mtp -99.25 101.16 12.38 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.9 m -81.97 116.09 21.44 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.532 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.496 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 38.8 ttpt -93.08 109.77 21.25 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.6 m -107.35 132.52 20.89 Favored Pre-proline 0 C--N 1.298 -1.655 0 C-N-CA 124.373 1.069 . . . . 0.0 109.821 -174.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -71.72 115.01 4.13 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.68 1.586 . . . . 0.0 111.998 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -58.26 140.87 52.41 Favored 'General case' 0 C--O 1.278 2.605 0 C-N-CA 124.078 0.951 . . . . 0.0 111.278 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.55 -33.11 6.93 Favored Glycine 0 N--CA 1.427 -1.951 0 CA-C-N 115.749 -0.659 . . . . 0.0 114.051 -175.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.48 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 50.1 pttt . . . . . 0 CA--C 1.474 -1.972 0 O-C-N 120.995 -1.297 . . . . 0.0 112.635 -174.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 . . . . . 0 N--CA 1.444 -0.73 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.0 t -89.45 60.35 5.16 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.513 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 17.4 m -68.25 -39.59 81.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.573 173.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -110.39 121.97 46.57 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.457 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 86.7 m-20 -57.44 -28.42 63.3 Favored 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 124.153 0.981 . . . . 0.0 111.239 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 51.9 m -68.65 -26.27 65.24 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -73.64 -42.24 61.68 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.641 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 18.3 t -58.84 -49.7 76.75 Favored 'General case' 0 CA--C 1.475 -1.937 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.244 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HG3' ' H ' ' A' ' 32' ' ' GLY . 12.7 ttpt -53.54 -51.84 61.62 Favored 'General case' 0 N--CA 1.399 -2.995 0 CA-C-N 113.018 -1.901 . . . . 0.0 109.028 -175.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -59.88 -48.38 81.95 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 123.693 0.621 . . . . 0.0 111.38 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.4 t -60.2 -47.36 92.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 O-C-N 123.417 0.448 . . . . 0.0 110.707 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.1 m -60.49 -42.85 97.16 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.441 0.696 . . . . 0.0 111.9 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.6 mtp180 -65.08 -30.47 71.43 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.083 0.468 . . . . 0.0 110.24 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 m -85.46 -16.72 38.72 Favored 'General case' 0 CA--C 1.574 1.871 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.888 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.48 ' HG3' ' HE2' ' A' ' 9' ' ' LYS . 55.1 mt-10 -78.92 -38.26 37.83 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.365 -0.834 . . . . 0.0 110.309 172.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 133.39 34.7 0.31 Allowed Glycine 0 C--N 1.31 -0.908 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.1 m-85 -121.78 147.92 49.59 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -59.58 -38.34 82.89 Favored 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 122.467 2.111 . . . . 0.0 112.325 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.539 HG23 ' HB2' ' A' ' 46' ' ' TYR . 8.8 t -158.85 176.38 12.41 Favored 'General case' 0 N--CA 1.426 -1.667 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.068 -175.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.451 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -155.28 158.97 28.81 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.3 t -156.63 162.37 39.86 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 17' ' ' ASN . 59.2 m -96.11 156.97 16.11 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.302 0.572 . . . . 0.0 111.63 -171.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.439 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 8.2 t70 -145.85 156.62 43.68 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 124.306 1.042 . . . . 0.0 108.61 -176.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.4 107.08 10.74 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -142.29 7.81 1.78 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.4 m -149.04 160.52 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.343 -175.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.26 82.99 0.24 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 122.204 1.002 . . . . 0.0 110.007 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.78 -143.41 10.41 Favored Glycine 0 N--CA 1.403 -3.527 0 N-CA-C 107.492 -2.243 . . . . 0.0 107.492 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.513 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 23.0 mtp180 -141.68 119.86 12.16 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 117.509 0.654 . . . . 0.0 109.481 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -102.17 142.77 32.9 Favored 'General case' 0 N--CA 1.428 -1.556 0 O-C-N 123.432 0.457 . . . . 0.0 110.346 -172.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.2 t -94.13 142.12 27.76 Favored 'General case' 0 C--O 1.268 2.049 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.338 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.496 ' CD1' ' HG2' ' A' ' 4' ' ' LYS . 51.6 m-85 -135.85 139.41 43.39 Favored 'General case' 0 N--CA 1.418 -2.044 0 O-C-N 124.159 0.912 . . . . 0.0 110.421 176.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.465 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 59.8 m -96.24 137.68 34.96 Favored 'General case' 0 C--N 1.261 -3.248 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.698 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.539 ' HB2' HG23 ' A' ' 31' ' ' THR . 22.0 m-85 -108.36 135.6 49.4 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 120.992 0.425 . . . . 0.0 110.939 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -147.43 145.75 22.71 Favored Pre-proline 0 C--N 1.298 -1.643 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.385 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.04 124.19 8.91 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.343 2.029 . . . . 0.0 112.605 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.0 m -117.01 166.38 13.09 Favored Pre-proline 0 C--N 1.276 -2.593 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 170.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.42 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 22.5 Cg_exo . . . . . 0 C--O 1.259 1.574 0 C-N-CA 121.661 1.574 . . . . 0.0 110.217 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.439 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 62.2 mtt85 . . . . . 0 N--CA 1.474 0.769 0 CA-C-O 120.96 0.41 . . . . 0.0 111.841 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 68.1 mtm -103.2 108.57 19.83 Favored 'General case' 0 CA--C 1.483 -1.616 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.7 m -85.92 116.68 24.3 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.073 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.496 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 36.9 ttpt -95.78 110.17 22.36 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 67.0 m -110.37 132.71 21.38 Favored Pre-proline 0 C--O 1.202 -1.407 0 C-N-CA 124.253 1.021 . . . . 0.0 110.385 -174.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 5.1 Cg_exo -72.37 119.49 6.17 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 121.947 1.765 . . . . 0.0 112.489 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m -62.83 146.6 52.28 Favored 'General case' 0 C--O 1.274 2.365 0 C-N-CA 123.86 0.864 . . . . 0.0 110.8 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.85 -27.03 4.19 Favored Glycine 0 N--CA 1.432 -1.608 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.914 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.1 pttt . . . . . 0 CA--C 1.497 -1.089 0 CA-C-O 122.257 1.027 . . . . 0.0 111.784 -176.356 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.433 -1.285 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.459 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 2.5 t -83.77 67.35 9.48 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.962 0.887 . . . . 0.0 110.2 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.2 m -89.84 -25.59 5.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.978 174.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -113.76 115.75 28.3 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.189 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 92.2 m-20 -57.53 -31.17 65.82 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.939 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.2 m -66.92 -27.47 67.51 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 122.703 0.401 . . . . 0.0 111.133 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.481 ' O ' HG23 ' A' ' 23' ' ' VAL . 47.3 t30 -72.33 -46.24 56.44 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.459 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 9.1 t -57.82 -47.13 83.51 Favored 'General case' 0 CA--C 1.48 -1.746 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.0 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 23.2 tttp -54.6 -55.72 26.53 Favored 'General case' 0 N--CA 1.4 -2.932 0 CA-C-N 112.772 -2.013 . . . . 0.0 109.313 -175.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -61.29 -41.46 97.0 Favored 'General case' 0 CA--C 1.493 -1.237 0 O-C-N 124.001 0.813 . . . . 0.0 111.682 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 19' ' ' ASN . 89.6 t -61.95 -51.33 73.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 99.4 m -58.75 -40.8 84.94 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.221 0.95 . . . . 0.0 111.341 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 56.5 mtp180 -64.15 -33.18 75.18 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 121.063 0.458 . . . . 0.0 110.582 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.0 m -85.88 -13.34 48.21 Favored 'General case' 0 CA--C 1.579 2.095 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.031 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 23' ' ' VAL . 54.4 mt-10 -82.14 -39.66 22.95 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.352 -0.843 . . . . 0.0 109.627 172.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.46 38.82 0.13 Allowed Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.57 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 92.5 m-85 -128.01 148.89 69.24 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -62.55 -35.45 70.73 Favored 'Trans proline' 0 C--O 1.242 0.706 0 C-N-CA 122.463 2.109 . . . . 0.0 112.311 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.563 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.7 t -158.23 170.46 22.21 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.273 -176.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 45' ' ' CYS . . . -147.76 155.91 26.69 Favored Glycine 0 N--CA 1.415 -2.703 0 N-CA-C 107.296 -2.321 . . . . 0.0 107.296 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.535 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 35.7 m -156.96 152.76 27.06 Favored 'General case' 0 C--N 1.283 -2.309 0 C-N-CA 123.79 0.836 . . . . 0.0 110.85 -176.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.7 m -94.96 132.1 40.18 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.237 0.541 . . . . 0.0 111.167 -172.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.4 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 26.8 t70 -120.32 156.31 31.56 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.124 -173.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.15 108.19 14.38 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -141.46 10.94 2.09 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.2 m -156.86 167.25 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.84 80.7 0.89 Allowed 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.682 0.753 . . . . 0.0 109.06 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.41 -157.99 27.46 Favored Glycine 0 N--CA 1.412 -2.907 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -124.43 132.25 53.5 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 117.206 0.503 . . . . 0.0 110.66 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -111.69 133.98 53.57 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 52.9 t -81.8 135.09 35.48 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.496 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 54.3 m-85 -132.31 140.2 48.49 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-O 121.79 0.805 . . . . 0.0 110.185 175.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.457 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 46.3 m -95.14 139.67 31.15 Favored 'General case' 0 C--N 1.252 -3.64 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.132 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.563 ' HB2' HG23 ' A' ' 31' ' ' THR . 35.4 m-85 -112.11 135.0 53.32 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.631 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -147.5 143.94 18.7 Favored Pre-proline 0 C--N 1.294 -1.841 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.603 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.17 122.07 7.74 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.352 2.035 . . . . 0.0 112.471 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 76.9 m -115.13 161.53 29.01 Favored Pre-proline 0 C--N 1.276 -2.607 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 170.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.439 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 17.7 Cg_endo . . . . . 0 C--O 1.262 1.719 0 C-N-CA 121.808 1.672 . . . . 0.0 110.836 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.425 ' HD2' ' O ' ' A' ' 50' ' ' PRO . 58.0 mtt85 . . . . . 0 CA--C 1.513 -0.466 0 CA-C-O 121.213 0.53 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 63.6 mtt -107.39 98.39 8.02 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 174.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.9 m -77.77 113.01 15.21 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.622 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.535 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.4 ttpt -92.94 110.56 22.02 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.4 m -109.36 131.4 21.88 Favored Pre-proline 0 C--N 1.296 -1.735 0 C-N-CA 124.137 0.975 . . . . 0.0 109.64 -174.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -71.76 114.63 4.01 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.755 1.637 . . . . 0.0 111.523 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -57.46 139.73 52.44 Favored 'General case' 0 C--O 1.274 2.359 0 C-N-CA 124.292 1.037 . . . . 0.0 111.36 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.64 -29.54 10.74 Favored Glycine 0 N--CA 1.425 -2.086 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.896 -176.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.588 ' HG3' ' CG ' ' A' ' 27' ' ' GLU . 34.1 mtmt . . . . . 0 CA--C 1.476 -1.889 0 CA-C-N 118.337 1.069 . . . . 0.0 109.078 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 CA--C 1.511 -0.543 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.679 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 6.9 t -88.33 64.0 7.39 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.887 0.851 . . . . 0.0 109.182 176.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.464 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 19.3 m -72.85 -35.2 48.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.189 171.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -109.98 119.2 38.57 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.3 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 55.4 m-80 -64.77 -30.32 71.33 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.467 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.5 m -68.85 -24.47 64.36 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 122.568 0.347 . . . . 0.0 110.421 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.422 ' O ' HG23 ' A' ' 23' ' ' VAL . 54.2 t30 -74.01 -46.1 45.74 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.679 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 33.1 t -55.28 -47.32 75.69 Favored 'General case' 0 CA--C 1.474 -1.963 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.98 176.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 19.2 tttp -54.57 -53.26 56.94 Favored 'General case' 0 N--CA 1.391 -3.379 0 CA-C-N 112.278 -2.237 . . . . 0.0 109.33 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -61.86 -42.98 99.7 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 123.5 0.5 . . . . 0.0 111.521 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 19' ' ' ASN . 48.4 t -64.94 -43.94 96.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.019 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 74.6 m -64.0 -40.9 97.39 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 120.96 0.409 . . . . 0.0 111.388 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 52.7 mtp180 -67.06 -26.06 66.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.955 0.407 . . . . 0.0 110.727 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.7 p -85.21 -36.43 20.98 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 175.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.588 ' CG ' ' HG3' ' A' ' 9' ' ' LYS . 56.9 mt-10 -57.04 -45.61 83.05 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 120.612 0.244 . . . . 0.0 111.333 168.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 135.39 43.72 0.11 Allowed Glycine 0 C--N 1.318 -0.46 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.849 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.466 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 89.5 m-85 -128.61 149.58 72.29 Favored Pre-proline 0 C--N 1.307 -1.266 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -62.25 -37.68 60.23 Favored 'Trans proline' 0 C--O 1.24 0.602 0 C-N-CA 122.394 2.063 . . . . 0.0 112.286 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.536 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.6 t -155.29 169.07 25.04 Favored 'General case' 0 N--CA 1.418 -2.065 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.438 -176.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.54 152.15 24.26 Favored Glycine 0 N--CA 1.408 -3.226 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.577 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 46.8 m -155.07 157.66 37.88 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 124.09 0.956 . . . . 0.0 110.002 -177.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 46.2 m -91.67 153.81 19.42 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.994 0.426 . . . . 0.0 112.076 -170.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.567 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 13.3 t70 -148.38 158.31 44.03 Favored 'General case' 0 C--O 1.255 1.349 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.542 -177.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -118.86 111.14 18.03 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-O 121.61 0.719 . . . . 0.0 109.902 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -145.38 6.42 1.11 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.479 177.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.82 164.41 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.265 -174.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.05 80.75 1.23 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.022 0.915 . . . . 0.0 109.002 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.26 -144.52 11.29 Favored Glycine 0 N--CA 1.403 -3.551 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.464 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 19.7 mtp180 -139.55 118.59 12.6 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -104.75 144.51 31.64 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 121.268 0.556 . . . . 0.0 110.23 -173.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.3 t -92.83 141.27 28.62 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.997 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.567 ' CD1' ' HB3' ' A' ' 35' ' ' ASP . 42.5 m-85 -133.74 140.57 47.06 Favored 'General case' 0 N--CA 1.414 -2.242 0 O-C-N 124.053 0.846 . . . . 0.0 109.889 175.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.466 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 58.6 m -94.52 135.34 36.07 Favored 'General case' 0 C--N 1.255 -3.506 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.521 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 33' ' ' SER . 28.0 m-85 -108.89 133.7 52.55 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.743 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -144.85 138.31 14.26 Favored Pre-proline 0 C--N 1.294 -1.812 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.975 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.4 121.7 8.24 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.744 2.296 . . . . 0.0 112.27 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.7 p -121.64 162.24 37.51 Favored Pre-proline 0 C--N 1.273 -2.755 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 172.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.425 ' O ' ' HD2' ' A' ' 1' ' ' ARG . 13.6 Cg_endo . . . . . 0 CA--C 1.533 0.464 0 C-N-CA 122.113 1.875 . . . . 0.0 111.503 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.697 ' HD3' ' O ' ' A' ' 50' ' ' PRO . 32.2 mtp180 . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 120.825 0.345 . . . . 0.0 111.677 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 69.5 mtm -105.01 113.81 27.63 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.1 m -90.96 117.93 29.94 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.112 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.481 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 39.4 ttpt -94.22 110.52 22.25 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.0 m -111.48 131.63 22.22 Favored Pre-proline 0 C--N 1.295 -1.765 0 C-N-CA 124.426 1.09 . . . . 0.0 110.357 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.04 129.31 21.54 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.051 1.834 . . . . 0.0 113.119 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.1 p -58.9 141.72 52.72 Favored 'General case' 0 C--O 1.269 2.102 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.45 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -97.71 -29.17 7.89 Favored Glycine 0 N--CA 1.431 -1.67 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.442 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.663 ' NZ ' ' HG3' ' A' ' 27' ' ' GLU . 9.6 pttm . . . . . 0 C--O 1.246 0.903 0 CA-C-N 117.889 0.844 . . . . 0.0 112.889 -175.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.415 ' HB3' HG13 ' A' ' 15' ' ' VAL . 5.6 m-85 . . . . . 0 N--CA 1.436 -1.168 0 CA-C-O 120.854 0.359 . . . . 0.0 111.334 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.0 t -93.94 62.92 3.18 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.522 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 17.7 m -72.79 -34.78 47.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.865 172.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -120.8 127.71 52.2 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -176.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 93.2 m-20 -56.61 -27.94 59.34 Favored 'General case' 0 C--O 1.2 -1.548 0 C-N-CA 124.395 1.078 . . . . 0.0 111.57 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.6 m -64.38 -34.87 79.18 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 122.95 0.5 . . . . 0.0 112.29 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.524 ' O ' HG23 ' A' ' 23' ' ' VAL . 49.5 t30 -69.29 -45.35 69.83 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.644 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 20.7 t -58.22 -51.9 67.82 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-N 114.541 -1.208 . . . . 0.0 108.779 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.528 ' HG3' ' H ' ' A' ' 32' ' ' GLY . 15.3 ttpt -52.17 -53.03 48.11 Favored 'General case' 0 N--CA 1.406 -2.645 0 CA-C-N 113.299 -1.773 . . . . 0.0 109.554 -174.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -61.61 -45.65 93.2 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.189 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 19' ' ' ASN . 58.3 t -60.22 -48.9 86.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 O-C-N 123.47 0.482 . . . . 0.0 110.262 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 95.2 m -59.33 -40.69 87.12 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 123.573 0.749 . . . . 0.0 111.418 177.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.2 mtp180 -66.02 -28.53 68.94 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.285 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.424 ' HB ' ' NZ ' ' A' ' 9' ' ' LYS . 4.4 m -77.73 -29.37 51.13 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.036 175.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.663 ' HG3' ' NZ ' ' A' ' 9' ' ' LYS . 42.2 mt-10 -75.57 -22.71 56.75 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.749 0.309 . . . . 0.0 111.448 177.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.94 21.89 3.39 Favored Glycine 0 CA--C 1.501 -0.84 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.234 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.7 m-85 -106.54 145.15 30.44 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -60.58 -33.99 92.98 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.521 2.147 . . . . 0.0 112.463 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.542 HG23 ' HB2' ' A' ' 46' ' ' TYR . 9.9 t -160.82 175.43 12.58 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -175.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.528 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -154.05 158.41 28.12 Favored Glycine 0 N--CA 1.428 -1.855 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.465 ' HB3' ' CE1' ' A' ' 46' ' ' TYR . 15.5 t -153.77 163.64 39.69 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 59.6 m -95.82 152.9 18.06 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.281 0.562 . . . . 0.0 112.041 -172.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.453 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 8.7 t70 -144.1 156.73 44.47 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 124.462 1.105 . . . . 0.0 108.26 -177.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.17 107.18 10.5 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -141.67 8.69 1.96 Allowed 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.3 m -150.28 161.16 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.544 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.34 82.35 0.37 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.207 1.004 . . . . 0.0 109.583 177.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.07 -146.9 15.52 Favored Glycine 0 N--CA 1.404 -3.497 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 -177.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.522 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 21.5 mtp180 -140.71 118.38 11.64 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 117.759 0.78 . . . . 0.0 109.319 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -103.1 132.6 49.24 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-O 121.394 0.616 . . . . 0.0 111.014 -171.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.6 t -84.17 138.87 32.77 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.646 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.481 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 43.5 m-85 -131.7 139.64 49.09 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.751 0.786 . . . . 0.0 110.023 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.496 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 44.6 m -95.33 138.65 32.73 Favored 'General case' 0 C--N 1.252 -3.632 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.518 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.542 ' HB2' HG23 ' A' ' 31' ' ' THR . 21.5 m-85 -110.79 136.75 49.37 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 120.853 0.359 . . . . 0.0 110.973 -178.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -146.72 143.18 18.19 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.68 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.37 119.86 6.4 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.343 2.029 . . . . 0.0 112.458 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 95.1 m -111.75 159.27 33.99 Favored Pre-proline 0 C--N 1.276 -2.61 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 171.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.697 ' O ' ' HD3' ' A' ' 1' ' ' ARG . 38.2 Cg_exo . . . . . 0 C--O 1.251 1.156 0 C-N-CA 121.685 1.59 . . . . 0.0 109.528 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.435 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 61.4 mtt85 . . . . . 0 CA--C 1.512 -0.519 0 CA-C-O 121.212 0.529 . . . . 0.0 111.777 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.6 mtm -110.41 101.03 9.78 Favored 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 175.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.5 m -80.1 112.23 17.22 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.289 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.564 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 37.3 ttpt -93.14 111.24 22.81 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.5 m -117.68 124.05 29.21 Favored Pre-proline 0 C--N 1.293 -1.889 0 C-N-CA 123.734 0.814 . . . . 0.0 110.385 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -64.16 123.31 11.66 Favored 'Trans proline' 0 CA--C 1.521 -0.137 0 C-N-CA 122.294 1.996 . . . . 0.0 112.72 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -61.38 141.72 57.43 Favored 'General case' 0 C--O 1.281 2.714 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.502 -177.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.31 -30.0 11.56 Favored Glycine 0 N--CA 1.419 -2.448 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.761 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.523 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 45.6 pttt . . . . . 0 N--CA 1.418 -2.068 0 C-N-CA 117.655 -1.618 . . . . 0.0 113.852 -174.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 N--CA 1.434 -1.243 0 CA-C-O 121.045 0.45 . . . . 0.0 112.171 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.604 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 7.6 t -83.36 70.48 10.18 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.645 0.736 . . . . 0.0 109.066 176.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.487 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 90.5 t -73.32 -51.12 27.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.242 171.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.505 ' OD1' ' HB ' ' A' ' 18' ' ' THR . 5.4 t-20 -98.97 124.32 43.86 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.21 -176.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 93.4 m-20 -62.14 -29.15 70.14 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 114.383 -1.28 . . . . 0.0 112.61 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.505 ' HB ' ' OD1' ' A' ' 16' ' ' ASN . 9.8 m -65.12 -34.09 77.57 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 123.204 0.602 . . . . 0.0 110.584 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -70.01 -45.15 67.86 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.604 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 15.1 t -56.95 -46.94 81.77 Favored 'General case' 0 CA--C 1.48 -1.739 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.084 177.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 21.3 tttp -55.53 -53.98 49.7 Favored 'General case' 0 N--CA 1.391 -3.39 0 CA-C-N 112.567 -2.106 . . . . 0.0 108.701 -176.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -58.42 -48.05 81.93 Favored 'General case' 0 CA--C 1.499 -0.995 0 O-C-N 123.99 0.806 . . . . 0.0 111.194 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.5 t -60.81 -47.32 93.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 O-C-N 123.313 0.383 . . . . 0.0 110.594 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 69.6 m -61.49 -40.42 94.51 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 123.2 0.6 . . . . 0.0 111.839 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 47.5 mtp180 -66.9 -28.86 68.65 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.268 0.556 . . . . 0.0 110.17 178.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.1 m -85.48 -18.58 33.13 Favored 'General case' 0 CA--C 1.572 1.826 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.493 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.523 ' HG3' ' HE2' ' A' ' 9' ' ' LYS . 57.4 mt-10 -78.23 -40.98 35.68 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.4 -0.812 . . . . 0.0 110.424 171.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 135.53 38.48 0.18 Allowed Glycine 0 C--N 1.312 -0.781 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.51 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 89.1 m-85 -126.89 149.99 70.42 Favored Pre-proline 0 C--N 1.308 -1.214 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -63.61 -35.69 57.53 Favored 'Trans proline' 0 C--O 1.242 0.684 0 C-N-CA 122.392 2.062 . . . . 0.0 112.514 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.527 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.5 t -157.15 169.89 23.74 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.23 -176.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.68 153.74 25.53 Favored Glycine 0 N--CA 1.41 -3.056 0 N-CA-C 107.933 -2.067 . . . . 0.0 107.933 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.634 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 34.6 m -157.5 149.53 22.4 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 124.447 1.099 . . . . 0.0 110.139 -177.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.1 m -85.33 141.89 29.72 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -171.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.848 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 16.9 t70 -149.55 -172.28 4.1 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -132.69 127.71 35.4 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 120.945 -1.097 . . . . 0.0 110.977 -173.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.669 ' CE1' ' HG2' ' A' ' 42' ' ' LYS . 5.8 p-80 -149.13 11.16 0.81 Allowed 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 167.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.509 HG13 ' CD2' ' A' ' 37' ' ' HIS . 2.5 m -147.76 155.86 9.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.791 -174.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.03 84.79 0.99 Allowed 'General case' 0 C--N 1.314 -0.944 0 O-C-N 124.385 1.053 . . . . 0.0 108.963 177.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.19 -137.4 5.48 Favored Glycine 0 N--CA 1.404 -3.435 0 N-CA-C 107.901 -2.08 . . . . 0.0 107.901 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.487 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 18.8 mtp180 -136.53 119.6 16.52 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 117.453 0.626 . . . . 0.0 110.821 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.669 ' HG2' ' CE1' ' A' ' 37' ' ' HIS . 50.3 tptt -105.36 145.94 30.1 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 121.705 0.764 . . . . 0.0 111.125 -172.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 40.8 t -92.26 141.03 29.01 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.577 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.848 ' CD2' ' HB3' ' A' ' 35' ' ' ASP . 31.9 m-85 -130.88 140.87 50.27 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.51 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 61.4 m -95.55 133.77 39.2 Favored 'General case' 1 C--N 1.24 -4.173 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.872 -179.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.634 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 22.8 m-85 -107.58 133.91 51.35 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.591 -177.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -140.87 134.45 14.84 Favored Pre-proline 0 C--N 1.295 -1.798 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.351 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.21 118.28 5.6 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.947 2.431 . . . . 0.0 112.682 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 p -116.76 161.29 32.97 Favored Pre-proline 0 C--N 1.271 -2.838 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 172.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.435 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 18.3 Cg_endo . . . . . 0 C--O 1.264 1.79 0 C-N-CA 121.947 1.764 . . . . 0.0 111.375 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.445 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 59.5 mtt85 . . . . . 0 N--CA 1.467 0.376 0 CA-C-O 121.086 0.47 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.0 mtt -111.82 101.44 9.78 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.2 m -81.48 111.89 18.22 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.738 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.484 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 38.1 ttpt -93.54 110.97 22.54 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.106 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 86.8 m -109.13 133.11 20.85 Favored Pre-proline 0 C--N 1.3 -1.567 0 C-N-CA 124.381 1.072 . . . . 0.0 109.837 -177.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 3.8 Cg_exo -72.72 117.44 5.13 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 121.832 1.688 . . . . 0.0 112.15 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -61.8 146.81 48.41 Favored 'General case' 0 C--O 1.274 2.357 0 C-N-CA 123.728 0.811 . . . . 0.0 110.244 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -110.78 -24.77 5.42 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.497 -0.859 . . . . 0.0 114.014 -175.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.698 ' HD2' HG13 ' A' ' 23' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.484 -1.573 0 CA-C-O 122.153 0.978 . . . . 0.0 110.578 -174.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 . . . . . 0 CA--C 1.507 -0.69 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 6.3 t -90.5 64.35 5.8 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-O 121.868 0.842 . . . . 0.0 109.061 176.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.514 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 18.5 m -72.47 -36.47 54.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.559 171.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -111.74 121.46 45.16 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.3 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 54.7 m-80 -64.66 -31.21 72.32 Favored 'General case' 0 C--O 1.214 -0.787 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.451 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.0 m -67.43 -24.27 65.62 Favored 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 122.592 0.357 . . . . 0.0 110.537 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -73.69 -48.05 35.02 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.651 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 16.1 t -56.09 -44.36 78.94 Favored 'General case' 0 CA--C 1.477 -1.85 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.132 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 22.5 tttp -54.77 -54.95 35.4 Favored 'General case' 0 N--CA 1.392 -3.351 0 CA-C-N 112.79 -2.005 . . . . 0.0 109.264 -175.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -62.21 -43.06 99.69 Favored 'General case' 0 CA--C 1.497 -1.094 0 O-C-N 123.815 0.697 . . . . 0.0 110.745 -176.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.698 HG13 ' HD2' ' A' ' 9' ' ' LYS . 72.9 t -56.95 -52.52 54.52 Favored 'Isoleucine or valine' 0 C--O 1.253 1.257 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.702 178.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 92.9 m -63.31 -38.03 89.56 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 124.363 1.04 . . . . 0.0 111.829 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 53.7 mtp180 -65.21 -29.08 69.85 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.092 0.472 . . . . 0.0 110.171 177.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 m -85.65 -14.61 45.01 Favored 'General case' 0 CA--C 1.578 2.036 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.793 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.475 ' OE2' ' HG3' ' A' ' 9' ' ' LYS . 47.2 mt-10 -86.99 -25.4 24.3 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.293 -0.879 . . . . 0.0 110.543 174.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.33 39.84 0.57 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.607 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 91.8 m-85 -129.17 148.56 69.59 Favored Pre-proline 0 C--N 1.311 -1.067 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -64.0 -34.19 59.93 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.346 2.03 . . . . 0.0 112.267 177.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.51 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.1 t -156.93 168.74 26.57 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.005 -176.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.64 153.63 25.46 Favored Glycine 0 N--CA 1.408 -3.216 0 N-CA-C 106.853 -2.499 . . . . 0.0 106.853 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.621 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 46.1 m -155.91 158.97 38.87 Favored 'General case' 0 C--N 1.275 -2.644 0 C-N-CA 123.704 0.802 . . . . 0.0 110.297 -176.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.1 m -92.61 157.06 16.69 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.259 0.552 . . . . 0.0 111.841 -170.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.505 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 7.5 t70 -148.08 155.19 41.18 Favored 'General case' 0 C--O 1.256 1.438 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.989 -177.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -122.09 110.1 15.35 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -147.08 8.6 0.95 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.507 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.9 m -149.43 164.07 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.129 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.385 -174.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.4 80.47 1.4 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.108 0.956 . . . . 0.0 109.011 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.77 -148.22 18.07 Favored Glycine 0 N--CA 1.403 -3.521 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 -176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.514 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 20.8 mtp180 -139.1 117.85 12.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 117.517 0.659 . . . . 0.0 109.486 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -101.09 141.67 33.64 Favored 'General case' 0 N--CA 1.421 -1.886 0 O-C-N 123.519 0.512 . . . . 0.0 110.395 -172.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.3 t -94.75 139.1 31.71 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.974 177.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.505 ' CD2' ' HB3' ' A' ' 35' ' ' ASP . 46.6 m-85 -134.27 142.29 47.27 Favored 'General case' 0 N--CA 1.42 -1.939 0 O-C-N 123.956 0.785 . . . . 0.0 109.855 175.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.487 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 39.8 m -94.68 139.14 31.62 Favored 'General case' 0 C--N 1.256 -3.487 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.311 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.621 ' CE1' ' HB2' ' A' ' 33' ' ' SER . 30.2 m-85 -113.99 134.49 54.81 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.783 -178.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HE2' ' OG1' ' A' ' 5' ' ' THR . 51.9 pttt -140.98 134.72 14.86 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.481 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.12 110.64 2.87 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.922 2.414 . . . . 0.0 112.237 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 p -109.29 163.17 17.64 Favored Pre-proline 0 C--N 1.274 -2.708 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 173.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.445 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 29.7 Cg_exo . . . . . 0 C--O 1.263 1.725 0 C-N-CA 121.938 1.759 . . . . 0.0 110.996 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ARG . . . . . 0.418 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 59.2 mtt85 . . . . . 0 CA--C 1.514 -0.437 0 CA-C-O 121.159 0.504 . . . . 0.0 111.835 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.3 mtt -108.71 100.62 9.83 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 174.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.5 m -80.67 114.56 19.64 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.605 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.518 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 38.7 ttpt -92.82 110.7 22.15 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.7 m -110.64 131.15 22.23 Favored Pre-proline 0 C--N 1.295 -1.798 0 C-N-CA 124.355 1.062 . . . . 0.0 110.126 -175.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -66.25 127.38 17.38 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 121.719 1.613 . . . . 0.0 111.968 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.3 p -60.07 143.41 52.13 Favored 'General case' 0 C--O 1.271 2.185 0 O-C-N 123.914 0.759 . . . . 0.0 111.415 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -97.1 -28.93 8.29 Favored Glycine 0 N--CA 1.425 -2.064 0 O-C-N 123.721 0.638 . . . . 0.0 114.518 -176.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.556 ' NZ ' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.26 1.62 0 CA-C-N 118.947 1.374 . . . . 0.0 112.47 -175.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 N--CA 1.446 -0.625 0 CA-C-O 120.9 0.381 . . . . 0.0 111.992 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.663 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 7.1 t -88.65 69.56 8.79 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.503 0.668 . . . . 0.0 109.263 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.524 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 62.1 t -68.23 -56.6 12.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.042 172.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -101.5 127.66 48.09 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.769 -176.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 91.0 m-20 -56.52 -31.17 63.85 Favored 'General case' 0 C--O 1.204 -1.292 0 C-N-CA 124.417 1.087 . . . . 0.0 111.518 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.4 m -64.25 -28.92 70.06 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 123.519 0.728 . . . . 0.0 111.192 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -74.43 -45.1 48.63 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.663 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 24.9 t -56.77 -46.5 81.44 Favored 'General case' 0 CA--C 1.471 -2.084 0 CA-C-N 114.343 -1.298 . . . . 0.0 107.799 176.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 19.9 tttp -53.78 -54.89 31.84 Favored 'General case' 0 N--CA 1.394 -3.25 0 CA-C-N 112.664 -2.062 . . . . 0.0 109.219 -175.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -60.44 -45.66 92.86 Favored 'General case' 0 CA--C 1.502 -0.886 0 O-C-N 123.95 0.781 . . . . 0.0 110.794 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.514 HG13 ' CD ' ' A' ' 9' ' ' LYS . 95.6 t -60.74 -49.29 85.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.745 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.407 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 83.9 m -61.91 -37.97 86.61 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 123.025 0.53 . . . . 0.0 111.255 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 48.6 mtp180 -68.13 -25.18 65.16 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.809 0.338 . . . . 0.0 110.443 178.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.8 m -80.08 -37.39 33.91 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.763 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -69.88 -25.42 63.7 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.398 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.56 31.12 1.28 Allowed Glycine 0 CA--C 1.509 -0.318 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.523 176.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.487 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 89.4 m-85 -118.85 148.52 44.71 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.32 -35.32 73.99 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.419 2.08 . . . . 0.0 112.363 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.553 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.6 t -157.51 170.56 22.14 Favored 'General case' 0 N--CA 1.42 -1.96 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.156 -176.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.26 152.31 24.4 Favored Glycine 0 N--CA 1.403 -3.553 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.61 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 25.4 m -151.96 156.68 40.52 Favored 'General case' 0 C--N 1.278 -2.521 0 C-N-CA 124.557 1.143 . . . . 0.0 109.398 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.5 m -91.86 152.43 20.09 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 120.938 0.399 . . . . 0.0 111.823 -172.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.545 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 13.0 t70 -145.84 158.3 43.87 Favored 'General case' 0 C--O 1.256 1.44 0 C-N-CA 124.158 0.983 . . . . 0.0 108.885 -176.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.03 107.74 13.01 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -139.2 6.93 2.38 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 m -149.79 160.69 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.37 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.224 -174.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.55 83.9 0.6 Allowed 'General case' 0 C--N 1.323 -0.57 0 O-C-N 124.234 0.959 . . . . 0.0 109.04 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.85 -143.71 10.61 Favored Glycine 0 N--CA 1.402 -3.568 0 N-CA-C 107.854 -2.099 . . . . 0.0 107.854 -177.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.524 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 30.7 mtp180 -141.16 119.73 12.41 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 117.462 0.631 . . . . 0.0 109.798 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -108.16 138.77 43.86 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.338 0.589 . . . . 0.0 110.644 -173.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.0 t -85.21 136.09 33.67 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.296 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.545 ' CD2' ' HB3' ' A' ' 35' ' ' ASP . 32.5 m-85 -128.85 137.06 51.25 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-O 121.888 0.851 . . . . 0.0 109.991 175.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.487 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 44.5 m -95.08 134.36 37.87 Favored 'General case' 0 C--N 1.25 -3.726 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.417 -176.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.61 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 21.6 m-85 -107.38 135.8 48.25 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 120.893 0.378 . . . . 0.0 110.753 -178.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -144.8 138.67 14.6 Favored Pre-proline 0 C--N 1.298 -1.65 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.042 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.81 121.33 7.8 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.738 2.292 . . . . 0.0 112.513 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 p -119.18 164.16 22.77 Favored Pre-proline 0 C--N 1.272 -2.801 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 171.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.418 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 31.2 Cg_exo . . . . . 0 C--O 1.262 1.718 0 C-N-CA 121.847 1.698 . . . . 0.0 110.892 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.424 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 60.9 mtt85 . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 120.877 0.37 . . . . 0.0 111.797 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 67.6 mtm -101.76 106.73 17.77 Favored 'General case' 0 CA--C 1.482 -1.649 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.6 m -85.02 114.31 22.08 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.049 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.525 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.4 ttpt -94.04 110.22 21.93 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.3 m -110.06 131.78 21.8 Favored Pre-proline 0 C--N 1.29 -2.003 0 C-N-CA 124.383 1.073 . . . . 0.0 110.156 -176.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -65.97 125.78 14.76 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.813 1.675 . . . . 0.0 112.16 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.6 p -59.42 138.37 57.68 Favored 'General case' 0 C--O 1.274 2.362 0 O-C-N 123.965 0.791 . . . . 0.0 111.584 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.6 -37.7 5.21 Favored Glycine 0 N--CA 1.421 -2.317 0 O-C-N 123.667 0.605 . . . . 0.0 113.545 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.509 ' NZ ' ' HG3' ' A' ' 27' ' ' GLU . 22.9 pttm -103.22 -3.22 26.02 Favored 'General case' 0 N--CA 1.414 -2.26 0 C-N-CA 117.98 -1.488 . . . . 0.0 112.791 -174.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.522 ' O ' ' HD3' ' A' ' 11' ' ' LYS . 24.5 t80 -71.69 121.42 18.82 Favored 'General case' 0 CA--C 1.485 -1.55 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.472 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HD3' ' O ' ' A' ' 10' ' ' PHE . 43.7 mmtm -133.17 103.58 6.08 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 113.976 -1.465 . . . . 0.0 107.284 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 146.76 -162.65 28.54 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 119.943 -1.123 . . . . 0.0 111.8 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -95.27 117.93 31.15 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 8.7 t -86.49 71.84 10.37 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 176.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.1 m -76.9 -45.34 31.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.631 -0.668 . . . . 0.0 110.912 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -103.71 144.85 30.91 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 58.3 m-80 -73.23 -27.3 61.52 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 120.717 0.294 . . . . 0.0 111.13 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.1 m -60.2 -38.27 82.79 Favored 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 124.083 0.953 . . . . 0.0 112.494 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.472 HD21 ' HA ' ' A' ' 14' ' ' CYS . 1.1 p-10 -68.93 -42.46 76.74 Favored 'General case' 0 CA--C 1.497 -1.068 0 O-C-N 121.391 -0.818 . . . . 0.0 110.197 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.645 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 16.9 t -59.2 -46.43 88.46 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 22.9 tttp -53.41 -54.85 30.86 Favored 'General case' 0 N--CA 1.394 -3.262 0 CA-C-N 112.453 -2.158 . . . . 0.0 108.878 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -62.36 -40.36 96.15 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 123.736 0.647 . . . . 0.0 111.96 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 19' ' ' ASN . 59.4 t -67.56 -41.07 85.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.267 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.5 m -67.17 -39.63 86.47 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 120.813 0.34 . . . . 0.0 110.714 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.584 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 61.4 mtp180 -64.03 -30.52 71.59 Favored 'General case' 0 C--O 1.213 -0.867 0 CA-C-O 120.916 0.389 . . . . 0.0 110.888 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.4 p -82.45 -31.81 29.25 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.509 ' HG3' ' NZ ' ' A' ' 9' ' ' LYS . 51.5 mt-10 -66.51 -35.01 79.19 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.804 173.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.14 37.35 0.35 Allowed Glycine 0 C--N 1.316 -0.583 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.748 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.584 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 93.3 m-85 -126.19 147.11 58.39 Favored Pre-proline 0 N--CA 1.432 -1.372 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -62.52 -32.32 80.07 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 122.445 2.097 . . . . 0.0 112.427 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.557 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.2 t -159.97 170.83 20.51 Favored 'General case' 0 N--CA 1.42 -1.93 0 O-C-N 122.069 -0.395 . . . . 0.0 110.033 -176.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 45' ' ' CYS . . . -148.73 154.27 25.73 Favored Glycine 0 N--CA 1.413 -2.89 0 N-CA-C 107.399 -2.281 . . . . 0.0 107.399 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.553 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 52.1 m -156.66 158.64 37.35 Favored 'General case' 0 C--N 1.281 -2.403 0 C-N-CA 123.868 0.867 . . . . 0.0 110.263 -176.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.5 m -91.91 150.18 21.17 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.216 0.532 . . . . 0.0 111.613 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.5 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 12.4 t70 -141.11 159.42 42.26 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.486 -178.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.35 105.98 9.88 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -140.04 7.07 2.22 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 m -148.31 160.96 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.56 0 CA-C-N 114.357 -1.292 . . . . 0.0 107.513 -175.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.58 84.37 0.43 Allowed 'General case' 0 C--N 1.32 -0.698 0 O-C-N 124.282 0.989 . . . . 0.0 109.699 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 148.19 -144.91 12.91 Favored Glycine 0 N--CA 1.404 -3.48 0 N-CA-C 108.708 -1.757 . . . . 0.0 108.708 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -129.08 124.92 36.05 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.8 tptt -111.3 128.29 55.9 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 121.346 0.593 . . . . 0.0 110.322 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 30.3 t -77.72 135.79 38.08 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.389 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 40.5 m-85 -130.72 146.72 52.26 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.498 0.666 . . . . 0.0 110.012 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.463 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 40.4 m -101.9 138.33 39.01 Favored 'General case' 0 C--N 1.253 -3.615 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.339 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.557 ' HB2' HG23 ' A' ' 31' ' ' THR . 33.9 m-85 -111.84 135.9 51.84 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.706 -178.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -146.94 142.37 17.01 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.951 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.29 118.32 5.47 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.472 2.115 . . . . 0.0 112.211 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 75.3 m -111.23 163.94 16.16 Favored Pre-proline 0 C--N 1.273 -2.718 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.424 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 26.5 Cg_exo . . . . . 0 C--O 1.261 1.641 0 C-N-CA 121.684 1.589 . . . . 0.0 110.163 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.425 ' HD2' ' O ' ' A' ' 50' ' ' PRO . 61.9 mtt85 . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 120.946 0.403 . . . . 0.0 111.812 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.1 mtt -105.85 109.36 21.29 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 46' ' ' TYR . 10.5 m -87.14 121.37 29.51 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.155 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.547 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 38.3 ttpt -98.96 110.56 23.15 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.2 m -113.16 132.3 22.47 Favored Pre-proline 0 C--N 1.3 -1.584 0 C-N-CA 124.293 1.037 . . . . 0.0 110.707 -176.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.71 132.24 30.11 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.459 2.106 . . . . 0.0 113.78 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.7 p -71.21 147.13 48.57 Favored 'General case' 0 C--O 1.267 1.983 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.591 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.74 -45.74 2.05 Favored Glycine 0 C--O 1.263 1.952 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.951 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.539 ' HD3' ' CD ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -92.51 3.63 55.13 Favored 'General case' 0 CA--C 1.471 -2.081 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.62 -174.423 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.464 ' CD2' HG21 ' A' ' 23' ' ' VAL . 17.4 t80 -79.5 119.11 22.04 Favored 'General case' 0 N--CA 1.404 -2.736 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.942 177.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' HD2' ' C ' ' A' ' 10' ' ' PHE . 7.6 mmmt -131.56 99.86 4.95 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 150.09 -166.99 30.04 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 119.658 -1.258 . . . . 0.0 112.261 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -87.54 118.44 27.02 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 123.252 0.621 . . . . 0.0 112.124 -178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 8.5 t -87.98 72.4 9.27 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.552 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 22.8 m -69.14 -45.45 79.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.388 173.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -115.81 151.74 34.65 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.969 0.414 . . . . 0.0 109.973 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 93.2 m-20 -73.11 -31.07 64.1 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -176.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.0 m -59.15 -37.85 78.3 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.403 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.2 p-10 -68.85 -43.4 75.53 Favored 'General case' 0 CA--C 1.499 -0.989 0 O-C-N 121.55 -0.719 . . . . 0.0 109.868 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.615 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 17.8 t -61.52 -44.41 97.11 Favored 'General case' 0 CA--C 1.471 -2.087 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 22.3 tttp -54.74 -55.12 33.33 Favored 'General case' 0 N--CA 1.393 -3.277 0 CA-C-N 112.688 -2.051 . . . . 0.0 108.735 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -60.28 -45.11 94.48 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 123.916 0.76 . . . . 0.0 111.384 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.464 HG21 ' CD2' ' A' ' 10' ' ' PHE . 85.4 t -62.48 -44.74 99.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.62 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.4 m -66.89 -34.6 78.15 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 122.806 0.442 . . . . 0.0 111.863 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 50.0 mtp180 -69.2 -27.21 65.29 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.162 0.506 . . . . 0.0 109.83 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.9 m -82.51 -27.68 31.58 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.735 175.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.539 ' CD ' ' HD3' ' A' ' 9' ' ' LYS . 8.7 mm-40 -67.06 -46.74 73.41 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 121.741 -0.599 . . . . 0.0 110.401 171.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 134.9 39.65 0.17 Allowed Glycine 0 C--N 1.311 -0.825 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.496 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 95.3 m-85 -127.11 148.01 64.12 Favored Pre-proline 0 N--CA 1.434 -1.239 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -61.39 -33.05 89.48 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.511 2.141 . . . . 0.0 112.363 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.506 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.6 t -159.35 170.52 21.63 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.038 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.6 153.66 25.48 Favored Glycine 0 N--CA 1.409 -3.146 0 N-CA-C 107.37 -2.292 . . . . 0.0 107.37 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.597 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 39.4 m -156.78 158.71 37.33 Favored 'General case' 0 C--N 1.279 -2.473 0 C-N-CA 124.014 0.926 . . . . 0.0 110.095 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 44.2 m -91.0 156.74 17.72 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.3 0.571 . . . . 0.0 112.331 -170.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.485 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 22.9 t70 -148.36 152.45 37.07 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.03 -177.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.66 107.77 14.1 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -141.19 7.48 2.0 Allowed 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 m -149.59 160.6 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.506 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.217 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.68 84.2 0.45 Allowed 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 124.289 0.993 . . . . 0.0 109.094 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.71 -145.72 13.75 Favored Glycine 0 N--CA 1.403 -3.523 0 N-CA-C 107.763 -2.135 . . . . 0.0 107.763 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.552 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 32.5 mtp85 -140.1 117.61 11.48 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 117.568 0.684 . . . . 0.0 109.938 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -102.74 136.45 42.56 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-O 121.33 0.586 . . . . 0.0 110.735 -172.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.4 t -87.51 135.78 33.21 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.184 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.547 ' CD1' ' HG2' ' A' ' 4' ' ' LYS . 40.1 m-85 -129.9 146.34 51.61 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-O 121.718 0.771 . . . . 0.0 110.482 175.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.496 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 35.4 m -97.61 136.92 37.3 Favored 'General case' 0 C--N 1.252 -3.645 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.056 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.597 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 25.8 m-85 -111.54 136.11 51.18 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.913 -177.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -146.73 144.02 19.66 Favored Pre-proline 0 C--N 1.295 -1.774 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.705 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.08 120.56 6.67 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.372 2.048 . . . . 0.0 112.566 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 84.1 m -113.02 163.93 16.77 Favored Pre-proline 0 C--N 1.277 -2.551 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 170.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.425 ' O ' ' HD2' ' A' ' 1' ' ' ARG . 26.2 Cg_exo . . . . . 0 C--O 1.235 0.34 0 C-N-CA 121.838 1.692 . . . . 0.0 110.47 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.436 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 62.9 mtt85 . . . . . 0 CA--C 1.507 -0.701 0 CA-C-O 121.063 0.459 . . . . 0.0 112.045 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 66.9 mtm -105.12 107.95 19.2 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 174.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.1 m -83.5 117.13 22.89 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.798 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.639 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 36.7 ttpt -97.09 110.16 22.77 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 100.0 m -113.33 128.17 25.98 Favored Pre-proline 0 C--N 1.294 -1.822 0 C-N-CA 123.998 0.919 . . . . 0.0 110.662 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -69.39 115.98 4.3 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.992 1.795 . . . . 0.0 112.998 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -54.8 141.38 33.08 Favored 'General case' 0 C--O 1.276 2.492 0 C-N-CA 124.98 1.312 . . . . 0.0 110.376 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.29 -19.33 10.72 Favored Glycine 0 N--CA 1.433 -1.511 0 O-C-N 124.205 0.941 . . . . 0.0 114.601 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.473 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 49.0 pttt -118.35 15.5 13.9 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 118.546 1.173 . . . . 0.0 111.759 -176.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.51 ' HA ' HG11 ' A' ' 23' ' ' VAL . 57.8 t80 -62.32 136.16 57.79 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 114.389 -1.278 . . . . 0.0 113.002 -178.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.01 122.47 35.97 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 113.816 -1.538 . . . . 0.0 112.469 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.4 -175.29 25.66 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.122 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.57 139.41 32.12 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 2.9 t -88.93 65.6 7.61 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.146 0.974 . . . . 0.0 109.605 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.0 m -89.3 -29.95 5.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.024 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -107.9 114.74 28.9 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.028 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 55.4 m-80 -61.79 -29.69 70.32 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.863 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.8 m -67.03 -25.72 66.41 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 122.574 0.349 . . . . 0.0 110.883 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.497 ' O ' HG23 ' A' ' 23' ' ' VAL . 45.1 t30 -70.78 -48.26 55.21 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.595 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 12.9 t -56.74 -47.59 79.69 Favored 'General case' 0 CA--C 1.476 -1.888 0 CA-C-N 114.2 -1.364 . . . . 0.0 108.131 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 21.0 tttp -54.37 -55.26 30.34 Favored 'General case' 0 N--CA 1.399 -3.018 0 CA-C-N 112.68 -2.054 . . . . 0.0 109.634 -175.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -63.25 -38.53 91.53 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 123.757 0.661 . . . . 0.0 111.568 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.51 HG11 ' HA ' ' A' ' 10' ' ' PHE . 57.8 t -66.27 -45.73 89.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 95.4 m -63.63 -39.75 95.15 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 120.931 0.396 . . . . 0.0 111.071 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.573 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 59.3 mtp180 -64.76 -30.24 71.24 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 121.018 0.437 . . . . 0.0 110.502 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.0 p -85.58 -27.63 25.39 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.473 ' HG3' ' HE2' ' A' ' 9' ' ' LYS . 50.6 mt-10 -66.97 -40.33 87.43 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.691 171.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 134.32 41.04 0.16 Allowed Glycine 0 C--N 1.318 -0.468 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.701 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.573 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 95.0 m-85 -130.3 148.64 70.66 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -177.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -61.99 -34.79 79.9 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.448 2.099 . . . . 0.0 112.354 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.551 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.3 t -157.95 170.98 21.1 Favored 'General case' 0 N--CA 1.422 -1.867 0 O-C-N 122.056 -0.402 . . . . 0.0 110.354 -176.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 45' ' ' CYS . . . -148.52 153.84 25.48 Favored Glycine 0 N--CA 1.414 -2.777 0 N-CA-C 107.31 -2.316 . . . . 0.0 107.31 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.521 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 44.5 m -155.83 157.02 35.73 Favored 'General case' 0 C--N 1.281 -2.408 0 C-N-CA 123.5 0.72 . . . . 0.0 110.799 -176.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.416 ' SG ' ' HA ' ' A' ' 17' ' ' ASN . 58.0 m -94.85 125.72 39.69 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.788 -172.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.55 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 30.7 t70 -122.66 166.92 14.1 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.839 -174.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -122.34 116.04 23.35 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.331 0.586 . . . . 0.0 110.949 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -148.39 6.28 0.75 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 m -147.84 167.66 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.195 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.22 82.18 0.53 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 122.173 0.987 . . . . 0.0 110.146 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.09 -140.31 9.94 Favored Glycine 0 N--CA 1.401 -3.647 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.704 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -126.2 130.6 51.28 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -111.65 130.56 55.72 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 40.4 t -75.49 134.5 40.8 Favored 'General case' 0 C--O 1.278 2.569 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.639 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 40.0 m-85 -131.86 141.75 49.5 Favored 'General case' 0 N--CA 1.42 -1.957 0 O-C-N 123.933 0.771 . . . . 0.0 109.729 175.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.469 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 54.2 m -96.81 139.01 33.5 Favored 'General case' 0 C--N 1.252 -3.671 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.965 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.551 ' HB2' HG23 ' A' ' 31' ' ' THR . 37.1 m-85 -112.35 134.72 53.73 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.767 -178.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -147.1 143.91 18.97 Favored Pre-proline 0 C--N 1.295 -1.791 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.726 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.06 121.6 7.41 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.469 2.113 . . . . 0.0 112.655 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 77.0 m -116.14 161.83 29.14 Favored Pre-proline 0 C--N 1.278 -2.532 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 170.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.436 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 16.4 Cg_endo . . . . . 0 C--O 1.26 1.611 0 C-N-CA 122.018 1.812 . . . . 0.0 110.972 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.9 mtt -105.25 114.14 28.15 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 175.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 46' ' ' TYR . 15.8 m -93.01 122.59 35.53 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.221 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.469 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 27.3 ttpp -101.23 109.86 21.79 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.0 m -116.31 127.98 26.34 Favored Pre-proline 0 C--O 1.196 -1.729 0 C-N-CA 124.258 1.023 . . . . 0.0 111.117 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -66.98 125.08 13.08 Favored 'Trans proline' 0 N--CA 1.474 0.366 0 C-N-CA 122.365 2.043 . . . . 0.0 112.784 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 m -70.39 142.37 52.08 Favored 'General case' 0 C--O 1.273 2.339 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.67 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.17 -40.97 6.77 Favored Glycine 0 N--CA 1.427 -1.909 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.957 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.536 ' HD3' ' CD ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -90.95 4.24 52.51 Favored 'General case' 0 CA--C 1.477 -1.862 0 C-N-CA 118.489 -1.285 . . . . 0.0 112.94 -175.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.488 ' CD2' HG21 ' A' ' 23' ' ' VAL . 13.8 t80 -87.19 119.17 27.15 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.705 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -130.64 162.14 30.04 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 113.764 -1.562 . . . . 0.0 107.646 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.05 -137.71 13.43 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.252 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.4 ' HB3' HG13 ' A' ' 15' ' ' VAL . 12.7 m-85 -122.65 113.94 19.92 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.668 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.9 t -85.66 67.7 10.16 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.508 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 18.7 m -74.25 -32.88 32.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.692 172.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -119.97 121.84 39.87 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.642 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 92.9 m-20 -56.73 -27.01 58.43 Favored 'General case' 0 C--O 1.208 -1.099 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.881 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.3 m -66.91 -29.77 69.74 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -74.96 -40.58 60.68 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.668 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 16.2 t -59.17 -48.9 79.89 Favored 'General case' 0 CA--C 1.473 -2.013 0 CA-C-N 114.228 -1.351 . . . . 0.0 108.271 177.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.522 ' HG3' ' H ' ' A' ' 32' ' ' GLY . 15.5 ttpt -55.01 -50.6 68.62 Favored 'General case' 0 N--CA 1.391 -3.404 0 CA-C-N 113.322 -1.763 . . . . 0.0 109.104 -176.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -60.09 -49.07 79.09 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.212 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.488 HG21 ' CD2' ' A' ' 10' ' ' PHE . 93.0 t -60.33 -43.49 93.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 123.207 0.317 . . . . 0.0 110.825 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 68.9 m -64.75 -38.51 91.23 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 122.991 0.517 . . . . 0.0 112.068 177.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.403 ' HD2' ' HG2' ' A' ' 21' ' ' LYS . 35.9 mtp180 -69.93 -25.08 63.5 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.191 0.52 . . . . 0.0 109.965 177.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -82.85 -27.67 30.65 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.895 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.536 ' CD ' ' HD3' ' A' ' 9' ' ' LYS . 7.8 mm-40 -68.6 -42.21 78.49 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.769 -0.582 . . . . 0.0 110.607 172.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.96 35.59 0.47 Allowed Glycine 0 C--N 1.312 -0.788 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.454 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 87.2 m-85 -121.19 149.53 51.85 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -60.12 -39.75 66.58 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.486 2.124 . . . . 0.0 112.441 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.552 HG23 ' HB2' ' A' ' 46' ' ' TYR . 9.4 t -154.66 174.2 15.32 Favored 'General case' 0 N--CA 1.424 -1.732 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.141 -176.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.522 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -151.88 153.05 24.69 Favored Glycine 0 N--CA 1.418 -2.516 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.621 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 28.2 m -153.79 154.06 33.3 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 123.922 0.889 . . . . 0.0 110.391 -177.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.7 m -87.4 157.13 19.31 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.161 0.505 . . . . 0.0 112.109 -170.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.502 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 9.0 t70 -147.18 158.0 43.8 Favored 'General case' 0 C--O 1.257 1.46 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.061 -175.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.16 107.8 12.14 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -140.9 7.16 2.04 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 m -149.79 166.5 3.03 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.957 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -175.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.17 -30.13 66.15 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 123.974 0.796 . . . . 0.0 111.208 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.11 -170.23 42.66 Favored Glycine 0 N--CA 1.427 -1.927 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.508 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 19.9 mtp180 -114.29 118.17 33.17 Favored 'General case' 0 C--N 1.282 -2.351 0 O-C-N 121.698 -0.883 . . . . 0.0 109.731 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -102.14 149.68 24.03 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.309 -171.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 25.6 t -98.84 139.06 35.08 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 115.063 -0.972 . . . . 0.0 108.982 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.502 ' CD1' ' HB3' ' A' ' 35' ' ' ASP . 22.9 m-85 -132.49 135.74 46.21 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-O 122.052 0.93 . . . . 0.0 109.68 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.454 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 58.6 m -90.7 141.36 28.87 Favored 'General case' 0 C--N 1.246 -3.924 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.007 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.621 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 24.0 m-85 -111.75 134.92 52.99 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.829 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -147.28 145.61 22.48 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.854 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.04 116.66 4.72 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 122.395 2.063 . . . . 0.0 112.483 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.401 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 72.8 m -111.19 169.76 5.97 Favored Pre-proline 0 C--N 1.28 -2.44 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 171.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 49' ' ' CYS . 13.5 Cg_endo . . . . . 0 C--O 1.255 1.327 0 C-N-CA 122.16 1.907 . . . . 0.0 111.832 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.425 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 59.5 mtt85 . . . . . 0 CA--C 1.513 -0.468 0 CA-C-O 121.157 0.503 . . . . 0.0 111.819 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 63.8 mtt -110.63 101.23 9.91 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 18.5 m -80.36 114.51 19.31 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.67 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.516 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.6 ttpt -93.29 111.18 22.75 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 96.9 m -113.14 131.84 22.67 Favored Pre-proline 0 C--N 1.298 -1.651 0 C-N-CA 124.29 1.036 . . . . 0.0 110.18 -176.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 4.6 Cg_exo -72.17 114.46 3.99 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.015 1.81 . . . . 0.0 112.268 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.61 144.75 30.81 Favored 'General case' 0 C--O 1.269 2.127 0 C-N-CA 124.39 1.076 . . . . 0.0 110.475 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.66 -22.37 8.12 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 115.218 0.847 . . . . 0.0 115.218 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.574 ' HD2' HG13 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -108.19 -6.39 16.43 Favored 'General case' 0 CA--C 1.475 -1.916 0 C-N-CA 117.759 -1.576 . . . . 0.0 111.609 -174.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.444 ' CD2' HG21 ' A' ' 23' ' ' VAL . 29.7 t80 -65.62 144.4 56.97 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 113.395 -1.729 . . . . 0.0 109.936 172.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.48 132.4 9.71 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.555 176.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.66 -170.92 14.94 Favored Glycine 0 N--CA 1.433 -1.542 0 C-N-CA 120.466 -0.874 . . . . 0.0 111.49 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -87.78 114.43 24.38 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 4.3 t -83.22 71.84 10.18 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.946 0.879 . . . . 0.0 109.355 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.1 m -87.06 -32.17 6.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.603 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -108.38 120.51 42.6 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 54.8 m-80 -61.48 -28.35 69.23 Favored 'General case' 0 C--O 1.214 -0.766 0 O-C-N 123.731 0.644 . . . . 0.0 111.836 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.7 m -64.75 -28.32 69.5 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 123.593 0.757 . . . . 0.0 110.816 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -73.66 -46.37 46.95 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.653 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 15.9 t -56.87 -44.85 82.65 Favored 'General case' 0 CA--C 1.472 -2.02 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.079 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 22.6 tttp -55.08 -55.12 34.6 Favored 'General case' 0 N--CA 1.393 -3.276 0 CA-C-N 112.85 -1.977 . . . . 0.0 108.989 -175.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -61.72 -43.74 98.26 Favored 'General case' 0 CA--C 1.497 -1.084 0 O-C-N 123.906 0.754 . . . . 0.0 110.957 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.574 HG13 ' HD2' ' A' ' 9' ' ' LYS . 89.8 t -60.29 -48.83 86.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.884 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.6 m -63.03 -39.53 95.03 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.826 0.85 . . . . 0.0 111.649 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 54.1 mtp180 -64.42 -30.95 71.98 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.238 0.542 . . . . 0.0 110.024 177.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.0 m -85.65 -11.06 54.76 Favored 'General case' 0 CA--C 1.58 2.114 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.656 176.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -88.06 -27.41 22.0 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.242 -0.911 . . . . 0.0 110.287 172.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.52 34.05 0.78 Allowed Glycine 0 C--N 1.318 -0.439 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.636 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.0 m-85 -124.14 148.85 58.77 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -63.59 -34.76 62.66 Favored 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 122.394 2.063 . . . . 0.0 112.277 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.508 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.0 t -156.96 170.67 21.99 Favored 'General case' 0 N--CA 1.416 -2.126 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.085 -176.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 45' ' ' CYS . . . -148.33 154.93 26.17 Favored Glycine 0 N--CA 1.409 -3.163 0 N-CA-C 107.085 -2.406 . . . . 0.0 107.085 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.546 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 43.9 m -155.15 152.79 29.86 Favored 'General case' 0 C--N 1.277 -2.551 0 C-N-CA 123.628 0.771 . . . . 0.0 110.641 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.418 ' SG ' ' HA ' ' A' ' 17' ' ' ASN . 51.0 m -92.4 127.78 38.01 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.448 -172.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.631 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 35.0 t70 -127.24 169.43 13.51 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.047 -175.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -121.23 118.44 29.61 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.246 0.546 . . . . 0.0 111.371 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -149.3 5.52 0.64 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 174.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 m -147.38 167.01 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.316 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.66 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.5 82.17 1.09 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.741 0.781 . . . . 0.0 108.916 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.45 -150.95 23.2 Favored Glycine 0 N--CA 1.406 -3.302 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -177.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -121.78 127.48 50.67 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 122.65 -0.323 . . . . 0.0 110.672 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -109.78 132.63 53.98 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.0 t -77.21 134.64 38.57 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 174.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.631 ' CD1' ' HB3' ' A' ' 35' ' ' ASP . 46.9 m-85 -130.54 141.65 50.48 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-O 121.553 0.692 . . . . 0.0 109.337 173.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.461 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 57.3 m -96.12 139.36 32.4 Favored 'General case' 0 C--N 1.254 -3.576 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.274 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.546 ' CE1' ' HB2' ' A' ' 33' ' ' SER . 26.1 m-85 -112.9 134.23 54.51 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 121.002 0.429 . . . . 0.0 110.702 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -143.78 137.09 14.03 Favored Pre-proline 0 C--N 1.295 -1.798 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.337 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.84 118.8 5.89 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.796 2.331 . . . . 0.0 112.465 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.05 164.15 20.08 Favored Pre-proline 0 C--N 1.272 -2.786 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 171.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.425 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 32.9 Cg_exo . . . . . 0 C--O 1.264 1.796 0 C-N-CA 121.958 1.772 . . . . 0.0 110.952 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.692 ' HD3' ' OXT' ' A' ' 50' ' ' PRO . 31.7 mtp180 . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 121.184 0.516 . . . . 0.0 112.089 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.9 mtm -107.62 106.3 16.59 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.2 m -86.34 116.17 24.33 Favored 'General case' 0 C--N 1.269 -2.899 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.71 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.506 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.8 ttpt -92.97 111.42 23.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.8 m -114.9 130.47 24.15 Favored Pre-proline 0 C--N 1.295 -1.803 0 C-N-CA 124.337 1.055 . . . . 0.0 110.336 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.54 131.48 28.02 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.147 1.898 . . . . 0.0 113.253 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 10' ' ' PHE . 10.0 p -59.95 143.46 51.57 Favored 'General case' 0 C--O 1.27 2.159 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.711 177.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.68 -32.31 6.01 Favored Glycine 0 N--CA 1.427 -1.918 0 O-C-N 123.58 0.55 . . . . 0.0 113.528 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.556 ' NZ ' ' HG3' ' A' ' 27' ' ' GLU . 16.1 pttm -120.24 19.26 12.2 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 118.276 1.038 . . . . 0.0 112.706 -174.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.543 ' HA ' HG11 ' A' ' 23' ' ' VAL . 59.7 t80 -63.88 135.43 56.55 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.843 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.95 118.1 28.03 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 113.498 -1.683 . . . . 0.0 112.67 -176.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.6 -160.84 19.63 Favored Glycine 0 N--CA 1.434 -1.461 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.319 173.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -88.86 138.05 31.77 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 122.993 0.517 . . . . 0.0 110.768 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.1 t -93.43 64.15 3.62 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.868 0.842 . . . . 0.0 108.977 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.501 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 18.8 m -73.83 -34.78 41.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.027 172.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -119.69 125.52 48.88 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.51 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 91.4 m-20 -56.56 -28.18 59.57 Favored 'General case' 0 C--O 1.199 -1.596 0 O-C-N 124.312 1.007 . . . . 0.0 111.354 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 89.9 m -67.4 -29.65 69.21 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.513 ' O ' HG23 ' A' ' 23' ' ' VAL . 45.6 t30 -70.05 -46.27 65.35 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.651 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 24.3 t -57.62 -51.5 69.23 Favored 'General case' 0 CA--C 1.478 -1.823 0 CA-C-N 113.991 -1.459 . . . . 0.0 108.745 177.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 11.4 ttpt -51.64 -53.76 35.27 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-N 113.275 -1.784 . . . . 0.0 109.502 -174.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -62.7 -40.93 98.68 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.404 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.543 HG11 ' HA ' ' A' ' 10' ' ' PHE . 60.2 t -65.97 -42.46 91.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.588 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.6 m -64.85 -41.99 95.26 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 120.973 0.416 . . . . 0.0 110.853 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 43.5 mtp180 -65.21 -29.32 70.11 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.004 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 p -81.65 -30.95 32.54 Favored 'General case' 0 C--O 1.215 -0.727 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 175.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.556 ' HG3' ' NZ ' ' A' ' 9' ' ' LYS . 48.1 mt-10 -68.67 -34.94 76.55 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.889 173.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.87 36.76 0.38 Allowed Glycine 0 C--N 1.314 -0.642 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.883 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.7 m-85 -123.57 148.9 57.2 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.37 -35.96 58.59 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.121 1.881 . . . . 0.0 112.294 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.527 HG23 ' HB2' ' A' ' 46' ' ' TYR . 8.8 t -157.74 175.5 13.81 Favored 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.88 -175.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -154.88 153.72 25.0 Favored Glycine 0 N--CA 1.417 -2.616 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.593 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 32.8 m -155.24 160.98 41.25 Favored 'General case' 0 C--N 1.285 -2.2 0 C-N-CA 123.636 0.774 . . . . 0.0 110.763 -177.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.4 m -93.17 153.84 18.4 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -171.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.516 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 9.9 t70 -147.49 157.29 43.51 Favored 'General case' 0 C--O 1.255 1.376 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.173 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -121.71 110.77 16.36 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 121.549 0.69 . . . . 0.0 109.231 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -146.16 7.69 1.04 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.423 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 m -149.06 165.53 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.243 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.489 -174.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.34 83.11 1.41 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.56 -148.42 19.43 Favored Glycine 0 N--CA 1.405 -3.389 0 N-CA-C 107.833 -2.107 . . . . 0.0 107.833 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.501 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 19.1 mtp180 -137.6 118.08 13.82 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 117.663 0.732 . . . . 0.0 109.58 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -103.69 134.6 46.74 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-O 121.423 0.63 . . . . 0.0 111.146 -172.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 5.9 t -84.6 136.9 33.58 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.542 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.516 ' CD1' ' HB3' ' A' ' 35' ' ' ASP . 39.1 m-85 -129.84 138.97 51.28 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-O 121.8 0.81 . . . . 0.0 109.845 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.438 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 56.9 m -95.53 136.04 36.42 Favored 'General case' 0 C--N 1.246 -3.919 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.348 -177.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.593 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 27.9 m-85 -107.61 135.19 49.48 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.863 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -146.27 140.82 15.77 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.716 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 130.95 20.27 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.536 2.158 . . . . 0.0 112.506 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.3 p -129.81 158.26 74.24 Favored Pre-proline 0 C--N 1.27 -2.875 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 171.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.692 ' OXT' ' HD3' ' A' ' 1' ' ' ARG . 31.7 Cg_exo . . . . . 0 C--O 1.275 2.329 0 C-N-CA 121.894 1.729 . . . . 0.0 110.472 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 29.3 ttm105 . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 121.258 0.552 . . . . 0.0 111.756 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 90.4 mtp -98.04 105.88 18.09 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.631 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.9 m -85.38 118.02 24.66 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.705 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.533 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 37.5 ttpt -97.39 110.52 23.06 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 98.1 m -111.55 131.48 22.31 Favored Pre-proline 0 C--N 1.29 -2.001 0 C-N-CA 124.106 0.962 . . . . 0.0 110.31 -176.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -66.54 126.42 15.48 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.002 1.801 . . . . 0.0 112.36 178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.1 p -63.2 142.28 58.44 Favored 'General case' 0 C--O 1.273 2.294 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.499 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.78 -32.75 5.53 Favored Glycine 0 N--CA 1.428 -1.889 0 CA-C-N 115.951 -0.568 . . . . 0.0 114.341 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.525 ' HD2' HG13 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -111.76 -1.56 15.58 Favored 'General case' 0 CA--C 1.476 -1.895 0 O-C-N 120.976 -1.308 . . . . 0.0 111.008 -173.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.459 ' CD2' HG21 ' A' ' 23' ' ' VAL . 28.0 t80 -75.14 129.49 37.62 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 113.332 -1.758 . . . . 0.0 109.067 169.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.75 102.72 2.39 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.238 174.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.51 -174.09 38.86 Favored Glycine 0 N--CA 1.426 -2.005 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -80.25 111.0 16.21 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.275 0.559 . . . . 0.0 111.809 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.666 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 8.0 t -82.05 71.05 9.09 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.69 -60.17 3.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.787 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -100.93 140.71 34.84 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.931 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 91.8 m-20 -64.76 -28.01 69.29 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.496 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.6 m -63.85 -35.08 79.47 Favored 'General case' 0 CA--C 1.575 1.918 0 C-N-CA 123.236 0.614 . . . . 0.0 112.482 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.466 HD21 ' HA ' ' A' ' 14' ' ' CYS . 1.2 p-10 -72.26 -40.72 67.45 Favored 'General case' 0 CA--C 1.494 -1.193 0 O-C-N 121.179 -0.951 . . . . 0.0 109.761 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.666 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 23.1 t -59.82 -45.75 91.4 Favored 'General case' 0 CA--C 1.472 -2.043 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 24.0 tttp -53.69 -55.04 29.61 Favored 'General case' 0 N--CA 1.395 -3.215 0 CA-C-N 112.551 -2.113 . . . . 0.0 108.807 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -62.44 -43.71 98.16 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.24 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.525 HG13 ' HD2' ' A' ' 9' ' ' LYS . 92.3 t -60.94 -48.41 89.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.597 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.4 m -63.05 -38.54 91.6 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.789 0.835 . . . . 0.0 111.286 177.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 56.1 mtp180 -64.47 -31.36 72.53 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-O 121.282 0.563 . . . . 0.0 110.145 177.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.2 m -85.46 -10.66 55.81 Favored 'General case' 0 CA--C 1.578 2.032 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.548 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 23' ' ' VAL . 68.7 mt-10 -88.13 -28.75 21.06 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.245 -0.909 . . . . 0.0 110.215 172.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.95 33.22 0.7 Allowed Glycine 0 C--N 1.318 -0.463 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.703 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.603 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.4 m-85 -123.89 147.51 54.03 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -63.69 -32.13 68.73 Favored 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.462 2.108 . . . . 0.0 112.269 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.494 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.1 t -159.37 171.5 19.66 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.02 -176.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -149.93 156.82 26.94 Favored Glycine 0 N--CA 1.408 -3.196 0 N-CA-C 107.405 -2.278 . . . . 0.0 107.405 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.571 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 39.8 m -157.42 156.89 32.99 Favored 'General case' 0 C--N 1.28 -2.445 0 C-N-CA 124.072 0.949 . . . . 0.0 110.235 -177.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.3 m -94.12 139.43 31.0 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.0 0.428 . . . . 0.0 111.257 -171.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.551 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 20.8 t70 -131.4 162.85 29.21 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.422 -176.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -120.6 112.55 19.05 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-O 121.627 0.727 . . . . 0.0 110.485 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -147.89 6.6 0.8 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.362 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 m -147.02 165.97 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.218 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.364 -175.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.25 83.46 0.75 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.826 0.822 . . . . 0.0 109.536 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.18 -143.35 12.04 Favored Glycine 0 N--CA 1.405 -3.37 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -127.01 125.9 42.22 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -111.42 125.02 53.44 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.39 0.614 . . . . 0.0 110.246 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 33.8 t -72.23 135.2 46.0 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.64 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.551 ' CD1' ' HB3' ' A' ' 35' ' ' ASP . 39.3 m-85 -130.55 143.21 50.61 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-O 121.499 0.666 . . . . 0.0 109.605 174.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.482 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 35.3 m -97.17 136.95 36.96 Favored 'General case' 0 C--N 1.25 -3.753 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.997 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.571 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 38.4 m-85 -112.18 136.15 51.95 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.585 -177.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -147.13 144.58 19.95 Favored Pre-proline 0 C--N 1.296 -1.743 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.907 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.93 120.56 6.42 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 122.457 2.105 . . . . 0.0 112.584 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.4 m -116.79 169.35 7.36 Favored Pre-proline 0 C--N 1.277 -2.553 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 171.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.263 1.734 0 C-N-CA 121.904 1.736 . . . . 0.0 110.208 174.777 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.418 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 58.2 mtt85 . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 121.063 0.459 . . . . 0.0 111.87 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.8 mtt -107.63 99.71 9.18 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 17.7 m -80.36 114.42 19.24 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.623 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.526 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.6 ttpt -92.63 110.33 21.76 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 33.4 m -108.8 131.9 21.5 Favored Pre-proline 0 C--N 1.301 -1.523 0 C-N-CA 124.27 1.028 . . . . 0.0 109.809 -174.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 5.8 Cg_exo -72.3 116.28 4.65 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.66 1.573 . . . . 0.0 111.865 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -58.13 139.04 55.58 Favored 'General case' 0 C--O 1.278 2.558 0 C-N-CA 123.944 0.898 . . . . 0.0 111.097 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.57 -30.34 9.89 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.787 -175.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.488 ' NZ ' ' HG3' ' A' ' 27' ' ' GLU . 21.5 pttm -105.05 7.01 33.79 Favored 'General case' 0 N--CA 1.42 -1.954 0 C-N-CA 118.406 -1.318 . . . . 0.0 112.562 -175.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.41 ' CD2' HG21 ' A' ' 23' ' ' VAL . 24.6 t80 -82.73 116.66 22.19 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.641 177.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -126.06 134.68 51.33 Favored 'General case' 0 C--N 1.269 -2.928 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.311 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.62 -161.41 14.17 Favored Glycine 0 N--CA 1.432 -1.608 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.877 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -97.81 123.57 41.83 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.1 t -91.8 60.15 3.85 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.558 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 17.4 m -69.98 -33.28 54.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.513 173.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.488 HD21 ' HB ' ' A' ' 18' ' ' THR . 19.5 t30 -111.34 121.19 44.59 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.86 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -61.88 -26.08 67.94 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.059 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.488 ' HB ' HD21 ' A' ' 16' ' ' ASN . 97.8 m -67.43 -31.21 71.25 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.423 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -59.43 -54.25 48.87 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.591 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 5.9 t -56.64 -49.72 74.17 Favored 'General case' 0 CA--C 1.464 -2.341 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.243 -177.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.505 ' HG3' ' H ' ' A' ' 32' ' ' GLY . 0.9 OUTLIER -55.48 -46.54 76.89 Favored 'General case' 0 N--CA 1.395 -3.2 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.607 -176.203 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -68.02 -44.09 77.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.229 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.41 HG21 ' CD2' ' A' ' 10' ' ' PHE . 76.2 t -64.13 -40.83 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.407 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.8 m -66.2 -41.86 89.58 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 120.866 0.365 . . . . 0.0 111.571 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 35.3 mtp180 -66.55 -28.63 68.68 Favored 'General case' 0 C--O 1.211 -0.958 0 CA-C-O 120.915 0.388 . . . . 0.0 111.017 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 p -81.92 -30.97 31.59 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.488 ' HG3' ' NZ ' ' A' ' 9' ' ' LYS . 53.1 mt-10 -68.3 -32.67 72.98 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.659 172.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.12 36.29 0.55 Allowed Glycine 0 C--N 1.315 -0.631 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.977 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 92.6 m-85 -122.13 149.23 53.87 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -60.82 -38.47 70.02 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.308 2.006 . . . . 0.0 112.277 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.529 HG23 ' HB2' ' A' ' 46' ' ' TYR . 9.1 t -158.07 173.89 16.05 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.112 -175.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.505 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -153.99 154.13 25.3 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.458 ' HB3' ' CE2' ' A' ' 46' ' ' TYR . 23.2 t -150.3 154.58 38.12 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.6 m -87.47 156.16 19.68 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 120.831 0.348 . . . . 0.0 110.569 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.469 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 22.8 t70 -145.01 153.86 41.93 Favored 'General case' 0 C--O 1.255 1.368 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.564 -175.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -119.75 105.74 11.44 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -144.13 6.14 1.33 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.118 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.0 m -148.04 164.94 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.877 -175.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.1 80.94 0.96 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.048 0.928 . . . . 0.0 109.365 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.52 -147.38 16.75 Favored Glycine 0 N--CA 1.405 -3.43 0 N-CA-C 107.833 -2.107 . . . . 0.0 107.833 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.558 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 20.8 mtp180 -139.24 117.76 12.14 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 117.581 0.691 . . . . 0.0 109.668 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -101.05 146.93 26.81 Favored 'General case' 0 N--CA 1.422 -1.835 0 O-C-N 123.536 0.522 . . . . 0.0 109.975 -172.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.4 t -97.98 141.37 31.03 Favored 'General case' 0 C--O 1.266 1.964 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.526 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 47.4 m-85 -134.87 138.08 43.83 Favored 'General case' 0 N--CA 1.419 -1.983 0 O-C-N 124.165 0.916 . . . . 0.0 110.411 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.475 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 61.5 m -96.05 135.81 37.32 Favored 'General case' 0 C--N 1.258 -3.408 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.84 -177.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.529 ' HB2' HG23 ' A' ' 31' ' ' THR . 21.7 m-85 -106.92 134.64 49.77 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 120.863 0.363 . . . . 0.0 110.803 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -144.49 137.81 14.11 Favored Pre-proline 0 C--N 1.296 -1.755 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.846 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.4 120.68 7.32 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.659 2.24 . . . . 0.0 112.362 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 p -118.28 164.45 20.23 Favored Pre-proline 0 C--N 1.272 -2.778 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 171.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.418 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 34.6 Cg_exo . . . . . 0 C--O 1.263 1.732 0 C-N-CA 121.816 1.677 . . . . 0.0 110.875 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.42 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 63.0 mtt85 . . . . . 0 N--CA 1.469 0.492 0 CA-C-O 121.023 0.44 . . . . 0.0 112.157 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 89.2 mtp -99.25 101.16 12.38 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.9 m -81.97 116.09 21.44 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.532 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.496 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 38.8 ttpt -93.08 109.77 21.25 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.6 m -107.35 132.52 20.89 Favored Pre-proline 0 C--N 1.298 -1.655 0 C-N-CA 124.373 1.069 . . . . 0.0 109.821 -174.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -71.72 115.01 4.13 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.68 1.586 . . . . 0.0 111.998 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -58.26 140.87 52.41 Favored 'General case' 0 C--O 1.278 2.605 0 C-N-CA 124.078 0.951 . . . . 0.0 111.278 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.55 -33.11 6.93 Favored Glycine 0 N--CA 1.427 -1.951 0 CA-C-N 115.749 -0.659 . . . . 0.0 114.051 -175.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.48 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 50.1 pttt -103.51 6.99 37.8 Favored 'General case' 0 CA--C 1.474 -1.972 0 O-C-N 120.995 -1.297 . . . . 0.0 112.635 -174.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.455 ' CD2' HG21 ' A' ' 23' ' ' VAL . 22.8 t80 -87.42 127.4 35.22 Favored 'General case' 0 N--CA 1.4 -2.93 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.012 176.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.41 ' HE3' ' HB3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -151.7 104.04 3.0 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.92 176.08 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 156.63 -167.51 33.61 Favored Glycine 0 N--CA 1.424 -2.163 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -84.82 119.18 25.02 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.0 t -89.45 60.35 5.16 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.513 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 17.4 m -68.25 -39.59 81.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.573 173.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -110.39 121.97 46.57 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.457 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 86.7 m-20 -57.44 -28.42 63.3 Favored 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 124.153 0.981 . . . . 0.0 111.239 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 51.9 m -68.65 -26.27 65.24 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -73.64 -42.24 61.68 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.641 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 18.3 t -58.84 -49.7 76.75 Favored 'General case' 0 CA--C 1.475 -1.937 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.244 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HG3' ' H ' ' A' ' 32' ' ' GLY . 12.7 ttpt -53.54 -51.84 61.62 Favored 'General case' 0 N--CA 1.399 -2.995 0 CA-C-N 113.018 -1.901 . . . . 0.0 109.028 -175.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -59.88 -48.38 81.95 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 123.693 0.621 . . . . 0.0 111.38 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.455 HG21 ' CD2' ' A' ' 10' ' ' PHE . 92.4 t -60.2 -47.36 92.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 O-C-N 123.417 0.448 . . . . 0.0 110.707 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.1 m -60.49 -42.85 97.16 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.441 0.696 . . . . 0.0 111.9 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.6 mtp180 -65.08 -30.47 71.43 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.083 0.468 . . . . 0.0 110.24 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 m -85.46 -16.72 38.72 Favored 'General case' 0 CA--C 1.574 1.871 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.888 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.48 ' HG3' ' HE2' ' A' ' 9' ' ' LYS . 55.1 mt-10 -78.92 -38.26 37.83 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.365 -0.834 . . . . 0.0 110.309 172.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 133.39 34.7 0.31 Allowed Glycine 0 C--N 1.31 -0.908 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.1 m-85 -121.78 147.92 49.59 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -59.58 -38.34 82.89 Favored 'Trans proline' 0 C--O 1.238 0.502 0 C-N-CA 122.467 2.111 . . . . 0.0 112.325 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.539 HG23 ' HB2' ' A' ' 46' ' ' TYR . 8.8 t -158.85 176.38 12.41 Favored 'General case' 0 N--CA 1.426 -1.667 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.068 -175.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.451 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -155.28 158.97 28.81 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.3 t -156.63 162.37 39.86 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 17' ' ' ASN . 59.2 m -96.11 156.97 16.11 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.302 0.572 . . . . 0.0 111.63 -171.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.439 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 8.2 t70 -145.85 156.62 43.68 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 124.306 1.042 . . . . 0.0 108.61 -176.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.4 107.08 10.74 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -142.29 7.81 1.78 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.4 m -149.04 160.52 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.343 -175.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.26 82.99 0.24 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 122.204 1.002 . . . . 0.0 110.007 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 151.78 -143.41 10.41 Favored Glycine 0 N--CA 1.403 -3.527 0 N-CA-C 107.492 -2.243 . . . . 0.0 107.492 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.513 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 23.0 mtp180 -141.68 119.86 12.16 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 117.509 0.654 . . . . 0.0 109.481 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -102.17 142.77 32.9 Favored 'General case' 0 N--CA 1.428 -1.556 0 O-C-N 123.432 0.457 . . . . 0.0 110.346 -172.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.2 t -94.13 142.12 27.76 Favored 'General case' 0 C--O 1.268 2.049 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.338 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.496 ' CD1' ' HG2' ' A' ' 4' ' ' LYS . 51.6 m-85 -135.85 139.41 43.39 Favored 'General case' 0 N--CA 1.418 -2.044 0 O-C-N 124.159 0.912 . . . . 0.0 110.421 176.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.465 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 59.8 m -96.24 137.68 34.96 Favored 'General case' 0 C--N 1.261 -3.248 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.698 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.539 ' HB2' HG23 ' A' ' 31' ' ' THR . 22.0 m-85 -108.36 135.6 49.4 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 120.992 0.425 . . . . 0.0 110.939 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -147.43 145.75 22.71 Favored Pre-proline 0 C--N 1.298 -1.643 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.385 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.04 124.19 8.91 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.343 2.029 . . . . 0.0 112.605 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.0 m -117.01 166.38 13.09 Favored Pre-proline 0 C--N 1.276 -2.593 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 170.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.42 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 22.5 Cg_exo . . . . . 0 C--O 1.259 1.574 0 C-N-CA 121.661 1.574 . . . . 0.0 110.217 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.439 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 62.2 mtt85 . . . . . 0 N--CA 1.474 0.769 0 CA-C-O 120.96 0.41 . . . . 0.0 111.841 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 68.1 mtm -103.2 108.57 19.83 Favored 'General case' 0 CA--C 1.483 -1.616 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.7 m -85.92 116.68 24.3 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.073 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.496 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 36.9 ttpt -95.78 110.17 22.36 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 67.0 m -110.37 132.71 21.38 Favored Pre-proline 0 C--O 1.202 -1.407 0 C-N-CA 124.253 1.021 . . . . 0.0 110.385 -174.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 5.1 Cg_exo -72.37 119.49 6.17 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 121.947 1.765 . . . . 0.0 112.489 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m -62.83 146.6 52.28 Favored 'General case' 0 C--O 1.274 2.365 0 C-N-CA 123.86 0.864 . . . . 0.0 110.8 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.85 -27.03 4.19 Favored Glycine 0 N--CA 1.432 -1.608 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.914 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -109.5 18.3 20.5 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-O 122.257 1.027 . . . . 0.0 111.784 -176.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.452 ' HA ' HG11 ' A' ' 23' ' ' VAL . 51.4 t80 -69.23 140.27 54.51 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 113.997 -1.456 . . . . 0.0 112.244 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.433 ' O ' ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -131.16 134.71 46.77 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 114.284 -1.326 . . . . 0.0 111.709 -177.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.29 176.22 41.97 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.546 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.92 130.57 36.74 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.459 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 2.5 t -83.77 67.35 9.48 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.962 0.887 . . . . 0.0 110.2 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.2 m -89.84 -25.59 5.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.978 174.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -113.76 115.75 28.3 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.189 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 92.2 m-20 -57.53 -31.17 65.82 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.939 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.2 m -66.92 -27.47 67.51 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 122.703 0.401 . . . . 0.0 111.133 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.481 ' O ' HG23 ' A' ' 23' ' ' VAL . 47.3 t30 -72.33 -46.24 56.44 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.459 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 9.1 t -57.82 -47.13 83.51 Favored 'General case' 0 CA--C 1.48 -1.746 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.0 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 23.2 tttp -54.6 -55.72 26.53 Favored 'General case' 0 N--CA 1.4 -2.932 0 CA-C-N 112.772 -2.013 . . . . 0.0 109.313 -175.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -61.29 -41.46 97.0 Favored 'General case' 0 CA--C 1.493 -1.237 0 O-C-N 124.001 0.813 . . . . 0.0 111.682 -177.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 19' ' ' ASN . 89.6 t -61.95 -51.33 73.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 99.4 m -58.75 -40.8 84.94 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.221 0.95 . . . . 0.0 111.341 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 56.5 mtp180 -64.15 -33.18 75.18 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 121.063 0.458 . . . . 0.0 110.582 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.0 m -85.88 -13.34 48.21 Favored 'General case' 0 CA--C 1.579 2.095 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.031 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 23' ' ' VAL . 54.4 mt-10 -82.14 -39.66 22.95 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.352 -0.843 . . . . 0.0 109.627 172.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.46 38.82 0.13 Allowed Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.57 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 92.5 m-85 -128.01 148.89 69.24 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -62.55 -35.45 70.73 Favored 'Trans proline' 0 C--O 1.242 0.706 0 C-N-CA 122.463 2.109 . . . . 0.0 112.311 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.563 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.7 t -158.23 170.46 22.21 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.273 -176.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 45' ' ' CYS . . . -147.76 155.91 26.69 Favored Glycine 0 N--CA 1.415 -2.703 0 N-CA-C 107.296 -2.321 . . . . 0.0 107.296 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.535 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 35.7 m -156.96 152.76 27.06 Favored 'General case' 0 C--N 1.283 -2.309 0 C-N-CA 123.79 0.836 . . . . 0.0 110.85 -176.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.7 m -94.96 132.1 40.18 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.237 0.541 . . . . 0.0 111.167 -172.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.4 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 26.8 t70 -120.32 156.31 31.56 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.124 -173.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.15 108.19 14.38 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -141.46 10.94 2.09 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.2 m -156.86 167.25 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.84 80.7 0.89 Allowed 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.682 0.753 . . . . 0.0 109.06 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.41 -157.99 27.46 Favored Glycine 0 N--CA 1.412 -2.907 0 N-CA-C 108.53 -1.828 . . . . 0.0 108.53 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -124.43 132.25 53.5 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 117.206 0.503 . . . . 0.0 110.66 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -111.69 133.98 53.57 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 52.9 t -81.8 135.09 35.48 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.496 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 54.3 m-85 -132.31 140.2 48.49 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-O 121.79 0.805 . . . . 0.0 110.185 175.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.457 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 46.3 m -95.14 139.67 31.15 Favored 'General case' 0 C--N 1.252 -3.64 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.132 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.563 ' HB2' HG23 ' A' ' 31' ' ' THR . 35.4 m-85 -112.11 135.0 53.32 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.631 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -147.5 143.94 18.7 Favored Pre-proline 0 C--N 1.294 -1.841 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.603 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.17 122.07 7.74 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.352 2.035 . . . . 0.0 112.471 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 76.9 m -115.13 161.53 29.01 Favored Pre-proline 0 C--N 1.276 -2.607 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 170.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.439 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 17.7 Cg_endo . . . . . 0 C--O 1.262 1.719 0 C-N-CA 121.808 1.672 . . . . 0.0 110.836 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.425 ' HD2' ' O ' ' A' ' 50' ' ' PRO . 58.0 mtt85 . . . . . 0 CA--C 1.513 -0.466 0 CA-C-O 121.213 0.53 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 63.6 mtt -107.39 98.39 8.02 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 174.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.9 m -77.77 113.01 15.21 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.622 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.535 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 38.4 ttpt -92.94 110.56 22.02 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.4 m -109.36 131.4 21.88 Favored Pre-proline 0 C--N 1.296 -1.735 0 C-N-CA 124.137 0.975 . . . . 0.0 109.64 -174.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -71.76 114.63 4.01 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.755 1.637 . . . . 0.0 111.523 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -57.46 139.73 52.44 Favored 'General case' 0 C--O 1.274 2.359 0 C-N-CA 124.292 1.037 . . . . 0.0 111.36 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.64 -29.54 10.74 Favored Glycine 0 N--CA 1.425 -2.086 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.896 -176.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.588 ' HG3' ' CG ' ' A' ' 27' ' ' GLU . 34.1 mtmt -92.51 -19.84 21.56 Favored 'General case' 0 CA--C 1.476 -1.889 0 CA-C-N 118.337 1.069 . . . . 0.0 109.078 -175.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -70.24 113.02 7.0 Favored 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 114.148 -1.387 . . . . 0.0 111.909 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -138.03 76.16 1.56 Allowed 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 113.592 -1.64 . . . . 0.0 112.593 -179.706 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.47 -167.19 38.1 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -82.78 120.2 25.32 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.679 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 6.9 t -88.33 64.0 7.39 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.887 0.851 . . . . 0.0 109.182 176.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.464 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 19.3 m -72.85 -35.2 48.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.189 171.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -109.98 119.2 38.57 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.3 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 55.4 m-80 -64.77 -30.32 71.33 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.467 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.5 m -68.85 -24.47 64.36 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 122.568 0.347 . . . . 0.0 110.421 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.422 ' O ' HG23 ' A' ' 23' ' ' VAL . 54.2 t30 -74.01 -46.1 45.74 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.679 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 33.1 t -55.28 -47.32 75.69 Favored 'General case' 0 CA--C 1.474 -1.963 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.98 176.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 19.2 tttp -54.57 -53.26 56.94 Favored 'General case' 0 N--CA 1.391 -3.379 0 CA-C-N 112.278 -2.237 . . . . 0.0 109.33 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -61.86 -42.98 99.7 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 123.5 0.5 . . . . 0.0 111.521 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 19' ' ' ASN . 48.4 t -64.94 -43.94 96.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.019 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 74.6 m -64.0 -40.9 97.39 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 120.96 0.409 . . . . 0.0 111.388 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 52.7 mtp180 -67.06 -26.06 66.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.955 0.407 . . . . 0.0 110.727 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.7 p -85.21 -36.43 20.98 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 175.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.588 ' CG ' ' HG3' ' A' ' 9' ' ' LYS . 56.9 mt-10 -57.04 -45.61 83.05 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 120.612 0.244 . . . . 0.0 111.333 168.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 135.39 43.72 0.11 Allowed Glycine 0 C--N 1.318 -0.46 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.849 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.466 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 89.5 m-85 -128.61 149.58 72.29 Favored Pre-proline 0 C--N 1.307 -1.266 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -62.25 -37.68 60.23 Favored 'Trans proline' 0 C--O 1.24 0.602 0 C-N-CA 122.394 2.063 . . . . 0.0 112.286 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.536 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.6 t -155.29 169.07 25.04 Favored 'General case' 0 N--CA 1.418 -2.065 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.438 -176.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.54 152.15 24.26 Favored Glycine 0 N--CA 1.408 -3.226 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.577 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 46.8 m -155.07 157.66 37.88 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 124.09 0.956 . . . . 0.0 110.002 -177.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 46.2 m -91.67 153.81 19.42 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.994 0.426 . . . . 0.0 112.076 -170.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.567 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 13.3 t70 -148.38 158.31 44.03 Favored 'General case' 0 C--O 1.255 1.349 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.542 -177.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -118.86 111.14 18.03 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-O 121.61 0.719 . . . . 0.0 109.902 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -145.38 6.42 1.11 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.479 177.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.82 164.41 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.265 -174.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.05 80.75 1.23 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.022 0.915 . . . . 0.0 109.002 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.26 -144.52 11.29 Favored Glycine 0 N--CA 1.403 -3.551 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.464 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 19.7 mtp180 -139.55 118.59 12.6 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -104.75 144.51 31.64 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 121.268 0.556 . . . . 0.0 110.23 -173.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.3 t -92.83 141.27 28.62 Favored 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.997 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.567 ' CD1' ' HB3' ' A' ' 35' ' ' ASP . 42.5 m-85 -133.74 140.57 47.06 Favored 'General case' 0 N--CA 1.414 -2.242 0 O-C-N 124.053 0.846 . . . . 0.0 109.889 175.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.466 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 58.6 m -94.52 135.34 36.07 Favored 'General case' 0 C--N 1.255 -3.506 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.521 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 33' ' ' SER . 28.0 m-85 -108.89 133.7 52.55 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.743 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -144.85 138.31 14.26 Favored Pre-proline 0 C--N 1.294 -1.812 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.975 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.4 121.7 8.24 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.744 2.296 . . . . 0.0 112.27 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.7 p -121.64 162.24 37.51 Favored Pre-proline 0 C--N 1.273 -2.755 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 172.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.425 ' O ' ' HD2' ' A' ' 1' ' ' ARG . 13.6 Cg_endo . . . . . 0 CA--C 1.533 0.464 0 C-N-CA 122.113 1.875 . . . . 0.0 111.503 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.697 ' HD3' ' O ' ' A' ' 50' ' ' PRO . 32.2 mtp180 . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 120.825 0.345 . . . . 0.0 111.677 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 69.5 mtm -105.01 113.81 27.63 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.1 m -90.96 117.93 29.94 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.112 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.481 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 39.4 ttpt -94.22 110.52 22.25 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.0 m -111.48 131.63 22.22 Favored Pre-proline 0 C--N 1.295 -1.765 0 C-N-CA 124.426 1.09 . . . . 0.0 110.357 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.04 129.31 21.54 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.051 1.834 . . . . 0.0 113.119 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 10' ' ' PHE . 11.1 p -58.9 141.72 52.72 Favored 'General case' 0 C--O 1.269 2.102 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.45 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -97.71 -29.17 7.89 Favored Glycine 0 N--CA 1.431 -1.67 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.442 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.663 ' NZ ' ' HG3' ' A' ' 27' ' ' GLU . 9.6 pttm -126.01 23.56 7.14 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-N 117.889 0.844 . . . . 0.0 112.889 -175.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.481 ' HA ' HG11 ' A' ' 23' ' ' VAL . 63.6 t80 -67.96 140.16 56.41 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.85 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.421 ' HD2' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -126.63 131.55 51.44 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.893 -176.504 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.31 -157.47 28.01 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.103 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.415 ' HB3' HG13 ' A' ' 15' ' ' VAL . 5.6 m-85 -93.22 138.48 31.57 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 122.724 0.41 . . . . 0.0 111.334 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 5.0 t -93.94 62.92 3.18 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.522 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 17.7 m -72.79 -34.78 47.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.865 172.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -120.8 127.71 52.2 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -176.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 93.2 m-20 -56.61 -27.94 59.34 Favored 'General case' 0 C--O 1.2 -1.548 0 C-N-CA 124.395 1.078 . . . . 0.0 111.57 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.6 m -64.38 -34.87 79.18 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 122.95 0.5 . . . . 0.0 112.29 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.524 ' O ' HG23 ' A' ' 23' ' ' VAL . 49.5 t30 -69.29 -45.35 69.83 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.644 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 20.7 t -58.22 -51.9 67.82 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-N 114.541 -1.208 . . . . 0.0 108.779 178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.528 ' HG3' ' H ' ' A' ' 32' ' ' GLY . 15.3 ttpt -52.17 -53.03 48.11 Favored 'General case' 0 N--CA 1.406 -2.645 0 CA-C-N 113.299 -1.773 . . . . 0.0 109.554 -174.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -61.61 -45.65 93.2 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.189 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 19' ' ' ASN . 58.3 t -60.22 -48.9 86.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 O-C-N 123.47 0.482 . . . . 0.0 110.262 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 95.2 m -59.33 -40.69 87.12 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 123.573 0.749 . . . . 0.0 111.418 177.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 40.2 mtp180 -66.02 -28.53 68.94 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.285 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.424 ' HB ' ' NZ ' ' A' ' 9' ' ' LYS . 4.4 m -77.73 -29.37 51.13 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.036 175.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.663 ' HG3' ' NZ ' ' A' ' 9' ' ' LYS . 42.2 mt-10 -75.57 -22.71 56.75 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.749 0.309 . . . . 0.0 111.448 177.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.94 21.89 3.39 Favored Glycine 0 CA--C 1.501 -0.84 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.234 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 94.7 m-85 -106.54 145.15 30.44 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -60.58 -33.99 92.98 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.521 2.147 . . . . 0.0 112.463 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.542 HG23 ' HB2' ' A' ' 46' ' ' TYR . 9.9 t -160.82 175.43 12.58 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -175.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.528 ' H ' ' HG3' ' A' ' 21' ' ' LYS . . . -154.05 158.41 28.12 Favored Glycine 0 N--CA 1.428 -1.855 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.465 ' HB3' ' CE1' ' A' ' 46' ' ' TYR . 15.5 t -153.77 163.64 39.69 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 59.6 m -95.82 152.9 18.06 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.281 0.562 . . . . 0.0 112.041 -172.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.453 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 8.7 t70 -144.1 156.73 44.47 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 124.462 1.105 . . . . 0.0 108.26 -177.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.17 107.18 10.5 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -141.67 8.69 1.96 Allowed 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.3 m -150.28 161.16 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.544 -174.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.34 82.35 0.37 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.207 1.004 . . . . 0.0 109.583 177.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.07 -146.9 15.52 Favored Glycine 0 N--CA 1.404 -3.497 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 -177.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.522 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 21.5 mtp180 -140.71 118.38 11.64 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 117.759 0.78 . . . . 0.0 109.319 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -103.1 132.6 49.24 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-O 121.394 0.616 . . . . 0.0 111.014 -171.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.6 t -84.17 138.87 32.77 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.646 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.481 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 43.5 m-85 -131.7 139.64 49.09 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.751 0.786 . . . . 0.0 110.023 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.496 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 44.6 m -95.33 138.65 32.73 Favored 'General case' 0 C--N 1.252 -3.632 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.518 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.542 ' HB2' HG23 ' A' ' 31' ' ' THR . 21.5 m-85 -110.79 136.75 49.37 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 120.853 0.359 . . . . 0.0 110.973 -178.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -146.72 143.18 18.19 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.68 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.37 119.86 6.4 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.343 2.029 . . . . 0.0 112.458 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 95.1 m -111.75 159.27 33.99 Favored Pre-proline 0 C--N 1.276 -2.61 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 171.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.697 ' O ' ' HD3' ' A' ' 1' ' ' ARG . 38.2 Cg_exo . . . . . 0 C--O 1.251 1.156 0 C-N-CA 121.685 1.59 . . . . 0.0 109.528 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.435 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 61.4 mtt85 . . . . . 0 CA--C 1.512 -0.519 0 CA-C-O 121.212 0.529 . . . . 0.0 111.777 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.6 mtm -110.41 101.03 9.78 Favored 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 175.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.5 m -80.1 112.23 17.22 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.289 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.564 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 37.3 ttpt -93.14 111.24 22.81 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 53.5 m -117.68 124.05 29.21 Favored Pre-proline 0 C--N 1.293 -1.889 0 C-N-CA 123.734 0.814 . . . . 0.0 110.385 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -64.16 123.31 11.66 Favored 'Trans proline' 0 CA--C 1.521 -0.137 0 C-N-CA 122.294 1.996 . . . . 0.0 112.72 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -61.38 141.72 57.43 Favored 'General case' 0 C--O 1.281 2.714 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.502 -177.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.31 -30.0 11.56 Favored Glycine 0 N--CA 1.419 -2.448 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.761 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.523 ' HE2' ' HG3' ' A' ' 27' ' ' GLU . 45.6 pttt -106.52 2.14 25.96 Favored 'General case' 0 N--CA 1.418 -2.068 0 C-N-CA 117.655 -1.618 . . . . 0.0 113.852 -174.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.485 ' CD2' HG21 ' A' ' 23' ' ' VAL . 25.5 t80 -83.08 129.95 35.08 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.457 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -131.38 162.69 29.56 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 173.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.7 -153.42 19.87 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.457 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -106.66 111.76 24.45 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.045 0.45 . . . . 0.0 112.171 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.604 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 7.6 t -83.36 70.48 10.18 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.645 0.736 . . . . 0.0 109.066 176.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.487 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 90.5 t -73.32 -51.12 27.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.242 171.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.505 ' OD1' ' HB ' ' A' ' 18' ' ' THR . 5.4 t-20 -98.97 124.32 43.86 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.21 -176.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 93.4 m-20 -62.14 -29.15 70.14 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 114.383 -1.28 . . . . 0.0 112.61 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.505 ' HB ' ' OD1' ' A' ' 16' ' ' ASN . 9.8 m -65.12 -34.09 77.57 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 123.204 0.602 . . . . 0.0 110.584 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -70.01 -45.15 67.86 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.604 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 15.1 t -56.95 -46.94 81.77 Favored 'General case' 0 CA--C 1.48 -1.739 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.084 177.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 21.3 tttp -55.53 -53.98 49.7 Favored 'General case' 0 N--CA 1.391 -3.39 0 CA-C-N 112.567 -2.106 . . . . 0.0 108.701 -176.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -58.42 -48.05 81.93 Favored 'General case' 0 CA--C 1.499 -0.995 0 O-C-N 123.99 0.806 . . . . 0.0 111.194 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.485 HG21 ' CD2' ' A' ' 10' ' ' PHE . 67.5 t -60.81 -47.32 93.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 O-C-N 123.313 0.383 . . . . 0.0 110.594 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 69.6 m -61.49 -40.42 94.51 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 123.2 0.6 . . . . 0.0 111.839 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 47.5 mtp180 -66.9 -28.86 68.65 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.268 0.556 . . . . 0.0 110.17 178.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.1 m -85.48 -18.58 33.13 Favored 'General case' 0 CA--C 1.572 1.826 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.493 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.523 ' HG3' ' HE2' ' A' ' 9' ' ' LYS . 57.4 mt-10 -78.23 -40.98 35.68 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.4 -0.812 . . . . 0.0 110.424 171.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 135.53 38.48 0.18 Allowed Glycine 0 C--N 1.312 -0.781 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.51 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 89.1 m-85 -126.89 149.99 70.42 Favored Pre-proline 0 C--N 1.308 -1.214 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -63.61 -35.69 57.53 Favored 'Trans proline' 0 C--O 1.242 0.684 0 C-N-CA 122.392 2.062 . . . . 0.0 112.514 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.527 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.5 t -157.15 169.89 23.74 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.23 -176.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.68 153.74 25.53 Favored Glycine 0 N--CA 1.41 -3.056 0 N-CA-C 107.933 -2.067 . . . . 0.0 107.933 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.634 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 34.6 m -157.5 149.53 22.4 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 124.447 1.099 . . . . 0.0 110.139 -177.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.1 m -85.33 141.89 29.72 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -171.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.848 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 16.9 t70 -149.55 -172.28 4.1 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -132.69 127.71 35.4 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 120.945 -1.097 . . . . 0.0 110.977 -173.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.669 ' CE1' ' HG2' ' A' ' 42' ' ' LYS . 5.8 p-80 -149.13 11.16 0.81 Allowed 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 167.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.509 HG13 ' CD2' ' A' ' 37' ' ' HIS . 2.5 m -147.76 155.86 9.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.791 -174.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.03 84.79 0.99 Allowed 'General case' 0 C--N 1.314 -0.944 0 O-C-N 124.385 1.053 . . . . 0.0 108.963 177.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.19 -137.4 5.48 Favored Glycine 0 N--CA 1.404 -3.435 0 N-CA-C 107.901 -2.08 . . . . 0.0 107.901 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.487 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 18.8 mtp180 -136.53 119.6 16.52 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 117.453 0.626 . . . . 0.0 110.821 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.669 ' HG2' ' CE1' ' A' ' 37' ' ' HIS . 50.3 tptt -105.36 145.94 30.1 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 121.705 0.764 . . . . 0.0 111.125 -172.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 40.8 t -92.26 141.03 29.01 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.577 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.848 ' CD2' ' HB3' ' A' ' 35' ' ' ASP . 31.9 m-85 -130.88 140.87 50.27 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 173.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.51 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 61.4 m -95.55 133.77 39.2 Favored 'General case' 1 C--N 1.24 -4.173 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.872 -179.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.634 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 22.8 m-85 -107.58 133.91 51.35 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.591 -177.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -140.87 134.45 14.84 Favored Pre-proline 0 C--N 1.295 -1.798 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.351 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.21 118.28 5.6 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.947 2.431 . . . . 0.0 112.682 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.5 p -116.76 161.29 32.97 Favored Pre-proline 0 C--N 1.271 -2.838 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 172.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.435 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 18.3 Cg_endo . . . . . 0 C--O 1.264 1.79 0 C-N-CA 121.947 1.764 . . . . 0.0 111.375 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.445 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 59.5 mtt85 . . . . . 0 N--CA 1.467 0.376 0 CA-C-O 121.086 0.47 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.0 mtt -111.82 101.44 9.78 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.2 m -81.48 111.89 18.22 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.738 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.484 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 38.1 ttpt -93.54 110.97 22.54 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.106 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 86.8 m -109.13 133.11 20.85 Favored Pre-proline 0 C--N 1.3 -1.567 0 C-N-CA 124.381 1.072 . . . . 0.0 109.837 -177.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 3.8 Cg_exo -72.72 117.44 5.13 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 121.832 1.688 . . . . 0.0 112.15 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -61.8 146.81 48.41 Favored 'General case' 0 C--O 1.274 2.357 0 C-N-CA 123.728 0.811 . . . . 0.0 110.244 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -110.78 -24.77 5.42 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.497 -0.859 . . . . 0.0 114.014 -175.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.698 ' HD2' HG13 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -105.53 -3.2 22.7 Favored 'General case' 0 CA--C 1.484 -1.573 0 CA-C-O 122.153 0.978 . . . . 0.0 110.578 -174.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.476 ' CD2' HG21 ' A' ' 23' ' ' VAL . 30.4 t80 -67.19 116.75 8.33 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 113.471 -1.695 . . . . 0.0 108.499 171.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -128.29 94.05 3.8 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 150.65 -161.12 28.89 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.693 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -90.19 127.79 36.21 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 6.3 t -90.5 64.35 5.8 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-O 121.868 0.842 . . . . 0.0 109.061 176.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.514 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 18.5 m -72.47 -36.47 54.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.559 171.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -111.74 121.46 45.16 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.3 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 54.7 m-80 -64.66 -31.21 72.32 Favored 'General case' 0 C--O 1.214 -0.787 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.451 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.0 m -67.43 -24.27 65.62 Favored 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 122.592 0.357 . . . . 0.0 110.537 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -73.69 -48.05 35.02 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.651 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 16.1 t -56.09 -44.36 78.94 Favored 'General case' 0 CA--C 1.477 -1.85 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.132 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 22.5 tttp -54.77 -54.95 35.4 Favored 'General case' 0 N--CA 1.392 -3.351 0 CA-C-N 112.79 -2.005 . . . . 0.0 109.264 -175.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -62.21 -43.06 99.69 Favored 'General case' 0 CA--C 1.497 -1.094 0 O-C-N 123.815 0.697 . . . . 0.0 110.745 -176.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.698 HG13 ' HD2' ' A' ' 9' ' ' LYS . 72.9 t -56.95 -52.52 54.52 Favored 'Isoleucine or valine' 0 C--O 1.253 1.257 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.702 178.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 92.9 m -63.31 -38.03 89.56 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 124.363 1.04 . . . . 0.0 111.829 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 53.7 mtp180 -65.21 -29.08 69.85 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.092 0.472 . . . . 0.0 110.171 177.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 m -85.65 -14.61 45.01 Favored 'General case' 0 CA--C 1.578 2.036 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.793 176.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.475 ' OE2' ' HG3' ' A' ' 9' ' ' LYS . 47.2 mt-10 -86.99 -25.4 24.3 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.293 -0.879 . . . . 0.0 110.543 174.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.33 39.84 0.57 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.607 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 25' ' ' ARG . 91.8 m-85 -129.17 148.56 69.59 Favored Pre-proline 0 C--N 1.311 -1.067 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -64.0 -34.19 59.93 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.346 2.03 . . . . 0.0 112.267 177.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.51 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.1 t -156.93 168.74 26.57 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.005 -176.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.64 153.63 25.46 Favored Glycine 0 N--CA 1.408 -3.216 0 N-CA-C 106.853 -2.499 . . . . 0.0 106.853 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.621 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 46.1 m -155.91 158.97 38.87 Favored 'General case' 0 C--N 1.275 -2.644 0 C-N-CA 123.704 0.802 . . . . 0.0 110.297 -176.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.1 m -92.61 157.06 16.69 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.259 0.552 . . . . 0.0 111.841 -170.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.505 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 7.5 t70 -148.08 155.19 41.18 Favored 'General case' 0 C--O 1.256 1.438 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.989 -177.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -122.09 110.1 15.35 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -147.08 8.6 0.95 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.507 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.9 m -149.43 164.07 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.129 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.385 -174.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.4 80.47 1.4 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.108 0.956 . . . . 0.0 109.011 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.77 -148.22 18.07 Favored Glycine 0 N--CA 1.403 -3.521 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 -176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.514 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 20.8 mtp180 -139.1 117.85 12.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 117.517 0.659 . . . . 0.0 109.486 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -101.09 141.67 33.64 Favored 'General case' 0 N--CA 1.421 -1.886 0 O-C-N 123.519 0.512 . . . . 0.0 110.395 -172.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.3 t -94.75 139.1 31.71 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.974 177.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.505 ' CD2' ' HB3' ' A' ' 35' ' ' ASP . 46.6 m-85 -134.27 142.29 47.27 Favored 'General case' 0 N--CA 1.42 -1.939 0 O-C-N 123.956 0.785 . . . . 0.0 109.855 175.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.487 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 39.8 m -94.68 139.14 31.62 Favored 'General case' 0 C--N 1.256 -3.487 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.311 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.621 ' CE1' ' HB2' ' A' ' 33' ' ' SER . 30.2 m-85 -113.99 134.49 54.81 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.783 -178.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HE2' ' OG1' ' A' ' 5' ' ' THR . 51.9 pttt -140.98 134.72 14.86 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.481 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.12 110.64 2.87 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.922 2.414 . . . . 0.0 112.237 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 p -109.29 163.17 17.64 Favored Pre-proline 0 C--N 1.274 -2.708 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 173.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.445 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 29.7 Cg_exo . . . . . 0 C--O 1.263 1.725 0 C-N-CA 121.938 1.759 . . . . 0.0 110.996 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.418 ' HD2' ' OXT' ' A' ' 50' ' ' PRO . 59.2 mtt85 . . . . . 0 CA--C 1.514 -0.437 0 CA-C-O 121.159 0.504 . . . . 0.0 111.835 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.3 mtt -108.71 100.62 9.83 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 174.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.5 m -80.67 114.56 19.64 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.605 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.518 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 38.7 ttpt -92.82 110.7 22.15 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.7 m -110.64 131.15 22.23 Favored Pre-proline 0 C--N 1.295 -1.798 0 C-N-CA 124.355 1.062 . . . . 0.0 110.126 -175.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -66.25 127.38 17.38 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 121.719 1.613 . . . . 0.0 111.968 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.3 p -60.07 143.41 52.13 Favored 'General case' 0 C--O 1.271 2.185 0 O-C-N 123.914 0.759 . . . . 0.0 111.415 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -97.1 -28.93 8.29 Favored Glycine 0 N--CA 1.425 -2.064 0 O-C-N 123.721 0.638 . . . . 0.0 114.518 -176.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.556 ' NZ ' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -121.13 -2.64 9.61 Favored 'General case' 0 C--O 1.26 1.62 0 CA-C-N 118.947 1.374 . . . . 0.0 112.47 -175.505 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.457 ' CD2' HG21 ' A' ' 23' ' ' VAL . 32.0 t80 -65.66 120.62 13.28 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 113.76 -1.564 . . . . 0.0 109.202 169.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.2 ptmm? -137.09 84.54 2.07 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.516 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 166.07 -166.16 38.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -83.7 119.12 24.39 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 122.88 0.472 . . . . 0.0 111.992 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.663 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 7.1 t -88.65 69.56 8.79 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.503 0.668 . . . . 0.0 109.263 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.524 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 62.1 t -68.23 -56.6 12.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.042 172.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -101.5 127.66 48.09 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.769 -176.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 91.0 m-20 -56.52 -31.17 63.85 Favored 'General case' 0 C--O 1.204 -1.292 0 C-N-CA 124.417 1.087 . . . . 0.0 111.518 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.4 m -64.25 -28.92 70.06 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 123.519 0.728 . . . . 0.0 111.192 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -74.43 -45.1 48.63 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.663 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 24.9 t -56.77 -46.5 81.44 Favored 'General case' 0 CA--C 1.471 -2.084 0 CA-C-N 114.343 -1.298 . . . . 0.0 107.799 176.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 17' ' ' ASN . 19.9 tttp -53.78 -54.89 31.84 Favored 'General case' 0 N--CA 1.394 -3.25 0 CA-C-N 112.664 -2.062 . . . . 0.0 109.219 -175.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -60.44 -45.66 92.86 Favored 'General case' 0 CA--C 1.502 -0.886 0 O-C-N 123.95 0.781 . . . . 0.0 110.794 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.514 HG13 ' CD ' ' A' ' 9' ' ' LYS . 95.6 t -60.74 -49.29 85.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.745 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.407 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 83.9 m -61.91 -37.97 86.61 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 123.025 0.53 . . . . 0.0 111.255 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 29' ' ' PHE . 48.6 mtp180 -68.13 -25.18 65.16 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.809 0.338 . . . . 0.0 110.443 178.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.8 m -80.08 -37.39 33.91 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.763 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -69.88 -25.42 63.7 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.398 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.56 31.12 1.28 Allowed Glycine 0 CA--C 1.509 -0.318 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.523 176.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.487 ' CG ' ' HB3' ' A' ' 45' ' ' CYS . 89.4 m-85 -118.85 148.52 44.71 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.32 -35.32 73.99 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.419 2.08 . . . . 0.0 112.363 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.553 HG23 ' HB2' ' A' ' 46' ' ' TYR . 7.6 t -157.51 170.56 22.14 Favored 'General case' 0 N--CA 1.42 -1.96 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.156 -176.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.26 152.31 24.4 Favored Glycine 0 N--CA 1.403 -3.553 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.61 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 25.4 m -151.96 156.68 40.52 Favored 'General case' 0 C--N 1.278 -2.521 0 C-N-CA 124.557 1.143 . . . . 0.0 109.398 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.5 m -91.86 152.43 20.09 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 120.938 0.399 . . . . 0.0 111.823 -172.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.545 ' HB3' ' CD2' ' A' ' 44' ' ' TYR . 13.0 t70 -145.84 158.3 43.87 Favored 'General case' 0 C--O 1.256 1.44 0 C-N-CA 124.158 0.983 . . . . 0.0 108.885 -176.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.03 107.74 13.01 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -139.2 6.93 2.38 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 m -149.79 160.69 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.37 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.224 -174.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.55 83.9 0.6 Allowed 'General case' 0 C--N 1.323 -0.57 0 O-C-N 124.234 0.959 . . . . 0.0 109.04 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.85 -143.71 10.61 Favored Glycine 0 N--CA 1.402 -3.568 0 N-CA-C 107.854 -2.099 . . . . 0.0 107.854 -177.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.524 ' NE ' ' HA ' ' A' ' 15' ' ' VAL . 30.7 mtp180 -141.16 119.73 12.41 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 117.462 0.631 . . . . 0.0 109.798 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -108.16 138.77 43.86 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.338 0.589 . . . . 0.0 110.644 -173.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.0 t -85.21 136.09 33.67 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.296 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.545 ' CD2' ' HB3' ' A' ' 35' ' ' ASP . 32.5 m-85 -128.85 137.06 51.25 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-O 121.888 0.851 . . . . 0.0 109.991 175.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.487 ' HB3' ' CG ' ' A' ' 29' ' ' PHE . 44.5 m -95.08 134.36 37.87 Favored 'General case' 0 C--N 1.25 -3.726 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.417 -176.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.61 ' CE2' ' HB2' ' A' ' 33' ' ' SER . 21.6 m-85 -107.38 135.8 48.25 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 120.893 0.378 . . . . 0.0 110.753 -178.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -144.8 138.67 14.6 Favored Pre-proline 0 C--N 1.298 -1.65 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.042 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.81 121.33 7.8 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.738 2.292 . . . . 0.0 112.513 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.6 p -119.18 164.16 22.77 Favored Pre-proline 0 C--N 1.272 -2.801 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 171.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.418 ' OXT' ' HD2' ' A' ' 1' ' ' ARG . 31.2 Cg_exo . . . . . 0 C--O 1.262 1.718 0 C-N-CA 121.847 1.698 . . . . 0.0 110.892 178.911 . . . . . . . . 1 1 . 1 stop_ save_